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ABSTRACT 
The Chircop lab identified >12 clathrin-mediated endocytic proteins with roles during 
mitosis including Sorting Nexin 9 (SNX9). SNX9 has two distinct mitotic roles: 1) during 
metaphase, where it stabilises clathrin to the mitotic spindle for the formation of inter-
microtubule bridges and 2) during cytokinesis, where it is recruited to the intracellular bridge 
(ICB) for abscission. I sought to understand how these roles are regulated by 
phosphorylation. SNX9 is phosphorylated on twenty residues, of which I selected six for 
further study – Y56, S176, Y177, Y219, Y239, T275. By assessing individual phospho-
deficient and phospho-mimetic mutants of GFP-SNX9 I found that the two mitotic roles of 
SNX9 are regulated by phosphorylation. Phospho-mimetic mutations Y56E and T275E 
delayed mitotic progression. Y56 lies within the SH3 domain (protein binding) and T275 
lies within the PX domain (phospholipid binding) of SNX9. By pull-down we found that 
Y56E disrupts binding to DynII and OCRL; known to bind the SH3 domain of SNX9. The 
phospho-mimetic mutation Y56E induced multi-polar anaphase. This correlates with 
delayed metaphase duration. I found that Y56E expressing cells feature: 1) reduced clathrin 
at the spindle and 2) poor centriole cohesion. Therefore, Y56E appears to induce 
‘centrosome fragmentation’ resulting from ‘cohesion fatigue’. During cytokinesis, SNX9 
locates to the ICB only during the final one-third of the abscission phase of cytokinesis, 
when the 'active' abscission process is occurring. This localisation is disrupted by phospho-
mimetic mutation T275E. This correlates with greater duration of the abscission phase of 
cytokinesis. We speculate that SNX9 is recruited to the ICB by binding PI3P. I propose: 1) 
during late interphase, SNX9 facilitates trafficking of clathrin to the maturing centrosome, 
2) during mitosis, phosphorylation at Y56 ‘de-activates’ SNX9, 3) at mitotic exit,
phosphatase activity resumes SNX9 activity at the membrane for cytokinesis. 
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1.1. Background 
1.1.1. Cancer 
Cancer is a disease of abnormal cell growth and proliferation. It is the formation of an 
abnormal mass of cells, termed a tumour, that proliferate excessively regardless of signals 
to inhibit growth or promote death (Luo and Elledge, 2008). Cancer is currently the 
leading cause of death in Australia with more than 44,000 people succumbing in 2013 
(Cancer Council Australia, 2011). It is estimated that one in two Australian men and one in 
three Australian women will be diagnosed with cancer by the age of 85 (Cancer Council 
Australia, 2011).  
 
Cancer cells are characterised by genome instability, that is, a high rate of alteration or 
mutation of the genome (Shen, 2011). Lesions and breaks in DNA occur frequently as a 
result of the intrinsic instability of DNA (Lindahl, 1993) and mutagenic factors such as 
oxidative stress (Evans et al., 2004) or ultra-violet radiation (Ikehata and Ono, 2011). 
Aneuploidy and chromosomal instability may also arise from an unfaithful segregation of 
chromosomal material during mitosis (Bakhoum et al., 2014). Genome stability is 
maintained through systems that repair DNA lesions (Shen, 2011) and block the 
proliferations of cells with unrepaired DNA lesions (Shimada and Nakanishi, 2006). Strict 
co-ordination of mitosis prevents the development of cells with chromosomal instability 
(Bakhoum et al., 2014). Hereditary or, more commonly, sporadic mutations that 
compromise these systems give rise to a high rate of mutation or aneuploidy (Shimada and 
Nakanishi, 2006). The majority of alterations that resultantly accumulate in these cells are 
not necessarily tumourigenic (Salk et al., 2010); however, alterations in tumour suppressor 
genes and proto-oncogenes promote cell growth, checkpoint avoidance and resistance to 
death (Komarova et al., 2008). These alterations are clonally expanded as the nascent 
cancer cell divides (Negrini et al., 2010). A cell from within this clonal population might 
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then develop a second tumorigenic mutation that confers a selective advantage against its 
neighbouring clones and this cycle of clonal expansions continues indefinitely, thus 
forming a tumour (Salk et al., 2010). Dysregulation of the frequency and fidelity of cell 
division is thus a critical aspect of tumorigenesis. 
 
1.1.2. Cell Cycle 
Cell division comprises two key phases; interphase and mitosis (Alberts, 2002). The DNA 
and organelles of the cell are duplicated in interphase and these cellular components are 
segregated into two equal populations in mitosis (Alberts, 2002). The late stages of 
mitosis, termed cytokinesis, involve the physical separation of the two nascent daughter 
cells (Alberts, 2002). The cycle is complete with the interphase daughter cells that may 
continue through the cell cycle again or may exit the cycle into a state of quiescence 
depending on the cell’s programming for differentiation and the availability of mitogenic 
cytokines (Lehninger et al., 2008). A sequence of checkpoints prevent progress through the 
cell cycle until certain pre-requisites are met (Latif et al., 2001, Silva et al., 2011). This 
ensures faithful division or, failing that, neutralisation of the cell either by inducing 
senescence or programmed cell death, which is termed apoptosis (Childs et al., 2014). 
 
The longest part of the cell cycle is interphase, which consists of three stages. Cell growth 
occurs in concert with organelle and protein duplication in the first Gap (G1) phase, before 
DNA and centrosome duplication occur in the Synthesis (S) phase, followed by the second 
Gap (G2) phase where the cell finalises preparation for mitosis (Lehninger et al., 2008). 
The cell is then driven into mitosis by the up-regulation of Cyclin Dependent Kinase 1 
(CDK1)-cyclin B complex activity (Vermeulen et al., 2003). Mitosis is a multi-step 
process that results in the separation of cellular components and chromatin (Fig 1.1).  
  
Figure 1.1: Cell cycle comprises cell growth (interphase) and division (mitosis).
Morphological changes of a HeLa cell expressing fluorescently tagged α-tubulin
(green) and histone H2B (magenta) throughout the cell cycle. DNA and proteins are
duplicated in interphase before being divided between two nascent daughter cells in
mitosis. From prophase to metaphase, DNA (magenta) condenses into chromosomes
and is organised along the metaphase plate by the mitotic spindle (green). From
anaphase to telophase the chromosomal material (magenta) is faithfully separated by
the mitotic spindle between nascent daughter cells. Overlapping microtubules in the
cleavage furrow condense into the Intracellular Bridge (ICB) and finally cut to
separate during the abscission stage of cytokinesis. Representative images prepared
by Scott Page. Phases are separated by Δ.
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The phases of mitosis are (1) prophase, chromatin condenses into rod-shaped 
chromosomes and the mitotic spindle forms; (2) prometaphase, the nuclear envelope 
breaks down and the mitotic spindle begins interacting with chromosomes; (3) metaphase, 
the mitotic spindle aligns chromosomes along the center of the cell; (4) anaphase, 
chromosomes separate into two faithful pools, (5) telophase, chromosomes de-condense 
and the nuclear envelope re-forms; and (6) cytokinesis, physical scission of connecting cell 
membrane generates two independent daughter cells (Alberts, 2002). Mitotic exit, the 
transition from metaphase into anaphase and cytokinesis, is signalled by proteasome 
mediated destruction of cyclin B resulting in phosphatase activity overwhelming CDK1 
mediated phosphorylation (Wurzenberger and Gerlich, 2011). Cytokinesis is composed of 
two distinct parts: ingression, where the membrane along the cleavage furrow invaginates 
to form the intracellular bridge (ICB) and abscission, which involves the assembly of the 
protein complexes for the scission of the ICB (Chircop, 2014). 
 
1.1.3. Membrane Trafficking in Mitosis 
An emerging field in understanding cell division is the role played by membrane 
trafficking. That is, the trafficking of proteins via membrane bound organelles to different 
compartments of the cell. The changes in the plasma membrane involved in cell rounding 
and daughter cell separation rely on shifting the membrane network in co-ordinated 
fashion. Cytokinesis especially is reliant on membrane trafficking machinery to co-
ordinate scission of the ICB (Albertson et al., 2005). On the basis of observations that 
transferrin uptake was reduced during metaphase, it was believed that receptor-mediated 
endocytosis shut down between mitotic entry and mitotic exit (Fielding et al., 2012, 
Schweitzer et al., 2005). Royle and colleagues (2005) discovered that membrane 
trafficking protein clathrin contributed to the stability of the mitotic spindle in a capacity 
independent of its canonical function. These findings led to the paradigm that clathrin 
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mediated endocytosis proteins (CME) were performing secondary ‘moonlighting’ roles 
during mitosis (Fielding and Royle, 2013).  
 
Tacheva-Grigorova and colleagues (2013) countered the claim that CME is shut down 
during mitosis. The authors demonstrated that previous studies may have been confounded 
by: 1) the method by which rate of transferrin uptake was quantitated, and 2) artefactual 
effects induced by treatment of cells with synchronisation agents (Tacheva-Grigorova et 
al., 2013). A decrease in gross transferrin uptake was observed during metaphase; 
however, this was attributed to reduced transferrin receptor at the cell surface because of 
an inhibition of receptor recycling back to the surface (Tacheva-Grigorova et al., 2013). 
Despite this, the field remains controversial with the latest publication reporting that rigid 
cortical actin is responsible for CME endocytosis shutdown during mitosis (Kaur et al., 
2014). Therefore, in the case of each protein, thorough investigation is necessary to 
ascertain whether their contribution to mitosis is through their canonical function or a 
secondary role (Royle, 2013). In the case of clathrin, its role at the mitotic spindle involves 
formation of a structure not associated with its canonical function in membrane trafficking 
(Royle, 2013). 
 
Other membrane trafficking proteins have since been discovered to be involved in spindle 
function (Royle, 2013). For example GTPases Rab6 and Rab11 (Das et al., 2014, Royle, 
2013) as well as golgin GM130 (Wei et al., 2015) have been implicated in the stability of 
the mitotic spindle poles and the bundling of spindle microtubules. The Cycle Cycle Unit 
(Chircop lab at CMRI) has identified more than 12 endocytosis proteins that contribute to 
the completion of mitosis (Smith and Chircop, 2012, Ma and Chircop, 2012, Lian et al., 
2015). One of these is Sorting Nexin 9 (SNX9). SNX9 is a membrane binding protein 
adaptor that canonically functions in CME (Lundmark and Carlsson, 2003). The Chircop 
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lab has shown that SNX9 has two distinct mitotic roles: (1) during metaphase, where it 
regulates chromosome alignment by contributing to mitotic spindle stability and (2) an 
endocytosis dependent role during cytokinesis, where it contributes to the delivery of 
membrane bound cargo to the ICB for abscission (Ma and Chircop, 2012, Ma et al., 
2013b). The authors claimed that the role of SNX9 in metaphase is a secondary 
‘moonlighting’ role independent of its role in endocytosis (Ma and Chircop, 2012). This 
claim was based on the observation that depletion of SNX9, in cells synchronised to 
metaphase, did not affect endocytosis (Ma and Chircop, 2012). However, this is a single 
study that has not yet been replicated. Therefore, it is yet uncertain whether the role of 
SNX9 during metaphase is related to its canonical function in endocytosis or a secondary 
‘moonlighting’ role.  
 
1.2. SNX9 
SNX9 is a ~70kDa member of the Sorting Nexin family of membrane adaptor proteins, 
characterised by a lipid binding Phox-homology (PX) domain (Teasdale and Collins, 
2012). SNX9 belongs to a sub-group that also have a protein binding SRC Homology 3 
(SH3) domain and membrane detecting Bin1/Amphiphysin/Rvs167 (BAR) domain (SH3-
PX-BAR; Teasdale and Collins, 2012). SNX9 has no isoforms but might be functionally 
redundant with the other SH3-PX-BAR proteins: SNX18 and SNX33 (UniProt, 2015).  
 
1.2.1. SH3-PX-BAR structure 
SNX9 features a protein binding N-terminus, comprising an SH3 domain followed by an 
Low Complexity (LC) domain, and a lipid binding C-terminus; a PX domain flanked either 
side by Yoke domains and capped by a C-terminal BAR domain (Lundmark and Carlsson, 
2009). SNX18 and SNX33 conform to the same tertiary structure but are differentiated by 
Chapter 1. Introduction 
 
 
8 
their primary structure (Teasdale and Collins, 2012). The smallest functional unit of SNX9 
is understood to be a dimer (Childress et al., 2006).  
The membrane binding C-terminus of SNX9 functions to facilitate detection and 
tubulation of membrane. The BAR domains of two SNX9 monomers interface over a long 
stretch of sequence through hydrophobic and charged interactions (Dislich et al., 2011, van 
Weering et al., 2012; Fig 1.2). The resulting dimer forms a curved quaternary structure 
with a positively charged exposed surface to bind to negatively charged membrane 
(Dislich et al., 2011, van Weering et al., 2012). SNX9 is recruited to membrane through 
the detection of membrane curvature by its BAR domain and binding of its PX domain to 
phosphoinositidies (PIPs; Pylypenko et al., 2007). PIPs are membrane lipids that contain a 
specialised 1D-myo-inositol head with three hydroxyl groups available for reversible 
phosphorylation (Seet and Hong, 2006). There are seven combinations of single, double 
and triple phosphorylations in the inositol head group that define the array of possible 
isoforms of PIPs (Kutateladze, 2012). SNX9 is able to bind most PIP isoforms: PI3P, 
PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3 (Teasdale and Collins, 2012, Posor et al., 2013, 
Badour et al., 2007, Shin et al., 2008). The PX domain of SNX9 specifically facilitates 
interactions with phosphatidylinositol-3-phosphates including PI3P and PI(3,4,5)P3 (Teasdale 
and Collins, 2012, Badour et al., 2007) and might also facilitate binding to PI(3,4)P2 and 
PI(3,5)P2 (Shin et al., 2008). Within a SNX9 dimer the PX domain associates with the last 
two helices of the BAR domain of the same monomer (Nakamura et al., 2012; Fig 1.2), 
which also contributes to PIP selectivity. The membrane detecting BAR domain, situated 
on the C-terminus of the PX domain, primarily mediates binding to PI(4,5)P2 (Teasdale and 
Collins, 2012, Pylypenko et al., 2007). In-vitro assays indicate that SNX9 PX-BAR binds 
PI(3,4)P2 with greatest preference (Posor et al., 2013, Shin et al., 2008). 
  
Figure 1.2: Dimerisation of SNX9 occurs at a BAR-BAR domain interface.
Crystal structure of SNX9 PX-BAR (aa230-595; 3DYT; Wang et al., 2008).
Representative image comprises the BAR domain of a SNX9 monomer (red)
interfacing the BAR domain of another SNX9 monomer (blue). The PX domain of
each monomer interfaces weakly with it’s BAR domain. Each monomer in this
crystal structure lacks the protein binding N-terminus (aa1-229).
PX domain
PX domainBAR interface
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Flanking the PX domain are short Yoke domains that contribute to the tertiary structure of 
the PX-BAR C-terminus in order to enhance membrane bending and define the unique 
curvature of the SNX9 subfamily (Pylypenko et al., 2008, Pylypenko et al., 2007, Wang et 
al., 2008). In conjunction with the flanking Yoke domains, the PX domain facilitates the 
insertion of SNX9 into plasma membrane inducing membrane deformation (Pylypenko et 
al., 2007, Park et al., 2014). SH3-PX-BAR dimers oligomerise into sheets, by tip-loop 
interactions, able to deform membrane to uniformly tubulate membrane (van Weering et 
al., 2012, van Weering et al., 2010). 
A proline rich sequence of the PX domain also enables interactions with other Src 
homology (SH2/SH3) domains (Badour et al., 2007, Teasdale and Collins, 2012). Adaptor 
protein p85 recruits SNX9, through its PX domain, for the internalisation of CD28 (Badour 
et al., 2007). Additionally, the PX domain of SNX9 stimulates the activity of 
phosphoinositide 4-phosphate-5-kinases to generate PI(4,5)P2 (Shin et al., 2008). 
The protein binding N-terminus of SNX9 serves as an adaptor to associate 
membrane trafficking proteins with the tubulated membrane interfaced by the PX-BAR C-
terminus. The SH3 domain of SNX9 permits binding to proteins with proline rich domains 
(PRDs) involved in: protein phosphorylation, i.e. activated CDC42 kinase 1 (ACK1; 
Yeow-Fong et al., 2005); membrane scission, i.e. dynamin 1 (dynI; Soulet et al., 2005), 
dynamin 2 (dynII; Lundmark and Carlsson, 2004); actin polymerization, i.e. Wiskott-
Aldrich syndrome protein (WASP; Badour et al., 2007), Neural WASP (N-WASP; Shin et 
al., 2007), F-BAR and double SH3 domains protein 1 (FCHSD1; Cao et al., 2013), Cordon 
Bleu (Wayt and Bretscher, 2014); phosphoinositide de-phosphorylation, i.e. Lowe 
oculocerebrorenal syndrome protein (OCRL1; Nandez et al., 2014), synaptojanin 1 (SJ1; 
Yeow-Fong et al., 2005), synaptojanin 2 (SJ2; Chuang et al., 2012); protein ubiquitination, 
i.e. E3 ubiquitin-protein ligase Itchy homolog (ITCH; Baumann et al., 2010); Ras 
signalling, i.e. son of sevenless guanine exchange factors (Schulze and Mann, 2004); RNA 
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binding signal transduction, i.e. Src-associated in mitosis 68 kDa protein (Sam68; Asbach 
et al., 2012) and extracellular matrix degradation, i.e. Disintegrin and metalloproteinase 
domain-containing protein 9 (ADAM9) and ADAM15 (Kleino et al., 2015, Lundmark and 
Carlsson, 2009). SNX33 is also able to bind ADAM8 (Kleino et al., 2015) and only binds 
particular isoforms of ADAM15 (Kleino et al., 2009). The LC domain is unstructured but 
comprises protein binding motifs that facilitate binding to proteins involved in vesicle 
coating, i.e. clathrin (Lundmark and Carlsson, 2003, Ma et al., 2013b), adaptor protein 
complex 2 (AP-2; Lundmark and Carlsson, 2003); actin polymerization, i.e. actin-related 
protein 2/3 (ARP2/3; Pollard, 2007); invadopodia markers; i.e. tyrosine kinase substrate 
with five SH3 domains (TKS5; Bendris et al., 2016b); and metabolism proteins, i.e. 
aldolase (Lundmark and Carlsson, 2004, Park et al., 2010a).  
1.2.2. SNX proteins in membrane trafficking 
Internalisation of membrane generates vesicles that are transported for the delivery of 
cargo proteins either within the vesicle lumen or integrated in the membrane. Newly 
formed vesicles, that give rise to early endosomes, mature into multi-vesicular bodies or 
late endosomes that form new vesicles within their lumen (Huotari and Helenius, 2011). 
Vesicles bud from either early or late endosomes to fuse with mature lysosomes, resulting 
in the degradation of their cargo, or return to the cell surface to ‘recycle’ their cargo 
(Huotari and Helenius, 2011). Proteins in the endoplasmic reticulum and processed in the 
Golgi network are delivered to its target plasma membrane or membranous organelle via 
vesicles (Huotari and Helenius, 2011). Cargo may also be trafficked in retrograde fashion 
from endosomes to the trans-golgi network (Huotari and Helenius, 2011) or to the nucleus 
for import (Chaumet et al., 2015). 
 The destination of membrane is primarily defined by its composition of PIPs 
and Rab GTPase (Rab) proteins. The co-incidence of Rab and SNX proteins on a 
membrane 
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domain enriched with PIPs and cargo leads to vesicle budding and trafficking. There are at 
least 49 SNX and 60 Rab proteins in the human genome that recognise a sub-group of 
cargo and direct trafficking to particular compartments of the membrane network 
(Stenmark, 2009). Rab proteins bind to membrane and, in a GTP bound active state, 
activate effectors to both recognise cargo and direct cargo trafficking (Stenmark, 2009). 
SNX proteins directly interact with cargo and assist in the deformation of membrane 
necessary for vesicle budding (Carlton and Cullen, 2005). SNX proteins can act as 
adaptors; recruiting other factors for vesicle scission (Shin et al., 2008) and motility (van 
Weering et al., 2010). The spatiotemporal distribution of PIP isoforms, and therefore the 
recruitment of Rab and SNX proteins, in the cell is regulated by PIP enzymes (Majerus and 
York, 2009, Mayinger, 2012). These include: 1) phospholipases, which cleave the 
specialised inositol head to convert PIPs to unspecialised diacylglycerol; 2) PIP 
phosphatases, which remove phosphorylation from particular inositol hydroxyl groups; and 
3) PIP kinases, which add phosphorylation onto particular inositol hydroxyl groups
(Majerus and York, 2009). In turn Rab and SNX proteins control the activity of PIP 
enzymes to direct the trafficking of cargo to other compartments of the membrane network 
(Stenmark, 2009). 
1.2.3. SNX9 facilitates endocytosis 
The key function of SNX9 is facilitating CME; however, the exact role of SNX9 in CME 
is not known with confidence. There are several models that describe the role of SNX9 in 
CME based on the structure of SNX9 (Fig 1.3 A). The enrichment of cargo, e.g. activated 
receptors, in a region of plasma membrane leads to the nucleation of a clathrin coated pit 
(Fig 1.3 B). Membrane adaptor AP-2 binds cargo proteins and PI(4,5)P2 (Antonescu et al., 
2011) and associates them with clathrin and accessory proteins involved in the formation 
of a vesicle (Lundmark and Carlsson, 2009). Clathrin organizes into a lattice-like shell 
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comprising heavy and light chains (Bonifacino and Lippincott-Schwartz, 2003) on the 
cytoplasmic side of the membrane, which becomes invaginated (Lundmark and Carlsson, 
2009). Monomeric SNX9 is kept inactive in the cytosol in complex with aldolase and dynII 
until released by phosphorylation (Lundmark and Carlsson, 2004, Rangarajan et al., 2010; 
Fig 1.3 C) whereupon it dimerises. One model proposes that SNX9 dimers are then 
recruited to clathrin coated pits by the coincidence detection of PI(4,5)P2, clathrin, AP-2 and 
membrane curvature (Lundmark and Carlsson, 2009, Sisan et al., 2010). Nunez and 
colleagues (2011) propose that SNX9 is a nucleation organiser; binding to clathrin coated 
pit nucleations and clustering them through its interface with the actin cytoskeleton. 
Membrane bound SNX9 binds WASP, releasing it from its auto-inhibited state, and 
ARP2/3 to polymerise actin filaments (Pollard, 2007) that could conceivably cluster 
clathrin hotspots. Additionally both AP-2 and SNX9 promote the localised activity of 
phosphatidylinositol-4-phosphate-5-kinase (PIP5K) activity to generate PI(4,5)P2 (Shin et 
al., 2008, Krauss et al., 2006, Bairstow et al., 2006), which would reinforce further 
clathrin, AP-2 and SNX9 recruitment in a positive feedback loop (Haucke, 2005). 
The role of SNX9 in early intermediates of CME is contentious due to the 
prevailing evidence that SNX9 is most enriched at later stages of clathrin coated pit 
development (Taylor et al., 2011, Posor et al., 2013, Nandez et al., 2014). These later 
studies use a range of human and mouse cell lines (Taylor et al., 2011, Posor et al., 2013, 
Nandez et al., 2014) and are therefore more likely to be physiologically relevant than the 
older studies that were performed solely in African green monkey kidney cells (Nunez et 
al., 2011, Sisan et al., 2010). The second role proposed to be fulfilled by SNX9 is in 
clathrin coated pit maturation. A sub-population of PI(4,5)P2 is hydrolysed by the activity of 
phosphoinositide 5-phosphatases, generating PI(4)P, and phosphoinositide 3-kinase 
PI3KC2α, which produces PI(3,4)P2 (Posor et al., 2013). PI(3,4)P2 reinforces enrichment of 
SNX9 for formation of the vesicle neck (Posor et al., 2013; Fig 1.3 D). The 
14 
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phosphoinositide 5-phosphatase activity of SJ2 is necessary for clathrin coated pit 
formation at early stages of clathrin mediated endocytosis (Rusk et al., 2003). It is possible 
that SJ2 contributes to the generation of PI(3,4)P2 for the enrichment of SNX9. SNX9 is able 
to bind SJ2 (Chuang et al., 2012). Therefore SNX9 might stimulate SJ2 activity to 
reinforce SNX9 enrichment in a positive feedback loop, analogous to SNX9 mediated 
stimulation of PIP kinases to generate PI(4,5)P2 (Shin et al., 2008).  
A sheet of SNX9 dimers, oligomerised through lateral contacts, envelops the 
curved and PIP (PI(4,5)P2, PI(3,4)P2) rich clathrin coated pit membrane (Lundmark and 
Carlsson, 2009, Ramachandran and Schmid, 2008). SNX9 then constricts clathrin coated 
pit membrane by stimulating: 1) dynII activity and 2) actin polymerisation. SNX9 
stimulates WASP and ARP2/3 mediated actin filament polymerisation (Gallop et al., 2013, 
Merrifield et al., 2002, Pollard, 2007; Fig 1.3 D). SNX9 is believed to stabilise the 
recruitment of dynII, which forms ring structures around the vesicle neck (Soulet et al., 
2005). Together, these provide an extrusion force that forms a Ω shaped clathrin coated pit. 
Co-depletion of PI3KC2α and dynII prevented recruitment of SNX9 to clathrin coated pits 
and resulted in the accumulation of clathrin coated pits, which is indicative of maturation 
failure (Posor et al., 2013). Stimulation of dynII GTPase activity leads to vesicle neck 
scission and destabilisation of dynamin from the membrane (Schmid and McMahon, 2007, 
Ramachandran and Schmid, 2008). SNX9 is believed to stimulate dynII on the basis that 
expression of SNX9 ΔSH3 truncation mutants was unable to stimulate dynII GTPase 
activity (Soulet et al., 2005) and resulted in the formation of abnormally long clathrin 
coated pits, indicative of membrane scission failure (Shin et al., 2008). Actin 
polymerisation provides a supplementary force that ‘pinches off’ the nascent vesicle 
(Gallop et al., 2013, Merrifield et al., 2002, Pollard, 2007). In neurons, SNX9 promotes 
vesicle neck formation and scission through activation of brain enriched dynI and N-
WASP (Shin et al., 2007). 
Figure 1.3: SNX9 is involved in clathrin coated pit maturation. (A) SNX9 binds
proteins via SH3 and LC domains and binds membrane with PX domain, flanked by
Yoke (Y) domains, and C-terminal BAR domain. (B) A clathrin coated pit forms at a
site enriched with cargo (activated receptor), PI(4,5)P2, AP-2 and clathrin complexes.
(C) SNX9 monomers, kept inactive bound to aldolase and DynII, are targeted for
dimerization by phosphorylation. (D) SNX9 dimers, oligomerised into sheets, are
recruited to clathrin coated pits by the coincidence detection of PI(3,4)P2 (PX domain),
clathrin and AP-2 (LC domain), PI(4,5)P2 and membrane curvature (BAR domain).
SNX9 SH3 domain promotes DynII GTPase activity and WASP mediated actin
polymerisation to extrude the vesicle neck and eventually cut and “pinch” off the
nascent vesicle.
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There is some evidence that SNX9 functions beyond vesicle release. Taylor and colleagues 
(2011) reported that SNX9 peaks in concentration after vesicle neck scission. This 
timing of SNX9 enrichment favours the model that SNX9 is involved in coupling clathrin 
coated pit maturation with the disassembly of CME machinery (Nandez et al., 
2014). Phosphoinositide 5-phosphatase OCRL1 is recruited to late clathrin 
coated pit intermediaries and hydrolyses PI(4,5)P2 to PI4P, disrupting the 
association of CME machinery with vesicle membrane (Nandez et al., 2014). 
Hydrolysis of PI(4,5)P2 also dissociates SNX9 (Nandez et al., 2014). This is required 
for the destabilisation of actin filaments surrounding the newly formed vesicle (Nandez 
et al., 2014). Cells derived from patients with Lowe syndrome, characterised by 
depletion of OCRL1, featured an aberrant accumulation of clathrin, AP-2, SNX9 and 
actin comets on cytoplasmic vesicles (Nandez et al., 2014). SNX9 binds OCRL1 and 
therefore might stabilise its recruitment or stimulate its activity on newly formed 
clathrin coated vesicles (Nandez et al., 2014). Similarly, SNX9 binds SJ1 (Yeow-
Fong et al., 2005), which is a brain enriched isoform of SJ2 involved in the uncoating 
of clathrin from synaptic vesicles (Pechstein et al., 2015).  
It is possible that SNX9 performs all the functions discussed. In such a model, 
SNX9 is recruited to early clathrin coated pit intermediaries, in low concentrations, by 
PI(4,5)P2. The conversion of PI(4,5)P2 to PI(3,4)P2, by SJ2 in conjunction with PI3KC2α, 
promotes enrichment of SNX9. SNX9 contributes to clathrin coated pit maturation and 
scission, culminating in enrichment after vesicle release. Overwhelming OCRL1 activity 
fully hydrolyses PI(4,5)P2 dissociating SNX9 from the newly formed vesicle. 
The SH3-PX-BAR subfamily also facilitates other modes of endocytosis, including 
macropinocytosis (Wang et al., 2010) and fluid phase endocytosis (Yarar et al., 2007). The 
role of SNX9 in these processes is likely in the re-organisation of cortical actin (Lundmark 
and Carlsson, 2009, Yarar et al., 2007). In contrast to CME, SNX9 is recruited to sites of 
incipient micropinocytosis by PI(3,4,5)P3 (Wang et al., 2010). On the basis that 
16 
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SNX9 compensates GTPase regulator associated with focal adhesion kinase (Graf1) 
depletion, Bendris and colleagues (Bendris et al., 2016b) proposed that SNX9 is also 
involved in clathrin independent carriers/glycosylphosphotidylinositol anchored 
protein enriched compartments (CLIC/GEEC) internalisation. These different 
modes of endocytosis specialise in the uptake of different cargo and nutrients. 
1.2.4. SNX9 regulates cargo sorting and trafficking 
After internalisation, clathrin coated vesicles are uncoated and fuse together to form early 
endosomes (Fig 1.4; (Huotari and Helenius, 2011, Merrifield and Kaksonen, 2014). This 
process is, in part, facilitated by the conversion of PI(3,4)P2 and PI(4,5)P2 into PI3P (Nakatsu 
et al., 2015; Fig 1.4). This is achieved either by the combined activities of 
phosphoinositide 4-phosphatase Sac2/INPP5F and OCRL1 or the phosphatase activities of 
SJ1 (Nakatsu et al., 2015) and PI3KC2α (Campa et al., 2015). This process releases SNX9 
into the cytosol (Nandez et al., 2014). Beyond internalisation, SNX9 has been implicated 
in a variety of membrane trafficking events (Fig 1.4).  
SNX9 appears to localise to vesicle-like structures throughout the cytoplasm but 
little else is known about the mechanistic details of SNX9 cargo trafficking (Lundmark and 
Carlsson, 2003). One study reported localisation of SNX9 to the golgi apparatus and trans-
golgi network (Soulet et al., 2005); however, this is not observed consistently (Childress et 
al., 2006, Lundmark and Carlsson, 2003, MaCaulay et al., 2003). HeLa cells were used in 
both contradicting studies (Lundmark and Carlsson, 2003, Soulet et al., 2005) so the 
controversy is not explained by cell type or species-specific differences. AP-1 binds PI4P 
enriched in the trans-golgi network and recruits clathrin for vesicle budding (Schmid, 
1997, Wang et al., 2003). SNX9 is able to bind clathrin and AP-1 (Hirst et al., 2003), but is 
unable to bind PI4P (Shin et al., 2008) and does not co-localise with AP-1 (Lundmark and 
Carlsson, 2003, Haberg et al., 2008, Hirst et al., 2003). Therefore it is not likely that SNX9 
is recruited to sites of trans-golgi network vesicle budding. In contrast, SNX18 has been 
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reported to co-localise with AP-1 positive endosomes (Haberg et al., 2008) and has been 
implicated in the budding of vesicles from the trans-golgi network for autophagosome 
biogenesis (Knaevelsrud et al., 2013). It’s not known if SNX18 can bind PI4P. PI(4,5)P2 
exists at golgi, where it is believed to recruit effector proteins for co-ordination of golgi 
cisternae with the cytoskeleton (Mayinger, 2009). SNX9 and SNX18 might function as 
PI(4,5)P2 effectors at the golgi (Fig 1.4) but requires further investigation.  
A recent study reported that SNX9 co-localised with Rab5 positive early 
endosomes labelled with EEA1 (Sasaki et al., 2017). This study contradicts the study by 
Lundmark and Carlsson (2003), which found that SNX9 positive vesicles do not co-
localise with EEA1 labelled early endosomes. Sasaki and colleagues (2017) made their 
claim based on African green monkey kidney Cos7 cells whereas Lundmark and Carlsson 
(2003) based their claim on Human cervical cancer HeLa and bone marrow leukemia K-
562 cells. It is possible that the different localisations reflect cell type or species-specific 
phenotypes, but this cannot be determined without screening a number of different cell 
lines. The identity of SNX9 positive vesicles thus remains controversial; however, the 
enrichment of PI3P in early endosomes (Raiborg et al., 2013) suggests that it is possible 
that SNX9 contributes to vesicle budding at early endosome membrane (Fig 1.4). SNX9 
transduces TGFβ signalling, critical for T cell differentiation (Li and Flavell, 2008), by 
delivering phosphorylated transcription factor Smad3 to the nuclear membrane for 
internalization into the nucleus (Wilkes et al., 2015; Fig 1.4). In macrophages activated by 
lipopolysaccharide (LPS) stimulation, SNX9 generates Rab9 positive mitochondria derived 
vesicles to then fuse with late endosomes for mito-autophagy (Matheoud et al., 2016). 
SNX9 targets activated Epidermal Growth Factor Receptor (EGFR), following 
endocytosis, to late endosomes for degradation in lysosomes (Lin et al., 2002; Fig 1.4).  
SNX9 might contribute to cancer cell metastasis through the recycling of factors 
that mediate cell motility to the cell surface (Bendris et al., 2016a, Bendris et al., 2016b). 
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Investigation into this role is complicated by the inconsistent correlation of SNX9 
expression with cancer aggressiveness (Bendris et al., 2016a, Bendris et al., 2016b). In a 
human breast adenocarcinoma cell line, over-expression of SNX9 enhances the rate of 
cancer cell metastasis (Bendris et al., 2016b). This is likely due to up-regulation of SNX9 
leading to increased recycling of matrix metalloproteases to the surface (Howard et al., 
1999; Fig 1.4) resulting in increased matrix degradation (Bendris et al., 2016a). In contrast, 
expression of SNX9 was found to be reduced in aggressive mammary invasive ductal 
carcinoma and non-small cell lung cancers relative to primary tumours and healthy tissue 
(Bendris et al., 2016a). Bendris and colleagues (2016a) proposed that SNX9 regulates the 
recruitment of invadopodia maturing factors to the cell surface, thus increasing cell 
motility, through inhibition of p50GAP stimulated Cdc42 GTPase activity (Hicks et al., 
2015, Bendris et al., 2016a). 
Orthologues of the SH3-PX-BAR subfamily in D. melanogaster (DSH3PX1; 
Knaevelsrud et al., 2013) and C. elegans (LST-4; Chen et al., 2013) are involved in the 
formation of autophagosomes. In C. elegans, the coincidence of PI3P, PI(4,5)P2, clathrin 
heavy chain 17 orthologue CHC-1, AP-2 and dyn1 on the surface of a phagosome recruits 
LST-4 where it stabilises dyn-1 enrichment and promotes phagosome maturation through 
the incorporation of early endosomes and lysosomes (Lu et al., 2011, Chen et al., 2013, 
Almendinger et al., 2011). LST-4 and dyn1 are believed to contribute to the retention of 
Rab5, for phagosome maturation, then are released upon local enrichment of Rab7 
(Almendinger et al., 2011). In mammalian cells SNX18 has been found to contribute to the 
formation of autophagosomes (Knaevelsrud et al., 2013). SNX18 tubulates perinuclear 
recycling endosomes, marked with autophagy related 16-like 1 (Atg16L1) protein and 
Rab11, to provide membrane for phagophore expansion (Knaevelsrud et al., 2013). SNX9 
might also contribute to autophagocytosis in human cells but this is unknown.   
Figure 1.4: SNX9 trafficks cargo throughout the membrane network. PIP
phosphatases and kinases alter the PIP composition of a newly formed clathrin
coated vesicle to dissociate SNX9 and clathrin coat (blue arrows). Uncoated vesicles
fuse together to form early endosomes enriched in PI3P. SNX9 is likely recruited by
cargo and PI3P to early endosomes. SNX9 tubulation of membrane forms vesicles for
the targeted trafficking of various cargo proteins (black arrows). Cargo trafficking
throughout the rest of the membrane network is believed to not involve SNX9 (grey
arrows).
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1.2.5. SH3-PX-BARs perform redundant functions 
The three members of the SH3-PX-BAR sub-family share the same domains but differ in 
primary structure (Haberg et al., 2008). The region of highest variability between SNX9, 
SNX18 and SNX33 is in the LC domain (Lundmark and Carlsson, 2009, Haberg et al., 
2008). There is evidence that SNX9, SNX18 AND SNX33 perform redundant roles in 
membrane trafficking; however, the extent of this redundancy is not well understood. 
 
SNX9, SNX18 AND SNX33 have only been observed to homo-dimerise; hetero-
dimerisation between these proteins has only been observed in the conditions of exogenous 
over-expression of both proteins (Dislich et al., 2011, Haberg et al., 2008). Primary 
structure differences between the BAR domains of SNX9 and SNX33 are responsible for 
low hetero-dimerisation affinity (Dislich et al., 2011). There is limited evidence that 
hetero-dimers of SNX9 and SNX18 might exist in CME (Park et al., 2010b). Given that 
SNX18: 1) binds PI(4,5)P2 at clathrin coated pits, 2) stimulates dynamin GTPase activity, 
and 3) binds WASP; there is at least reason to believe that SNX9 and SNX18 have some 
functional redundancy in CME (Park et al., 2010b). In support of this depletion of both 
SNX18 and SNX9 had a more profound effect on transferrin CME than knockdown of 
SNX9 alone (Posor et al., 2013). 
 
The sub-cellular localisation of SNX9, SNX18 AND SNX33 differs, suggesting that they 
are acting on altogether separate portions of the membrane trafficking network (Haberg et 
al., 2008). In contrast to SNX9 binding to AP-2, which is enriched at sites of CME, SNX18 
has a preference for AP-1, which places it in peripheral endosomal structures (Haberg et 
al., 2008). SNX9 and SNX33 co-localise at the ICB during cytokinesis whereas SNX18 
was not observed there (Ma and Chircop, 2012). 
 
Chapter 1. Introduction 
 
 
22 
1.3. SNX9 in metaphase spindle formation 
It was recently discovered that SNX9 is important for the faithful division of chromosomal 
material in mitosis (Ma and Chircop, 2012, Ma et al., 2013b). SNX9 was observed to 
localise at the spindle poles during prometaphase (Ma and Chircop, 2012). Knockdown of 
SNX9, but not SNX18 or SNX33, resulted in a delay in the duration of metaphase and an 
increase in metaphase plate width (Ma and Chircop, 2012), which are indicative of 
chromosome segregation defects (Ma and Chircop, 2012). In a subsequent publication, Ma 
and colleagues (2013b) found that depletion of SNX9 resulted in reduced clathrin 
enrichment at the mitotic spindle. Together, these findings led to the proposal that SNX9 is 
necessary for the delivery of clathrin to the spindle poles during prometaphase for 
stabilisation of the metaphase spindle (Ma et al., 2013b). In this section I will describe the 
process of faithful chromosome segregation during mitosis and then explore the 
mechanisms by which SNX9 might contribute to the recruitment of clathrin to the mitotic 
spindle. 
 
1.3.1. Centrosome replication 
Formation of the mitotic spindle for the faithful segregation of chromosomes begins at the 
centrosome. The centrosome is a cytoplasmic organelle of approximately 1µm in diameter 
(Schatten and Sun, 2009a). The core structure of the centrosome is two barrel shaped 
centrioles, linked by interconnecting fibres, with each centriole comprising a bundle of 
microtubules arranged in nine-fold symmetry (Meraldi and Nigg, 2002). One barrel is 
termed the mother centriole and is distinguished from the daughter centriole by distal 
appendages involved in anchoring microtubules (Fujita et al., 2016). The centrioles are 
enveloped by a network of proteins termed the pericentriolar material (Schatten and Sun, 
2009b). The primary function of the centrosome is the nucleation of microtubules from γ-
tubulin (γ-tub) complexes that make up the interphase cytoskeleton and mitotic spindle 
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(Loffler et al., 2006). Aggregates of structural and regulatory proteins, termed peri-
centriolar satellites, occupy the pericentriolar material and contribute to the organisation of 
microtubules and transport of proteins to and from the centrosome (Hori and Toda, 2017). 
 
The centrosome is involved in all stages of cell division and deregulation of the 
centrosome cycle can disrupt the cell cycle (Doxsey et al., 2005b). In interphase, the 
duplication of the centrosome is co-ordinated with the duplication of the genome such that 
inhibition of the centrosome cycle results in cell cycle arrest (Loffler et al., 2006). This is 
essential so that upon entry into mitosis, each cell has two copies of DNA and two 
centrosomes that will re-arrange to form the bi-polar spindle, for equal segregation of 
chromosomes between the 2 daughter cells (Shimada and Nakanishi, 2006).  
 
At the start of S phase, CDK2-cyclin E activity signals replication of the centrosome 
(Hinchcliffe and Sluder, 2002). Pro-centriole structures form at the base of the mother and 
daughter centrioles (Fujita et al., 2016). Scaffold protein SAS-6 is recruited to both mother 
and daughter centriole by protein kinase Plk4 mediated phosphorylation (Kleylein-Sohn et 
al., 2007). Homo-dimers of SAS-6 oligomerise into a cartwheel like structure (Fujita et al., 
2016). Gamma-tubulin ring complex (γ-TURC) structures form around the cartwheel and 
radially nucleate microtubules (Fujita et al., 2016). Centriolar protein CPAP, recruited by 
protein kinase Plk2 mediated phosphorylation, stabilises the cartwheel structure and 
recruits tubulin monomers for centriole elongation (Chang et al., 2010). The newly 
forming centriole barrels elongate from late S phase through to G2 (Fujita et al., 2016). 
CP110 caps the distal end of growing centrioles to terminate elongation (Schmidt et al., 
2009). In late G2 phase, the centrosomes undergo a maturation process, which involves the 
recruitment of pericentriolar material proteins and separation of the two pairs of centrioles 
(Doxsey et al., 2005a). CPAP in the pericentriolar material forms a scaffold for the 
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enrichment of pericentriolar material proteins and tethering to the centrosome (Fujita et al., 
2016). Structural protein PCM1 recruits Plk1 for maturation of the centrosome (Wang et 
al., 2013). Phosphorylation of pericentrin by Plk1 facilitates the recruitment of γ-tub and 
kinase Aurora A (Fujita et al., 2016). Aurora A positively feeds back into maintaining Plk1 
activity for the stability of the pericentriolar material (Fujita et al., 2016). At mitotic entry 
Nek2 mediated phosphorylation dissociate the fibres linking the two matured centrosomes 
(Fujita et al., 2016). Plk1 recruits molecular motor Eg5 for centrosome mobility (Mardin 
and Schiebel, 2012).  
1.3.2. Mitotic Entry 
The first stage of mitosis, prophase, involves the dissolution of the nucleus and the 
condensation of chromosomal material into 23 chromatid pairs (Alberts, 2002). Each 
chromatid has been replicated in S-phase and remains bound to the its ‘sister’ chromatid by 
cohesin complexes (McIntosh et al., 2012). As the chromatids condense, cohesin 
complexes dissociate from the DNA except at the centromere, which is the point at which 
the sister chromatids remain conjoined until anaphase (McIntosh et al., 2012). As the 
chromosomes condense, the duplicated centrosomes migrate to opposite poles of the cell. 
γ-TURC complexes at the centrosomes begin to nucleate microtubules comprising α/β 
heterodimers to form the mitotic spindle (Doxsey et al., 2005b). Some microtubules are 
polymerised distal to the metaphase plate and are called ‘astral’ microtubules (McIntosh et 
al., 2012). The astral microtubules interact with the actin rich cytoskeleton beneath the 
plasma membrane and assist to shape the mitotic spindle and define the location of the 
cleavage plane (McIntosh et al., 2012).  
In addition to the separation of chromosomal material, the process of mitosis requires the 
separation of cellular components between daughter cells. In prophase, the cytoskeleton 
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disassembles and the membranous organelles re-organise to be separated (Derby and 
Gleeson, 2007). Protein production and trafficking, involving the production of proteins at 
the endoplasmic reticulum and transport to the golgi apparatus for modification via 
membrane vesicles, are down-regulated (Fielding and Royle, 2013). There is little 
consensus on the structure of the endoplasmic reticulum during mitosis (Yeong, 2013). 
Conflicting research conducted in HeLa cells suggests the endoplasmic reticulum either 
remains as cisternae or dissociates into tubules (Yeong, 2013). Nonetheless there is 
evidence that protein export from ribosomal ER is inhibited by CDK1 (Yeong, 2013). The 
coatomer protein complex II (COPII), which functions in transporting vesicles from the 
endoplasmic reticulum to the golgi apparatus, concentrates at the endoplasmic reticulum of 
interphase cells (Yeong, 2013). At the onset of mitosis, CDK1 activity is believed to 
disperse COPII proteins into the cytoplasm thus halting protein trafficking from the ER 
(Yeong, 2013). Concomitantly, CDK1-cyclin B and Plk1 phosphorylate GRASP65 
resulting in the unstacking of the golgi apparatus into single cisternae (Derby and Gleeson, 
2007). Subsequently, CDK1 phosphorylates golgin GM130, thus abolishing the interaction 
of GM130 with golgins necessary for vesicle fusion with golgi membranes (Derby and 
Gleeson, 2007). The 'orphan' vesicles and cisternae are believed to diffuse throughout the 
cytoplasm until the late stages of mitosis (Derby and Gleeson, 2007), though there is some 
evidence that they are divided between nascent daughter cells by the mitotic spindle (Wei 
et al., 2015). 
1.3.3. Mitotic Spindle 
Various families of proteins regulate the mitotic spindle. Microtubules are dynamic but can 
be stabilised through positive feedback by microtubule-associated proteins (Walczak and 
Heald, 2008). Microtubule motor proteins transport regulatory and structural proteins 
along the mitotic spindle throughout the various stages of mitosis (Walczak and Heald, 
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2008). The localisation dependent activity of many of these proteins is believed to be 
controlled by RanGTP (Dasso, 2002, Kalab et al., 2006). RanGTP localises in a 
concentration gradient; RanGTP is most concentrated at the chromosomes and becomes 
gradually more diffuse further away (Kalab and Heald, 2008). This gradient is formed by 
guanine exchange factor RCC1 mediated recruitment of RanGTP to the chromosomes and 
by RanGAP regulated degradation of cytoplasmic RanGTP (Kalab et al., 2006).  
RanGTP interacts with importin α and β to release spindle assembly proteins from the 
nucleus in the late stages of interphase. Similarly, during mitosis RanGTP facilitates vital 
protein interactions (Dasso, 2002). Prominent downstream targets of RanGTP include 
microtubule associated proteins NuMA and TPX2, which function in spindle assembly, as 
well as microtubule motor protein XCTK2 in X. laevis, which is important for bipolar 
spindle organisation (Walczak and Heald, 2008). 
Recent studies (Wei et al., 2015, Hehnly and Doxsey, 2014, Hobdy-Henderson et al., 
2003) have demonstrated that golgi vesicles and recycling endosomes, thought to be 
inactive during mitosis, contribute to the organisation of spindle microtubules. GM130, 
which coats dissociated golgi vesicles in mitosis, sequesters TPX2 away from importin α 
inhibition (Wei et al., 2015). TPX2 interacts with Aurora-A kinase to promote microtubule 
nucleation at the spindle poles (Wei et al., 2015). GM130 then captures spindle filaments 
thus linking golgi membrane with the spindle for even inheritance between nascent 
daughter cells (Wei et al., 2015). Other membrane-bound organelles similarly associate 
with the mitotic spindle (Hehnly and Doxsey, 2014, Hobdy-Henderson et al., 2003). 
Rab11, which coats recycling endosomes, binds γ-TURC complexes and microtubules at 
the spindle poles (Hehnly and Doxsey, 2014). Knockdown of Rab11 resulted in spindle 
mis-orientation, a marker of destabilised aster microtubules, and mis-localised spindle pole 
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proteins (Hehnly and Doxsey, 2014). Additionally Rab5, an early endosome marker, 
localises to membrane around the spindle pole where it regulates NuMA for spindle 
maturation (Das et al., 2014). 
1.3.4. Prometaphase 
Prophase ends and prometaphase begins as the mitotic spindle reaches and begins 
interacting with the chromosomes. A pair of protein platforms recruited to the centromere, 
termed kinetochores, form the interface between sister chromatids and each side of the 
mitotic spindle (Walczak and Heald, 2008). A specialised set of spindle microtubule 
bundles, termed kinetochore fibres (K-fibres), transiently bind to the kinetochores 
(Walczak and Heald, 2008). This is believed to occur via two mechanisms that may indeed 
co-exist (Walczak and Heald, 2008). The first mechanism, called ‘search and capture’, 
involves the random probing of K-fibres polymerised from spindle poles until 
chromosomes are bi-oriented (Holy and Leibler, 1994). The second mechanism, known as 
‘self-assembly’, involves the nucleation of microtubules proximal to the chromosomes into 
antiparallel bundles independent of the centrosomes (McKim and Hawley, 1995). The 
result of these interactions is the alignment of chromatid pairs to the centre of the cell, 
termed the ‘metaphase plate’ (Walczak and Heald, 2008). The subsequent formation and 
destruction of these kinetochore attachments, which forms the basis of metaphase, begins 
in late prometaphase (Walczak and Heald, 2008).  
1.3.5. Metaphase 
The attachment of K-fibres to kinetochores are regulated by co-operating positive and 
negative feedback loops to ultimately result in amphitelic attachments, whereby the two 
kinetochores of one centromere are bound to single K-fibres nucleated from opposing 
spindle poles (Walczak and Heald, 2008). Progress into anaphase is prevented by the 
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Spindle Assembly Checkpoint (SAC) until all chromatid pairs are involved in amphitelic 
attachments (Musacchio and Salmon, 2007). Kinetochores with either no attachments or 
only one K-fibre bound (monotelic attachment), recruit SAC proteins to halt progress into 
anaphase (Musacchio and Salmon, 2007). 
The SAC comprises a complex of many proteins primarily regulated by kinase Aurora B 
(Jia et al., 2013). SAC proteins bind to kinetochores, with either no attachments or only 
one K fibre, to halt progress into anaphase (McEwen and Dong, 2009). Aurora B 
phosphorylates the Hec1 sub-unit of the Ndc80 complex at the kinetochore breaking any 
improper kinetochore-microtubule attachments (Jia et al., 2013). Bub1-Bub3 and BubR1-
Bub3 complexes are activated at these ‘unattached’ kinetochores by Aurora B to prevent 
ubiquitin ligase APC/C mediated separation of centromeres, which would drive the cell 
into anaphase (Jia et al., 2013). In addition, Bub1 phosphorylates Cdc20, which also 
inhibits APC/C (Jia et al., 2013). When a pair of kinetochores on the one centromere is 
properly bound to K-fibres nucleated from opposing spindle poles, the tension delocalises 
Aurora B and the Bub3 complexes from the kinetochores resultantly enabling phosphatase 
Cdc20 mediated activation of APC/C (Jia et al., 2013). When this is complete for all 
chromosome pairs, the cell is driven into anaphase (Jia et al., 2013).  
Inappropriate attachments, classed merotelic or syntelic, are destroyed prior to 
chromosome segregation in anaphase to prevent aneuploidy (Walczak and Heald, 2008). 
Syntelic attachments, which occurs when two K-fibres originating from the sample spindle 
pole bind both kinetochores of a centromere, are destroyed by SAC proteins (Musacchio 
and Salmon, 2007). Merotelic attachments exist when K-fibres originating from opposing 
spindle poles bind the same kinetochore (Gregan et al., 2011). The mechanism by which 
merotelic attachments are corrected is not yet understood but it has been suggested to 
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involve a centromeric pool of Aurora B (Gregan et al., 2011). Cells can enter anaphase 
with merotelic attachments because they are not detected by the SAC (Gregan et al., 2011). 
They are believed to be the link between multi-polar spindles, the lagging of individual 
chromosomes in anaphase and CIN in cancer (Gregan et al., 2011). Merotelic attachments 
are theorised to survive when in an abundance greater than can be managed by the 
mechanism for their destruction, as occurs in cells with multi-polar spindles (Gregan et al., 
2011). Chromatid pairs with merotelic attachments segregate, during anaphase, slower than 
amphitelically attached chromatid pairs (Gregan et al., 2011). This phenotype, termed 
chromosome lagging, results in aneuploidy through the unequal segregation of 
chromosomes (Gregan et al., 2011). 
1.3.6. Anaphase and Telophase 
The migration of chromatids to spindle poles in anaphase is mediated by depolymerisation 
of K-fibres and the ‘flux’ of tubulin monomers from the kinetochore to the spindle pole 
that functions analogous to a conveyer belt (Walczak and Heald, 2008). The 
depolymerisation of K-fibres at the kinetochore end does not interfere with the attachment 
of the fibre to the kinetochore, which indicates the presence of a ‘sleeve’ complex that 
maintains attachment between fibre and centromere (Westermann et al., 2005). It is 
hypothesised that this ‘sleeve’ comprises rings of microtubule-kinetochore coupling 
protein Dam1 (Westermann et al., 2005). The ‘flux’ of tubulin is achieved by: 1) 
microtubule motor protein dynein that transports microtubule depolymerising kinesin 
Kif2A to the spindle poles to depolymerise tubulin, and 2) cytoplasmic linker associated 
proteins (CLASPs) that catalyse tubulin incorporation at the kinetochore end (Maiato et al., 
2005, Merdes et al., 2000). Thus tubulin is incorporated at the kinetochore, removed at the 
spindle pole and recycled back to the kinetochore.  
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In the final stage of mitosis, telophase, the nuclear envelope reforms and the chromosomes 
de-condense (McIntosh, 2012). Adjacent to each nucleus the centrioles of each centrosome 
separate and a proteinaceous linker forms between mother and daughter centriole (Fujita et 
al., 2016). This dissociation of centrioles is an important licensing step for the next round 
of centrosome replication that prevents replication initiating during mitosis (Fujita et al., 
2016). Kinases Myt1 and Wee1 restore ER trafficking in the late stages of mitosis 
(Nakajima et al., 2008). Phosphatase PP2A removes the phosphorylation on GM130 and 
golgi cisternae reform, although causation between these two events has not yet been 
demonstrated (Derby and Gleeson, 2007). As this is occurring, the plasma membrane is 
physically abscised between the two reformed nuclei, through the process of cytokineis, to 
release two identical daughter cells (McIntosh et al., 2012).  
1.3.7. SNX9 in metaphase 
Knockdown of SNX9 reduces the rate of microtubule nucleation from spindle poles (Ma et 
al., 2013b) and leads to poor alignment of chromosomes (Ma and Chircop, 2012). Ma and 
colleagues (2013) proposed that this reflected a role in recruiting clathrin to the spindle. 
Clathrin promotes centrosome maturation during S phase (Foraker et al., 2012) and during 
mitosis forms inter-microtubule bridges for the stabilisation of the mitotic spindle (Lin et 
al., 2010, Fu et al., 2010, Cheeseman et al., 2013, Booth et al., 2011).  
A clathrin heavy chain (CHC) triskelion, which is able to bind to motifs in the LC domain 
of SNX9, forms a complex with TACC3 and microtubule bound ch-TOG for microtubule 
nucleation and stabilisation. The TACC3/CHC/ch-TOG inter-microtubule bridges are 
believed to form at the spindle poles (Cheeseman et al., 2013). In late interphase, clathrin 
promotes centrosome maturation by stabilising the microtubule binding protein ch-TOG at 
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the nascent spindle poles (Foraker et al., 2012). TACC3 is targeted to the spindle poles by 
phosphorylation at Ser558 by Aurora A (Lin et al., 2010). At the spindle poles TACC3 
complexes with CHC triskelia and microtubule bound ch-TOG to contribute to spindle 
assembly (Fu et al., 2010). In prometaphase and metaphase this complex forms inter-
microtubule bridges to stabilise K-fibres for the fulfilment of the SAC (Booth et al., 2011, 
Fu et al., 2010, Lin et al., 2010, Ma et al., 2013a, Cheeseman et al., 2013). It is likely that 
these clathrin mediated bridges also promote nucleation and stability of non-K-fibre 
spindle microtubule fibres as well because perturbation of clathrin appears to disrupt 
spindle organisation (Lin et al., 2010, Fu et al., 2010, Ma et al., 2013b) and microtubule 
regrowth (Ma et al., 2013a). 
SNX9 localises to the forming spindle during prometaphase (Ma et al., 2013b). Ma and 
colleagues (2013b) proposed that SNX9 is recruited to the prometaphase spindle to enrich 
CHC then dissociates from the spindle as the spindle matures and CHC-TACC3-chTOG 
complexes take hold (Ma et al., 2013b). In support of this, knockdown of SNX9 resulted 
in: 1) mitotic defects comparable to the knockdown of CHC and 2) reduced spindle 
localised CHC and TACC3 (Ma et al., 2013a). Over-expression of a SNX9 mutant, 
incapable of binding CHC (LC2), resulted in a loss of spindle CHC and TACC3 
comparable to the knockdown of SNX9 (Ma et al., 2013a). The dominant negative effect 
of this mutant suggests that SNX9-LC2 is sequestering endogenous SNX9, or another 
critical spindle component, through mutant/endogenous hetero-dimerisation, away from 
the spindle.  
This model suggests that SNX9 directly binds clathrin at the mitotic spindle; however, the 
mode by which SNX9 is itself recruited to the mitotic spindle is not known. SNX9 may be 
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sequestered to the spindle poles, in a way similar to TACC3, for targeting to the mitotic 
spindle. Ma and colleagues (2013b) observed that Ser176, in the LC domain of SNX9, is 
located within an Aurora A consensus motif. Therefore, Aurora A-mediated 
phosphorylation of Ser176 might target SNX9 to the spindle poles where it would 
contribute to CHC/TACC3 complex formation (Ma et al., 2013b). Ser176 is proximal to 
clathrin binding motifs and therefore phosphorylation there might alternatively regulate 
binding to CHC after being targeted to the spindle poles by another mechanism. 
GAK and B-myb have also been proposed to be involved in the localisation of clathrin at 
the mitotic spindle and therefore may provide insights into the role played by SNX9 in 
metaphase (Royle, 2011). GAK, a homolog of auxilin, which is required for the uncoating 
of clathrin-coated vesicles, is a serine/threonine kinase that is activated by cyclin-G 
(Royle, 2011). It has been proposed that GAK is an upstream regulator of clathrin 
localisation to the mitotic spindle as knockdown of GAK has been observed to result in 
spindle defects and a loss of clathrin at the spindle (Shimizu et al., 2009). B-Myb and its 
homolog D-Myb have been implicated in contributing to genome stability by participating 
in the checks and balances that ensure the equal segregation of chromosomes in mitosis 
(Yamauchi et al., 2008). Further work presented evidence that B-Myb forms a complex 
with Clafi, which is necessary for transporting clathrin to the mitotic spindle (Yamauchi et 
al., 2008). A mutant that did not interfere with B-Myb’s role as a transcriptional factor but 
did interfere with its ability to complex with Clafi resulted in misaligned chromosomes 
(Yamauchi et al., 2008). Perturbation of endogenous SNX9 did not completely dissociate 
CHC and TACC3 from the mitotic spindle (Ma et al., 2013a), which is indicative of a 
redundant mechanism. Therefore SNX9 may fulfil a role shared with B-myb and GAK in 
recruiting clathrin to the mitotic spindle (Fig 1.5).  
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The association of SNX9 with spindle localised clathrin was made based on siRNA 
targeted knockdown of SNX9 (Ma and Chircop, 2012, Ma et al., 2013b). An inherent issue 
with knockdown studies is that many defects can accumulate in the 48-72 hours between 
transfection and fixation (Royle, 2013). This period of time, depending on the cell line, is 
sufficient for several cycles of mitosis and thus represents ample opportunity for the 
development of indirect consequences. The loss of spindle localised clathrin in SNX9 
knockdown cells, for example, may be confounded by structural defects in spindle 
formation as a result of perturbation of other roles of SNX9. Indeed there are several 
mechanisms by which SNX9 may affect spindle stability independent of clathrin. 
Knockdown of SNX9 resulted in the mis-localisation of Rab11 coated recycling 
endosomes and GM130 coated golgi vesicles during cytokinesis (Ma and Chircop, 2012). 
These membrane bound organelles, as well as Rab5 coated early endosomes, have also 
been implicated in organisation of spindle microtubules during metaphase (Wei et al., 
2015, Hehnly and Doxsey, 2014, Hobdy-Henderson et al., 2003, Das et al., 2014). It is 
therefore possible that SNX9 regulates the proper localisation of membrane bound 
organelles to spindle poles where they contribute to spindle nucleation and organisation 
(Fig 1.5). In this model SNX9 might tubulate membrane from Rab5 early endosomes for 
the generation of vesicles that are then targeted to the spindle poles. These vesicles might 
also contribute to membrane that matures into Rab11 coated recycling endosomes targeted 
to the spindle via dynein mediated transport (Hehnly and Doxsey, 2014). The localisation 
of SNX9 during prometaphase may reflect the targeting and delivery of these membrane 
vesicles to the forming spindle. These membrane vesicles might then form the scaffold for 
stabilising clathrin triskelia at the spindle such that clathrin eventually forms inter-
microtubule bridges between nascent K-fibres.  
Figure 1.5: SNX9 stabilises spindle localised clathrin. A) Clathrin triskelia
complexes with phosphorylated TACC3 and microtubule bound ch-TOG to stabilise
microtubule bundles. SNX9 stabiliess spindle localised clathrin and thus ensures
proper chromosome alignment (Schematic prepared by Maggie Ma). Two models
that may explain these observations are: (B) Direct recruitment of clathrin triskelia at
the forming spindle in prometaphase, or (C) SNX9 generates Rab5 coated vesicles
and contributes membrane to Rab11 coated vesicles that accumulate at the spindle
pole and that form a scaffold for clathrin recruitment.
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1.4. SNX9 in cytokinesis 
Knockdown of each member of the SH3-PX-BAR subfamily induced multi-nucleation, 
indicative of cytokinesis failure, suggesting that they are key to the completion of 
cytokinesis (Ma and Chircop, 2012). Cytokinesis occurs through two key stages: the 
ingression of membrane between the two nascent daughter cells followed by the abscission 
of the membrane. Cytokinesis failure may originate from defects in either ingression or 
abscission. On the basis that there is general consensus that endocytosis fully resumes 
during cytokinesis, the role of SNX9 in cytokinesis is believed to be related to its canonical 
functions in CME and membrane trafficking (Ma and Chircop, 2012).  
1.4.1. Ingression 
After the separation of chromosomes, bundles of anti-parallel microtubules, termed the 
central spindle, remain at the centre of the dividing cell and form the scaffold for the 
assembly of complexes necessary for cytokinesis (Glotzer, 2005). By late anaphase, the 
ubiquitin-mediated destruction of cyclin B inactivates Cdk1 (Glotzer, 2005). Thus the 
activity of phosphatases overwhelms the rate of Cdk1 substrate phosphorylation and results 
in the de-activation of proteins involved in the assembly of the mitotic spindle (Glotzer, 
2005). The de-phosphorylation of microtubule associating protein PRC1 and the 
centralspindlin complex, which comprises the microtubule motor protein MKLP1 and the 
Rho family GTPase activating protein RACGAP1, enables them to bind to the central 
spindle and begin bundling microtubules (Glotzer, 2005). 
Many proteins are recruited to the central spindle in late anaphase and early 
telophase with the aim of forming a “contractile ring” (Glotzer, 2005). RhoA GTPase 
modules, activated by nucleotide exchange factor ECT2, activate Rho kinase (ROCK) and 
the myosin phosphatase-targeting (MYPT) sub-unit to enable the formation of myosin and 
actin complexes (Glotzer, 2005). The formation of unbranched actin filaments is mediated 
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by formins, which are also released from autoinhibition by RhoA, and profilin (Glotzer, 
2005). Myosin II, comprising a parallel dimer of heavy chains each with an essential light 
chain and a regulatory light chain, is key to shaping the plasma membrane into a furrow 
around the contractile ring (Glotzer, 2005). The activity of myosin II is controlled by an 
auto-inhibitive mechanism that is altered by ROCK mediated phosphorylation of its 
regulatory light chain (Glotzer, 2005). The RhoA mediated de-activation of MYPT 
stabilises the phosphorylated state of myosin regulatory light chain (Glotzer, 2005). This 
phosphorylation event permits myosin II to form fibres and eventually translocate actin 
filaments (Glotzer, 2005). As the myosin/actin complexes ingress the plasma membrane 
and generate a furrow, the actin filaments are progressively destabilised by cofilin 
(Glotzer, 2005). The formation and compression of the contractile ring forms the 
ingression stage of cytokinesis and is followed by the process of physically cleaving the 
membrane around the contractile ring, termed abscission. 
1.4.2. SNX9 in ingression 
Knockdown of all members of the SH3-PX-BAR subfamily in HeLa cells resulted in the 
disruption of phosphorylated MRLC localisation from the ingressing furrow, associated 
with an ingression delay (Ma and Chircop, 2012). Based on the finding that SNX33 
contributes to cytokinesis by interacting with WASP to regulate actin polymerisation 
(Lundmark and Carlsson, 2003, Badour et al., 2007, Zhang et al., 2009), Ma and Chircop 
(2012) hypothesised that SNX9 stabilises phosphorylated MRLC at the ingressing furrow 
by recruiting WASP. Binding of WASP to the Drosophila ortholog of SNX9, DSH3PX1, 
is dependent on the phosphorylation state of Tyr56 (Worby et al., 2002). The 
phosphorylation site Tyr56 is conserved in human SNX9 (Hornbeck et al., 2004). 
Therefore one possible model is that Tyr56 is dephosphorylated at mitotic exit, promoting 
SNX9 mediated activation of WASP and thus ARP2/3 actin filament nucleation. 
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1.4.3. Abscission 
As the furrow ingresses on a condensing midbody, membrane vesicles from the golgi and 
recycling endosomes accumulate at the intracellular bridge and increase the surface area of 
the plasma membrane by at least 25% (Guizetti and Gerlich, 2010). The knockdown of 
vesicle markers, including Rab11 (Yu et al., 2007), results in furrow regression suggesting 
that they are necessary to satisfy an 'abscission checkpoint' (Guizetti and Gerlich, 2010). 
Rab11 recycling endosomes, as well as downstream effector proteins function in the 
clearance of factors and remodelling of the PIP composition of the membrane (Albertson et 
al., 2005, Echard, 2008, Montagnac et al., 2008, Prekeris and Gould, 2008, Schiel et al., 
2011, Neto et al., 2011). In the late stages of ingression, the binding of Rab11 family 
interacting protein 3 (FIP3) with the centralspindlin subunit RACGAP1 competitively 
prevents ECT2 binding and thus halts RhoA activity (Guizetti and Gerlich, 2010). This 
accelerates the activity of cofilin in disassembling actin filaments. In addition, midbody 
microtubules are progressively depolymerised (Guizetti and Gerlich, 2010). 
Abscission occurs in two steps. Early in abscission, enrichment of PI(4,5)P2 at the 
midbody membrane stabilises the structural components of the ICB (Echard, 2012). The 
majority of endosomes at the ICB are within microtubule bundles and therefore believed to 
be restricted from fusion with the mid-body membrane (Schiel et al., 2011). The first step 
of abscission is a second ingression event on one side of the ICB (Schiel et al., 2011). The 
site of the secondary ingression is characterised by depolymerisation of microtubules and 
concentrated endosome fusion (Schiel et al., 2011). Rab11 and Rab35 recycling 
endosomes have been observed to be enriched at the ICB and FIP3 coated endosomes 
dominate the ICB (Schiel et al., 2011). The endosomes fuse with the secondary ingression 
membrane for the delivery of abscission factors (Schiel et al., 2011).  
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The second step of abscission features the thinning and lateral expansion of the ICB 
leading rapidly into scission (Schiel et al., 2011). Once the midbody has been reduced to a 
region only 200nm wide, ESCRT proteins assemble and catalyse the final stage of 
abscission (Guizetti and Gerlich, 2010). The degradation of polo like kinase 1 (PLK1) and 
activity of phosphatases at mitotic exit enables centrosomal protein CEP55 to bind to 
mitotic kinesin-like protein 1 (MKLP1; (Guizetti and Gerlich, 2010). MKLP1 translocates 
CEP55 from the spindle midzone to the midbody (Agromayor and Martin-Serrano, 2013). 
A complex of ESCRT-1 subunit tumour susceptibility gene 101 (TSG101) and ESCRT-
associated protein apoptosis-linked gene-2 interacting protein X (ALIX) is recruited to the 
midbody by CEP55 (Agromayor and Martin-Serrano, 2013). These proteins subsequently 
recruit ESCRT-III to induce abscission (Agromayor and Martin-Serrano, 2013). The 
timing of abscission is also dependent on the destabilisation of microtubule bundles 
mediated by the de-activation of Aurora B, believed to ensure the removal of lagging 
chromosomes from the intracellular bridge to prevent chromosomal damage (Guizetti and 
Gerlich, 2010). ATPase spastin severs the remaining overlapping microtubules (Connell et 
al., 2009) and ATPase VPs4 drives ESCRT-III mediated scission of membrane (Hill and 
Babst, 2012). 
1.4.4. SNX9 in abscission 
The role of SNX9 in cytokinesis is likely to be related to its canonical function in CME 
and membrane trafficking (Ma and Chircop, 2012). Knockdown of all three members of 
the SH3-PX-BAR subfamily perturbed Rab11 recycling endosome localisation to the ICB 
(Ma and Chircop, 2012). Knockdown of SNX9, but not SNX18 or SNX33, also resulted in 
the mis-localisation of GM130 coated vesicles to the ICB (Ma and Chircop, 2012). How 
SNX9 regulates the localisation of these endosomes is not known but is likely indirect, i.e. 
through CME and vesicle budding contributing membrane to the recycling pathway. 
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These findings suggest that cytokinesis failure following depletion of SNX9 might 
result from the failure to target abscission factors to the ICB. For example SNX9 might be 
involved in the delivery of binding partner OCRL1 to shape the PIP composition of the 
ICB (Dambournet et al., 2011). Rab35 coated recycling endosomes deliver OCRL to the 
ICB where it hydrolyses PI(4,5)P2 (Dambournet et al., 2011). This signals de-stabilisation of 
F-actin at the ICB to lead into the late stages of abscission (Echard, 2012, Dambournet et 
al., 2011). Cells with downregulated OCRL1 had increased rates of cytokinesis failure 
(Dambournet et al., 2011), comparable to SNX9 knockdown (Ma and Chircop, 2012). 
Therefore SNX9 might be necessary for recycling endosome mediated delivery of OCRL1 
to the ICB (Fig 1.6). 
Another binding partner of SNX9, dynII, localises to the midbody and is necessary 
for successful completion of cytokinesis (Chircop et al., 2011). Endogenous SNX9 and 
SNX33 has also been observed at the midbody of the intra-cellular bridge and therefore 
may interact with dynII for the membrane abscission (Ma and Chircop, 2012). In early 
abscission there is not likely to be an interaction as dynII localised to the ICB is kept in a 
SH3 binding deficient state by phosphorylation of S764 in its PRD (Chircop et al., 2011). 
In late abscission this phosphorylation is removed by calcium dependent phosphatase 
Calcineurin (CaN; (Chircop et al., 2011), which would facilitate binding to SNX9. The role 
of dynII and SNX9 at the midbody is not known. One possibility is that, together, SNX9 
and dynII function in the biogenesis of autophagosomes. Autophagosomal removal of actin 
and RhoGAP from the ICB serves as a checkpoint to ensure proper co-ordination of 
cytokinesis (Belaid et al., 2013). Given the role of dynII and SNX9 in autophagosome 
maturation in C. elegans (Lu et al., 2011, Chen et al., 2013, Almendinger et al., 2011), it is 
possible that they function together to clear F-actin for proper co-ordination of abscission 
in human cells (Fig 1.6).  
Figure 1.6: SNX9 might contribute to the formation of the secondary ingression
site. We propose that SNX9 aids in formation of the secondary ingression site by the
following mechanisms. SNX9 contributes to the targeting of OCRL1 to the ICB.
OCRL1 hydrolyses PI(4,5)P2 leading to the de-stabilisation of F-actin. Microtubules
are depolymerised and endosomes fuse with membrane. CaN mediated de-
phosphorylation of DynII enables an interaction with SNX9 that leads to clearance of
actin factors. The unsupported membrane undergoes a second ingression and
abscission is completed with the polymerisation and activity of ESCRT complexes.
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1.5. Phospho-regulation of mitotic function of SNX9 
In this thesis I sought to further investigate the role of SNX9 in: 1) mitotic spindle 
organisation, and 2) cytokinesis. One of the facets yet unexplored is the mechanism by 
which these functions are regulated. If, as Ma and colleagues (2013) proposed, the role of 
SNX9 in stabilising clathrin at the mitotic spindle is secondary and independent of its 
canonical function in membrane trafficking, then a regulatory mechanism should exist to 
‘switch’ SNX9 between functions. Phosphorylation has been proposed as having the 
potential to be important in regulating the mitotic functions of SNX9 (Ma et al., 2013b). 
There are several reasons to believe that the mitotic roles of SNX9 would be regulated by 
its phosphorylation state. Firstly, the orchestrated events of mitosis are co-ordinated 
through the competing activities of kinases and phosphatases (Dephoure et al., 2008). 
Secondly, other CME proteins implicated in mitosis are regulated by phosphorylation 
during mitosis (Chircop et al., 2011, Chircop et al., 2010). Finally, it is already understood 
that the canonical function of SNX9 in membrane trafficking is regulated by 
phosphorylation (Lin et al., 2002, Bendris et al., 2016a, Childress et al., 2006, Worby et 
al., 2002, Lundmark and Carlsson, 2004).  
Thus, I hypothesised that the mitotic role of SNX9 is regulated by phosphorylation. I 
sought to test this hypothesis by examining the effect of phospho-deficient and phospho-
mimetic mutations on the functionality of SNX9 in mitosis. The three specific aims of this 
thesis are: 
To assess whether phosphorylation regulates the mitotic function of SNX9. 
This chapter screens a list of selected phosphorylation sites for relevance to the 
mitotic function of SNX9. Phospho-mimetic and phospho-deficient mutants of 
SNX9 are generated. Mitotic duration of cells overexpressing SNX9 phospho-
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mutants are compared with a transferrin uptake to assess which mutants affect the 
mitotic, but not CME, role of SNX9. 
To investigate the role of Tyr56 in regulating the metaphase function of SNX9. 
In the previous chapter the role of SNX9 in metaphase was affected by the 
phosphorylation state of Tyr56. In this chapter the mitotic spindle in cells 
expressing dominant negative mutant Tyr56Glu is examined to investigate details 
of how Tyr56 regulates the metaphase role of SNX9. 
To investigate the role of Thr275 in regulating the cytokinesis function of SNX9. 
In the first results chapter the role of SNX9 in cytokinesis was affected by the 
phosphorylation state of Thr275. In this chapter the consequence of 
phosphorylation at Thr275 on the role of SNX9 in cytokinesis is explored with 
time-lapse microscopy. 
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2.1. Generating mutated SNX9 plasmids 
GFP-SNX9 and GST-SNX9 expression constructs were previously obtained as described 
(Ma et al., 2013b). Mutations of phosphorylation sites were introduced by site directed 
mutagenesis. Maggie Ma generated GFP-SNX9 and GST-SNX9 mutant constructs using 
the primers listed below (Table 2.1).  
Table 2.1: DNA Primers for site-directed mutagenesis (Maggie Ma) 
Name Sequence 
Tyr56Glu FOR GGCTGGTTCCCACAGACGAGGTTGAAATTTTACCCAG 
Tyr56Glu REV CTGGGTAAAATTTCAACCTCGTCTGTGGGAACCAGCC 
Ser176Ala FOR GGGCCCAAATCCTCTGCCTACTTTAAGGATTCAGAG 
Ser176Ala REV CTCTGAATCCTTAAAGTAGGCAGAGGATTTGGGCCC 
Ser176Glu FOR GGGATGGGCCCAAATCCTCTGAATACTTTAAGGATTCAGAGTCAG 
Ser176Glu REV CTGACTCTGAATCCTTAAAGTATTCAGAGGATTTGGGCCCATCCC 
Tyr177Glu FOR GGGCCCAAATCCTCTTCCGAGTTTAAGGATTCAGAGTCAGC 
Tyr177Glu REV GCTGACTCTGAATCCTTAAACTCGGAAGAGGATTTGGGCCC 
Tyr219Glu FOR CCTGGCACGGAACAGGAGTTGTTGGCCAAACAAC 
Tyr219Glu REV GTTGTTTGGCCAACAACTCCTGTTCCGTGCCAGG 
Tyr239Glu FOR CCCATCATTGTTGGAGATGAGGGCCCAATGTGGG 
Tyr239Glu REV CCCACATTGGGCCCTCATCTCCAACAATGATGGG 
Thr275Ala FOR CATCGAATATCAGCTAGCCCCTACTAACACTAATC 
Thr275Ala REV GATTAGTGTTAGTAGGGGCTAGCTGATATTCGATG 
Thr275Glu FOR GCTACATCGAATATCAGCTAGAGCCTACTAACACTAATCGATC 
Thr275Glu REV GATCGATTAGTGTTAGTAGGCTCTAGCTGATATTCGATGTAGC 
I generated the remaining GFP-SNX9 mutant constructs required using the primers listed 
below (Table 2.2). GenScript was commissioned for the generation of the following GST-
SNX9 mutant constructs: Tyr56Phe, Tyr177Phe, Tyr219Phe and Tyr239Phe. The Chircop 
lab donated alpha-tubulin-mCherry, mCherry-Rab11 and pBlueScript (pBS) constructs. 
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Table 2.2: DNA Primers for site-directed mutagenesis 
Name Sequence 
Tyr56Phe FOR GGCTGGTTCCCACAGACTTCGTTGAAATTTTACCC 
Tyr56Phe REV GGGTAAAATTTCAACGAAGTCTGTGGGAACCAGCC 
Tyr177Phe FOR GGGCCCAAATCTTCTTCCTTCTTTAAGGACTCAGAGTCAG 
Tyr177Phe REV CTGACTCTGAGTCCTTAAAGAAGGAAGAAGATTTGGGCCC 
Tyr219Phe FOR GGCACGGAGCAGTTTTTGTTGGCCAAACAAC 
Tyr219Phe REV GTTGTTTGGCCAACAAAAACTGCTCCGTGCC 
Tyr239Phe FOR CCCATCATTGTTGGAGATTTTGGCCCCATGTGG 
Tyr239Phe REV CCACATGGGGCCAAAATCTCCAACAATGATGGG 
2.1.1. Site directed mutagenesis 
Each site directed mutagenesis PCR reaction solution was prepared with the following; 
5 µL 10X buffer for PfuUltra™ II (Agilent),  
1 µL each of forward and reverse primer at a concentration of 125 µg/mL, 
1 µL of dNTP mix (Roche),  
40 µL sterile Milli-Q™ water (Millipore) 
1 µL PfuUltra™ II HS Fusion DNA polymerase (Agilent),  
1 µL of DNA at a concentration of 50 ng/µL. 
The mixture was then run on a Mastercycler (Eppendorf) with a program which entails: 
95 oC for 30 seconds 
95 oC for 30 seconds  
60 oC for 1 minute   
68 oC for 8 minute 
68 oC for 1 minute 
16-20
cycles 
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The PCR mixtures were incubated at 37 oC overnight in the shaking incubator with 5 µL of 
Buffer B (Promega) and 1 µL of restriction enzyme Dpn1 (Promega). 
2.1.2. Agarose gel electrophoresis 
A 1 % solution of agarose with 1X Tris-Borate-EDTA (TBE; Roche) was boiled in a 
microwave and allowed to cool to ~50 οC in a heated waterbath. GelRed™ Dye (Biotium) 
was added at a 1/10000 dilution to the solution, which was then poured into a sealed 
electrophoresis tray. After allowing the gel to set, the gel was transferred to an 
electrophoresis chamber (Bio-Rad) and submerged in 1X TBE (Roche) solution. 5 μL of 
DNA for analysis was mixed with 1 μL of Blue/Orange 6X loading dye (Promega) and 
loaded into gel. PCR product was run in parallel with 100 ng of the relevant uncut template 
DNA. The gel was run at 80 V with a Power Pack (Bio-Rad) and visualised on a 
FluorChem™ 5500 (Alpha Innotech) imaging apparatus with UV transmitted light. 
2.1.3. Agar plates 
Luria Broth Agar (LB-agar) was autoclaved at 121 οC for 1 hour and was allowed to cool 
to ~60 οC in a heated water-bath prior to adding Kanamycin (Kan) or Ampicillin (Amp) to 
a final concentration of 50 μg/ml and 100 μg/ml respectively. 
2.1.4. Transforming competent E. coli 
A 100 µL aliquot of JM109 competant cells was thawed on ice then incubated on ice for 
20 minutes with 5 µL of a PCR reaction. The bacteria was placed at 42 oC for 30 seconds 
prior to a 2 minute incubation on ice. The bacteria were then transferred to 1 mL of Luria 
Broth (LB) media and incubated in a shaking incubator (Bioline) for 1 hour at 37 oC and 
200 RPM. The bacterial culture was then spread on a KanR plate. 
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2.1.5. Streaking plates from glycerol stocks 
The glycerol stock was placed on dry ice. The inoculation loop was sterilised and, once 
cooled, dipped into the stock and applied to a Kan agar plate using a 16-streak method 
followed by a Z-streak method. The plate was incubated overnight at 37 oC placed upside 
down. 
2.1.6. Colony selection 
Using asceptic technique, a colony was selected with a pipette tip and dropped into a 
sterile tube pre-loaded with 2-5 mL LB + Kan. The tubes were kept in a shaking incubator 
at 37 oC and 200 RPM for 16 hours. 
2.1.7. Mini-prep and glycerol stock 
After colony selection, a 700 µL aliquot of bacterial culture was added to 300 µL of 
glycerol in a cryovial and stored at -80 oC. DNA was extracted from the remainder of the 
culture with a PureYield™ Plasmid Mini-prep System (Promega). The bacterial culture 
was spun down for 30 seconds at 16100 g and supernatant discarded. The bacterial pellet 
was resuspended in 600 µL of Milli-Q™ water (Millipore). 100 µL of Cell Lysis Buffer 
was added and inverted 6 times. 350 µL of Neutralisation Solution was added and mixed 
by inverting. The mixture was spun down for 3 minutes at 16100 g and supernatant 
transferred to a Mini Binding Column and Collection Tube. The mixture was spun down 
for 15 seconds at 16100 g and flow through discarded. 200 µL of Endotoxin Removal 
Wash was added and spun down for 15 seconds at 16100 g. 400 µL of Column Wash was 
added followed by centrifugation for 30 seconds at 16100 g. 30 µL of Elution Buffer was 
added directly to the mini-column matrix and after 1 minute eluted by centrifugation for 15 
seconds at 16100 g. Eluent was stored at -20 oC. 
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2.1.8. Maxi-prep 
Two starter cultures of 3 mL LB for each plasmid were incubated at 37 oC and 200 RPM 
for 8 hours. One of each pair of starter cultures was then selected to transfer into a maxi-
culture of 250 mL LB and incubated for a further 18 hours. The bacterial culture was then 
spun down at 5000 g for 10 minutes. The supernatant was discarded. DNA was extracted 
using the PureYield™ Plasmid Maxiprep System (Promega). The cell pellet was 
resuspended in 12 mL of Cell Resuspension Solution. To this 12 mL of Cell Lysis Buffer 
was added and inverted gently for 3 minutes at room temperature. 12 mL of Neutralisation 
Solution was added and inverted 10-15 times to mix. The solution was spun down at 
14,000 g for 20 minutes. The supernatant was run through a Clearing Column and Maxi 
Binding Column. The column was washed with 5 mL of Endotoxin Removal Wash, then 
20 mL of Column Wash. The column was dried with 5-10 minutes of vacuum clearing. 
The column was left for 10 minutes in 1 mL of Nuclease-Free Water then eluted by 
centrifugation at 1000 g for 5 minutes. Eluent was stored long term at -20 oC. 
2.1.9. Nano-drop and Sequencing 
Concentration of DNA was measured with Nano-Drop™ 2000 Spectrophotometer 
(ThermoFischer). Sequencing reactions, analysed by AGRF, were prepared by diluting 
400-600 µg of DNA into a total of 12 µL of Milli-Q™ water (Millipore) including 125 µg
of primer. Sequencing primers used listed below. 
Table 2.3 DNA Sequencing Primers 
Name Sequence 
SNX9 206 FOR CTTGTGGAAATTCAGTGG 
SNX9 411 REV GTTGTTGGGAGTGTTTGTG 
SNX9 504 FOR CTGGGATGGGCCCAAATC 
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SNX9 1001 FOR GGATGACCAGGATGTGTC 
SNX9 1380 FOR CATGATGCAATAACAGAAG 
EGFP-C1 FOR CATGGTCCTGCTGGAGTTCGTG 
pGEX FOR GGGCTGGCAAGCCACGTTTGGTG 
2.1.10. Sequence Alignment 
The amino acid sequence of Homo sapiens (Q9Y5X1) SNX9, and orthologues from model 
organisms Mus musculus (Q91VH2), Xenopus laevis (Q6DEE0), Danio rerio SNX9A 
(Q4V9K0), Danio rerio SNX9b (Q5SPP2), Drosophila Melanogaster (Q9NCC3), 
Caenorhabditis elegans (Q8I4E2), was derived (UniProt, 2015). These sequences were 
entered into Clustal Omega Multiple (protein) Sequence Alignment tool to generate a 
sequence alignment (Goujon et al., 2010). 
2.1.11. Crystal Structure Visualisation 
Crystal structures derived from PDB (Berman et al., 2000) were visualised using Rasmol 
(Sayle and Milner-White, 1995). The structures used include the 2nd SH3 domain of 
CD2AP in complex with a proline rich peptide from human ARAP1 (4X1V; Rouka et al., 
yet to be published), SNX9 LC4 complexed with rabbit muscle aldolase (3LGE; 
Rangarajan et al., 2010) and SNX9 PX-BAR bound to PI(3)P (2RAK; Pylypenko et al., 
2007). 
2.2. HeLa cell culture 
2.2.1. Tissue culture of mammalian cell lines 
HeLa cells were maintained in RPMI (Gibco) + 10 % Foetal Bovine Serum (FBS; Gibco) 
+ 1 % Penicillin/Strepavidin (P/S; Gibco) at 37 oC and 5 % CO2. In preparation for sub-
cultivation, cells were rinsed with PBS and covered in a thin film of 0.25% Trypsin-EDTA 
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solution (Gibco). After a short incubation at 37 oC, cells were resuspended in full media 
and then pelleted at 800 g for 1 minute. The cell pellet was resuspended in 10 mL of full 
media and a 15 μL aliquot was added to a cytometer and number of cells were estimated. 
1x106 cells were then transferred to a T150 for culturing over two nights. Large batches of 
cells were produced and aliquots of 1x106 cells were frozen down in full media with 5 % 
DMSO and stored in liquid nitrogen. An aliquot of cells would be thawed rapidly at 37 oC 
and washed by centrifugation at 800 g for 1 minute in full media. These cells were then 
added to full media in a T25 flask and sub-cultivated around 4 times before using for 
experiments. When passaged ~15 times, cells would be discarded and another aliquot 
thawed. Transient transfection of cell lines with protein expression constructs was 
achieved either with Lipofectamine® 2000 reagent (Thermo Fisher) or electroporation 
using the Neon® Transfection System (Thermo Fisher). Whenever 1.2 μg of DNA is used, 
it consisted of a cocktail of 200 μg of SNX9 construct of interest, 200 μg of α-
tubulin::mCherry and 800 μg of carrier vector pBS. 
2.2.2. Lipofectamine® 2000 reagent (Thermo Fisher) 
HeLa cells were seeded onto glass coverslips to achieve an estimated confluency of 60-70 
% and allowed to attach for 16 hours. The next day, cells were transfected using a 
construct : transfection reagent ratio of 1.2 µg : 1.2 µL diluted in RPMI (Gibco) media 
(without FBS or P/S). The transfection media was replaced with complete RPMI (Gibco) 
at 6 hours after transfection. 
2.2.3. Neon® Transfection System (Thermo Fisher) 
HeLa cells were detached and 1x106 cells were separated and washed twice in PBS with 
centrifugation at 800 g. Cells were resuspended in 50 µL of R2 solution and mixed with 
1.2 µg of construct DNA diluted in 50 µL of R2 solution. The solution was positioned in 
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contact with E2 buffer and held in place with a Neon pipette. Two pulses of 1005 V of 
electric current at a width of 35 mm were passed through the solution using the Neon 
Electroporator (Thermo Fisher). The solution was transferred to RPMI (Gibco) with 5 % 
FBS (without P/S) and seeded onto coverslips. Neon transfection was used solely for 
transfecting siRNA into HeLa cells. siRNA sequences used are listed below. 
Table 2.4 Small Interfering RNA 
siRNA Target sequence* 5’-3’ Reference 
Luciferase CGUACGCGGAAUACUUCGA Invitrogen 
SNX9-A AACCUACUAACACUAAUCGAU (Lundmark and Carlsson, 2004) 
SNX9-B AACAGUCGUGCUAGUUCCUCA (Shin et al., 2008) 
CHC GCAAUGAGCUGUUUGAAGA (Huang et al., 2004) 
2.3. Live Cell Imaging 
2.3.1. Live cell time-lapse microscopy 
40,000 cells were seeded onto a 35 mm single well live cell imaging plate with glass 
bottom. Following 24 hours, the cells were transfected using Lipofectamine 2000 as 
discussed. After another 24 hours, plates were loaded into the Cell Voyager Inverted 
Confocal Microscope (Olympus). Fields containing healthy cells and distributed 
throughout the plate were selected. Cells were kept at 37 oC with 5 % CO2 and a z-stack of 
images that captured the whole cells were taken every 4 minutes for 24 hours. Imaging 
conditions ranged between replicates from 100-200 milli-seconds of exposure and 10-20 % 
laser strength for both 488 and 567 channels but were consistent between treatment groups 
within each biological replicate. The settings were adjusted for each replicate to minimise 
oxidative damage without acquiring a signal too weak to observe mitotic ultra-structures. 
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2.3.2. mCherry-α-tubulin 
Expression of mCherry-α-tubulin was used as a marker for mitotic structures. Key 
structures characteristic of the different stages of mitosis comprise α-tubulin: the spindle 
poles during prophase, the mitotic spindle during metaphase, and the ICB during 
cytokinesis. The formation and disassembly of each of these structures was used to 
consistently demarcate the different stages of mitosis. The breakdown of the nuclear 
envelope resulting in the even distribution of α-tubulin throughout the cell was used as a 
proxy for the start of prophase. This coincided with an accumulation of α-tubulin at the 
spindle poles, which were separating to opposite ends of the cell. Throughout: prophase, 
prometaphase and metaphase, α-tubulin forms the mitotic spindle. The separation of the 
mitotic spindle toward each spindle pole was used as the start of anaphase. This coincided 
with the flattening of the central spindle, also comprising α-tubulin, into the ICB. The 
duration between the start of anaphase and the formation of the ICB was used as the 
duration of the ingression stage of cytokinesis. Severing of the ICB and movement of 
residual microtubule bundles, attached to each daughter cell, away from each other was 
used as a proxy for the completion of mitosis. 
2.3.3. Fluorescent fusion protein expression 
Exogenous expression of mCherry-α-tubulin has dominant negative effects on mitosis 
(Supplementary A). For this reason the fluorescence intensity, and thus level of expression, 
of mCherry-α-tubulin and GFP-SNX9 was measured. Maximum intensity projections were 
exported from the Cell Voyager Software (Olympus) at time-points 20 minutes prior to a 
cell’s entrance into prophase. MetaMorph software (Molecular Devices) was used to 
manually draw a region the cell outline defined in the GFP-SNX9 image and transferred to 
the corresponding α-tubulin::mCherry image. The average fluorescence intensity of the 
cell in both images was recorded and the average background fluorescence of an empty 
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space in the field was subtracted. Fields of cells were selected for analysis on the basis on 
ensuring similar expression of mCherry-α-tubulin and GFP-SNX9 between treatment 
groups within a biological replicate. Cells that skewed the distribution of protein 
expression were removed until expression of both GFP-SNX9 and mCherry-α-tubulin was 
not significantly different between treatment groups within a biological replicate.  
2.3.4. Metaphase defects 
Cells were assigned a ‘metaphase defect’ category using the following criteria: 
• Normal: The cell begins with two discernible spindle poles and continues into
anaphase with chromosomal material being divided faithfully between two nascent
daughter cells.
• Late Multi-polar: The cell begins with two discernible spindle poles but prior to
continuing into anaphase at least one of the spindle poles splits into two or more
poles. This typically results in the chromosomal material being split into more than
two nuclei divided between the two nascent daughter cells.
• Early Multi-polar: The cell begins with multiple discernible spindle poles that
separate the chromosomal material into multiple daughter cells.
• Mitotic catastrophe: The cell does not reach anaphase but rather undergoes
apoptosis or necrosis during metaphase.
2.3.5. Cytokinesis defects 
Cells were assigned a ‘cytokinesis defect’ category using the following criteria: 
• Normal: Formation of the ICB is followed by eventual scission.
• Unstable Ingression: Ingression is characterised by rapid ‘jerking’ movements of
the central spindle between nascent daughter cells that eventually resolves into
formation of the ICB.
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• Ingression failure: Formation of the ICB either does not occur or occurs but is
immediately followed by re-expansion of the cleavage furrow. In both cases the
cell must become multi-nucleated.
• Abscission failure: Formation of the ICB is followed by a period of time (at least
three frames; 12+ minutes) where the ICB is stable before the cleavage furrow re-
expands and the cell becomes multi-nucleated.
2.3.6. ICB localisation of SNX9 
SNX9 was recorded as having localised to the ICB if the GFP-SNX9 fluorescence met all 
the conditions of the following criteria: 1) GFP-SNX9 at the ICB had to exceed the 
fluorescence of cytosolic GFP-SNX9; 2) the enriched fluorescence is in the same plane as 
the mid-body as determined by the Cherry-α-tubulin images and 3) the enriched 
fluorescence was present on the ICB for more than one frame (i.e. at least 4 minutes). 
2.3.7. Statistical Analysis 
Due to technical limitations, each biological replicate was limited to a trio of wild type 
GFP-SNX9 as a control and the phospho-deficient and phospho-mimetic mutants of a 
particular phospho-site. Non-equal variance was always assumed. Over the 24 hours that 
cells were imaged, HeLa cells were observed to undergo 1-2 rounds of mitosis. Given the 
inherent heterogeneity of HeLa cells, and the nature of chromosomal inheritance through 
mitosis, individual cells were not likely to be independent of the cells around them. The 
duration of mitosis of a daughter cell was found to be dependent on its mother cell 
(Supplementary B). Cells from different fields on the same plate were not dependent 
(Supplementary B). To account for this dependence, the average of a field of cells was 
used as each independent data point. An equal number of fields were taken from each 
treatment group within a biological replicate. Twelve fields, from 3-4 equally weighted 
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biological replicates represented independent data-points. Phospho-mutants were 
compared to each other and the control by a Kruskal-Wallis One way ANOVA with a 
Dunn’s multiple comparisons test to assess differences in timing in any of the 3 
combinations: wild type v. phospho-mimetic, wild-type v.s. phospho-deficient, phospho-
mimetic v.s. phospho-deficient using p ≤ 0.05 as the cut-off for significance. Statistical 
tests were performed using GraphPad (PRISM). For analysis of metaphase and cytokinesis 
defects, data was pooled from all biological replicates and pairwise Chi-squared Fisher’s 
Exact tests were performed. 
2.3.1. Rab11 localisation 
The localisation of Rab11 was assessed using the MetaMorph (Molecular Devices) 
software. In each cell a circle was drawn around each of the inner pools, outer pools, the 
ICB and a sample of the cell cytosol and Rab11-mCherry fluorescence was measured. 
Fluorescence intensity at the inner pools, outer pools and ICB were normalised to the cell 
cytosol sample. This was repeated for every time-point from Anaphase to Completion. The 
trend-line was taken from the average of 3 biological replicates, each an average of 10 
cells. 
2.3.1. Clathrin localisation at spindle 
Images were exported from the Cell Voyager software and imported into MetaMorph. The 
average fluorescence intensity of a circle around the cell (CO) and a circle around the 
spindle (CS) was measured. The average fluorescence intensity of the outer doughnut 
(representing cytosolic clathrin light chain; CLC) was calculated using (Fluorescence of 
CO minus Fluoresence CS) divided by (Area of CO minus Area of CS). The average 
fluorescence intensity of the inner circle (spindle localised clathrin) was divided by the 
average fluorescence intensity of the outer doughnut. This value represented the factor of 
Chapter 2. Methods 
56 
CLC-mCherry enrichment on the spindle. This value was then normalised to the wildtype 
SNX9 control. 
2.4. Fixed cell microscopy 
2.4.1. Cell Staining 
24 hours after transfection of cells on coverslips, cells were fixed either by 15 minute 
incubation in 3.7 % PFA at room temperature or 3 minutes in ice-cold 100 % MeOH. PFA 
fixed cells were permeabilised for 5 minutes in 0.5 % triton-X-100 and subsequently 
washed. Cells were then blocked in 5 % BSA/PBS for 1 hour. Cells fixed in 100 % MeOH 
were incubated in PBS for 30 minutes. Coverslips were incubated for 2 hours at 37 oC in 
primary antibody (Table 2.3) in 5 % BSA/PBS then washed off three times with 5 minute 
incubations in PBS and replaced with secondary antibody (Table 2.4) in 5 % BSA for 1 
hour. Secondary antibody was washed as described above and cells were incubated for 10 
minutes in 0.2 μg/mL 4',6-diamidino-2-phenylindole (DAPI). Coverslips mounted onto 
glass slides using Prolong Diamond Antifade (Thermo Fisher) reagent and after 24 hours 
coverslips were sealed with clear nail polish. Slides were imaged on the LSM880 Zeiss 
Confocal microscope.  
Table 2.5 Primary antibodies 
Primary antibody Dilution used Supplier 
Mouse anti-α-tubulin 1 : 2000 Sigma-Aldrich 
Rabbit anti-SNX9 1 : 1000 Proteintech 
dynamin 2 1 : 200 Abcam 
Phospho-dynamin 2-S768 1 : 100 In-house 
OCRL1 1: 200 Proteintech 
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Centrin 2 1 : 200 Abnova 
GFP-A488 conjugated 1 : 500 Life Technologies 
CHC 1 : 500 BD Biosciences 
Table 2.6 Secondary antibodies 
Primary antibody Dilution used Supplier 
anti rabbit-A488 conjugated 1 : 1000 Life Technologies 
Anti mouse-A488 conjugated 1 : 1000 Life Technologies 
Anti mouse-A568 conjugated 1 : 1000 Life Technologies 
Anti rabbit-A568 conjugated 1 : 1000 Life Technologies 
2.4.2. Centriole assay 
Cells were fixed in methanol at -20 oC for 2-3 minutes and then allowed to recover in PBS 
at room temperature for 30 minutes. The cells were then stained, as previously described, 
for GFP and centrin 2 and with DAPI. Cells in metaphase or anaphase were imaged with 
the LSM880 confocal microscope (Zeiss). A line was drawn through each cell in Zen Blue 
(Zeiss) software and the average fluorescence intensity of GFP-SNX9 measured. 12 cells 
were selected from each treatment group on the basis of their fluorescence to ensure an 
even distribution of GFP-SNX9 expression between treatment groups. The images of the 
selected cells were then imported into Imaris (Bitplane). The 3D spot module was run on a 
cropped portion of the image that included only one cell at a time and used to render spots 
of highest centrin 2 fluorescence intensity of approximately 0.15μM in width. The 
‘distance between spots’ package was then run to determine the distance, in three 
dimensions, between the center of each spot. The minimum distance, that is the distance 
between the center of a spot and the center of the closest other spot, was recorded as the 
measure of distance between centrioles. Limited resolution did not allow us to definitively 
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determine whether the detection of only one centriole indicated the presence of only one 
centriole or two centrioles quite tightly packed. Thus a cell with 2 centrosomes, each 
containing 1-2 centrioles, was considered to have a normal number of centrioles. A cell 
with 3+ centrioles in one centrosome, or with multiple centrosomes, was determined to 
have supernumerary centrioles. 
2.4.3. Transferrin uptake assay 
40000 cells were seeded into each well of a 12 well plate and incubated at 37 oC. Cells 
were transfected as discussed before. Upon washout of transfection media, cells were 
suspended with trypsin and seeded into 6 wells of a 96 well plate that has been coated with 
50 μg/mL of fibronectin (Sigma) for 2 hours at 37 oC and then washed out with PBS. Each 
solution added to the 96 well plate was added to a volume of 200 μL. Cells were allowed 
to settle for 6-12 hours then starved in RPMI (Gibco) for another 6-12 hours. RPMI 
(Gibco) media was flicked out and replaced with transferrin- ligand conjugated with 
alexa594 fluorophore (transferrin-A594; Invitrogen) diluted to 5 μg/mL in RPMI (Gibco) 
media. After 8 minutes, the cells were placed on ice and washed with PBS then replaced 
with an ice cold high pH acid wash (0.2M acetic acid + 150mM NaCl + pH adjusted to 4.5 
with NaOH) and incubated on ice for 15 minutes. The acid wash solution was flicked out 
and the cells were washed twice with PBS and finally replaced with 3.7 % PFA for 10 
minutes at room temperature. The cells were washed with PBS and incubated with 200 
μg/mL for 15 minutes at room temperature. The cells were washed and stored in PBS at 4 
oC. 
The 96 well plate was imaged with an ImageXpress Micro XLS Widefield High-Content 
Analysis System. 16 fields were imaged from each well with 3 wells per treatment group. 
A custom analysis module was generated to select cells that are GFP positive and to 
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measure the integrated intensity of both A594 puncta and GFP fluorescence within each 
cell. Data is presented as the average fluorescence intensity of the 3 wells per treatment 
group; each of which is the average of the 16 fields per well. 
2.5. Western Blot 
Western Blotting was used to determine the specificity of the antibody against SNX9. 
2.5.1. Cell lysis 
Cells harvested on ice were washed by centrifugation at 375g for 5 minutes with PBS 
twice. Supernatant was discarded and cell pellet was snap-frozen in liquid nitrogen and 
stored at -80 oC. Frozen pellets were thawed into lysis buffer and sonicated on ice. The 
lysates were centrifugated at 18,000 g for 15 minutes at 4 oC. Supernatant was stored at -
80oC. Lysis buffer consisted of (25 mM Tris-HCl pH 7.4, 1 % triton X-100, 250 mM NaCl, 
1 mM EGTA, 1 mM PMSF, 20 µg/ml Leupeptin, 200 μM Sodium Orthovanadate, EDTA-
free-Complete Protease Inhibitor tablet (Roche)). 
2.5.2. Protein concentration 
The protein concentration of lysates was determined by Bradford Assay using a Protein 
Assay Dye Reagent Concentrate diluted 1/5 in Milli-Q™ water (Millipore). A standard 
curve was generated by determining the A595 of solutions of BSA diluted to various 
concentrations in PBS. The A595 was read for each sample in triplicate on a VersaMax 
ELISA microplate reader (Molecular Devices) and the concentration of each sample was 
interpolated from the BSA standard curve. 
2.5.3. SDS-PAGE 
Lysates diluted with lysis buffer to have equal protein concentration were heated at 90oC 
for 10 minutes in 1X Sample Buffer and then loaded into a 10% Mini-Protean TGX gel 
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(Bio-Rad) and run at 100V in 1X TGS buffer. Samples run alongside Precision Plus 
molecular weight markers (Bio-Rad). 4X Sample Buffer stock made of: 0.5M Tris-HCl pH 
6.8, 20% glycerol, 2% SDS, 20% beta-mercaptoethanol, 0.01% coomassie brilliant blue. 
2.5.4. Immuno-blotting 
Proteins embedded in the gel were transferred to nitrocellulose membrane for 16 hours at 
35 V and 2 hours at 80 V. The transfer efficiency was checked by staining the membrane 
with a ponceau S-stain (0.1% ponceau S and 1% glacial acetic acid). The blot was blocked 
overnight in 5 % BSA/PBS blocking buffer. The blot was then incubated overnight at 4 oC 
in 1 : 1000 SNX9 antibody (Proteintech) in TBS-T (TBS, pH 7.5, 0.1% Tween 20). Blots 
were washed four times for 15 minutes each time with PBS + 0.5% tween20. Blots were 
then incubated in 0.1 µg/ml monoclonal anti- β-actin/HRP conjugated and 0.13 µg/ml anti-
Rabbit IgG/HRP of secondary antibody in TBS-T buffer for 1 hour. Membranes were 
washed again and developed using ECL reagent Super Signal® West Dura Extended 
Duration Substrate (Thermo Fisher) and an SRX-101A X-ray film processor (Konika 
Minolta) 
2.6. GST-SNX9 Pulldowns 
Following is the protocol used by Chin Wong, Sushma Rao and Steven He to perform the 
GST-SNX9 pulldowns. The Western Blot protocol detailed below was performed on 
the GST-pulldowns by Chin Wong, Sushma Rao, Steven He as well as myself (Dadar 
Ahmadi Pirshahid). This section was written by Steven He. 
2.6.1. Expression and extraction of GST-SNX9 proteins in E. coli 
A starter culture was prepared by dipping a sterile tip into the appropriate glycerol stock 
and inoculating 50 mL of LB-media (30 µg/mL Amp). This was incubated overnight at 
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37oC with shaking at 210 rpm. The starter culture was then added to 350 mL LB media (30 
µg/mL Amp) and cultured at 37 oC, 210 rpm until an OD600 of 0.6-0.8 was achieved. A 
pre-induction sample was kept as a control for SDS-PAGE. The culture was then induced 
with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma Aldrich) for 4 hours at 
37 oC, 210 rpm. A post-induction sample was additionally obtained for SDS-PAGE. The 
E.coli was then pelleted by centrifugation at 10,000 rpm, 4 oC for 15 minutes. Supernatant
was discarded and the bacterial pellet was stored at -80 oC until use. The bacterial pellet 
was resuspended in STE buffer (300 mM NaCl, 10 mM Tris, 1mM EDTA) supplemented 
with 10 µg/mL lysozyme and kept on ice for 30 minutes. Following this, 4.5 mM DTT and 
1% (v/v) Triton-X was added before probe sonication using a Branson Sonifier 250 
(Emerson Electric Co.) for 1 minute intervals a total of three times (Duty cycle: constant, 
Output: 2). The solution was centrifuged at 12,000 rpm, 4 oC for 10 minutes and the lysate 
containing the GST protein was collected.  
1.33 mL of glutathione sepharose 4B (GE Healthcare) was dispensed into falcon tubes and 
pelleted by spinning for 5 minutes at 500 rpm, 4oC. The supernatant was aspirated and the 
beads were resuspended in PBS with 0.1% Triton-X 100 before being spun down as 
previously mentioned. Following this 3 PBS washes were carried out on the beads. The 
glutathione sepharose beads were then added to the sonicated lysate and incubated for hour 
at 4oC whilst on a rotating wheel. The samples were then centrifuged at 500 rpm, 4 oC for 
5 minutes and the lysate was aspirated. The GST-protein bound beads were then washed 
again 3 times with PBS. Beads were transferred from falcon tubes to Eppendorf tubes and 
soaked in 50% glycerol made up with PBS. The samples were spun for an additional 5 
minutes at 500 rpm before being resuspended in 50% glycerol in PBS and stored at -20oC 
until use. 
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2.6.2. HeLa cell lysis 
Metaphase synchronised HeLa cells were prepared and supplied by Daniel Yagoub and 
Sushma Rao according to the published protocol (Rao et al., 2016). Cells were 
synchronised to metaphase by treatment with 40ng/ml Nocodazole for 14 h before 
collection by mitotic shake. Both asynchronous and metaphase synchronised cells were 
pelleted and then lysed according to the following protocol. HeLa cell pellet was 
resuspended in lysis buffer (1 µL per 2x105 cells; 5 mMTris pH 7.4, 1 mM EDTA, 
1 mM EGTA, 1% triton X-100, 1 mM PMSF, 2% (w/v) leupeptin, 1% (v/v) protease 
inhibitor cocktail set II (Millipore), 1 tablet EDTA free protease inhibitor (Roche)  
and incubated for 15 minutes at room temperature. Cells were then lysed 
by probe sonication using a Branson Sonifier 250 (Emerson Electric Co.) for 1 
minute intervals a total of three times (Duty cycle: constant, Output: 2.5) with the 
tube being replaced on ice for 20 seconds between intervals. Lysate was 
collected and cellular debris pelleted by centrifuging at 18,000 g for 10 minutes 
at 4oC. Without disturbing the top lipid layer, the supernatant was collected and 
protein concentration was measured using a Direct Detect Infrared Spectrometer 
(Millipore). The sample was then stored at -20 oC until use. 
2.6.3. Pulldown 
Approximately 10 µg of GST-SNX9 fusion proteins (WT, Y56E, Y56F, T275E, T275A) 
bound to sepharose beads were added to Illustra Microspin columns (GE Healthcare) and 
then normalised to uniform bead volumes using blank sepharose beads. The beads were 
washed by PBS addition, centrifugation at 500-1000 rpm for 2 minutes at 4oC. This was 
repeated a total of three times. The spin columns were then plugged and 2 mg of 
metaphase HeLa cell lysate was added, made up to a final volume of at least 200 µL using 
lysis buffer and incubated for 60 minutes at 4 oC on a rotary wheel. Spin columns were 
then unplugged and centrifuged for 2 minutes t 1500 g and 4oC to collect the unbound 
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 fraction. The sample was washed using bead wash solution (20 mM Tris pH 7.4, 1 mM 
EDTA, 1 mM EGTA, 1 EDTA-free protease inhibitor tablet (Roche) and centrifugation for 
2 minutes at 1500 g, 4oC to collect wash fractions. This was repeated a total of three times. 
Spin columns were plugged and 80 µL of 2x SDS sample buffer (40 mM Tris pH 6.8, 
6.5% (v/v) glycerol, 1.2 mM EGTA, 1.2% (w/v) SDS, 0.01% (w/v) bromophenol blue, 8% 
(v/v) β-mercaptoethanol). Spin columns were capped and then incubated for 5 minutes at 
85oC. Eluate was then collected in sterile microfuge tubes by centrifuging at 9000 g for 1 
minute and stored at -20 until use.
2.6.4. Western Blotting 
Pulldown eluate was incubated for 5 minutes at 85oC and then loaded onto two 10% Mini-
PROTEAN TGX precast gels (Bio-rad) and run for 90 minutes at 120V. One of the gels 
was stained using Colloidal Coomassie (17% (w/v) ammonium sulfate, 3% (v/v) 
phosphoric acid, 0.1% (w/v) Coomasie blue G-250, 34% (v/v) methanol) for 60 minutes, 
followed by destaining overnight in dH2O as a loading control to ensure equal amounts of 
protein in each condition. The remaining gel was transferred to a 0.2 µm nitrocellulose 
membrane using a Trans-Blot Turbo system (Mini format, mixed molecular weight; Bio-
rad) then stained with Ponceau (0.5% (w/v) Ponceau S in 1% acetic acid) for 5 minutes and 
destained for 2 minutes in dH2O to confirm protein transfer. The membrane was blocked in 
1% polyvinylpyrollidone (average MW 40,000) in TBS-T (TBS, pH 7.5, 0.1% Tween 20) 
overnight at 4oC with light agitation. The membrane was incubated with the primary 
antibody in TBS for 60-90 minutes at room temperature with light agitation, followed by a 
wash with TBS-T for 15 minutes. This wash step was repeated a total of four times. The 
membrane was then incubated with the secondary antibody in TBS for 60-90 minutes, 
followed by additional wash steps as above. The blot was covered in SuperSignal West 
Pico chemiluminescent substrate solution (Thermo Fischer) as per the manufacturer’s 
instructions. Blots were developed using an SRX-101A X-ray film processor 
(Konika Minolta).
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Dynamin 2 1 : 1000 
AP-2 1 : 1000 
CHC 1 : 1000 
OCRL1 1 : 1000 
SNX9 1 : 1000 
Monoclonal  mouse anti-β-
actin/HRP 
1:200000 
                      
Abcam 
Abcam 
BD Biosciences 
Proteintech 
Proteintech 
Sigma-Aldrich 
Table 2.8 Secondary antibodies 
Primary antibody Dilution used Supplier 
Polyclonal goat anti-mouse 
immunoglobulins/HRP 
1:10000 Dako 
Polyclonal swine anti-rabbit 
immunoglobulins/HRP 
1:10000 Dako 
2.7. Pulldown analysis by Mass Spectrometry 
Following is the protocol used by Daniel Yagoub to analyse the GST-SNX9 pulldowns by 
mass spectrometry and then sequence feature enrichment analysis. This section was written 
by Daniel Yagoub. 
2.7.1. Sample preparation 
For mass spectrometric analysis, pulldowns using SNX9 wild-type and mutant (Tyr56Glu, 
Tyr56Phe, Thr275Ala, Thr275Glu) bait proteins with synchronised metaphase 
HeLa lysates were performed as described above but subsequently digested ‘on-bead’. 
Table 2.7 Primary antibodies 
Primary antibody Dilution used Supplier 
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Prior to elution, beads were washed again twice with ammonium bicarbonate (20 
mM). Columns were replugged and an immersive volume (200 uL) of DTT (10 
mM) in ammonium bicarbonate (20 mM) solution was added to beads. Samples 
were incubated at 55 °C for 30 minutes. Iodoacetamide was then added to a 
final concentration of 15 mM and samples were incubated for 1 hour in the dark. 
600ng of trypsin (Promega) was then added and samples incubated overnight at 37 °C 
with shaking. Digestion was stopped by the addition of formic acid to a final 
concentration of 1%, and beads were then washed once with a solution of 60% 
acetonitrile + 0.1% formic acid (v/v). Samples were evaporated to dryness in a speedvac 
(ThermoFisher), and solid phase extraction was performed using home-made C18 
StageTips prior to reconstitution in 0.1% trifluoroacetic acid (TFA) for mass 
spectrometric analysis. 
2.7.2. Mass Spectrometry 
Samples were analysed on an OrbitrapVelos Pro ETD (Thermo Scientific), interfaced with 
an UltiMate 3000 HPLC and autosampler system (Dionex). Samples were loaded onto a 
fritted nanocolumn (75 um, ~15 cm) at 20 uL/min. Peptides were eluted using a linear 
gradient of H2O-CH3CN (98:2 (v/v), 0.1% formic acid) to H2O-CH3CN (64:36 (v/v), 
0.1% formic acid) at 250 nL/min over 120 minutes, and eluting peptides were ionized 
using positive-ion mode electrospray. The mass spectrometer was operating in data-
dependent acquisition (DDA) mode for all samples. A survey scan of m/z 350–1750 was 
acquired in the Orbitrap (resolution = 30 000 at m/z 400, with an accumulation target value 
of 1 million ions). Up to the 10 most abundant ions (>5000 counts) with charge states of 
+2 or greater were sequentially isolated and fragmented within the linear ion trap.
Collision-induced dissociation was used with an activation q = 0.25 and activation time of 
30 ms at a target value of 30 000 ions. The m/z values selected for tandem mass 
spectrometry (MS/MS) were dynamically excluded for 30 seconds. 
2.7.3. Sequence database searching and data processing 
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Raw files were processed using MaxQuant software (version 1.5.3.8; (Cox and Mann, 
2008) using the Andromeda search engine, searching against the Swiss-Prot human 
database (23/06/2016 release; (Bairoch and Apweiler, 2000). Search parameters were as 
follows: digestion with trypsin, variable modifications of N-terminal acetylation, 
methionine oxidation, cysteine carbamidomethylation, peptides of minimum seven or more 
amino acids, maximum of two missed cleavages, and peptide and protein false discovery 
rate of 0.01. For search tolerances, MS1 was set to <4.5 ppm and MS2 was set to 0.50 Da. 
The label-free quantitation (LFQ) module was used for protein quantitation. LFQ 
minimum ratio count was two. Re-quantify was selected, and matching between runs (from 
and to) was selected. Resulting data has been deposited to the ProteomeXchange 
Consortium. 
After processing with MaxQuant, a manual filtering step was performed in order to 
remove anomalous peptide matches. This concerned cases in which no MS/MS events 
were recorded for any peptides derived from a given protein in one sample, such that the 
identification of the protein in that sample was therefore achieved exclusively by peptide 
matching (using the ‘match between runs’ feature of MaxQuant). For these cases, unless 
the LFQ algorithm had also successfully matched ≥15% of total identified peptides 
associated with the protein across all samples within that same sample, the LFQ value was 
set to 0. LFQ values were then loaded into Perseus (Tyanova et al., 2016), and proteins that 
were not identified in all three biological replicates in at least one experimental group 
(GST-only, wild-type SNX9, and SNX9 mutants) were discarded. For the purpose of 
statistical testing, missing values (zero values) were imputed from a downshifted normal 
distribution (width 0.3, down shift 1.8) in Perseus. The student’s t-test (two-sided) was 
used for all pair-wise comparison of experimental groups (p<0.05, log[base2] fold-change 
> 2, permutation-based FDR of 0.05). DAVID tools (Jiao et al., 2012) was used for
functional annotation and protein enrichment analysis. 
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3. TYR56 AND THR275 REGULATE THE
MITOTIC FUNCTION OF SNX9 
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3.1. Introduction 
The orchestrated events of mitosis are co-ordinated through the competing activities of 
kinases and phosphatases (Dephoure et al., 2008). Ma and colleagues (2012) indicated that 
SNX9 might also be targeted to its role during mitosis by phosphorylation. Thus, in this 
chapter I sought to investigate whether phosphorylation of SNX9 regulates its function in 
mitosis. 
A candidate approach was taken, in addressing this aim, whereby the functional 
significance of known phosphorylation sites to the mitotic role of SNX9 was assessed. 
Phosphorylation sites throughout the structure of SNX9 were selected from a database of 
proteomic studies (Hornbeck et al., 2004). There are currently 20 phosphorylation sites 
identified in human SNX9 (Hornbeck et al., 2004). Phospho-sites were selected for further 
study on the basis that they had either been identified in cells in in-house experiments (Xia 
Yang, unpublished) or have been reported at least three times (Hornbeck et al., 2004). In 
cases where there were more than two candidate phospho-sites in the same domain, 
priority was given to phospho-sites identified in-house (Xia Yang, unpublished) or those 
reported the most number of times. The following six phospho-sites were chosen based on 
that criteria: Tyr56, Ser176, Tyr177, Tyr219, Tyr239 and Thr275 (Table 3.1). 
Of these: Tyr56, Tyr177 and Tyr239 have been previously studied (Worby et al., 2002, 
Bendris et al., 2016a). In Drosophila, phosphorylation of Tyr56 disrupted binding to 
WASP but bound more strongly to adaptor protein Dock, which is an orthologue of the 
human protein Nck (Worby et al., 2002). Tyr177 and Tyr239 were phosphorylated in cells 
co-expressing SNX9 and Src kinase (Bendris et al., 2016a). Expression of a SNX9 
phospho-deficient mutant, where Tyr177, Tyr239 and three other phospho-sites were 
mutated to phenylalanine, reduced invasiveness in cancer cell lines (Bendris et al., 2016a). 
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Table 3.1: SNX9 phosphorylation sites chosen from Phosphositeplus (Hornbeck et al., 
2004) and in-house proteomic studies (Xia Yang, unpublished). 
P site Peptide identified Location Evidence # Rep. 
Y56 RGLVPTDyVEILPSD SH3 
(Tsai et al., 2015); 
(Tsai et al., 2008) 
3 
S176 WDGPKSSsYFKDSES LC 
(Zhou et al., 2013); 
Identified in-house 
(Xia Yang, unpublished) 
5 
Y177 DGPKSSSyFKDSESA LC 
(Wolf-Yadlin et al., 2007); 
Identified in-house 
(Xia Yang, unpublished) 
12 
Y219 AKPGTEQyLLAKQLA N-1 Yoke
(Sharma et al., 2014); 
(Moritz et al., 2010); 
(Palacios-Moreno et al., 2015); 
14 
Y239 IPIIVGDyGPMWVYP N-l Yoke (Bai et al., 2012) 10 
T275 SYIEYQLtPTNTNRS PX 
(Sharma et al., 2014); 
Identified in-house 
(Xia Yang, unpublished) 
1 
No study has yet investigated the role of SNX9 phospho-sites in regulating the mitotic 
function of SNX9. This chapter sought to determine whether any of the selected residues 
regulate the mitotic function of SNX9 in a phospho-specific manner. 
3.2. Results 
3.2.1. Tyr56 and Thr275 are highly conserved throughout evolution 
The evolutionary conservation of each selected residue was assessed to indicate which 
phosphorylation site(s) are likely to have a significant impact on SNX9 function. The 
amino acid sequence of Homo sapiens (H. sapiens; human) SNX9 was compared with 
orthologs using Clustal Omega (Goujon et al., 2010, Li et al., 2015, McWilliam et al., 
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2013, Sievers et al., 2011) in the following model organisms: Mus musculus (M. musculus; 
mouse), Xenopus laevis (X. laevis; african clawed toad), Danio rerio (D. rerio; zebrafish), 
Drosophila Melanogaster (D. melanogaster; fruit fly) and Caenorhabditis elegans (C. 
elegans; nematode). Zebrafish have two isoforms of SNX9. The phosphorylation sites 
assessed locate in: the SH3 domain (Tyr56), the LC domain (Ser176/Tyr177), the N-
terminal Yoke domain (Tyr219/Tyr239) and the PX domain (Thr275; Fig 3.1 A). The 
phospho-sites Tyr56, Tyr219 and Thr275 are conserved throughout evolution, except for 
Thr275 in the SNX9b isoform in zebrafish, whereas Ser176, Tyr177 and Tyr239 are not 
conserved (Fig 3.1 B-E). The SH3 domain has many conserved residues including the PRD 
binding Trp39 (Shin et al., 2007; Fig 3.1 B) and a sequence motif, ‘GɸɸPxx(Y/F)(ɸ/π)’, 
common to 70.1% of all SH3 domains (Schultz et al., 1998, Letunic et al., 2015) 
‘GɸɸPxx(Y/F)(ɸ/π)’; where ‘ɸ’ refers to a hydrophobic residue, ‘π’ refers to a small 
residue and ‘x’ refers to any residue (Aasland et al., 2002). The PX domain is similarly 
well conserved; notably around the ‘RYKH’ motif, which co-ordinates with PI3P 
(Pylypenko et al., 2007; Fig 3.1 E). The LC domain and N-terminal Yoke domain are 
relatively unstructured (Fig 3.1 C-D) with the only notable exception being clathrin 
binding sequences (DWDEDWD; Ma et al., 2013b) within the LC domain (Fig 3.1 C). The 
PX and SH3 domain appear to be the most conserved therefore phosphorylation at Tyr56 
and Thr275 is most likely to affect structure and thus function. 
The location of each phosphorylation site in crystal structures of SNX9 was then examined 
to assess their proximity, in tertiary structure, to key protein and lipid binding interactions. 
The SH3 domain of SNX9 has not been crystallised; however, the primary and tertiary 
structure of SH3 domains are highly conserved (Schultz et al., 1998, Letunic et al., 2015) 
allowing extrapolation of our understanding of the SNX9 SH3 domain by analysing the 
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crystal structure of another protein that has been solved. The SH3 domain of CD2-
Associated protein, which contains the ‘GɸɸPxx(Y/F)(ɸ/π)’ motif, has been crystallised in 
complex with a proline rich polypeptide (Rouka et al., PDB; Fig 3.2 A). Tyr56 in SNX9 is 
equivalent to Phe161 in the SH3 domain of the CD2-Associated protein. The side-chain of 
Phe161 faces outward and is positioned between the bulky proline side-chains of the 
proline rich polypeptide (Fig 3.2 A). This suggests that Tyr56 is critical for facilitating the 
binding of the SNX9 SH3 domain with PRD domains as was found in the Drosophila 
ortholog of SNX9 (DSH3PX1; Worby et al., 2002).  
 
A portion of the LC domain (yellow), containing the Ser176 and Tyr177 phospho-sites, has 
been crystallised in complex with an aldolase tetramer (Rangarajan et al., 2010; Fig 3.2 B-
D). Trp169 (yellow) is necessary for binding with aldolase (redorange) residues Arg42, 
Leu310 and Gln306 through hydrophobic interactions and Glu34 through hydrogen bonds 
(Rangarajan et al., 2010; Fig 3.2 C). Ser176 and Tyr177 interact with aldolase residues 
(Ser275, Glu278; Fig 3.2 D) through hydrophobic interactions (Rangarajan et al., 2010). 
This suggests that phosphorylation at Ser176 and Tyr177 might affect binding to aldolase. 
 
Residues that encompass the Yoke-PX-BAR domains have been crystallised due to their 
relative rigidity (Pylypenko et al., 2007; Fig 3.2 E-F). The phospho-sites (magenta) in the 
N-terminal Yoke domain (cyan) face outward close only to Yoke domain loops (Fig 3.2 
E). The lipid binding residues (blue) of the PX domain form a hydrophilic and positively 
charged pocket that PI3P (orange) is able to nestle into (Fig 3.2 F). Thr275 is proximal to 
PIP binding but on the opposite face of the PX domain (Fig 3.2 F). Their conserved nature, 
and proximity of Tyr56 and Thr275 to critical protein and lipid binding sites, respectively, 
suggest that they are most likely to play a key role in regulating SNX9 function.  
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M. musculus 34[NVGGGWLEGKNNKGEQGLVPTDYVEILPNDGKD]66
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D. rerio (SNX9a)  34[NVGGGWVEAQNSRGNVGLVPVDYVEVNSASAQA]66
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X. laevis 156[GPAV-DDDDWDDDWDDTKSSPPGYLGYKDSE--]187
D. rerio (SNX9a) 156[SVYS-FDEEWDDDSDDGKST-GGYGGSQAED--]187
D. rerio (SNX9b) 156[GPGA-EDDEWDEEWDDMKSS-GGYAESEAGE--]187
D. melanogaster  156[GSNWDDEDDWSDDNDTYSEIGPGGQKSAGQSAR]187
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X. laevis 215[GLDQYLMAKQLAKTK-----EKIPIIIGDYGPM]242
D. rerio (SNX9a) 215[NPEVYLLTKHITKGN-----DRLSVYPGEVGPV]242
D. rerio (SNX9b) 215[GPELYLLSKQQTKGN------KLSVYSGEVGPV]242
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X. laevis 267[KSYIEYQLTATNTNR--SVNHRYKHFDWLERLL]298
D. rerio (SNX9a) 267[KSYIEYQITPNTTNR--PVNHRYKHFDWLERLV]298
D. rerio (SNX9b) 267[KSYIEYQVIPTTTNK--PVNHRYKHFDWLERLL]298
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C. elegans 267[KSFIAYSITSSLTNIQRQVSRRYKHFDWLEQLS]298
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Figure 3.1: Tyr56, Tyr219 and Thr275 are highly conserved throughout evolution.
(A) Schematic diagram of SNX9 domains and location of phospho-sites. Amino acid
sequence alignment of SNX9 orthologs at (B) Tyr56 in the SH3 domain, (C) Ser176
and Tyr177 in the LC domain, (D) Tyr219 and Tyr239 in the N-terminal Yoke domain,
(E) Thr275 in the PX domain. [Key; ‘*’ conserved, ‘:’ strongly similar, ‘.’ weakly
similar. Known residues of importance to protein and lipid binding are underlined.
Phosphorylation sites studied are in red].
(D)
(C)
(E)
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Figure 3.2: Tyr56, Ser176, Tyr177 and Thr275 are likely to affect SNX9 function
when phosphorylated. Crystal structure of (A) CD2-Associated Protein SH3 domain
(grey). Phe161 (magenta) is equivalent to Tyr56, as part of the GLxPxxFV motif
(green), and binds to the PRD (orange). (B) Aldolase tetramer. (C) SNX9 Trp169
(yellow) interacts with aldolase (redorange). (D) Phospho-sites (magenta) Tyr177 and
Ser176 interact with aldolase (redorange). (E) PX-BAR of SNX9 (grey) including
phospho-sites Tyr219 and Tyr239 (magenta) in N-terminal Yoke domain (cyan). (F)
PX domain comprising RYKH motif (blue) interact with PIP (orange) and proximal to
this is the Thr275 (magenta) phospho-site. (G) Schematic of phospho-site side-chains
(Y, S, T), their phospho-deficient (F, A) and phospho-mimetic (E) counterparts.
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3.2.2. Generating phospho-mutants 
To gain an understanding of the regulation of the mitotic role of SNX9 by individual 
phosphorylation sites, each site in the GFP-SNX9 construct was mutated by either 
Maggie Ma or I to either a phospho-deficient or a phospho-mimetic form. Phenylalanine 
served as a phospho-deficient counterpart to tyrosine because it is identical except for 
tyrosine’s hydroxyl group that facilitates phosphorylation (Fig. 3.2 G). Similarly 
alanine was a suitable phospho-deficient counterpart to serine and threonine phospho-
sites as it is similar in chemical structure (Fig. 3.2 G). In all cases, phospho-sites were 
mutated to glutamic acid to mimic permanent phosphorylation (Fig. 3.2 G). Our aim 
was to determine, by over-expressing these phospho-mutants, whether these phospho-
sites regulated mitosis. 
3.2.3. Mitotic localisation of phospho-mutants 
I first sought to examine whether the phospho-mutations affected the localisation of SNX9 
throughout mitosis compared to endogenous SNX9. I established, by use of targeted 
siRNA to knockdown SNX9, the specificity of an antibody that detects SNX9 (Fig 3.3 A). 
The level of detectable SNX9 protein after 48 hours, as represented by the intensity of 
SNX9 fluorescent staining, in KD HeLa cells (SNX9a, SNX9b) was visibly reduced when 
compared to negative controls (H20, Luc, CHC; Fig 3.3 A). I then examined the 
localisation of endogenous and exogenously expressed SNX9 during mitosis. In 
interphase, endogenous SNX9 displayed a diffuse cytosolic localisation marked with 
infrequent puncta (Fig 3.3 B). During mitosis these puncta almost completely disappear 
only to re-appear during cytokinesis (Fig 3.3 B). Endogenous SNX9 was not enriched at 
the prometaphase spindle (Fig 3.3 B), in contrast to what has been previously reported (Ma 
and Chircop, 2012). Cells were then transiently transfected with GFP-SNX9 expression 
constructs, fixed in MeOH, then stained with a fluorescently conjugated antibody against 
GFP to overcome the quenching effect of MeOH on GFP. Wild-type GFP-SNX9 and 
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phospho-mutants at 24 hours after transient transfection displayed the same pattern of 
localisation as endogenous SNX9 during interphase as well as the discrete stages of mitosis 
(Fig 3.3 - 3.6). The exception to this is that exogenously expressed SNX9 appears to be 
weakly enriched at the prometaphase spindle in some cells; however, this is also observed 
in cells expressing GFP tag only (Fig 3.3 C). This suggests that the weak enrichment of 
fluorescence does not reflect the specific localisation of SNX9 but rather artefactual 
immunoreactivity of the α-GFP antibody used. Endogenous SNX9 was observed at the 
ICB during late cytokinesis, in agreement with previous reports (Ma and Chircop, 2012). 
The localisation of the SNX9 phospho-mutants (Fig 3.3 - 3.6) did not differ from the wild 
type except for in the following exceptions: 1) Tyr56Glu (Fig 3.4 B) does not localise to 
puncta in interphase or throughout mitosis, and 2) neither Tyr56Glu nor Thr275Glu (Fig 
3.6 D) were at the ICB. Thus, the phosphorylation state of Tyr56 defines the localisation of 
SNX9 and both Tyr56 and Thr275 regulate the localisation of SNX9 during cytokinesis.  
3.2.4. Phospho-mutants do not affect CME 
I then examined whether over-expression of the SNX9 phospho-mutants affected CME in 
interphase HeLa cells. Uptake of fluorescently labelled receptor ligand transferrin, which is 
the archetypal CME cargo (Le Roy and Wrana, 2005), was measured to assess CME. The 
total fluorescence intensity of transferrin-A568 positive puncta was measured at 8 minutes 
after incubation with ligand. Transferrin uptake was not affected in cells expressing 
wildtype and phospho-mutant GFP-SNX9 (Fig 3.7 C). The lack of effect was not due to 
differences in the level of exogenously expressed protein as the GFP fluorescence of the 
cells did not significantly differ between treatment groups (Fig 3.7 D). It is not known if 
the lack of effect is due to saturation of transferrin uptake. These results suggest that over-
expression of the phospho-mutants do not affect the canonical function of SNX9 in CME. 
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Figure 3.3: Localisation of endogenous SNX9 is comparative to GFP-SNX9
phospho-mutants. (A) HeLa cells transfected with siRNA targeting Luciferase,
SNX9 (SNX9A and SNX9B) or CHC were lysed and run on Western Blot to detect for
SNX9 and loading control β-actin. HeLa cells transfected with: (B) water (C) a GFP
expression construct, (D) a GFP-SNX9 expression construct; and after 24 hours
stained for GFP (green) [SNX9 in the case of (B)], alpha-tubulin (red) and DAPI
(blue). Representative images are maximum intensity projections of a z-stack, except
for pro-metaphase, which is only one plane. Only one of the spindle poles can be seen
in some of the images of the prometaphase spindle.
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Figure 3.4: Localisation of Tyr56 and Ser176 phospho-mutants. HeLa cells
transfected with a: (A) GFP-SNX9-Tyr56Phe, (B) GFP-SNX9-Tyr56Glu; (C) GFP-
SNX9-Ser176Ala, (D) GFP-SNX9-Ser176Glu and after 24 hours stained for GFP
(green), alpha-tubulin (red) and DAPI (blue). Representative images are maximum
intensity projections of a z-stack, except for pro-metaphase, which is only one plane.
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Figure 3.5: Localisation of Tyr177 and Tyr219 phospho-mutants. HeLa cells
transfected with a: (A) GFP-SNX9-Tyr177Phe, (B) GFP-SNX9-Tyr177Glu; (C) GFP-
SNX9-Tyr219Ala, (D) GFP-SNX9-Tyr219Glu and after 24 hours stained for GFP
(green), alpha-tubulin (red) and DAPI (blue). Representative images are maximum
intensity projections of a z-stack, except for pro-metaphase, which is only one plane.
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Figure 3.6: Localisation of Tyr239 and Thr275 phospho-mutants. HeLa cells
transfected with a: (A) GFP-SNX9-Tyr239Phe, (B) GFP-SNX9-Tyr239Glu; (C) GFP-
SNX9-Tyr275Ala, (D) GFP-SNX9-Tyr275Glu and after 24 hours stained for GFP
(green), alpha-tubulin (red) and DAPI (blue). Representative images are maximum
intensity projections of a z-stack, except for pro-metaphase, which is only one plane.
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Figure 3.7: Over-expression of phospho-mutants do not affect CME. HeLa cells
were transfected with EGFP-N1, GFP-SNX9 or phospho-mutants. A transferrin
uptake assay was performed on these cells in three technical replicates (wells) in
three independent biological replicates. (A) 16 evenly spread images, from each
technical replicate, were taken of DAPI, transferrin-A568 and GFP. (B) A custom
IXM module was configured to i) isolate transferrin-A568 puncta; ii) generate masks
based on the GFP image and iii) superimpose the masks onto the transferrin-A568
puncta. The yellow masks define the region from which measurements were taken.
The output measurements are the average integrated intensity of (C) transferrin-A568
at 8 minutes after transferrin treatment (which was then normalised to the GFP
treatment group) and (D) GFP. Each data point is the average of a biological replicate
(~700 cells on average). Bars represent the mean and 95% confidence intervals. The
treatment groups were statistically compared using a Kruskal Wallis ANOVA with a
Dunns Multiple Comparisons post-test. Comparisons were made between WT and all
treatment groups, except GFP, as well as between each pair of phospho-deficient and
phospho-mimetic mutants. No comparisons were found to be statistically significant.
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3.2.5. Tyr56 and Thr275 respectively regulate the metaphase and cytokinesis 
function of SNX9 
Finally, I assessed whether over-expression of the phospho-mutants affected the duration 
of mitosis, as an indicator of whether they play a role in regulating the mitotic function of 
SNX9. Independent experiments conducted for each phospho-site, demarcated by colour, 
are presented normalised to the global WT mean. Each allele colour corresponds to its 
respective WT control colour. Expression of mCherry-α-tubulin was used as a microtubule 
marker to demarcate phases of mitosis (Fig 3.8 A). Phospho-mimetic mutants of Tyr56 and 
Thr275 delayed mitosis compared to their phospho-deficient counterparts (Fig 3.8). Cells 
expressing Tyr56Glu took 179 min to complete mitosis, which was significantly (p < 
0.001) longer than the 141 min taken by cells expressing Tyr56Phe (Fig 3.8 B). Tyr56Glu 
took 24 mins longer (p < 0.001) than Tyr56Phe cells to reach anaphase, which represents 
the majority of the mitotic delay. Thr275Glu significantly (p < 0.05) delayed mitosis 
relative to Thr275Ala (Fig 3.8B). Though not statistically significant (p < 0.1), Thr275Glu 
cells took 17 mins longer to complete abscission than Thr275Ala cells (Fig 3.8 E). These 
findings were not confounded by the level of phospho-mutant or α-tubulin mitotic marker 
expression as the GFP and mCherry fluorescence of the cells did not significantly differ 
between treatment groups (Fig 3.8 F-G). The GFP fluorescence of cells expressing GFP 
tag-only differed from wildtype GFP-SNX9 (Fig 3.8B) but this did not affect duration of 
mitosis (Fig 3.8). None of the phospho-mutants affected any parameter when compared to 
its respective WT control (Supplementary B). Thus, of the phospho-sites assayed, Tyr56 
and Thr275 were found to affect the mitotic function of SNX9. 
3.3. Discussion 
The first aim of this thesis was to evaluate the significance of phosphorylation in 
regulating the mitotic role of SNX9. In this chapter the effect of phospho-deficient and  
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Figure 3.8: Phospho-mimetic mutants Tyr56 and Thr275 induce delay in
metaphase and the abscission stage of cytokinesis respectively. HeLa cells were
transfected with one of wild-type GFP-SNX9, phospho-deficient mutant or phospho-
mimetic mutant and co-transfected with microtubule marker α-tubulin-mCherry.
Following 24 hours, cells were imaged every 4 minutes for 24 hours. Each
independent data point is the average of 3-17 cells from a single field. A total of 12
fields were selected from 3-4 biological replicates on the basis of ensuring even GFP
and mCherry fluorescence between treatment groups. Data was organised in this
fashion to meet the independence assumption of the statistical test used as well as
ensure that the mitotic timing observed was not confounded by level of mCherry-α-
tubulin and GFP-SNX9 expression (Supplementary A). The number of fields and the
number of biological replicates was kept consistent within each trio of wildtype
GFP-SNX9, phospho-deficient mutant and phospho-mimetic mutant. (A)
Representative image illustrates the morphological features used to define the stages
of mitosis. α-tubulin-mCherry is red and GFP-SNX9 is green. (B) Mitosis timing was
assessed as the duration between breakdown of the nuclear envelope to the
abscission of the ICB. Duration of mitosis was partitioned into the duration of (C)
Prophase to Anaphase: breakdown of the nuclear envelope to the separation of the
mitotic spindle; (D) Anaphase to ICB formation: separation of the mitotic spindle to
the full ingression of the ICB; and (E) ICB formation to Completion: full ingression
of the ICB to the scission of the ICB. Expression of (F) mCherry-α-tubulin, and (G)
GFP-SNX9 did not differ between treatment groups. In all graphs the bars represent
the mean and 95% confidence intervals of data normalised to the global mean of
wild-type controls. In all graphs each allele colour corresponds to its respective WT
control colour. All comparisons within each trio (WT, phospho-deficient, phospho-
mimetic) for each phosphorylation site was statistically made using a Kruskal Wallis
ANOVA with Dunns Multiple Comparisons post-test. GFP tag alone was compared
to WT GFP-SNX9 with a Mann-Whitney one-tailed t-test. All statistical tests were
performed on data prior to normalisation (Supplementary B). Non-significant
comparisons have not been visualised. *: p<0.05, ***: p<0.001. Normalisation was
performed to make all of the biological replicates visually comparable.
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phospho-mimetic mutations on the duration of mitosis was assessed. I found that the 
phospho-mimetic mutants of Tyr56 and Thr275 delayed mitosis, compared to their 
respective phospho-deficient mutants.  
Based on the findings in this chapter, I hypothesise that: 1) the PRD binding affinity of the 
SH3 domain, regulated by phosphorylation of Tyr56, is key to the metaphase role of 
SNX9; and 2): the PX domain of SNX9, regulated by phosphorylation of Thr275, is 
important to the role of SNX9 in cytokinesis.  
Cells over-expressing Tyr56Glu took longer to reach anaphase than cells over-expressing 
Tyr56Phe. Additionally, the Tyr56Glu mutation mis-localised exogenous SNX9 during 
interphase and cytokinesis. Together, these findings suggest that Tyr56 is key to the proper 
localisation of SNX9 and that over-expression of Tyr56Glu results in the dominant 
negative mis-localisation of binding partners, like clathrin, that are key to metaphase. 
Tyr56 likely regulates the functionality of the SNX9 SH3 domain. Visualisation of the 
crystal structure of Phe161 in the SH3 domain of CD2-Associated protein, which is 
homologous to Tyr56 in SNX9, indicates that the aromatic side-chain of Tyr56 in SNX9 
interfaces with the large hydrophobic side-chains of PxxP motifs. This suggests that Tyr56 
is critical for interactions with PRDs. The charged and polar nature of phosphorylation 
would likely disrupt these hydrophobic interactions. In support of this, phosphorylation of 
Tyr56 in drosophila orthologue DSH3PX1 prevented binding to WASP (Worby et al., 
2002), which interacts through the SH3 domain (Badour et al., 2007). Tyr56 is highly 
conserved between orthologues; therefore, it is likely that the Tyr56Glu mutant of human 
SNX9 is also unable to bind PRDs.  
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The localisation of SNX9 appears to be dependent on the SH3 domain. Tyr56Glu disrupted 
the localisation of SNX9 to puncta during interphase and to the ICB during cytokinesis. 
This is either due to: 1) the SH3 domain interacting with regulators that direct SNX9 
localisation; and/or 2) a proline rich protein directly recruits SNX9. Lundmark and 
Carlsson (2004) proposed that cytosolic SNX9 is kept in an inactive state in a complex 
with aldolase and dynII. The authors demonstrated that tyrosine phosphorylation signalling 
is necessary for targeting SNX9 from its inactive complex to membrane recruitment 
(Lundmark and Carlsson, 2004). One possibility is that SNX9 is recruited to the membrane 
by ACK phosphorylation. The SH3 domain of SNX9 binds to the ACK family of kinases 
(Yeow-Fong et al., 2005, Worby et al., 2002, Childress et al., 2006, Lin et al., 2002). ACK 
phosphorylation of SNX9 is key for the function of SNX9 in the targeting of activated 
EGFR for lysosomal degradation (Childress et al., 2006, Lin et al., 2002). It is possible that 
ACK binds and phosphorylates SNX9 to promote dimerisation and recruitment to the 
membrane. In this model Tyr56Glu would be unable to bind ACK and therefore would 
remain cytosolic. Alternatively, directly interacting with proline rich proteins such as 
dynII, WASP or OCRL1 may be necessary for the stabilisation of SNX9 to membrane. 
The role of Tyr56 in regulating the membrane recruitment of SNX9 could be tested by 
comparing, by Total Internal Reflection Fluorescence (TIRF) microscopy, the membrane 
recruitment of wildtype SNX9 and Tyr56 phospho-mutants.  
The cytosolic localisation of Tyr56Glu coincides with prolonged prophase to anaphase 
duration. Ma and colleagues (Ma et al., 2013b) proposed that SNX9 localises to the spindle 
during prometaphase where it stabilises spindle localised clathrin. This chapter contrasts 
with the study by Ma and colleagues (Ma et al., 2013b) in that I did not observe an 
enrichment of SNX9 at the prometaphase spindle. The difference in antibody used to 
visualise endogenous SNX9 might be responsible for this disparity; however, this does not 
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explain the absence of exogenous SNX9 enrichment to the spindle. Exogenous GFP-SNX9 
was observed at the prometaphase spindle; however, the same observation was made in 
cells expressing GFP tag alone suggesting that the immuno-reactivity of the spindle was 
artefactual and/or inconclusive. Additionally, exogenous GFP-SNX9 in live cell 
microscopy, not affected by the artefacts of fixed cell immunofluorescence, did not appear 
enriched at the spindle (Supplementary C). Though I cannot rule out that SNX9 might 
localise to the mitotic spindle in low concentrations, our findings suggest that SNX9 does 
not stabilise clathrin to the spindle through direct association but rather indirectly. Kinase 
GAK removes clathrin from vesicles whereupon it is transported to the mitotic spindle by 
B-myb (Royle, 2011, Shimizu et al., 2009, Yamauchi et al., 2008). SNX9 binds to OCRL1,
which uncoats clathrin coated vesicles (Nandez et al., 2014) and therefore might 
analogously contribute to the availability of clathrin for targeting to the spindle. Tyr56Glu, 
likely unable to bind OCRL1, might induce metaphase delay by failing to dissociate 
clathrin from clathrin coated vesicles. Thus, future work should seek to investigate 
whether: 1) binding to OCRL1 is affected by mutation of Tyr56Glu, and 2) expression of 
Tyr56Glu results in the mis-localisation of clathrin from the spindle (see section 4.2.3). 
The role of SNX9 in cytokinesis appears to be regulated by Thr275. There are several 
models of the role of SNX9 at different stages of cytokinesis. SNX9 is necessary for the 
correct enrichment of myosin regulatory light chain to the cleavage plane for myosin 
mediated ingression (Ma and Chircop, 2012). The duration of ingression was not affected 
by expression of Thr275Glu suggesting that Thr275 does not dominant negatively affect 
the role of SNX9 in ingression. SNX9 becomes enriched at the ICB and is critical for the 
successful completion of abscission (Ma and Chircop, 2012). Thr275 likely regulates the 
role of SNX9 in abscission as expression of Tyr275Glu delayed abscission timing. The 
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significance of Thr275 specifically to abscission could be assessed by assaying cells 
expressing Thr275 phospho-mutants for ingression and abscission failure.  
The proximity of Thr275 to the PIP binding motif of the PX domain suggests that it might 
regulate the binding affinity of SNX9 to phosphatidylinositol-3-phosphates. The simplest 
approach for studying PIP binding affinity is with a protein-lipid overlay assay (Narayan 
and Lemmon, 2006); however, the accuracy of this method is questionable. One reported 
use of this method reported that the PX domain of SNX9 binds PI(3,4,5)P3 but not PI3P 
(Badour et al., 2007), which does not reflect the consensus of evidence (Teasdale and 
Collins, 2012). Future work should explore the use of isothermal titration calorimetry to 
assess the binding affinity of Thr275 phospho-mutants for different PIP isoforms (Narayan 
and Lemmon, 2006). 
PI3P accumulates at the midbody through the activity of class III phosphoinositide 3-kinase 
(PI3K; (Sagona and Stenmark, 2010). Thr275Glu was notably absent from the ICB, which 
suggests that SNX9 is recruited to the ICB by PI3P and that recruitment of SNX9 to the 
ICB is regulated by Thr275. Tyr56Glu also did not localise to the ICB; however, this might 
be confounded by its similar mis-localisation in earlier stages of the cell cycle. The 
dominant negative effect of Thr275Glu expression on abscission duration is possibly 
through the formation of mutant and endogenous SNX9 hetero-dimers that are mis-
localised from the ICB, though this is entirely speculative. SNX9 is required for the 
delivery of Rab11 recycling endosomes to the ICB (Ma and Chircop, 2012). Future work 
should determine the effect of Thr275Glu expression on Rab11 localisation at the ICB to 
assess whether Thr275Glu expression mimics SNX9 depletion. 
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Neither Tyr56Glu or Thr275Glu affected transferrin uptake indicating that the dominant 
negative effect of these mutants on mitosis was not confounded by perturbation of CME. 
Redundancy in CME suggests that the lack of effect on CME does not mean that the role 
of SNX9 in CME was not disturbed. Dominant negative disruption of the function of 
endogenous SNX9 in CME could be overcome by endogenous SNX18 (Park et al., 2010b) 
as well as other proteins (Dergai et al., 2016, Bendris and Schmid, 2017). Subtle effects on 
CME could be better assessed with observation of ligand internalisation in live cells by 
time lapse microscopy such that the efficiency of CME could be evaluated. A positive 
control, such as siRNA knockdown of CHC, would have determined the sensitivity of the 
assay to detect changes in transferrin uptake. It is also important to note that though a 
transferrin uptake assay is commonly used to assess CME, there are subtle differences in 
the mechanism by which different receptors are internalised (McMahon and Boucrot, 
2011). SNX9 functions in the internalisation of EGFR (Lin et al., 2002), thus 
internalisation of EGF ligand should also be assessed. This finding also does not exclude 
the possibility that Tyr56Glu and Thr275Glu might perturb clathrin-independent modes of 
endocytosis or sorting of membrane beyond endocytosis. Further investigation of the 
mechanism of the effect of Tyr56Glu and Thr275Glu on mitosis must take this into 
consideration. 
In addressing our first aim, I found that the mitotic role of SNX9 is regulated by 
phosphorylation. The following chapters explore the mechanisms by which Tyr56 and 
Thr275 respectively regulate the metaphase and cytokinesis function of SNX9.  
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4.1. Introduction 
In the previous chapter (Chapter 3) we found that over-expression of Tyr56Glu resulted in 
metaphase delay. The phosphorylation state of Tyr56 regulates SH3 functionality in 
Drosophila (Worby et al., 2002). Therefore we hypothesised that the PRD binding affinity 
of the SH3 domain, regulated by phosphorylation of Tyr56, is key to the metaphase role of 
SNX9. We sought to test this hypothesis by investigating: 1) the role of phosphorylation at 
Tyr56 in regulating the PRD binding affinity of human SNX9 and 2) the significance of 
PRD binding affinity to the metaphase role of SNX9. 
4.2. Results 
4.2.1. Tyr56Glu disrupts binding to PRDs
A joint effort between Chin Wong (Pull-downs, Western Blots), Sushma Rao (Pull-
downs), Steven He (Pull-downs and Western Blots), Daniel Yagoub (Pull-downs and Mass 
spectrometry) and myself (Western Blots) tested whether phospho-mimetic mutation of 
Tyr56 disrupted binding of SNX9 to PRDs. Pull-downs using SNX9 wild-type and mutant 
(Tyr56Phe, Tyr56Glu, Thr275Ala, Thr275Glu) bait proteins with synchronised metaphase 
HeLa lysates were performed in biological triplicate and analysed on an Orbitrap mass 
spectrometer. The label-free quantitation (LFQ) module of MaxQuant (Cox and Mann, 
2008) identified, after data filtering in Perseus (details in chapter 2), a total of 691 proteins 
(Supplementary Table A). Pair-wise comparison of GST-alone versus wild-type SNX9 
identified 61 proteins as specific wild-type SNX9 interactors (Supplementary Table B). 
Gene ontology (GO) analysis using DAVID tools (Jiao et al., 2012) of proteins identified 
as specific wild-type SNX9 interactors returned three clusters with enrichment scores >1.3 
(Supplementary Table C). These clusters contained biological processes centrally relating 
to endocytosis, actin filament-binding, and phosphatidylinositol processing, reflecting the 
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established role of SNX9 (Badour et al., 2007, Nandez et al., 2014, Lundmark and 
Carlsson, 2009, Lundmark and Carlsson, 2003). Wild-type SNX9 pull-downs were then 
compared to the mutant forms (Tyr56Phe, Tyr56Glu, Thr275Ala, Thr275Glu) in a 
sequential pair-wise manner to determine the effect of these single amino acid site 
mutations on SNX9 protein-protein interactions. At the same statistical thresholds, only the 
Tyr56Glu mutant exhibited changes in protein binding, with a total of 22 proteins all 
showing reductions in binding relative to wild-type SNX9 (Supplementary Table D). No 
other SNX9 mutant showed statistically significant variations in protein binding relative to 
wild-type SNX9. The abundance of each SNX9 bait protein within each biological 
replicate did not differ (Supplementary Figure D). 
Tyr56Phe and Tyr56Glu were then directly compared to clarify the significance of 
phosphorylation at Tyr56. This highlighted 12 proteins which exhibited statistically 
significant differential binding between the Tyr56Glu and Tyr56Phe variants 
(Supplementary Table E). With the exception of RPN2, the remaining 11 genes encoding 
proteins that showed reduced binding to Tyr56Glu relative to wild-type SNX9 as well. Of 
these 11, 9 have been previously identified to be binding partners of SNX9. These include: 
WASL, WIPF1 and WIPF2 that function in actin polyermisation (Anton et al., 2007); 
ADAM9, which is a membrane protein involved in degrading extracellular matrix (Peduto, 
2009); dyn2, a GTPase key to endocytosis (Ferguson and De Camilli, 2012); OCRL, 
SYNJ1 and SYNJ2, which are lipid phosphatases (Nandez et al., 2014, Chang-Ileto et al., 
2011, Rusk et al., 2003), and Sam68 (KHDR1), which is a transcriptional regulator. With 
the exception of ADAM9, all of these genes encoding proteins function in CME. DynII, 
OCRL1 and actin polymerisation have roles in cytokinesis (Chircop et al., 2011, Ishida et 
al., 2011, Smith and Chircop, 2012, Dambournet et al., 2011, Glotzer, 2005). It is possible 
that the known binding partners also have roles in mitosis that are yet to be elucidated. Of 
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the other two proteins that have not been previously reported SNX9 binding partners, 
Cyclin K (CCNK) has an established role in regulating cell cycle progression (Barlat et al., 
1997, Edwards et al., 1998). Enrichment analysis for sequence features was then 
performed using DAVID tools for Uniprot sequence annotation features. Of the 61 proteins 
identified in this study as SNX9-binding proteins, 43% showed a compositionally biased 
poly-proline or proline-rich region (Supplementary Table F). 58% of these proteins bound 
less to Tyr56Glu. In contrast, only 11% of the proteins that: 1) bind SNX9, and 2) do not 
have a poly-proline or proline-rich region; bound less to Tyr56Glu. Strikingly, 75% of all 
proteins that showed reduced binding to SNX9-Y56E relative to SNX9-Y56F feature a 
poly-proline or proline-rich region (Supplementary Tables G, H). This supports our 
hypothesis that the Tyr56 site within the SH3 domain of SNX9 is important for mediating 
interactions with other proteins that bind through PRDs. A sub-group of the known 
interacting partners were validated by western blot. In both mass spectrometry (n = 3) and 
western blot (n = 2): 1) clathrin heavy chain (CHC) was not enriched by wildtype SNX9 or 
any phospho-mutants; 2) OCRL and dynII displayed reduced binding to Tyr56Glu 
compared to wildtype SNX9 and Tyr56Phe; 3) AP-2 bound wildtype SNX9 and binding 
was not affected by mutation at Tyr56 or Thr275 (Fig 4.1 A-B). Tyr56Glu similarly 
displayed reduced binding to OCRL and dynII from asynchronous cell lysate (Fig 4.1 C). 
DynII and OCRL1 are not known to have roles during metaphase. The sub-cellular 
localisation of OCRL1, dynII and pdynIIS764, which can differ in localisation to dynII 
(Chircop et al., 2011), was visualised in metaphase cells. OCRL1, but not dynII or 
pdynIIS764, localised at a structure resembling a mitotic spindle and was enriched at its 
respective poles (Fig 4.2 A). Expression of wildtype GFP-SNX9 or Tyr56 phospho-
mutants did not affect the localisation of OCRL1 to spindle poles (Fig 4.2 B). This 
suggests that OCRL1 is recruited to the spindle poles independent of SNX9 but suggests 
SNX9 might transiently associate with OCRL1 at the spindle poles during mitosis. 
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Label-free quantitation of SNX9-interacting proteins in pull-downs
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Figure 4.1: Tyr56Glu blocks binding to PRDs. Pull-downs were performed using
SNX9 wild-type and mutant (Tyr56Phe, Tyr56Glu, Thr275Ala, Thr275Glu) bait
proteins. (A) Three independent biological replicates were analysed on an Orbitrap
Mass spectrometer. Graph represents average label free quantitation (LFQ) intensity
of selected known SNX9 binding partners (CHC, OCRL1, dynII and subunits of AP-
2: AP2A1, AP2A2, AP2B1, AP2M1, AP2S1) for each bait protein. Amount of SNX9
did not differ between bait proteins (Supplementary Figure D). (B) Western blots
were performed on pulldowns, in biological duplicate, for validation of mass
spectrometry findings. Western blots were probed for CHC, OCRL1, dynII and the
AP2A1 subunit of the AP-2 complex. The amount of each bait protein was deemed
comparable by coomassie staining (Supplementary Figure E). Note that the order of
bait proteins changed between western blots and had to be corrected in this figure to
make the different pulldowns visually comparable. In particular Tyr56Phe and
Tyr56Glu technical replicates alternate in the original blot of ‘AP-2 n = 2’
(Supplementary Figure E). All of the whole western blots are available for reference
(Supplementary Figure E). (C) The same pull-down was performed with
asynchronous lysate (Supplementary Figure F) and probed for OCRL and dynII. Pull-
downs were performed by Chin Wong, Sushma Rao, Steven He and Daniel Yagoub.
Mass spectrometry and sequence feature enrichment analysis performed by Daniel
Yagoub. Western Blots performed by Chin Wong, Steven He and Dadar Ahmadi-
Pirshahid.
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Figure 4.2: OCRL1 is enriched at structures resembling mitotic spindle poles.
(A) HeLa cells were MeOH fixed and stained for dynII, pdynIIS764 and OCRL1.
Representative images display enrichment of OCRL1, but not dynII or pdynIIS764, at
the metaphase spindle. (B) HeLa cells exogenously expressing either wildtype GFP-
SNX9 or Tyr56 phospho-mutants were MeOH fixed 24 hours after transfection and
stained for OCRL1. Representative images of OCRL1 enrichment to the mitotic
spindle in presence of Tyr56 phospho-mutants.
95
Chapter 4. Tyr56 regulates the metaphase function of SNX9
Chapter 4. Tyr56 regulates the mitotic function of SNX9 
96 
4.2.2. Tyr56Glu impairs spindle pole integrity
Having established that the Tyr56Glu mutation reduces binding of SNX9 to some PRD 
containing proteins in-vitro, we then sought to determine the significance of this to the 
metaphase role of SNX9. Morphological defects consistent with metaphase failure were 
analysed in cells expressing SNX9 phospho-mutants. Three major morphological defects 
were assessed (Fig 4.3). These included: 1) formation of a bi-polar spindle that degenerates 
into a multi-polar spindle (Fig 4.3 B); 2) multiple microtubule organising centres that 
result in a multi-polar spindle (Fig 4.3 C); and 3) mitotic catastrophe (Fig 4.3 D). 
Cells expressing Tyr56Glu featured a greater rate of overall metaphase defects than 
cells expressing Tyr56Phe (30.2% v.s. 9.5%, p < 0.01; Fig 4.4 A), which corresponds to 
cells spending an increased period of time in metaphase. Cells expressing Tyr56Phe 
also displayed a lower rate of overall metaphase defects than cells expressing WT GFP-
SNX9 (9.5% v.s. 28.1%, p < 0.01; Fig 4.4 A). A similar trend was observed for the 
Tyr177 phospho-site. Cells expressing Tyr177Phe featured a lower rate of 
overall metaphase defects that cells expressing Tyr177Glu (14.7% v.s. 34.6%, p < 0.01 ; 
Fig 4.4 A) and WT GFP-SNX9 (14.7% v.s. 30.2%, p < 0.05 ; Fig 4.4 A). Over-expression 
of GFP-SNX9, or the remainder of the phospho-mutants when compared to the WT control 
or their respective phospho-mutants, did not result in a notable difference in the 
rate of metaphase defects (Fig 4.4 A).  
The majority of metaphase defects observed were bipolar spindles degenerating into multi-
polar spindles (Fig 4.4 B-D). The same trends were observed for this defect as for 
the overall metaphase defects (Fig 4.4 A-D). Expression of Tyr56Phe reduced spindle 
pole fragmentation when compared to Tyr56Glu (6.3% v,s, 27.0%, p < 0.001, Fig 4.4 
B) and WT GFP-SNX9 (6.3% v.s. 20.7%, p < 0.01, Fig 4.4 B). Expression of 
Tyr177Phe reduced spindle pole fragmentation when compared to Tyr177Glu (13.2% v,s, 
32.1%, p < 0.01, Fig 4.4 B) and WT GFP-SNX9 (13.2% v.s. 30.2%, p < 0.05, Fig 4.4 B).  
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Figure 4.3: Defects consistent with metaphase failure. Representative images
feature cells (labelled with alpha-tubulin-mCherry) undergoing prophase to
anaphase. Cells were categorised as either displaying (A) a normal metaphase
spindle, (B) formation of a bi-polar spindle that degenerates into a multi-polar
spindle, (C) multiple MTOCs that result in a multi-polar spindle, and (D) apoptotic
or necrotic cell death during metaphase.
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Figure 4.4: Tyr56Glu expression results in bi-polar spindles collapsing into
multi-polar spindles. HeLa cells were transfected with one of wild-type GFP-SNX9,
phospho-deficient mutant or phospho-mimetic mutant and co-transfected with
mitosis marker α-tubulin-mCherry. After 24 hours, transfected cells were imaged
every 4 minutes for 24 hours to visualise mitosis. The expression of GFP-SNX9 and
α-tubulin-mCherry was measured to make sure that they were consistent between
treatment groups (Fig 3.8; Supplementary A). Graphs represent the percentage of
cells pooled from all biological replicates for each treatment group that featured (A)
any metaphase defect, (B) multi-polar spindles that originated from bi-polar spindles
(C) multi-polar spindles that originated from multiple MTOCs and (D) mitotic
catastrophe. In all graphs each allele colour corresponds to its respective WT control
colour. Each column represents the percentage of pooled cells per treatment group
(52 – 95 cells) with bars representing 95% confidence intervals calculated by the
hybrid Wilson/Brown method. (A-D) Comparisons between treatment groups of the
trio (WT, phospho-deficient, phospho-mimetic) for each phosphorylation site were
statistically analysed by two sided Chi-square Fischer’s exact test. Non-significant
comparisons have not been visualised. *: p<0.05, **: p<0.01, ***: p<0.001
(A)
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Thr275Ala increased total metaphase defects compared to WT GFP-SNX9 (36.4% v.s. 
17.8%; p < 0.05; Fig 4.4A). This did not correspond to any significant difference in 
particular metaphase defects. Expression of wild-type GFP-SNX9 or any of the 
other phospho-mutants did not affect the rate of cells with multiple 
microtubule organising centres to begin with (Fig 4.4 C) or mitotic catastrophe 
(Fig 4.4 D). Therefore, the expression of Tyr56Glu appears to be inducing the 
fragmentation of bi-polar spindles into multi-polar spindles. 
Multi-polar spindles can result from centriole amplification (Kwon et al., 
2008). Supernumerary centrosomes, either as a result of overproduction of 
centrosomes or cytokinesis failure (Kwon et al., 2008), are typically clustered into 
two spindle poles (Maiato and Logarinho, 2014). Multi-polar spindles can form when 
these extra centrioles overcome clustering forces leading to their separation (Kwon 
et al., 2008). Multi-polar spindles may also form without centriole amplification 
as a result of failing centrosome integrity leading to: 1) the separation of 
mother and daughter centrioles; or 2) fragmentation of the spindle pole 
pericentriolar material carrying microtubule organising elements (Maiato and 
Logarinho, 2014). Therefore we sought to determine whether expression of 
Tyr56Glu induced multi-polar spindles through centriole amplification or through 
disruption of centrosome integrity. Centrioles were visualised, with 
immunofluorescent staining of centriole marker centrin-2, in mitotic cells 
expressing wildtype GFP-SNX9 and phospho-mutants (Fig 4.5). Cells were 
categorised as either being normal, that is having two centrosomes each containing 1-2 
centrioles (Fig 4.5 A), or abnormal; supernumerary (3+) centrioles in at least one 
centrosome or multiple centrosomes (Fig 4.5 B). Substantially, but not 
significantly, more cells expressing Tyr56Glu featured supernumerary centrioles 
than cells expressing Tyr56Phe or wildtype SNX9 (Fig 4.5 C).  
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Figure 4.5: Tyr56Glu disrupts spindle pole integrity. HeLa cells expressing wild-
type GFP-SNX9, a phospho-deficient mutant or a phospho-mimetic mutant (of Tyr56
and Thr275) were fixed, 24 hours after transfection, for 2-3 minutes in MeOH at -20
oC and stained for centriole marker centrin 2. Cells were selected from each
treatment group on the basis of GFP-SNX9 expression and imaged on a confocal
microscope. Selected cells were analysed with image analysis software IMARIS.
Centrioles were identified using the spot module looking for highest centrin 2
fluorescence intensity of approximately 0.15 - 0.20 μM in diameter. Cells were
categorised as either comprising: (A) 1-2 centrioles in each of two centrosomes; or
(B) supernumerary centrioles, defined as either 3+ centrioles in at least one
centrosome or multiple centrosomes. (C) Graph represents the percentage of cells,
pooled from all biological replicates, that featured supernumerary centrioles. Each
column represents the percentage of cells per treatment group (36 cells) with bars
representing 95% confidence intervals calculated by the hybrid Wilson/Brown
method. The proportion of supernumerary cells to normal cells in cells expressing
Ty56Glu and Tyr56Phe was statistically compared using a two-sided Chi-squared
Fischer’s exact test and were found to be non-significantly (p = 0.0795) different. (D)
For the cells that do not feature supernumerary centrioles, the distance between the
centre of each of these centrioles and the centre of the closest centriole in three
dimensions was calculated using the “distance between spots” module. Data is
presented as the average minimum distance between centrioles (n = 3; cells = 6-12
per independent biological replicate). Tyr56Glu and Tyr56Phe was statistically
compared using a one-tailed Mann-Whitney t-test and was found to be significantly
(p = 0.05; *) different. (E) Graph represents the level of expression of phospho-
mutants and wildtype SNX9. Tyr56Glu and Tyr56Phe was statistically compared
using a one-tailed Mann-Whitney t-test and was found to be non-significantly (p =
0.35) different. On all graph bars represent SEM.
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Supernumerary centrioles were not reliably more abundant in Tyr56Glu cells and could be 
caused by defects in interphase and cytokinesis. Thus centrosome amplification is likely to 
be a contributing factor but not wholly responsible for the formation of Tyr56Glu induced 
multi-polar spindles. Spindle pole integrity was then evaluated in cells without centrosome 
amplification. The distance between centrioles, in three dimensions, was significantly (p < 
0.05) greater in cells expressing Tyr56Glu relative to Tyr56Phe (Fig 4.5 D). Comparisons 
between Tyr56Phe and Tyr56Glu were not confounded by level of expression of phospho-
mutants (Fig 4.5 E). Therefore Tyr56Glu induced multi-polar spindles likely result from 
disruption of centrosome integrity, which may be exacerbated by centriole amplification. 
4.2.3. Tyr56 regulates CHC at the spindle
Prolonged metaphase duration can lead to the degeneration of bi-polar spindles, without 
centrosome amplification, into multi-polar spindles as a result of ‘cohesion fatigue’ 
(Maiato and Logarinho, 2014). The physical tension of attempting to properly segregate 
chromosomal material over a long period of time disengages centrioles and thus results in 
fragmented spindle poles (Maiato and Logarinho, 2014). This phenomenon best describes 
our observations of cells expressing Tyr56Glu. This would suggest that Tyr56Glu directly 
affected prophase to anaphase duration, which indirectly resulted in disruption of 
centrosome integrity and formation of multi-polar spindles. Knockdown of SNX9 results 
in metaphase delay as a result of a loss of spindle stabilised clathrin (Ma et al., 2013b, Ma 
and Chircop, 2012). De-stabilisation of clathrin from the spindle has also been reported to 
result in the formation of multi-polar spindles (Foraker et al., 2012). Therefore we sought 
to determine whether Tyr56Glu expression similarly disrupted localisation of clathrin to 
the spindle. With fixed cell immunofluorescence, Tyr56Glu expressing cells appear to 
have less clathrin enriched on the mitotic spindle than Tyr56Phe cells (Fig 4.6 A-C).  
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Figure 4.6: Tyr56Glu reduces clathrin enrichment at the spindle. (A-C)
Representative images of, cells expressing wildtype GFP-SNX9 or Tyr56 phospho-
mutants (green). HeLa cells were fixed 24 hours after transfection with 3.7 % PFA
and stained with anti-CHC (clathrin heavy chain; red) and DAPI (blue). (D) Cells co-
expressing wildtype GFP-SNX9, or Tyr56 phospho-mutants, and CLC-mCherry
(clathrin light chain) were imaged every 4 minutes for 24 hours. A maximum
intensity projection of the frame immediately prior to anaphase was generated for
each cell. The average fluorescence intensity of a circle around the cell (CO) and a
circle around the spindle (CS) was measured with Metamorph. The average
fluorescence intensity of the outer doughnut (representing cytosolic clathrin) was
calculated using (Fluorescence of CO minus Fluoresence CS) divided by (Area of CO
minus Area of CS). The average fluorescence intensity of the inner circle (spindle
localised clathrin) was divided by the average fluorescence intensity of the outer
doughnut. This value represented the factor of clathrin enrichment on the spindle.
The factor of clathrin enrichment in cells expressing Tyr56 phospho-mutants was
then normalised to wildtype GFP-SNX9. Tyr56Phe was compared to Tyr56Glu with
a Mann-Whitney t-test, * p = 0.05. n = 3, 19 – 38 cells per treatment group per
biological replicate.
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The clathrin that remains on the spindle in Tyr56Glu expressing cells is also more 
diffusely spread throughout the spindle compared to the discrete fibre-like organisation of 
clathrin inter-microtubule bridges observable in Tyr56Phe expressing cells (Fig 4.6 A-C). 
The enrichment of clathrin to the mitotic spindle in live cells was then assessed. Cells co-
expressing wildtype GFP-SNX9, or Tyr56 phospho-mutants, and CLC-mCherry were 
examined by live cell microscopy. The factor of clathrin enrichment to the metaphase 
spindle, compared to the cytosol, was quantitated in metaphase cells immediately prior to 
anaphase. In corroboration with observations made in fixed cell analysis, clathrin 
enrichment to the spindle was significantly (p = 0.05) reduced (Fig 4.6 D). Altogether, 
these findings suggest that stabilisation of clathrin to the mitotic spindle might depend on 
interactions, through the SH3 domain, between SNX9 and proline-rich proteins. 
4.3. Discussion 
The second aim of this thesis was to investigate the role of Tyr56 in regulating the 
metaphase function of SNX9. I propose that de-phosphorylation of Tyr56 is needed for 
SNX9 mediated stabilisation of clathrin to the mitotic spindle, which contributes to the 
efficient completion of metaphase and spindle pole integrity. This claim is based on the 
coinciding observations that: 1) expression of Tyr56Glu results in reduced clathrin at the 
mitotic spindle, and 2) Tyr56Glu binds some PRD containing proteins with much less 
affinity than phospho-deficient counterpart Tyr56Phe. 
4.3.1. Tyr56 regulates interactions with PRDs 
We found that phospho-mimetic mutation of SNX9 perturbed interactions with PRDs. 
Mutation of phospho-sites to glutamic acid was used to mimic phosphorylation at 
particular residues. Glutamic acid closely resembles a phosphorylated serine/threonine 
residue in terms of size and charge. In contrast, glutamic acid lacks the bulky aromatic ring 
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present in tyrosine, which means that it does not closely mimic the structure and chemistry 
of a phosphorylated tyrosine. This is significant because aromatic side-chains are 
critical for the interaction of SH3 domains with PRDs (Li, 2005). Thus, the inability of 
Tyr56Glu to bind some PRD containing proteins, observed in this chapter, may not reflect 
the effect that phosphorylation would have but rather simply be the consequence of 
lacking an aromatic ring. Phosphorylation of Tyr56 in D. melanogaster protein 
DSH3PX1 disrupted binding to WASP (Worby et al., 2002), which matches our 
findings with Tyr56Glu (Chapter 4). This suggests that in this case Tyr56Glu does 
sufficiently mimic pTyr. Worby and colleagues (Worby et al., 2002) also reported that 
the D. melanogaster protein Dock bound to DSH3PX1 with greater affinity after 
phosphorylation of Tyr56. In the present thesis Tyr56Glu did not bind to any 
proteins with greater affinity (Chapter 4). Thus Tyr56Glu lacks the gain-of-function 
effects phosphorylation is expected to confer. Pulldowns using SNX9 
phosphorylated on Tyr56 (pSNX9Y56) as bait might reveal novel interactions. If the 
kinase upstream of Tyr56 was identified, pSNX9Y56 could be prepared by using an in-
vitro kinase assay.  
The pulldown, analysed by mass spectrometry, revealed novel SNX9 binding partners. Of 
particular interest is serine/threonine kinase Aurora A, which is involved in the targeting of 
proteins to the G2/M centrosomes (Fujita et al., 2016, Lin et al., 2010). Ma and colleagues 
(Ma et al., 2013b) observed that Ser176, in the LC domain of SNX9, is located within an 
Aurora A consensus motif. This warrants further investigation, by in-vitro kinase assay, to 
verify whether Ser176 is an Aurora A substrate. Another novel interacting partner, cyclin 
K functions in cell cycle control and therefore might provide insight into the 
mitotic function of SNX9. However, interpretation of the pulldown data must be 
tempered by consideration of the in-vitro nature of the experiment. 
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The bait SNX9 used to conduct a pulldown differs from endogenous SNX9 in that: 1) it 
has a GST tag; 2) it has been expressed in a bacterial expression system and therefore lacks 
post-translational modifications; 3) it is a monomer. All of these factors have the potential 
to alter the native folding and therefore binding properties of the bait SNX9. This 
discrepancy is exemplified by our finding that SNX9 did not enrich clathrin, which has 
been reliably reported to be a binding partner (Lundmark and Carlsson, 2003, Ma et al., 
2013b). Lundmark and Carlsson (Lundmark and Carlsson, 2003) reported a similar issue 
whereby a SH3LC truncation mutant, but not full-length wildtype SNX9, was able to 
enrich clathrin. They proposed that cytosolic SNX9 exists in an inhibited resting state and 
becomes active, thus able to bind clathrin, at sites of endocytosis (Lundmark and Carlsson, 
2003). Non-specific binding of clathrin to GST may be masking SNX9 binding to CHC. 
It is also important to note that capture of a protein by bait does not necessitate 
direct binding. Enrichment analysis for sequence features revealed that a minority of 
proteins that bound to Tyr56Glu less than phospho-deficient Tyr56Phe and wildtype GFP-
SNX9 did not contain proline rich regions. It is therefore likely that Tyr56Glu has 
affected binding of proteins with SNX9 through mechanisms other than SH3-PRD 
interactions. A possible alternative is that these proteins are enriched indirectly through 
a protein with a proline rich sequence. Additionally, preparation of the whole cell 
lysate allows interactions to occur that would have been prevented by sub-cellular 
compartmentalisation. Novel binding partners of interest identified in this chapter, such as 
Aurora A, need to be verified by co-immunoprecipitation and high resolution co-
localisation studies. SNX9 bound many known interacting partners from the metaphase 
synchronised lysate. However, this cannot be necessarily interpreted to mean that 
these interactions occur during metaphase. The SNX9 bait used lacks any post-
translational modifications that 
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might occur during metaphase. Additionally, phosphorylation on proteins in the lysate that 
would have regulated interactions would not have been preserved because of the lack of 
phosphatase inhibitors. Therefore the pulldowns performed in this chapter do not inform an 
understanding of the metaphase specific function of SNX9. Rather, these pulldowns 
provide valuable insight into the relative binding affinity of the different phospho-mutants 
tested. I was able to conclude that Tyr56 represents a critical residue for the regulation of 
protein interactions with the SH3 domain of SNX9. Thr275 does not appear to regulate 
SNX9 binding to proteins. 
4.3.2. Tyr56 regulates stabilisation of spindle localised clathrin 
I found that over-expression of Tyr56Glu resulted in reduced spindle localised clathrin. 
Though this observation was evident in fixed cell microscopy, the magnitude of loss 
appeared to be small when quantitated in live cells. This suggests that the method by which 
clathrin enrichment to the spindle was quantitated could be improved. The validity of the 
assay could be evaluated by measuring the level of clathrin detected at the spindle in a 
clathrin knockdown model. Our quantitation method made the assumption that X-Y plane 
co-localisation with the mitotic spindle indicated association with the mitotic spindle. This 
is likely not the case, thus future work should seek to quantitatively evaluate the formation 
of clathrin mediated inter-microtubule bridges in Tyr56Glu expressing cells by electron or 
super resolution microscopy. 
4.3.3. Loss of clathrin from the spindle leads to centrosome fragmentation 
We found that Tyr56Glu over-expression induced: 1) delay in the duration between 
prophase and anaphase, 2) formation of multi-polar spindles, and 3) poor centriole 
cohesion. Together, these observations pheno-copy depletion of clathrin (Maiato and 
Logarinho, 2014, Foraker et al., 2012, Royle, 2012). Therefore we propose that Tyr56Glu 
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results in the mis-localisation of clathrin from the mitotic spindle and that all other 
observations are downstream consequences of this. 
Cells expressing Tyr56Glu featured a greater distance between centrioles, which is 
a marker of centriole cohesion, than cells expressing Tyr56Phe. Though poor centriole 
cohesion can be expected to lead to centrioles separating to form independent spindle poles 
and thus multi-polar spindles, we did not definitively demonstrate that this is the source of 
the difference between Tyr56Glu and Tyr56Phe. The multi-polar anaphase phenotype may 
also occur as a result of fragmentation of the pericentriolar material (Maiato and 
Logarinho, 2014). Microtubule nucleating and organising elements of the spindle poles can 
break off and serve as independent microtubule organising centres (Maiato and Logarinho, 
2014). Foraker and colleagues (Foraker et al., 2012) found that acute inactivation of 
clathrin during S phase resulted in fragmentation of pericentriolar material and microtubule 
nucleating protein γ-tubulin. Therefore it is plausible that the extra microtubule organising 
centres in Tyr56Glu induced multi-polar spindles are acentriolar. Future work should 
assess the effect of Tyr56Glu expression on the number of γ-tubulin positive foci in mitotic 
cells. Other markers of the pericentriolar material, such as Pericentriolar Matrix 1 (PCM1) 
and Pericentrin, could also be visualised to evaluate integrity of the pericentriolar material.  
Supernumerary centrioles are typically clustered into a bi-polar spindle (Quintyne 
et al., 2005). The same forces that are involved in maintaining centriole cohesion in a 
spindle pole with a normal number centrioles are involved in the clustering of 
supernumerary centrioles (Maiato and Logarinho, 2014). Thus metaphase delay induced by 
Tyr56Glu expression could also result in the de-clustering of supernumerary centrioles 
(Maiato and Logarinho, 2014). Though not to statistical significance, cells expressing 
Tyr56Glu featured substantially more supernumerary centrioles than cells expressing 
Tyr56Phe. Examining a larger sample size of cells may clarify the effect of Tyr56Glu on 
centriole number. Supernumerary centrioles may originate from a variety of sources: failed 
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cytokinesis, premature mitotic exit termed mitotic slippage and centriole amplification 
either from over-duplication or de-novo synthesis (Maiato and Logarinho, 2014). In the 24 
hours between transfection and imaging, expression of Tyr56Glu might have promoted one 
or more of these defects thus potentially confounding study of the mitotic role of SNX9. 
Future work should employ a method of inactivation whereby a tag would be added 
to SNX9 such that it was mis-localised with acute drug treatment (Robinson et al., 
2010, Foraker et al., 2012). It is worth noting that cells expressing Tyr56Phe featured 
fewer metaphase defects than WT GFP-SNX9. This suggests either that some of the 
over-expressed WT GFP-SNX9 is phosphorylated at Tyr56 or that Tyr56Phe has a 
gain of function on the integrity of the mitotic spindle. Tyr177Glu similarly appeared to 
increase the rate of spindle pole fragmentation compared to its phospho-deficient 
counterpart Tyr177Phe. Given the proximity of Tyr177 to the Aurora A consensus motif 
at Ser176, it is possible that Tyr177 also regulates clathrin localisation to the spindle and 
ought to be the subject of future investigation. The increase of metaphase defects 
by Thr275Ala also warrants further investigation though it could not be tied to a particular 
defect and so may reflect a broader issue carried forward from previous cycles.
4.3.4. OCRL1 might have a role in metaphase 
OCRL1 appeared to localise to structures resembling the mitotic spindle. In non-mitotic 
cells OCRL1 localises to: the trans-golgi network (Dressman et al., 2000); clathrin coated 
membrane, both at sites of endocytosis and clathrin coated vesicles (Erdmann et al., 2007); 
early and recycling endosomes (Dambournet et al., 2011, Hyvola et al., 2006) and at the 
basal bodies of primary cilia (Coon et al., 2012). The primary cilium is a single protrusion, 
of microtubule doublets surrounded by membrane that extends from the basal body into the 
surrounding extracellular matrix (Satir et al., 2010). The basal body of a primary cilium is 
formed from the differentiation of the mother centriole of the centrosome (Kim and 
Dynlacht, 2013). The primary cilium predominantly functions in extra-cellular signalling 
but is also speculated to inhibit cell division by sequestering the mother centriole (Satir et 
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al., 2010). Upon entry into the cell cycle from G0 the primary cilium is resorbed and the 
mother centriole, which formed the basal body, undergoes centriole replication (Satir et al., 
2010). If OCRL1 truly localised to the mitotic spindle poles, this would suggest that 
OCRL1 might be recruited to the mother centrioles. Future work should seek to validate 
this finding using siRNA targeting OCRL1 mRNA; demonstrating that immunoreactivity 
of the spindle pole is lost when OCRL1 is depleted. 
The function of OCRL1 at basal bodies is in the trafficking of proteins for 
assembly of the primary cilia (Coon et al., 2012). In conjunction, Rab8 and OCRL1 target 
proteins from the trans-golgi network to basal bodies (Coon et al., 2012). OCRL1 also 
traffics internalised cargo to basal bodies through recycling endosome intermediates, 
which may also involve Rab8 (Coon et al., 2012). The localisation of OCRL1 to 
centrosomes during mitosis could reflect an analogous role in delivering proteins for the 
assembly of the mitotic spindle. Both golgin coated vesicles and recycling endosomes 
become enriched at the spindle poles for spindle assembly (Hehnly and Doxsey, 2014, Wei 
et al., 2015). Clathrin might be delivered to the forming spindle by these membranous 
organelles. OCRL1 at the spindle poles might then dissociate clathrin from the membrane 
leading to its recruitment to the assembling spindle by association with pTACC3 and ch-
TOG. SNX9 might be involved in association with OCRL1; however, this assumes that 
SNX9 localises to the spindle. 
4.3.5. Conclusion 
Together our findings indicate that de-phosphorylation of Tyr56 is required for the 
metaphase role of SNX9 in stabilising clathrin to the mitotic spindle. Over-expression of 
phospho-mimetic Tyr56Glu reduced clathrin enrichment at spindle, which resulted in 
spindle pole fragmentation and metaphase delay. Further exploration into the mechanism 
of SNX9 mediated recruitment of clathrin to the spindle should investigate potential 
involvement of spindle associated OCRL1. 
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5.1. Introduction 
SNX9 is an important player in cytokinesis (Ma and Chircop, 2012). SNX9 ensures 
alignment of pMRLC along the cleavage furrow for ingression (Ma and Chircop, 2012). In 
abscission, the delivery of Rab11 recycling endosomes to the ICB requires SNX9 (Ma and 
Chircop, 2012). SNX9 is observed to be enriched at the ICB during abscission (Ma and 
Chircop, 2012); Chapter 3); however, the significance of this is not understood. In Chapter 
3 I found that phospho-mimetic mutation of residue Thr275 led to a loss of SNX9 
enrichment at the ICB. This correlated with a delay in abscission. Thr275 is proximal to 
the PI3P binding motif of the PX domain (Chapter 3). On the basis that PI3P accumulates at 
the ICB during cytokinesis (Sagona and Stenmark, 2010), I propose that: 1) SNX9 is 
recruited to the ICB by binding PI3P, and 2) interaction between SNX9 and PI3P is 
regulated by phosphorylation of Thr275. In this chapter I sought to investigate the 
mechanism by which Thr275Glu causes abscission delay.  
5.2. Results 
5.2.1. Thr275Glu impairs SNX9 enrichment to the ICB during abscission 
The role of SNX9 phosphorylation in cytokinesis was assayed, first by determining 
whether over-expression of the phospho-mutants generated morphological defects 
consistent with cytokinesis failure. The cytokinesis defects observed include: 1) an 
unstable ingression of the ICB resolving into successful abscission (Fig 5.1 B); 2) an 
unstable ingression of the ICB resulting immediately in cytokinesis failure (Fig 5.1 C); 3) 
ingression that eventually leads to abscission failure resulting in a multi-nucleated cell (Fig 
5.1 D). Cells over-expressing Thr275Glu displayed fewer cytokinesis defects than 
cells expressing Thr275Ala (1.4% v.s. 18.2%, p < 0.01; Fig 5.2 A) or WT GFP-SNX9 
(1.4% v.s. 12.3%, p < 0.05; Fig 5.2 A).
Metaphase Anaphase Ana + 4 min Ana + 8 min Ana + 12 min ICB formed ICB + 4 min
ICB + 8 min ICB + 12 min ICB + 16 min ICB + 20 min ICB + 24 min ICB + 28 min ICB + 32 min
ICB + 36 min ICB + 40 min ICB + 44 min ICB + 48 min ICB + 52 min ICB + 56 min ICB + 60 minN
or
m
al
 D
iv
is
io
n
(A)
U
ns
ta
bl
e 
In
gr
es
si
on
(B) Metaphase Anaphase Ana + 4 min Ana + 8 min Ana + 12 min Ana + 16 min ICB formed
ICB + 4 min ICB + 8 min ICB + 12 min ICB + 16 min ICB + 20 min ICB + 24 min ICB + 28 min
ICB + 32 min ICB + 36 min ICB + 40 min ICB + 44 min ICB + 48 min ICB + 52 min ICB + 56 min
Metaphase Anaphase Ana + 4 min Ana + 8 min Ana + 12 min Ana + 16 min ICB formed
ICB + 4 min ICB + 8 min ICB + 12 min ICB + 16 min ICB + 20 min ICB + 24 min ICB + 28 min
In
gr
es
si
on
 f
ai
lu
re
(C)
(D) Metaphase Anaphase Ana + 4 min Ana + 8 min Ana + 12 min Ana + 16 min Ana + 20 min
ICB formed ICB + 4 min ICB + 8 min ICB + 12 min ICB + 16 min ICB + 20 min ICB + 24 min
ICB + 28 min ICB + 32 min ICB + 36 min ICB + 40 min ICB + 44 min ICB + 48 min ICB + 52 min
ICB + 56 min ICB + 60 min ICB + 64 min ICB + 68 min ICB + 72 min ICB + 76 min ICB + 80 min
A
bs
ci
ss
io
n 
Fa
il
ur
e
Chapter 5. Thr275 regulates the cytokinetic function of SNX9
115
Figure 5.1: Cytokinesis defects. Representative images of cells transfected with α-
tubulin-mCherry (red). Cells were imaged, 24 hours after transfection, every 4
minutes for 24 hours to visualise mitosis. (A) Successful cytokinesis was
characterised by: i) ingression of membrane around central spindle microtubules;
followed by ii) microtubule thinning and eventual severing of the ICB. Cytokinesis
defects were assessed either to be: (B) an unstable ingression of the ICB resolving
into successful abscission; (C) an unstable ingression of the ICB resulting
immediately in cytokinesis failure; (D) ingression that eventually leads to abscission
failure resulting in a multi-nucleated cell.
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Figure 5.2: Thr275 induces mild cytokinesis defects. HeLa cells were transfected
with one of either wild-type GFP-SNX9 or a phospho-deficient mutant or a phospho-
mimetic mutant and co-transfected with α-tubulin-mCherry. After 24 hours,
transfected cells were imaged every 4 minutes for 24 hours to visualise mitosis. The
expression of GFP-SNX9 and α-tubulin-mCherry was measured to make sure that
they were consistent between treatment groups (Fig 3.8; Supplementary A). Graphs
represent the percentage of cells pooled from all biological replicates for each
treatment group that featured (A) any cytokinesis defect, (B) unstable ingression that
resolves into successful cytokinesis, (C) ingression failure, (D) abscission failure. (A-
D) Each column represents the percentage of pooled cells per treatment group (52 –
95 cells) with bars representing 95% confidence intervals calculated by the hybrid
Wilson/Brown method. In all graphs each allele colour corresponds to its respective
WT control colour. (A-D) Comparisons between treatment groups of the trio (WT,
phospho-deficient, phospho-mimetic) for each phosphorylation site were statistically
analysed by two sided Chi-square Fischer’s exact test. Non-significant comparisons
have not been visualised. *: p<0.05. **:p<0.01.
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This trend corresponded to significantly fewer unstable ingression events (0% v.s. 9.1%, p 
< 0.05; Fig 5.2 B) and noticeably, though not statistically significant, fewer ingression 
failure events (0% v.s. 5.5%, p < 0.1; Fig 5.2 C) in cells expressing Thr275Glu 
compared cells expressing Thr275Ala. Expression of the Thr275 mutants had no effect on 
the rate of abscission (Fig 5.2 D). Over-expression of GFP-SNX9, or any of the 
other phospho-mutants, did not result in a notable difference in the rate of cytokinesis 
defects (Fig 5.2). This suggests that the dominant negative effect of Thr275Glu expression 
has a mild effect but is not critical to cytokinesis. 
I then examined the timing of GFP-SNX9 enrichment at the ICB by time-lapse microscopy 
of live cells. SNX9 became enriched at the ICB during the late stages of abscission (Fig 
5.3A). This trend in localisation was observed in 30-50% of cells expressing wild-type 
GFP-SNX9 in each biological replicate (Fig 5.3). In the remainder of cells, GFP-SNX9 
appeared at the ICB in bursts that did not last longer than a single frame. In the cells that 
featured ICB enrichment, SNX9 appeared at the ICB on average 44 min after ingression 
and remained there for 32 min before disappearing from the ICB (Fig 5.3). In 52% of these 
cells, SNX9 disappearance from the ICB either coincided with completion of abscission or 
preceded completion by a single frame (4 min; Fig 5.3). The localisation of wildtype GFP-
SNX9 was then compared with that of the phospho-mutants (Fig 5.3). Prolonged 
enrichment of exogenously expressed SNX9 to the ICB was significantly less frequent in 
cells expressing phospho-mimetic mutants Tyr56Glu and Thr275Glu (Fig 5.3). Though not 
statistically significant, Thr275Glu localisation to the ICB occurred less frequently than 
Thr275Ala (Fig 5.3). These results indicate that: 1) SNX9 functions in the late stages of 
abscission; and 2) phosphorylation of Thr275 regulates the ICB stabilisation of SNX9 
during abscission. Tyr56Glu similarly localised to the ICB less frequently than Tyr56Phe; 
however, this is likely confounded by mis-localisation of Tyr56Glu earlier in the cell cycle. 
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Figure 5.3: Localisation of SNX9 to the ICB. HeLa cells were transfected with one
of wild-type GFP-SNX9, phospho-deficient mutant or phospho-mimetic mutant and
co-transfected with microtubule marker α-tubulin-mCherry. After 24 hours,
transfected cells were imaged every 4 minutes for 24 hours to visualise mitosis. (A)
SNX9 appears to localise to the ICB during late abscission (arrows mark where
SNX9 is at ICB). Graphs representing (B) the duration of time, after anaphase, until
SNX9 is observed at the ICB, (C) then the duration of time that SNX9 is observed at
the ICB followed by (D) the time between SNX9 leaving the ICB and completion of
abscission. In 35% of cells, SNX9 leaving the ICB coincided with completion of
abscission. (B-D) Data represented as box and whisker plot of quartiles. (E) The
localisation of GFP-SNX9 to the ICB was observed and noted as either present or
absent for each cell. Each independent data point is the average from a field of 3-17
cells. A total of 12 fields were selected from 3-4 biological replicates on the basis of
ensuring even GFP and mCherry fluorescence between treatment groups (Fig 3.8;
Supplementary A). The number of fields and the number of biological replicates was
kept consistent within each trio of wildtype GFP-SNX9, phospho-deficient mutant
and phospho-mimetic mutant. Graph represents the mean percentage and 95%
confidence intervals of the percentage of cells with GFP-SNX9 localised to the ICB.
In all graphs each allele colour corresponds to its respective WT control colour. The
trio (WT, phospho-deficient, phospho-mimetic) for each phosphorylation site were
statistically compared using a Kruskal Wallis ANOVA with a Dunns Multiple
Comparisons post-test. All non-significant comparisons have not been visualised.
GFP only was not observed to localise to the ICB. *: p<0.05, **: p<0.01
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5.2.1. Thr275 does not regulate the trafficking of Rab11 REs to the ICB 
The recruitment of SNX9 to the ICB in the last one-third of abscission suggests that SNX9 
is involved in processes following formation of the secondary ingression site. This stage of 
abscission is dominated by the fusion of endosomes, accumulated at the midbody, shaping 
the PIP architecture of the secondary ingression site membrane (Schiel et al., 2011). 
Therefore enrichment of SNX9 to the ICB may reflect the delivery of SNX9 coated 
membrane to the secondary ingression site. 
On the basis that SNX9 regulates Rab11 trafficking during cytokinesis, I hypothesised that 
SNX9 delivers Rab11 recycling endosomes to the secondary ingression site. The 
Thr275Glu mutation disrupted SNX9 localisation to the ICB. I sought to determine 
whether over-expression of Thr275Glu affected the delivery of Rab11 recycling 
endosomes. The localisation of Rab11 was monitored in cells co-expressing Thr275 
phospho-mutants. At the start of ingression, the localisation of Rab11 is most prominent at 
‘outer pools’ in each nascent daughter cell distal from the ICB (Fig 5.4 A). The outer pools 
rapidly fade as the Rab11 coated vesicles accumulate at the inner pools (proximal to the 
ICB) and at the ICB (Fig 5.4 A). Nearing completion Rab11 localisation becomes diffuse 
(Fig 5.4 A). Thr275Glu appears to increase the accumulation to the outer pools; however 
this did not translate into an observable loss of localisation to the inner pools or ICB (Fig 
5.4 B-D). Thus the abscission delay induced by phospho-mimetic mutant Thr275 does not 
appear to be mediated through the trafficking Rab11 recycling endosomes. 
5.3. Discussion 
The third aim of this study was to investigate the mechanism by which Thr275 regulates 
the function of SNX9 in cytokinesis. This aim comprises two elements: firstly the role of 
SNX9 in cytokinesis and secondly how Thr275 regulates that function.  
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Figure 5.4: Rab11 localisation to the ICB is unaffected by expression of Thr275
phospho-mutants. HeLa cells were transfected with one of wild-type GFP-SNX9,
Thr275Ala or Thr275Glu and co-transfected with Rab11-mCherry. After 24 hours,
transfected cells were imaged every 4 minutes for 24 hours to visualise mitosis. (A)
Using MetaMorph image analysis software, a circle was drawn in each cell around
each of the inner pools, outer pools, the ICB and a sample of the cell cytosol. Rab11-
mCherry fluorescence was measured. Fluorescence intensity at the inner pools, outer
pools and ICB were normalised to the cell cytosol sample. This was repeated for
every time-point from anaphase to completion. Representative image of Rab11-
mCherry in cytokinetic HeLa cell. The localisation of Rab11 at the (B) outer pools,
(C) inner pools and (D) ICB localisation was compared between cells expressing
wildtype SNX9 at the Thr275 phospho-mutants. Data is represented as the average
(±SEM) of 3 biological replicates, each an average of 10 cells.
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Thr275Glu appeared to increase the rate of increase the rate of ingression instability with a 
statistically insignificant increase in ingression failure compared to its phospho-
deficient counterpart Thr275Ala. Thr275Glu induced ingression instability more than 
failure, which suggests that the role of SNX9 in ingression is a highly redundant process. 
The ingression instability and failure events were nonetheless rare, which again 
suggests either redundancy and/or a much greater sample size is required to confidently 
conclude on the role of Thr275 in regulating a role of SNX9 in ingression. Thr275 might 
regulate a role of SNX9 in ingression but much work is needed to elucidate this. 
We found that SNX9 localises to the ICB in the late stages of abscission and that Thr275 
regulates the recruitment of SNX9 to the ICB. The timing of SNX9 enrichment to the ICB 
suggests that it is involved in the processes after formation of the secondary ingression site. 
One requirement of abscission, following secondary abscission, is the expansion of 
membrane by the incorporation of vesicles with the ICB membrane (Schiel et al., 2011). 
Over-expression of Thr275Glu did not affect Rab11 recycling endosome trafficking to the 
ICB.  
We found that the role of SNX9 in cytokinesis is regulated by Thr275 but the mechanism 
of its action remains elusive. We hold with the proposal that SNX9 is recruited to the ICB 
by PI3P. Live cell microscopy could be performed to assess whether ICB enrichment of 
SNX9 and PI3P, labelled with a double FYVE finger marker/plasmid (Gillooly et al., 
2000), temporally coincided. The effect of Thr275 phospho-mutation on the binding 
affinity of SNX9 for PI3P was not assessed due to time limitations but remains a 
worthwhile focus for further investigation.  
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A caveat to our claim is that only 30% - 50% of cells, in each biological replicate, 
expressing wildtype GFP-SNX9 featured SNX9 enrichment at the ICB. This low 
frequency questions the importance of SNX9 enrichment at the ICB to the successful 
completion of abscission. A repeat of the localisation study with a larger sample size, to 
account for the relative rarity of GFP-SNX9 localisation to the ICB, could determine 
whether the presence of GFP-SNX9 enrichment at the ICB correlates with a lower 
frequency of cytokinesis failure or shorter duration of cytokinesis. However, this data is 
confounded by the presence of functionally redundant proteins that are not observable. 
Cells that lack GFP-SNX9 localised to the ICB might have endogenous SNX9 fulfilling 
the required role. SNX18 and SNX33 have also been reported to localise to the ICB and 
are critical for cytokinesis (Ma and Chircop, 2012). Therefore future work should also 
examine the possibility that the three members of the SH3-PX-BAR sub-family perform 
redundant roles in cytokinesis. A cell model that lacked endogenous SH3-PX-BAR sub-
family expression would be most suitable for future experiments investigating the 
localisation of SNX9 during cytokinesis. We attempted to use CRISPR to develop a bi-
allelic SNX9 knockout cell line but found that this was toxic to cells (data not shown). An 
inducible SNX9 knockout system is necessary to circumvent toxicity issues. Alternatively 
a GFP tag could be knocked-in into both SNX9 alleles to fluorescently label the entire 
endogenous SNX9 population. The ideal cell line for studying the role of SNX9 in 
cytokinesis would feature: 1) a bi-allelic knock-in of GFP tag into the SNX9 gene; and 2) 
inducible knockout of SNX18 and SNX33. 
In this chapter we discovered that SNX9 has a distinct pattern of recruitment to the 
ICB and that this localisation is regulated by phosphorylation of Thr275Glu. This suggests 
that Thr275 regulates the role of SNX9 in cytokinesis. The effect of Thr275Glu over-
expression on cytokinesis was mild (Chapter 3); however, we expect that this effect might 
be greater in the absence of endogenous SNX9 and similarly redundant proteins. 
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6.1. Introduction 
This study contributes to past literature by providing mechanistic details for the function 
and regulation of SNX9. I propose that the mitotic functions of SNX9 are regulated by the 
phosphorylation state of Tyr56, regulating protein interactions, and of Thr275, regulating 
lipid interactions. Here, I describe possible models for the role of SNX9 during the cell 
cycle incorporating our current understanding of its phospho-regulation and suggest 
experiments that would further elucidate the involvement of SNX9 in mitosis. 
6.1.1. Tyr56 regulates clathrin recruitment to spindle 
Previous studies (Ma et al., 2013b, Ma and Chircop, 2012) established that SNX9 
functions in stabilising clathrin at the mitotic spindle. The present thesis builds on this 
knowledge to add that this role is regulated by the phosphorylation state of Tyr56. In 
contrast to the previous study, I was not able to conclusively report localisation of SNX9 to 
the prometaphase spindle. I found that SNX9 localised to discrete structures in interphase 
and cytokinesis but displayed cytosolic localisation between mitotic entry and mitotic exit. 
Cytosolic SNX9 is thought to be kept inactive in a complex with aldolase and dynII 
(Lundmark and Carlsson, 2004, Rangarajan et al., 2010; Fig 1.3 C). This suggests that 
SNX9 activity would be suppressed during prometaphase. A more in-depth exploration of 
the localisation of SNX9 during mitosis is required to conclusively address this hypothesis. 
The experimental systems used thus far to assess the role of SNX9, siRNA targeted 
depletion (Ma et al., 2013b, Ma and Chircop, 2012) and over-expression of dominant 
negative mutants (Chapters 3-5), feature long periods of time between transfection and 
observation. This means that the chromosome segregation defects observed in cells 
depleted of SNX9 and the multi-polar mitotic spindles observed in cells expressing 
Tyr56Glu might have resulted from perturbation of the role of SNX9 in interphase or 
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cytokinesis from a previous cycle. Therefore it is entirely possible that SNX9 does not 
have a role in prometaphase but rather contributes to centrosome maturation in interphase, 
with the downstream effect of ensuring proper chromosome segregation in metaphase. 
The question of whether SNX9 contributes to stabilisation of spindle localised clathrin 
during prometaphase or late interphase could be answered using more acute methods of 
perturbing SNX9 function. An example is the knock-sideways system, developed by 
Robinson and colleagues (Robinson et al., 2010). The knock-sideways system would 
ideally involve the stable insertion of a tag, comprising a rapamycin binding domain and a 
mitochondrial targeting sequence, into the endogenous SNX9 gene. This would then allow, 
upon treatment of the stably transfected cell line with rapamycin, the immediate diversion 
of the entire cell’s population of SNX9 to the mitochondria. This mis-localisation is 
effectively an acute knock-down that could be triggered at mitotic entry to evaluate the 
direct contribution of SNX9 to chromosome segregation. 
6.1.2. SNX9 contributes clathrin to the maturing centrosome 
Clathrin contributes to the maturation of duplicated centrosomes in late S and G2 stages of 
interphase (Foraker et al., 2012). Vesicle-like structures deliver clathrin to the centrosome 
(Foraker et al., 2012). Both depletion of SNX9 (Ma and Chircop, 2012) and over-
expression of dominant negative mutants (Chapter 3-4) resulted in reduced clathrin 
enrichment at the mitotic spindle. I propose that clathrin is delivered on clathrin coated 
vesicles to the centrosome. 
Over-expression of dominant negative SNX9 mutant Tyr56Glu affected clathrin 
localisation to the mitotic spindle but did not affect transferrin uptake in interphase cells 
(Chapter 3). This suggests that these clathrin coated vesicles do not originate from CME 
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events at the cell surface. Clathrin coated vesicles also form at the trans-golgi network for 
the delivery of proteins to endosomes (Hinners and Tooze, 2003). The golgi apparatus is 
closely associated with the centrosome (Sutterlin and Colanzi, 2010). In interphase, golgi 
ribbons surround the centrosome contributing to the nucleation and organisation of 
cytoskeletal microtubules (Sutterlin and Colanzi, 2010, Rios, 2014). Fragmented golgi 
vesicles remain associated with the centrosome and contribute to spindle microtubule 
organisation during mitosis (Sutterlin and Colanzi, 2010, Rios, 2014). Thus golgi derived 
vesicles might traffick cargo, including clathrin, to the centrosome. In support of this, 
depletion of golgi matrix proteins GM130 (Kodani and Sutterlin, 2008) and GRASP65 
(Sutterlin et al., 2002) result in the formation of multi-polar spindles. 
Ma and colleagues (2012) claimed that the golgin GM130 coated vesicles localisation 
during cytokinesis was affected by depletion of SNX9. As discussed in Chapter 1, SNX9 
has been reported to localise to the trans-golgi network and golgi apparatus (Soulet et al., 
2005); however, because SNX9 cannot bind PI4P (Shin et al., 2008), it is not likely to 
tubulate the PI4P rich trans-golgi network membrane to form nascent vesicles. Rather, 
SNX9 likely functions as a downstream effector of golgi localised PI(4,5)P2 in the co-
ordination of the cytoskeleton with golgi. Foraker and colleagues (2012) reported that the 
vesicular structures that delivered clathrin to the centrosome co-localised with pericentrin, 
which is trafficked by the peri-centriolar satellite network (Hori and Toda, 2017). This 
suggests that clathrin is being delivered by dynein mediated transport along microtubules 
anchored at pericentriolar satellites (Foraker et al., 2012). PI(4,5)P2 induced oligomerisation 
of SNX9 leads to activation of actin polymerisation (Yarar et al., 2007). Thus SNX9 might 
be recruited to the golgi by PI(4,5)P2 and activate WASP for the polymerisation of actin. 
This might be necessary for the structural association of microtubules, nucleated from peri-
centriolar satellites, with golgi ribbons. Thus linking the microtubule ‘highway’ from the 
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golgi to the destination centrosome. Investigation into the role of SNX9 at the trans-golgi 
network may reveal insight into its contribution to mitotic spindle stability.  
6.1.3. Tyr56 regulates SNX9 contribution to the maturing centrosome 
In this thesis, I have established that Tyr56 is important for the interaction between SNX9 
and several PRD-containing proteins, which suggests that Tyr56 regulates the association 
of the SNX9 SH3 domain with PRDs. The phospho-mutant that did not bind to PRD-
containing proteins, Tyr56Glu, also reduced the localisation of clathrin to the mitotic 
spindle. One possibility is that the Tyr56Glu mutant simply sequestered clathrin in the 
cytosol, effectively depleting the cell of clathrin. This does not seem likely because 
depletion of clathrin would drastically perturb CME, including the uptake of transferrin. 
Rather, it seems more likely that Tyr56Glu perturbs the specific targeting of clathrin to the 
mitotic spindle. 
The role of SNX9 in CME is highly redundant (Bendris and Schmid, 2017) meaning that 
the effect of perturbation of the role of SNX9 in CME can be subtle. The transferrin uptake 
assay performed in chapter 3 might not have been sensitive enough to detect the effect of 
the ‘loss of function’ of endogenous SNX9. Thus, it remains possible that dominant 
negative mutant Tyr56Glu disrupts the functionality of endogenous SNX9. This seems 
likely because if Tyr56Glu simply resulted in the mis-localisation of exogenous protein, it 
would be expected that there would be no effect on cell processes, i.e. mitosis. The 
hypothesised role of SNX9 in supporting the structures for delivery of golgi derived 
vesicles to the maturing centrosomes might not be as redundant as the role of SNX9 in 
CME. The consequence of this being that perturbation of endogenous SNX9 would be 
expected to have a more profound effect on trafficking from the trans-golgi network to the 
mitotic spindle than on CME. If SNX9 functioned in creating an actin network around the 
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golgi, it would be expected that Tyr56 would regulate this role. De-phosphorylation of 
Tyr56 in SNX9, or a golgi associated sub-population, would be necessary to bind WASP 
and thus activate actin polymerisation. Another possibility, though not mutually exclusive 
with the model above, is that clathrin coated vesicles from the plasma membrane also 
deliver clathrin to the spindle poles.  
I observed OCRL1 at structures that resembled mitotic spindle poles and OCRL1 has been 
previously reported to localise to basal bodies (Coon et al., 2012). It is possible that 
OCRL1 also localises to the maturing centrosomes during S phase; however, this is yet to 
be verified. Localisation of OCRL1 at the centrosome, specifically in S/G2 phase, could be 
assessed using fluorescent ubiquitination-based cell cycle indicator (FUCCI) cells whereby 
S/G2 cells would be demarcated as non-mitotic cells with a green fluorescence nuclei 
(Miwa et al., 2013). Assuming that OCRL1 does localise to the maturing centrosomes, as it 
does to the spindle poles during mitosis, OCRL1 might mediate hydrolysis of PI(4,5)P2 in 
pericentriolar clathrin coated vesicles derived from the plasma membrane to dismantle the 
clathrin coat and thus make clathrin available at the centrosome.  
SNX9 on plasma membrane derived clathrin coated vesicles might associate with OCRL1 
at the maturing centrosome. In such a case, it would be expected that phosphorylation of 
Tyr56 would regulate this interaction. However, this assumes that SNX9 localises to the 
maturing centrosomes, which is yet to be determined. A corollary of this model would be 
that cells expressing Tyr56Glu would feature a greater rate of monopolar asters, which 
would indicate defective centrosome maturation. Future work ought to assay the effect of 
Tyr56Glu expression on monopolar aster formation. A more conclusive interpretation of 
the role of SNX9 in stabilising spindle localised clathrin can be made once a consensus is 
formed on the localisation of SNX9 throughout the cell cycle. 
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6.1.4. Better visualisation of SNX9 localisation 
There are many conflicting reports on the sub-cellular localisation of SNX9 (Childress et 
al., 2006; Lundmark and Carlsson, 2003; McCaulay et al., 2003; Sasaki et al., 2017; Soulet 
et al., 2005). These inconsistencies indicate that there is a need for better visualisation of 
SNX9 in cells. There are many opportunities in fixed cell immunofluorescence microscopy 
to inadvertently create artifacts (Schnell et al., 2012). The method of fixation and cell 
permeabilisation can drastically alter the cellular localisation of a protein. This is because 
different conditions affect the preservation and exposure of epitopes, for immunological 
detection, in different ways (Schnell et al., 2012). In addition to this, antibodies can vary in 
their affinity for different epitopes and will engage in different non-specific interactions 
(Schnell et al., 2012). This is exemplified by the difference between my observation of the 
prometaphase localisation of endogenous SNX9 and that observed by previous work in the 
Chircop lab (Ma and Chircop, 2012). Additionally, fixed cell immunofluorescence is only 
able to capture a snapshot in time and does not provide information about the dynamics of 
a particular sub-cellular localisation. There are therefore advantages in examining protein 
localisation in live cells (Schnell et al., 2012). 
Live cell microscopy is not without limitations itself. Firstly, the protein of interest must be 
conjugated with a fluorophore. In the present thesis, an N-terminal GFP tag was used to 
monitor the expression and localisation of SNX9 and phospho-mutants. The GFP tag, 
though commonly used to visualise protein dynamics (Lippincott-Schwartz et al., 2001), 
has also been found to affect the function of proteins it is fused with (Snapp, 2005, 
Lisenbee et al., 2003). In Chapter 3 we observed that the localisation of GFP-SNX9 
matched the localisation of endogenous SNX9 indicating that, in this case, the GFP tag 
does not appear to have affected protein function.  
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Secondly, the fluorophore conjugated protein must be introduced into the cell. The 
transient expression of a protein under a constitutive promoter, as used in the present 
thesis, has the potential to create artifacts. The presence of a protein at abnormally 
high concentrations can make low affinity interactions that may not be physiologically 
relevant more likely to occur (Gibson et al., 2013). We did not determine how the level of 
phospho-site mutant expression compared to endogenous protein and so are 
uncertain of how physiologically relevant our findings are. Gene editing with 
techniques such as CRISPR whereby a GFP tag is ‘knocked into’ the SNX9 gene under 
the endogenous promoter could provide a way to avoid these issues (Cong et al., 
2013). Alternatively, to counter both issues discussed above, a small peptide tag could be 
‘knocked into’ the SNX9 gene and the localisation of endogenous SNX9 visualised with 
fluorescent chemical probes (Jung et al., 2013). A thorough examination of the dynamics 
of SNX9 localisation could elucidate the processes, in which SNX9 is purported to 
contribute. High resolution live cell microscopy co-localisation studies, of SNX9 with 
organelle markers, such as GM130 labelling of golgi, throughout the cell cycle could be 
used to investigate whether compartmentalisation and therefore function of SNX9 
evolves throughout the cell cycle. The localisation of phospho-mimetic and phospho-
deficient mutants could then also be assessed with greater confidence. 
6.1.5. Regulation of phosphorylation at Tyr56 
A study in D. melanogaster suggests that Tyr56 in DSH3PX1 is phosphorylated by DAck 
(Worby et al., 2002), the Drosophila ortholog of the human Ack kinases. Motif 
analysis has identified that Tyr56 fits within an EGFR phosphorylation motif 
(Amanchy et al., 2007). SNX9 is a major factor in the trafficking of activated 
EGFR for lysosomal degradation (Childress et al., 2006, Lin et al., 2002, Danson et al., 
2013). It is possible that the lysosomal targeting of activated EGFR, by SNX9, is 
counteracted by EGFR mediated 
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phosphorylation of Tyr56. Immediately prior to mitosis (G2), EGFR signalling leads to the 
activation of Nek2A at the centrosome to drive the separation of duplicated centrosomes 
for the formation of the bi-polar spindle (Mardin et al., 2013). I propose that, 
concomitantly, EGFR phosphorylates Tyr56 resulting in the diffuse cytosolic localisation 
and thus ‘de-activation’ of SNX9 (Fig 6.1). In this model, the role of SNX9 in centrosome 
maturation would be ‘switched off’ by phosphorylation at Tyr56 in preparation for mitotic 
entry. The Ack family of proteins function with SNX9 to promote EGFR degradation 
(Childress et al., 2006, Lin et al., 2002, Yeow-Fong et al., 2005) and so an alternative 
kinase upstream of Tyr56, in the same pathway, might be Ack1 or Ack2.  
The identity of SNX9 as a substrate of EGFR could be tested with in-vitro phosphorylation 
assays (Qiu et al., 2009). These assays have a bias towards type I errors; the experiment 
conditions enable low affinity interactions that are not physiologically relevant to occur. 
Therefore, validation in a cell line model, typically by MS quantitation of phosphorylation 
sites in cells co-expressing kinase/phosphatase and substrate (Bendris et al., 2016a), could 
supplement the in-vitro assay by identifying kinases that regulate SNX9. The hypothesis 
that Tyr56 phosphorylation is upregulated at mitotic entry could also be tested by 
quantifying the abundance of pSNX9Y56 by quantitative labelled or label-free mass 
spectrometry approaches on a sample of enriched phospho-peptides (Lian et al., 2015). The 
phosphorylation state of Tyr56 in asynchronous cells would be compared with prophase 
synchronised cells (Lian et al., 2015). The possible role of Tyr56 in regulating EGFR 
degradation could be tested by examining EGFR levels in tissue taken from homozygous 
Tyr56Glu mice generated with CRISPR. A SNX9 homozygous knockout mice strain has 
been developed that did not display any gross abnormalities and therefore could be used as 
a model for further studies (Liu et al., 2016).  
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Figure 6.1: Proposal of the role of SNX9 in contributing to centrosome
maturation. During S phase, SNX9 facilitates trafficking of golgi derived clathrin
coated vesicles to the centrosome. Clathrin coated vesicles from the plasma
membrane might also accumulate at centrosome. OCRL1 hydrolyses PI(4,5)P2
uncoating of clathrin from plasma membrane derived clathrin coated vesicles.
During G2, SNX9 is phosphorylated at Tyr56 resulting in a ‘de-activated’ state in the
cytosol. At mitotic exit, SNX9 is de-phosphorylated at Tyr56 and Thr275.
SNX9 activation of WASP and 
ARP2/3 mediated actin 
polymerisation links pericentriolar
satellite microtubules with golgi. 
Clathrin is delivered, along 
microtubules, to maturing 
centrosomes on golgi derived vesicles 
(green).
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6.1.1. Model proposed for the spindle associated role of SNX9 
Altogether, I propose the following model for the spindle associated role of SNX9 (Fig 
6.1). SNX9 facilitates trafficking of golgi derived clathrin coated vesicles, during S-phase, 
to the maturing centrosome. Clathrin is stabilised to the centrosome by binding ch-TOG. 
At mitotic entry, SNX9 is compartmentalised to the cytosol by EGFR mediated 
phosphorylation of Tyr56. This might be necessary to prevent SNX9 from interacting with 
proteins, such as clathrin, that might interfere with the role of the mitotic spindle in 
chromosome segregation. This model proposes that SNX9 mediates its mitotic functions 
through actin. It is known from studies D. melanogaster that DSH3PX1 is involved in 
actin polymerisation (Worby et al., 2002, Worby et al., 2001). Given the high homology of 
SNX9 and DSH3PX1 (Chapter 3) it is highly likely that SNX9 similarly functions through 
modulating the actin cytoskeleton. 
6.2. Thr275 regulates SNX9 localisation to ICB 
Phospho-mimetic mutants, Tyr56Glu and Thr275Glu, localised to the ICB less frequently 
than their phospho-deficient counterparts. On this basis, I propose that de-phosphorylation 
of Tyr56 and Thr275 at mitotic exit signals activation of SNX9 for its role in cytokinesis 
(Fig 6.2). During abscission, at the midbody, the PRD of dynII is dephosphorylated by 
CaN (Chircop et al., 2011) and PI3P is generated by PI3K. Dephosphorylation of dynII 
PRD is likely to increase binding affinity for the SNX9 SH3 domain. Similarly, the 
accumulation of PI3P is likely to promote binding of SNX9 to membrane. I propose that 
these events promote enrichment of SNX9 at the ICB to prepare the secondary ingression 
site for ESCRT assembly and membrane scission. The role of SNX9 at the ICB is not yet 
known but I speculate that it is involved in either: 1) the delivery of recycling endosomes 
to incorporate with secondary ingression site membrane, and/or 2) the auto-phagosomal 
clearance of RhoGAP for de-stabilisation of F-actin. 
Figure 6.2: SNX9 is de-phosphorylated at Tyr56 and Thr275 to be recruited to
the ICB. SNX9 facilitates delivery of recycling endosomes to the ICB. pdynIIS764
becomes enriched at the ICB. At a later stage of abscission, which might coincide
with formation of the secondary ingression site, pdynIIS764 is dephosphorylated and
PI3P accumulates. Recycling endosomes become incorporated with the ICB
membrane. Both events promote enrichment of SNX9, which is de-phosphorylated
at Tyr56 and Thr275. The function of SNX9 here is not yet known.
Recycling 
endosome (RE)
Early 
endosome
Midbody 
Ring 
OCRL
SNX9
PI(4,5)P2
enrichment
pdynIIS764
PI3P
enrichment
pDynIIS764 dynII
Ca2+
CaN
dynII
SNX9 is enriched at the 
ICB by PI3P, PI(4,5)P2
and dynII
REs integrate 
with membrane
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The C. elegans ortholog of SNX9, LST-4, functions alongside DYN-1 in promoting 
autophagosome maturation (Almendinger et al., 2011, Chen et al., 2013, Cheng et al., 
2015, Lu et al., 2011). Future studies ought to investigate the possibility that human SNX9 
and Dyn2 might function together in autophagosome maturation especially in signalling 
cytokinesis (Belaid et al., 2013). 
The phosphatases upstream of Tyr56 and Thr275 are unknown and warrant further 
investigation. Possible candidates, on the basis that they are involved in signalling mitotic 
exit, are dual specificity serine/threonine and tyrosine phosphatases: Cdc14a, Cdc14b and 
Ptpcd-1 (Chircop, 2012). Additionally, serine/threonine specific phosphatases PP1, PP2A 
and PP2B might regulate Thr275 (Chircop, 2012). In-silico analysis of consensus motifs 
could identify potential candidates for further investigation. 
6.3. Regulation of SNX9 by other phospho-sites 
My observation that the expression of the other phospho-mutants did not affect mitosis 
does not translate into evidence that those sites do not also regulate the mitotic function of 
SNX9. The effect of a mutation on exogenous protein function can be masked by the 
presence of endogenous protein. A ‘loss-of-function’ mutation will not necessarily affect 
cell processes in a dominant negative manner. Additionally, most kinase substrates must 
undergo multiple phosphorylation events before their function is altered (Ferrell and Bhatt, 
1997; Swain and Siggia, 2002). It is theorised that the purpose of this is to permit ‘kinetic 
proofreading’ by phosphatases between phosphorylation events thus minimising the impact 
of off-target phosphorylation (Ferrell and Bhatt, 1997; Swain and Siggia, 2002). Therefore, 
the single phospho-mimetic mutations used in this thesis may not have been sufficient to 
significantly alter the function of SNX9. The effect of multiple phospho-mutations on the 
role of SNX9 in mitosis should be assayed. For example, it is expected that Tyr177 and 
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Ser176 regulate the binding of SNX9 with proteins such as clathrin and AP-2 (Ma 
and Chircop, 2012, Ma et al., 2013b). In the present work, Tyr177Glu slightly affected 
mitosis timing and significantly increased the rate of metaphase defects. The role of 
Tyr177 and Ser176 should be investigated with a pulldown assay comparing the 
protein binding affinity of single mutants and a double Ser176Glu-Tyr177Glu mutant. 
Expression of the phospho-mutants of these sites in a inducible SNX9 knockout cell line 
might yield insight into phospho-regulation of SNX9.  
Another consideration is that the present thesis was completely conducted in HeLa cells. 
The background expression of signalling and regulatory proteins can vary drastically 
between cell lines (Mardin et al., 2013). Additionally, the karyotype of HeLa cells can vary 
drastically between batches (Frattini et al., 2015). Manipulations with known effects on 
mitosis such as knockdown of clathrin in my batch of HeLa cells might contextualise the 
biological significance of the dominant negative effects of SNX9 mutant expression. 
Investigation of the function of SNX9 is limited by the interdependence and redundancy of 
functions between SNX proteins. For example, SNX18 and SNX33 also contribute to 
cytokinesis (Ma and Chircop, 2012) but the level of redundancy with the role of SNX9 is 
not known. Therefore, an alternate cell line, with a different proteomic background, might 
require different aspects of SNX9 structure, function and regulation. An ideal alternative 
cell line model that these experiments can be validated in is RPE1, which is suitable for 
microscopy but also chromosomally stable (Thompson and Compton, 2008). 
6.4. Significance of Thesis 
SNX9 is an important player in cell division and may therefore represent a novel 
therapeutic target. Unsustainable levels of genome instability, through induction of multi-
polar anaphase divisions, can lead to the death of rapidly dividing cancer cells (Kwon et 
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al., 2008). Therefore, up-regulation of the phosphorylation of Tyr56 might be effective in 
treating cancer. Exploration of the kinase network that regulates the phosphorylation state 
of Tyr56 could provide insight into chemotherapeutic targets. Down-regulation of SNX9 
has been found in prostate cancer (Mao et al., 2011), melanoma and colorectal cancer (Ish-
Shalom et al., 2016), breast cancer and non-small cell lung cancers (Bendris et al., 2016a). 
Down-regulation of SNX9 in the mammary cells of mice has been identified as an early 
marker of tumorigenesis (Ganaie et al., 2017). Reduced levels of SNX9 expression within 
tumours is believed to accelerate metastasis and aggressiveness through an increase in 
matrix degradation activity (Bendris et al., 2016a). If, as we propose, phosphorylation of 
Tyr56 ‘de-activates’ SNX9 then it would be expected that up-regulation of Tyr56 
phosphorylation might also promote metastasis. Alternatively, it might have the opposite 
effect. A greater expression of SNX9, as observed in some breast cancers, has also been 
associated with acceleration of cell invasion (Bendris et al., 2016b). Thus, the role and 
regulation of the phosphorylation state of Tyr56 in cancer metastasis warrants further 
investigation. 
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Supplementary A: We sought to test assumptions regarding the live cell imaging of
Fig 3.8 to inform the method of statistical analysis. One of the assumptions made by
the statistical tests used is the independence of each individual data point. Over the
24 hours that the cells were imaged, cells were observed to undergo 1-2 rounds of
mitosis. Given the inherent heterogeneity of HeLa cells, and the nature of
chromosomal inheritance through mitosis, the independence of individual cells
needed to be evaluated. (A) The mitotic duration of mother cells correlated poorly
(R2 = 0.2927) but significantly (Spearman’s rho; p = 0.0006) with the mitotic
duration of their daughter cells. (B) In contrast, the mitotic duration of the mother
cells did not correlate (R2 = 0.002646) with daughter cells of the same plate but
different field (Spearman’s rho; p = 0.4902). (C) Neither did the mitotic duration of
mother cell and daughter cells from one field correlate (R2 = -0.04865) with the
mother cell and daughter cells taken from another field (Spearman’s rho; p =
0.3263). (D) Another key assumption made is that the transient expression of
mCherry-α-tubulin will not have confounding effects on mitosis. Cells expressing
mCherry-α-tubulin were monitored for mitotic defects. The cell population was
separated into four quartiles of mCherry-α-tubulin expression. Around 4% of cells
with the lowest quartile of mCherry-α-tubulin expression displayed mitotic defects
(Fig 3.8B). The rate of mitotic defect steadily rises in the 2nd, 3rd and 4th quartile to
9%, 26% and 39% respectively (Fig 3.8B). This emphasised the need to select cells
with low expression of mCherry-α-tubulin as well as to ensure that expression
remained the same between treatment groups. The GFP fluorescence of cells was
also kept consistent between treatment groups for good measure.
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Supplementary Figure A
Supplementary B: The following six (6) pages contain the non-normalised data for
Fig 3.8. HeLa cells were transfected with one of wild-type GFP-SNX9, phospho-
deficient mutant or phospho-mimetic mutant and co-transfected with microtubule
marker α-tubulin-mCherry. Following 24 hours, cells were imaged every 4 minutes
for 24 hours. Each independent data point is the average of 3-17 cells from a single
field. A total of 12 fields were selected from 3-4 biological replicates on the basis of
ensuring even GFP and mCherry fluorescence between treatment groups. Data was
organised in this fashion to meet the independence assumption of the statistical test
used as well as ensure that the mitotic timing observed was not confounded by level
of mCherry-α-tubulin and GFP-SNX9 expression (Supplementary A). The number of
fields and the number of biological replicates was kept consistent within each
triumvirate of wildtype GFP-SNX9, phospho-deficient mutant and phospho-mimetic
mutant. Statistical tests were performed on this data. In all graphs the bars represent
the mean and 95% confidence intervals of data normalised to the global mean of
wild-type controls. All comparisons within each triumvirate (WT, phospho-deficient,
phospho-mimetic) for each phosphorylation site was statistically made using a
Kruskal Wallis ANOVA with Dunns Multiple Comparisons post-test. GFP tag alone
was compared to WT GFP-SNX9 with a Mann-Whitney one-tailed t-test. All
statistical tests were performed on data prior to normalisation. Non-significant
comparisons have not been visualised. *: p<0.05, ***: p<0.001.
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Supplementary Figure C
Supplementary C: Exogenously expressed GFP-SNX9 imaged in live cell time-
lapse microscopy does not appear to be enriched at the prometaphase spindle.
Representative images of a cell expressing wild-type GFP-SNX9 (green) and
mCherry-α-tubulin (red).
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Supplementary Figure D
Supplementary D: LFQ intensity of SNX9 in pulldowns analysed by mass
spectrometry. This demonstrates that the amount of each bait protein did not differ
between treatment groups within each biological replicate. Method of data
processing is detailed in chapter 2.
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Supplementary Figure D
Supplementary Figure E
Supplementary E: The following seven pages are of the western blots and
corresponding coomassie stains of the pulldowns on metaphase synchronised lysate
to demonstrate that the amount of each bait protein was kept consistent for each
pulldown. Note that the order of bait proteins is different in different blots and are
specified on each image. Pulldowns were run on western blot in technical duplicate.
The coomassie stain varied. Pull-downs were performed by Chin Wong, Sushma
Rao, Steven He and Daniel Yagoub. Western Blots performed by Chin Wong, Steven
He and Dadar Ahmadi-Pirshahid.
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Supplementary Figure E
AP-2
n = 2
Note: The order of bait proteins differs between coomassie and 
western blot.
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OCRL1
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DynII
n = 1
Note: The order of bait proteins differs between coomassie and 
western blot.
GST WT Y56FY56E T275AT275E
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Supplementary Figure E
DynII
n = 2
Note: The order of bait proteins differs between coomassie and 
western blot.
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Supplementary Figure E
Supplementary Figure F
Supplementary F: Above are the western blots and corresponding coomassie stains
of the pulldowns on asynchronous lysate to demonstrate that the amount of each bait
protein was kept consistent for each pulldown. Pulldowns were run on western blot
in technical duplicate. The coomassie stain varied. Pull-downs and Western Blots
were performed by Chin Wong and Sushma Rao.
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Supplementary Table A 
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 1 of 20. 
# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
1 A1X283 21.702 24.040 21.195 24.144 23.357 23.193 19.183 23.887 21.280 23.255 22.920 22.417 22.033 24.276 21.780 23.635 23.263 22.693
2 Q13765 22.760 22.989 23.387 23.415 22.023 22.262 21.599 20.411 19.675 20.346 21.618 21.324 22.715 22.614 23.173 23.172 23.305 23.332
3 O00116 20.279 21.129 21.521 21.574 20.957 21.188 20.621 21.468 21.554 21.330 21.650 21.082 22.614 21.090 21.646 21.498 21.717 21.593
4 O00151 21.203 20.935 20.072 19.282 20.646 20.875 21.389 21.492 22.324 21.381 20.977 21.498 21.767 20.814 20.623 20.606 20.834 20.581
5 O00203 22.901 23.843 26.152 24.166 23.710 23.892 19.848 25.460 26.587 24.167 24.776 24.038 20.040 20.625 23.128 19.760 19.071 21.146
6 O00303 24.317 23.766 23.761 24.346 24.217 24.375 23.747 23.713 23.749 23.760 24.133 23.481 24.182 24.518 21.208 24.687 25.126 24.681
7 O00401 20.443 28.998 18.998 27.496 29.023 28.329 19.529 28.745 20.226 27.235 28.894 28.536 21.818 29.014 19.467 27.132 29.328 28.990
8 O00410 26.288 25.607 25.778 25.918 25.802 25.982 25.348 25.102 25.118 25.129 25.469 25.069 26.598 25.853 25.880 26.150 25.996 25.995
9 O00469 20.103 21.262 24.044 21.286 21.248 20.491 20.384 19.772 23.569 20.635 19.939 19.887 19.457 20.461 24.313 20.437 20.582 20.076
10 O00571 24.502 26.223 25.829 26.293 26.024 25.686 26.037 26.411 26.280 26.440 26.180 26.256 23.649 25.743 25.653 26.219 25.658 25.878
11 O00750 20.668 22.539 21.054 22.457 22.161 22.529 19.622 22.032 19.776 21.962 22.206 19.450 20.543 23.152 19.732 22.792 22.058 21.985
12 O14579 23.595 20.922 22.574 21.340 20.972 21.222 22.142 21.422 23.248 20.963 21.077 21.765 22.319 20.485 22.470 20.039 20.637 20.933
13 P47813 19.819 20.061 21.018 19.997 20.378 20.982 19.785 20.174 19.791 20.967 20.526 20.818 19.929 20.325 22.828 20.779 20.562 22.582
14 O14818 21.669 22.909 23.126 23.126 22.962 22.134 20.465 22.563 21.841 21.819 21.565 20.998 20.010 23.190 23.644 23.296 23.442 22.870
15 O14874 20.595 24.349 23.553 24.211 24.362 24.479 18.922 24.198 23.750 23.159 24.629 24.331 19.222 24.376 24.383 24.222 25.194 25.130
16 P19105 22.526 23.028 23.195 22.745 24.151 23.099 28.161 26.791 27.361 27.699 27.222 27.854 19.853 19.564 19.496 19.560 18.432 20.112
17 O14965 21.318 27.493 27.557 27.395 26.781 26.779 21.104 26.651 26.546 25.956 26.113 25.738 20.861 26.722 26.540 26.512 26.100 26.059
18 O14979 23.116 23.395 24.000 23.558 23.740 23.650 23.158 23.173 23.184 23.551 23.342 23.369 24.399 23.386 23.499 23.125 23.171 23.585
19 O14980 21.347 20.406 19.169 20.036 21.130 18.585 20.400 21.049 21.704 21.696 21.421 21.538 21.964 19.617 21.661 21.383 21.459 21.489
20 O15056 20.363 23.576 19.200 23.892 23.663 23.401 20.052 23.858 19.638 23.427 23.745 23.395 20.107 22.622 20.352 23.043 23.125 22.939
21 O15143 21.457 23.939 24.334 23.986 23.856 23.699 18.452 23.715 23.757 23.095 23.364 22.921 20.306 23.514 24.042 23.318 23.657 23.466
22 O15144 19.484 22.784 23.149 22.866 23.397 23.370 21.396 23.129 23.074 22.863 23.084 23.175 21.323 23.254 23.457 23.065 23.186 23.019
23 O15347 19.759 19.294 20.538 19.919 20.952 21.329 19.443 19.732 19.861 21.073 20.960 19.534 20.398 20.291 21.922 21.902 21.790 21.547
24 O15355 21.090 21.569 22.133 21.954 21.791 21.181 20.550 21.483 21.447 20.947 21.377 21.040 20.756 21.207 21.221 20.984 21.393 20.650
25 O15371 20.717 23.288 23.512 23.500 23.073 23.129 22.079 23.333 22.774 23.121 23.082 22.774 22.340 23.479 23.084 23.014 22.954 23.060
26 O43175 25.595 25.009 25.273 25.231 25.098 25.260 24.160 24.527 24.555 24.285 24.459 24.192 24.664 24.378 24.542 24.421 24.475 24.309
27 O43242 22.159 22.647 22.345 22.592 22.484 22.583 21.771 22.599 22.494 22.254 22.445 21.929 22.552 22.256 22.162 22.107 22.273 22.051
28 O43390 21.045 22.457 22.881 22.745 22.879 22.953 22.286 22.740 22.882 22.763 22.957 23.007 22.845 22.047 22.274 22.832 22.369 22.698
29 O43426 20.667 24.696 19.812 24.822 24.765 24.594 21.142 24.822 20.472 24.294 24.541 24.383 19.634 24.641 19.656 24.429 24.565 24.619
30 O43516 19.851 26.157 20.647 24.581 25.566 24.880 19.673 26.241 20.521 24.264 25.882 25.206 20.094 26.486 19.717 25.038 26.090 25.596
31 O43684 22.210 22.282 22.208 22.472 22.664 22.208 21.867 22.116 21.946 21.566 21.994 21.919 23.293 22.303 22.373 22.395 22.694 22.288
32 O43707 22.912 23.997 24.092 21.950 24.311 21.181 27.133 26.518 26.979 27.192 26.939 27.289 22.051 19.149 21.451 21.246 21.090 20.879
33 O43747 20.566 22.285 22.389 22.322 21.283 21.555 20.189 22.192 21.274 21.296 21.293 20.744 19.464 22.089 21.961 22.026 21.443 21.581
34 O43776 20.069 22.507 23.222 22.667 22.689 22.434 21.917 22.269 22.477 22.822 22.269 21.855 20.167 23.527 23.857 23.176 23.296 22.818
35 O43809 23.584 27.025 25.038 26.263 26.336 26.325 24.290 26.521 24.520 25.264 25.683 25.461 24.871 26.959 25.078 25.808 26.376 26.111
36 O43813 27.499 25.607 25.965 26.062 25.966 25.826 25.935 25.426 25.299 25.120 25.242 24.489 28.284 26.537 26.962 26.281 26.385 26.221
37 O43852 20.245 20.489 20.420 20.457 20.259 20.333 20.220 19.882 20.071 20.265 20.098 20.263 20.791 20.480 20.497 20.326 20.190 20.010
38 O43865 21.579 23.836 23.774 24.046 23.528 22.467 21.155 24.502 23.820 23.393 23.721 22.616 21.367 23.713 23.235 23.162 23.123 22.539
39 O60220 20.507 19.941 19.858 19.283 19.744 19.110 19.604 20.042 19.918 20.003 20.014 19.835 20.384 20.570 20.229 18.252 20.727 19.758
40 O60506 24.699 24.470 24.898 24.592 24.657 24.585 24.211 24.522 24.643 24.425 24.297 24.134 24.636 24.039 24.477 24.128 23.987 24.233
41 O60568 20.771 19.961 22.009 20.369 18.048 20.738 20.354 20.960 23.014 20.173 20.108 19.473 20.449 21.225 23.212 20.713 20.376 20.273
42 O60664 22.180 21.774 21.760 21.409 21.398 21.116 20.343 20.849 19.155 19.948 20.733 20.347 21.903 20.820 20.893 20.779 21.395 20.647
43 Q99880 23.787 24.216 24.084 23.983 23.933 23.874 25.703 25.679 25.428 25.565 25.051 25.514 25.023 23.986 24.358 24.305 23.982 24.472
44 O60869 24.781 23.736 24.038 24.105 23.917 23.835 23.577 23.441 23.218 23.015 23.255 22.589 26.089 23.963 24.104 23.568 23.359 23.427
45 O60884 20.470 20.252 19.074 21.118 23.959 23.847 18.999 23.254 24.186 24.485 23.652 24.370 22.458 22.996 24.227 23.872 24.018 23.753
46 O60885 19.866 25.937 20.569 24.803 24.730 23.552 20.244 25.915 21.671 23.574 24.214 22.880 20.139 25.538 19.861 23.876 23.989 22.651
47 O75128 20.926 21.385 21.332 19.059 21.626 20.050 22.089 23.835 22.408 22.672 22.982 22.656 20.247 22.781 18.902 21.866 21.983 21.735
48 O75340 22.730 22.471 22.256 22.492 21.963 22.229 20.281 22.921 22.289 22.654 22.043 21.988 22.245 19.483 22.349 22.279 22.067 21.678
49 O75348 21.376 21.039 20.574 20.862 20.709 20.069 20.924 19.983 20.443 20.155 20.988 19.311 20.989 19.403 20.475 19.766 20.126 20.085
50 O75369 21.083 21.753 19.634 20.920 22.798 20.156 25.266 24.092 25.186 25.377 24.270 25.303 22.879 20.505 20.488 20.602 21.552 20.613
51 O75390 23.204 24.183 24.448 24.347 24.572 24.095 23.039 24.238 24.119 23.954 23.903 23.696 23.425 24.862 25.256 25.566 25.280 24.992
52 O75521 23.265 20.075 22.328 20.034 22.056 21.941 22.423 22.196 22.101 22.282 22.502 21.929 23.356 21.914 22.298 22.745 22.182 22.006
53 O75533 22.569 22.445 22.464 22.207 22.450 22.084 23.058 22.649 22.482 22.204 22.445 22.552 22.571 21.615 22.069 21.800 21.717 21.747
54 O75534 22.309 21.531 22.113 21.690 22.114 21.944 21.229 21.420 22.078 21.272 21.585 21.016 21.516 21.751 22.354 21.624 21.481 21.149
55 O75643 20.067 23.846 24.512 23.651 23.652 23.452 23.901 23.980 24.486 24.512 24.034 24.490 22.614 23.658 23.729 22.983 23.391 23.235
56 O75821 20.025 19.336 20.099 20.367 21.759 19.167 19.474 21.011 19.342 21.397 21.346 21.489 19.822 19.711 19.382 21.404 21.391 21.292
57 O75822 20.820 19.753 22.456 20.348 20.177 22.102 19.567 22.074 22.043 19.342 19.521 20.929 21.896 22.139 22.814 22.106 22.350 22.051
58 O75909 20.745 26.230 18.614 25.858 26.458 26.030 19.455 26.418 19.000 24.515 26.159 25.277 19.610 26.909 19.126 26.543 27.199 26.986
59 O75947 21.657 21.657 21.646 21.566 21.467 21.437 22.408 22.162 22.375 22.557 22.376 22.134 22.907 21.588 21.817 21.628 21.236 21.234
60 O75964 21.648 19.969 18.903 20.163 21.693 21.529 22.108 21.407 21.522 21.823 21.953 21.893 21.606 21.448 21.184 18.860 19.317 18.435
61 O76003 25.999 24.335 19.771 24.539 24.962 24.422 23.594 24.177 23.880 24.603 24.258 23.811 25.390 25.274 24.903 24.924 24.520 24.762
62 O76021 20.593 20.952 22.070 21.325 22.696 22.753 23.193 23.033 23.419 23.921 23.720 23.765 20.540 19.604 20.995 20.724 21.856 21.730
63 O94826 22.445 20.955 20.073 19.195 19.057 19.407 22.261 22.050 21.611 22.144 22.738 19.089 22.902 22.339 22.286 22.392 22.757 22.222
64 O94875 22.506 24.652 23.265 24.399 24.416 23.323 25.319 25.609 25.680 25.482 25.614 25.729 19.837 25.406 21.142 24.661 24.728 24.198
65 O94973 21.261 26.877 27.362 26.953 26.955 27.061 20.314 25.948 26.098 25.925 26.126 25.811 21.409 26.597 27.023 26.974 26.632 26.924
66 O95340 23.507 23.400 23.560 23.741 23.793 23.947 23.592 23.863 24.039 23.796 24.111 23.932 24.545 23.705 23.859 24.099 24.424 24.328
67 O95347 21.808 20.694 19.593 19.592 21.223 20.205 21.641 19.796 21.847 21.714 21.825 21.721 22.321 20.537 19.144 21.289 21.477 21.279
68 O95373 23.482 22.514 22.838 22.453 22.360 22.520 22.028 21.741 21.825 22.183 22.075 22.017 23.333 21.896 22.501 22.504 22.671 22.609
69 O95573 22.641 21.993 23.049 22.878 22.333 22.419 21.848 22.370 22.932 22.029 22.158 21.808 22.537 21.630 21.607 21.146 21.214 19.630
70 O95782 20.882 29.252 29.595 29.414 29.305 29.354 22.251 28.235 28.465 28.208 28.469 28.274 21.213 29.061 29.300 29.069 29.093 28.993
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# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
71 O95816 20.046 21.552 21.351 20.745 21.664 21.390 22.441 21.974 22.096 22.331 22.146 22.467 23.073 21.410 21.724 22.189 21.250 21.285
72 O95817 20.047 19.398 19.243 21.091 20.886 20.009 19.570 19.380 20.718 19.070 20.661 20.021 20.474 20.087 19.897 19.622 21.143 20.359
73 P00338 26.156 26.521 26.309 26.261 26.174 26.324 25.302 25.751 25.260 25.634 25.500 25.427 25.525 26.198 26.233 25.926 25.816 25.948
74 P00367 20.785 22.846 23.108 22.887 23.123 23.079 20.814 22.937 23.445 22.632 22.964 22.167 21.506 23.586 24.334 23.975 23.748 23.764
75 P00387 22.281 20.262 21.997 21.937 21.968 21.741 21.610 21.331 21.350 21.453 21.797 21.359 22.501 22.021 22.346 22.111 22.067 22.169
76 P00390 22.208 21.235 20.137 21.503 20.693 20.610 21.425 21.275 20.325 20.310 20.717 19.426 21.541 21.862 20.977 21.155 20.906 20.828
77 P00558 19.727 20.838 20.970 19.955 19.272 19.601 20.544 20.208 19.648 19.161 19.611 20.291 21.904 19.695 20.465 19.455 19.769 21.811
78 P00966 21.058 19.598 19.446 22.393 22.356 22.545 22.785 22.942 23.241 22.415 22.992 22.489 22.952 23.555 23.429 23.331 23.267 23.978
79 P01891 23.355 23.162 23.464 23.327 23.304 23.114 22.476 22.936 22.841 22.906 23.019 22.749 23.964 22.829 23.151 23.199 23.433 23.314
80 P02545 24.990 25.366 25.307 25.368 24.912 24.692 25.317 25.338 25.412 25.166 25.273 25.073 26.114 25.651 25.772 25.564 25.371 25.420
81 P02786 23.108 23.600 23.568 23.800 24.000 23.628 24.151 23.509 23.510 23.673 23.817 23.763 24.723 23.407 23.633 24.036 23.807 23.746
82 P04075 20.352 28.021 27.958 28.066 28.189 28.262 21.994 27.323 27.318 27.266 27.474 27.262 19.668 28.192 28.255 28.081 27.997 27.908
83 P04183 22.596 21.605 22.163 22.179 22.410 22.080 21.745 22.024 22.319 21.669 21.808 21.387 22.407 22.368 18.753 21.555 18.883 21.976
84 P04406 30.044 29.678 29.995 30.013 30.147 30.114 28.701 29.428 29.246 29.289 29.604 29.294 29.913 29.949 30.012 29.979 30.169 29.844
85 P04792 27.207 26.649 26.960 26.991 27.120 26.901 26.816 26.696 26.930 27.167 26.900 26.977 26.437 26.386 26.468 26.780 26.791 26.362
86 P04843 24.422 23.993 24.282 24.170 24.162 24.023 24.909 24.601 24.808 24.728 24.549 24.515 24.412 23.422 23.865 24.107 24.230 24.152
87 P04844 23.140 18.643 22.761 20.623 22.908 19.943 19.414 23.168 23.580 19.730 23.130 22.936 23.139 19.800 22.849 19.119 19.016 20.119
88 Q93077 20.701 19.854 20.345 20.574 21.995 20.360 23.384 22.740 22.984 23.865 23.128 23.196 22.428 21.927 21.975 22.341 22.379 21.521
89 P05023 24.296 23.529 23.856 23.977 24.032 23.917 23.899 23.939 24.129 23.851 24.031 23.824 24.535 23.255 23.615 23.277 23.387 23.272
90 P05141 19.876 23.667 24.338 23.427 24.340 23.954 25.807 25.453 25.689 25.891 25.866 25.680 24.170 23.438 23.892 23.346 22.982 23.014
91 P05198 20.273 21.837 22.072 21.992 21.877 22.037 22.118 21.513 21.659 22.055 21.483 21.960 21.589 21.852 22.139 21.801 22.033 22.113
92 P05386 20.898 26.940 27.139 27.198 27.550 28.016 28.771 27.437 27.365 28.223 27.700 28.414 27.299 27.164 27.347 28.111 28.007 28.229
93 P05387 25.643 24.149 24.580 24.591 24.647 24.835 24.550 24.267 24.498 24.435 24.648 24.902 24.821 23.793 23.914 23.536 24.163 24.529
94 P05388 25.775 24.342 25.144 24.556 25.304 25.517 26.292 25.550 25.401 25.599 25.572 26.083 25.777 24.270 24.439 24.681 25.086 25.474
95 P05455 21.132 21.287 21.031 20.077 20.233 20.615 19.787 20.600 20.665 19.836 19.125 19.333 20.614 22.015 21.457 21.705 20.762 20.200
96 P05556 22.888 21.157 21.479 21.747 21.621 21.524 20.545 18.267 19.512 20.677 21.390 19.411 23.284 21.440 21.408 21.756 22.014 21.805
97 P05783 23.530 22.747 23.395 22.077 23.487 22.553 26.778 25.960 26.574 26.397 26.178 26.324 22.470 19.702 20.652 22.123 21.754 21.945
98 P06493 24.148 24.288 24.500 24.150 23.988 24.281 23.020 23.840 23.457 23.115 23.954 23.398 24.382 23.935 23.962 23.619 23.739 23.842
99 P06576 27.032 26.123 26.536 26.659 26.441 26.296 26.788 26.553 26.886 26.572 26.817 26.559 27.231 26.132 26.390 26.648 26.725 26.546
100 P06730 19.636 20.559 19.766 21.258 20.507 20.386 19.654 20.154 19.632 19.892 20.332 19.940 20.270 19.901 19.741 20.907 20.427 20.125
101 P06748 24.848 25.496 25.941 25.716 25.776 25.103 25.161 25.237 25.780 25.351 25.011 25.859 25.476 26.018 26.336 25.744 25.802 25.572
102 P06753 21.185 21.776 21.741 21.122 20.720 20.040 23.617 22.188 23.581 22.827 22.724 23.749 20.973 21.559 20.011 21.134 21.635 20.044
103 Q16778 20.735 21.004 19.919 20.978 20.812 20.919 22.587 22.419 22.059 22.094 21.355 22.589 21.937 21.084 21.539 20.746 20.471 19.558
104 P07195 22.221 23.506 22.791 23.125 22.431 21.767 21.018 21.286 21.519 21.304 21.539 21.296 21.534 22.085 22.324 22.287 21.933 22.067
105 P07237 20.290 24.333 20.173 21.956 20.612 20.733 18.341 20.747 19.183 19.509 19.061 19.655 19.957 24.709 20.069 23.469 20.770 20.646
106 P07355 28.469 26.408 26.069 26.075 26.177 25.802 28.489 27.462 27.543 27.811 27.701 27.524 26.969 26.185 26.168 25.645 25.658 26.288
107 P07437 27.994 28.436 28.494 28.409 28.445 28.220 27.890 28.248 28.400 28.436 28.330 28.246 28.057 27.923 28.094 28.058 28.072 27.933
108 P07814 23.071 23.388 24.025 23.644 24.007 23.343 24.188 23.908 24.298 23.924 24.075 23.991 24.403 22.868 22.958 23.087 23.445 23.415
109 P07900 26.553 27.168 26.866 27.097 26.837 25.821 25.225 26.348 25.681 26.122 25.371 24.975 27.479 27.150 26.925 27.555 27.229 26.863
110 P07910 24.909 24.205 24.133 24.187 24.735 24.699 24.906 24.112 24.375 24.349 24.298 24.669 25.903 23.979 24.029 24.159 24.700 25.026
111 P07919 22.908 22.583 23.743 23.583 23.581 22.747 23.657 23.715 24.185 24.014 23.501 23.631 25.237 24.563 24.349 23.898 24.070 23.817
112 P07992 21.766 21.172 22.948 22.396 20.396 19.504 20.132 21.998 23.215 19.844 22.569 20.025 19.639 21.037 23.252 19.162 19.610 20.320
113 P08195 28.391 27.631 28.057 28.012 27.827 27.832 27.725 27.644 27.714 27.595 27.801 27.588 28.665 27.422 27.627 27.734 27.885 27.519
114 P08237 20.775 22.616 22.624 22.828 22.669 22.650 18.315 21.744 21.910 21.844 21.791 19.677 22.569 22.608 23.182 23.006 23.067 22.598
115 P08238 29.397 29.957 29.759 30.037 29.522 28.803 28.057 29.072 28.441 28.760 28.327 28.145 30.031 30.254 30.071 30.190 29.969 29.698
116 P08574 24.184 23.718 24.307 23.855 24.408 23.309 23.874 24.483 24.486 23.932 24.232 23.259 24.490 24.360 24.457 24.274 24.438 23.792
117 P08621 19.681 23.991 23.284 23.654 23.743 23.381 22.697 22.912 23.043 23.059 23.004 23.229 20.762 23.698 23.628 23.987 23.514 23.433
118 P08670 24.642 24.436 24.739 23.544 24.891 23.492 28.095 27.460 27.819 27.768 27.489 28.378 23.666 23.237 22.882 23.145 23.288 23.084
119 P08708 23.383 24.248 25.323 24.308 24.553 25.499 23.182 23.097 23.294 23.033 23.196 23.398 24.936 25.296 26.193 24.880 25.297 26.030
120 P08754 22.685 22.103 21.839 22.696 21.981 22.244 21.730 21.804 21.473 21.610 21.601 21.413 22.963 21.810 22.087 21.861 21.813 21.887
121 P08865 25.223 26.295 27.048 26.334 26.328 26.791 25.088 24.840 24.789 24.606 24.610 24.902 26.011 26.856 27.771 26.607 26.959 27.485
122 P09234 20.404 20.471 19.686 20.323 20.717 19.239 19.827 20.562 20.250 20.221 20.272 20.567 20.056 20.648 21.047 20.881 20.671 20.927
123 P09496 21.315 21.392 22.894 21.071 20.799 20.004 21.376 22.144 23.138 21.601 21.279 21.307 20.348 20.658 22.745 21.067 18.693 18.659
124 P09651 26.731 27.198 27.147 27.110 27.367 26.930 27.183 26.248 26.432 26.893 26.695 27.352 27.560 26.873 27.021 27.789 27.661 27.874
125 P09972 20.878 23.573 23.954 24.221 23.547 23.903 19.894 20.167 22.825 22.354 22.802 22.930 20.935 23.237 23.561 23.662 23.864 23.677
126 Q71UI9 25.575 24.883 24.736 24.518 24.526 20.282 26.894 25.315 25.232 26.077 25.294 26.456 25.689 26.316 26.333 27.339 26.888 26.412
127 Q99878 27.018 26.673 26.876 26.511 26.414 26.444 28.092 27.376 27.968 28.154 27.697 28.382 27.793 26.936 27.446 27.231 27.295 27.377
128 P0DMV9 28.050 27.994 27.806 27.944 27.891 27.820 27.132 27.324 27.231 27.306 27.367 27.282 27.513 27.688 27.440 27.748 27.573 27.694
129 P10599 25.768 21.347 19.362 20.084 20.087 20.190 25.720 19.421 19.216 22.999 19.842 19.772 24.734 22.762 23.132 20.436 23.240 24.184
130 P10620 22.210 20.907 20.679 21.968 20.897 20.582 20.183 20.455 18.083 20.205 20.807 20.217 22.225 20.599 20.818 20.281 20.282 20.310
131 P10809 27.816 27.094 26.879 26.746 26.915 26.909 26.065 26.355 26.190 26.180 26.092 26.157 27.335 26.462 26.370 26.852 26.831 26.727
132 P11021 26.212 26.602 26.143 26.305 25.747 25.675 25.242 25.851 25.874 25.387 25.488 25.365 25.942 26.335 25.942 26.117 25.855 25.796
133 P11142 27.762 27.838 27.593 27.896 27.425 27.422 27.236 27.461 27.484 27.262 27.414 27.373 27.813 28.044 27.808 27.851 27.871 27.852
134 P11413 25.175 25.296 23.961 24.653 24.155 23.944 23.189 24.345 22.835 23.272 24.135 23.373 22.485 24.816 23.762 24.286 24.314 24.392
135 P11586 25.262 25.167 25.109 25.419 25.150 25.181 24.030 24.868 24.610 24.699 24.943 24.409 24.168 25.004 25.138 24.989 25.149 25.116
136 P11940 25.118 25.112 25.256 25.232 25.305 25.595 25.026 25.257 24.970 25.028 25.216 25.006 25.236 25.487 25.330 25.480 25.417 25.695
137 P12081 20.766 22.278 22.287 22.257 22.044 21.878 22.020 19.065 19.698 19.625 21.579 21.959 19.978 21.792 22.155 21.653 21.566 21.894
138 P12236 26.475 25.727 26.161 25.974 26.419 26.297 27.215 27.059 27.337 27.405 27.371 27.574 26.077 25.510 25.396 25.867 26.026 25.972
139 P12270 21.618 21.054 22.050 21.874 22.154 21.376 20.903 21.400 19.472 21.513 20.729 20.513 25.319 22.216 22.217 21.429 22.310 22.008
140 P12532 23.321 19.719 20.077 19.470 19.936 18.773 23.148 21.028 20.259 23.540 22.746 23.254 22.888 24.229 23.254 24.815 24.995 25.178
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 3 of 20. 
# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
141 P12956 24.278 23.636 23.779 23.449 23.701 23.395 23.563 23.892 24.118 23.578 24.002 23.606 24.832 23.876 23.705 23.677 23.656 23.663
142 P13010 24.729 23.578 24.113 24.052 24.225 23.710 24.368 23.953 24.432 23.706 24.245 24.008 25.024 23.588 24.353 23.700 23.922 23.891
143 P13639 29.102 28.270 28.279 28.202 28.342 28.607 28.292 27.864 27.790 27.883 27.914 27.922 27.682 28.030 28.281 28.277 28.622 28.672
144 P13987 21.156 20.514 20.630 20.717 20.430 19.981 21.744 21.524 22.250 22.379 21.287 22.659 22.701 19.097 19.835 20.469 20.701 20.300
145 P13995 21.470 22.046 21.992 22.021 21.769 21.860 20.794 21.820 22.045 21.667 18.374 21.743 21.760 22.017 21.842 22.069 22.030 21.800
146 P14314 19.611 21.276 21.029 21.047 21.416 18.978 19.129 20.262 19.770 19.216 19.475 19.883 20.686 22.137 21.459 21.649 21.285 20.682
147 P14618 26.495 26.424 25.579 25.631 25.258 24.812 26.021 26.774 26.394 26.580 26.721 26.448 26.157 27.219 26.599 26.822 26.452 26.715
148 P14625 25.628 26.438 26.591 26.626 26.361 25.646 24.843 25.999 25.587 25.808 25.098 24.853 26.316 26.618 26.600 26.648 26.569 26.102
149 P14866 23.364 24.535 24.089 23.946 24.419 24.399 24.218 24.614 24.223 24.546 24.531 24.382 25.074 24.051 23.903 23.569 24.130 24.388
150 P14923 22.980 21.990 22.151 22.305 21.766 22.046 22.174 22.059 22.326 22.171 22.022 19.350 22.614 21.667 21.602 21.881 21.800 21.570
151 P15311 23.677 24.566 24.528 24.498 24.552 24.580 23.709 23.639 23.473 23.679 23.480 23.424 24.955 25.145 25.442 25.345 25.174 25.330
152 P15880 25.467 26.162 27.008 26.193 26.749 27.428 25.993 25.189 25.459 25.754 25.347 26.005 26.643 27.036 27.840 26.741 27.101 27.786
153 P15924 25.818 23.379 24.420 24.341 24.784 23.411 25.996 25.361 26.104 25.715 26.167 25.399 27.151 23.449 24.458 22.204 23.101 23.031
154 P16152 32.823 31.712 31.808 32.034 32.051 31.958 32.749 31.569 31.817 31.747 31.902 31.577 33.276 31.748 32.031 32.200 32.278 32.023
155 P16403 20.906 21.112 20.636 20.480 20.314 20.603 21.698 22.185 22.563 21.844 21.921 22.245 20.741 18.719 19.685 20.611 19.945 20.243
156 P16435 25.226 24.481 24.744 24.934 24.798 24.722 24.435 24.018 24.142 24.029 24.460 24.005 25.165 24.233 24.476 24.441 24.917 24.668
157 P16615 22.692 21.734 22.315 21.919 22.747 21.796 22.327 22.971 23.047 22.142 23.160 22.192 22.430 21.372 21.696 19.515 21.389 21.544
158 P17096 21.598 21.422 21.756 21.555 22.361 21.650 22.439 22.751 23.141 22.516 22.729 22.455 22.549 21.801 22.202 21.820 22.549 21.889
159 P17812 21.291 22.676 22.163 22.394 21.108 19.866 19.938 21.755 21.804 21.396 18.862 21.043 20.908 22.745 21.678 22.258 21.580 21.751
160 P17844 24.977 26.291 25.694 25.710 25.834 25.686 25.837 26.060 25.746 25.948 26.023 25.990 24.560 25.192 25.159 25.428 25.523 25.442
161 P17858 23.021 24.194 23.928 24.018 23.581 23.375 22.584 23.795 23.778 22.968 23.226 23.086 23.282 24.214 24.160 23.871 23.867 23.736
162 P17987 24.640 25.624 26.302 25.866 25.897 26.071 24.724 25.391 25.533 25.251 25.268 24.862 25.176 25.599 26.018 26.346 26.449 26.159
163 P18077 23.256 22.132 22.799 22.338 22.124 22.966 22.850 22.704 22.896 23.282 23.062 23.430 22.535 21.483 21.782 21.104 21.412 22.207
164 P18124 25.580 24.849 25.223 24.961 25.595 25.341 25.991 25.885 26.289 26.176 25.910 26.117 25.990 24.609 25.014 24.352 24.734 25.201
165 P18621 22.999 22.967 23.779 22.987 23.776 23.699 24.313 24.167 24.439 24.187 24.043 24.507 24.612 22.210 23.526 22.562 23.002 24.131
166 P18754 22.086 20.353 21.872 19.714 21.297 21.628 20.589 19.551 20.808 20.650 21.047 18.382 21.901 21.450 21.776 21.799 22.053 22.131
167 P18859 21.502 21.147 20.491 21.448 20.237 20.860 21.259 22.487 21.543 21.194 21.975 21.323 21.423 20.167 19.700 20.333 21.097 21.120
168 P19338 25.041 26.311 27.023 26.458 26.794 26.457 26.287 26.503 26.677 26.660 26.614 26.877 25.516 26.183 26.980 26.228 26.464 26.707
169 P19784 20.822 24.444 24.452 24.775 24.191 23.975 20.353 25.891 24.565 25.214 25.392 25.047 20.755 24.362 24.529 24.665 23.818 23.928
170 P20290 20.635 20.350 20.693 19.992 21.770 22.496 19.732 20.925 20.561 19.514 21.133 20.608 20.958 22.515 23.028 22.328 22.228 22.528
171 P20674 22.645 22.310 20.009 22.106 22.318 19.595 22.681 22.700 22.505 22.680 22.914 22.026 24.047 22.887 22.595 22.524 22.662 22.533
172 P20700 23.736 23.484 23.908 23.867 23.652 23.664 23.907 23.705 24.099 23.851 23.836 23.536 25.235 23.753 23.920 23.784 23.899 23.924
173 P21266 33.906 32.051 32.453 32.405 32.648 32.713 33.853 32.067 32.162 32.366 32.378 32.474 33.827 31.839 31.903 32.333 32.753 32.514
174 P21291 25.521 23.777 23.504 23.866 24.397 23.794 25.810 25.465 25.528 25.527 25.819 25.790 24.819 23.607 24.003 23.669 23.734 23.996
175 P21333 26.261 25.685 25.798 25.732 25.568 25.494 26.497 26.277 26.567 26.650 26.544 26.498 25.831 25.162 25.227 25.244 25.095 25.059
176 P21796 24.788 23.438 24.174 23.849 24.043 23.639 24.089 23.568 24.059 23.554 24.279 24.083 24.179 22.607 22.985 23.011 22.952 23.160
177 P22087 20.209 21.511 21.668 21.507 21.816 21.402 22.347 22.259 22.471 22.704 22.402 22.521 20.855 21.489 20.968 20.425 20.306 20.252
178 P22234 26.333 25.358 25.108 25.318 24.891 24.979 24.292 24.363 23.933 24.526 24.382 24.156 24.673 25.218 24.752 25.339 25.567 25.239
179 P22314 21.380 22.349 21.600 21.764 19.541 19.153 19.701 21.207 19.685 19.565 18.719 19.950 20.625 22.542 20.409 21.619 19.614 20.244
180 P22392 25.009 22.631 22.599 22.505 22.290 21.592 23.957 23.492 23.337 23.134 22.976 22.709 24.400 22.648 23.718 22.031 21.818 23.541
181 P22626 26.976 27.227 27.401 27.355 27.393 27.169 27.259 26.732 26.832 27.081 26.817 27.120 27.746 26.832 27.410 27.129 27.142 27.241
182 P22695 20.460 21.854 21.839 22.018 21.505 21.560 21.700 21.581 21.745 21.571 21.581 19.090 22.328 21.198 21.555 21.226 21.614 21.442
183 P23193 20.752 20.174 20.443 20.558 19.654 19.915 20.310 20.182 20.138 19.466 20.290 20.194 20.079 20.727 20.564 20.590 19.045 19.924
184 P23246 23.585 29.148 26.186 28.542 28.439 27.900 25.015 28.778 25.514 27.856 27.685 26.667 24.616 29.656 26.685 29.209 29.132 28.367
185 P23258 21.271 20.781 21.925 21.270 21.858 19.039 19.349 21.655 22.105 20.059 21.583 21.225 21.069 21.513 21.901 21.839 22.013 21.465
186 P23284 26.708 25.855 26.379 26.131 26.219 26.308 25.233 25.587 25.628 25.371 25.587 25.454 26.547 26.285 26.718 26.018 26.203 26.337
187 P23396 26.682 27.402 28.373 27.582 27.813 28.399 26.791 26.469 26.889 26.535 26.629 26.951 26.961 27.760 28.535 27.703 27.964 28.606
188 P23528 26.252 23.890 24.376 23.786 24.591 23.161 26.051 25.187 25.844 25.895 25.395 26.050 24.675 20.366 22.417 22.692 22.671 23.446
189 P23588 24.747 25.309 25.045 25.415 25.188 25.559 24.904 24.755 24.588 24.942 25.168 24.793 25.923 26.058 26.130 26.589 26.504 26.560
190 P23921 24.471 24.035 24.471 24.293 24.505 24.235 23.005 23.466 23.996 23.544 23.970 23.504 23.468 24.569 24.933 24.470 24.349 24.904
191 P24534 22.881 19.631 19.865 19.943 19.899 22.306 22.281 22.362 22.302 19.851 22.257 21.919 22.852 23.020 23.099 22.245 22.973 22.753
192 P24539 21.904 19.794 21.513 21.264 22.536 20.388 22.382 22.302 23.121 21.732 22.230 22.062 23.535 21.218 22.186 20.951 21.086 21.453
193 P24752 22.195 22.151 22.032 22.246 22.205 22.073 19.926 22.122 22.264 22.347 22.111 22.083 21.992 22.188 22.348 22.939 22.714 21.918
194 P25205 20.668 23.991 24.393 23.680 23.552 23.647 23.067 23.971 24.671 23.294 23.390 23.527 22.860 23.669 24.836 23.824 23.767 23.536
195 P25398 25.273 26.195 26.923 26.129 26.376 27.417 25.116 25.528 25.773 25.256 25.540 25.150 25.764 26.547 27.304 26.120 26.587 27.162
196 P25440 20.774 25.801 26.373 25.819 24.316 22.890 19.633 25.965 25.892 25.212 24.006 22.028 19.911 23.629 23.510 22.901 21.597 20.887
197 P25685 21.134 21.160 21.392 19.434 21.134 21.233 21.549 21.497 22.154 21.475 19.744 18.753 21.684 20.775 21.236 21.455 21.722 21.473
198 P25705 27.032 26.139 26.606 26.592 26.696 26.549 26.764 26.755 26.979 26.703 27.056 26.701 27.625 26.721 26.951 26.885 27.149 27.047
199 P25786 20.024 23.825 23.425 23.990 23.686 22.951 19.701 23.637 22.936 22.908 22.834 22.083 19.711 24.020 24.244 23.417 23.475 22.695
200 P25787 20.340 22.994 22.995 23.042 22.920 23.160 20.219 22.286 22.377 22.736 22.326 19.226 20.020 22.789 22.798 23.320 23.300 22.821
201 P25788 20.071 22.121 22.090 22.224 21.920 21.486 19.998 21.683 21.335 21.517 21.450 20.532 21.164 21.636 21.534 21.874 21.714 21.230
202 P25789 20.405 21.804 22.387 22.080 21.863 21.333 19.915 21.258 20.791 21.199 20.899 21.354 21.177 21.664 21.998 23.287 22.952 22.158
203 P26038 20.881 20.658 20.721 20.507 20.854 20.040 19.285 18.804 20.367 20.672 18.872 20.482 20.749 21.171 21.881 21.663 20.985 21.421
204 P26196 20.023 23.761 23.500 23.614 23.555 23.560 22.608 23.478 23.057 23.300 23.168 23.055 23.267 23.680 23.556 23.712 23.864 23.654
205 P26368 23.994 23.546 23.899 23.312 24.163 23.986 25.005 24.996 24.558 24.813 24.231 24.952 19.972 23.477 23.845 24.420 24.857 24.785
206 P26373 23.965 23.672 24.087 23.763 24.364 24.386 25.283 24.949 25.118 25.022 24.869 25.122 24.705 23.576 24.063 23.488 23.975 24.396
207 P26583 20.769 20.158 20.726 20.293 20.842 20.536 19.830 20.950 20.107 20.723 20.819 20.959 22.286 19.528 20.819 21.275 21.347 21.769
208 P26599 26.387 25.552 26.045 25.679 26.005 26.143 26.021 25.600 25.550 25.818 25.786 25.924 26.591 25.844 26.284 25.817 26.147 26.150
209 P26639 21.197 24.935 25.060 24.971 24.735 24.631 21.561 24.141 24.109 24.161 24.154 23.913 20.488 25.352 26.062 25.649 25.386 24.957
210 P26640 23.675 23.867 24.271 23.940 23.924 23.829 22.431 23.340 23.522 23.210 23.186 22.660 23.507 23.617 23.826 24.030 23.863 23.703
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
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# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
211 P26641 26.211 25.505 26.101 25.765 25.865 25.723 25.284 25.352 25.271 25.173 25.300 24.856 27.122 25.932 26.227 26.116 26.204 25.923
212 P27348 22.932 24.445 23.065 24.034 23.054 20.641 23.617 23.796 23.285 23.948 23.342 22.963 22.016 19.815 19.933 19.771 23.708 20.784
213 P27635 22.457 22.420 22.725 22.133 22.783 22.597 23.759 23.298 23.503 23.912 23.472 23.641 24.214 22.061 22.285 22.139 22.664 22.935
214 P27695 19.877 22.552 22.544 22.560 21.860 22.032 21.770 22.023 22.155 19.130 22.365 22.433 20.661 22.589 22.860 22.596 22.188 22.251
215 P27797 24.691 25.498 25.016 25.654 25.109 24.421 20.140 24.448 21.795 22.854 21.032 21.463 25.384 25.420 25.065 25.628 25.070 24.925
216 P27816 23.637 22.121 22.484 22.843 22.212 22.553 22.153 22.157 22.125 21.944 22.100 21.943 23.833 22.293 22.599 22.179 22.502 22.109
217 P27824 25.938 24.901 25.009 25.326 25.369 25.293 24.597 25.297 25.153 25.284 25.654 24.973 25.706 24.825 24.904 25.134 25.354 25.278
218 P28066 21.150 21.823 22.189 22.395 21.743 21.765 20.546 21.308 21.362 20.807 18.791 21.573 21.898 22.929 22.765 22.744 22.230 22.621
219 P28072 19.753 21.626 22.382 21.574 21.504 21.119 19.929 21.229 19.776 20.532 20.074 19.998 21.091 22.931 23.170 22.637 22.417 22.166
220 P28074 21.428 22.606 22.806 22.598 22.484 21.609 20.010 21.681 20.225 20.940 20.878 19.989 20.791 22.450 22.973 22.485 22.441 22.153
221 P28482 20.157 21.068 20.231 20.066 20.573 19.355 19.192 20.161 20.626 20.424 20.457 20.158 20.380 21.853 21.310 20.859 20.735 20.774
222 P29692 24.123 25.060 25.109 25.115 24.914 24.693 23.144 24.294 24.377 23.738 23.855 23.087 25.194 25.274 25.367 24.911 25.178 24.781
223 P30048 22.377 22.911 19.116 22.169 21.442 21.493 21.962 21.862 21.190 21.823 20.140 20.707 21.906 22.326 21.507 22.322 21.662 21.609
224 P30050 25.488 24.256 24.620 24.425 25.064 24.845 26.056 25.779 25.733 25.828 25.747 26.107 25.670 24.701 24.830 24.323 24.648 25.243
225 P30153 23.186 23.548 23.098 23.335 23.388 23.280 22.768 23.328 23.130 23.537 23.163 22.802 20.618 23.572 23.006 24.324 23.444 23.089
226 P30405 25.884 23.527 24.039 24.799 23.553 23.812 25.155 23.465 23.846 24.321 23.281 23.394 25.315 23.976 24.737 25.165 23.910 24.232
227 P30419 21.381 20.944 22.065 21.372 21.664 20.294 18.781 21.499 20.742 21.574 21.837 21.250 22.182 22.295 22.649 22.448 22.535 22.578
228 P30508 20.952 20.515 20.669 20.492 17.913 21.199 19.996 20.857 21.149 21.163 21.298 20.629 21.319 20.768 20.585 20.514 20.875 20.831
229 P30566 19.950 22.656 21.950 22.502 22.760 22.635 18.910 21.037 21.357 21.449 22.274 21.259 21.480 23.645 23.748 24.346 23.974 24.066
230 P31153 22.573 22.944 22.528 22.449 21.802 21.595 21.481 22.724 21.901 21.612 21.332 21.226 22.267 22.545 21.781 22.007 21.253 21.562
231 P31327 24.977 25.260 25.284 25.433 24.972 25.060 24.900 25.067 25.101 24.932 25.062 24.901 25.791 25.849 25.824 25.925 25.881 25.893
232 P31689 20.621 22.655 22.830 22.540 22.856 22.454 22.624 22.851 22.763 22.798 22.800 23.117 22.966 22.947 23.156 22.868 23.004 23.177
233 P31930 22.922 20.589 21.784 19.825 21.925 21.666 21.301 21.484 21.466 21.341 21.481 21.314 22.959 21.032 21.053 21.013 21.235 20.944
234 P31942 21.674 22.421 22.636 22.801 22.592 22.120 21.454 21.490 21.627 21.855 21.339 21.788 21.251 20.409 21.667 21.171 21.537 19.637
235 P31943 24.830 26.069 25.979 26.158 26.046 25.683 25.627 26.130 25.788 26.010 25.810 26.011 24.746 25.720 25.415 25.891 25.854 25.697
236 P31948 21.479 23.543 23.139 23.489 22.715 22.125 21.651 22.833 21.955 22.276 21.934 20.686 22.536 23.756 23.407 23.428 23.101 22.265
237 P32119 25.415 24.066 24.269 24.375 24.233 24.341 24.110 23.500 23.369 23.570 23.651 23.209 24.997 24.286 24.156 23.920 24.066 23.990
238 P32322 23.378 24.469 23.778 24.064 23.560 23.737 22.326 23.658 23.193 22.720 23.033 23.042 23.786 25.031 24.410 24.612 24.626 24.883
239 P32969 25.209 24.072 24.760 24.407 24.816 25.083 25.977 25.170 25.370 25.699 25.349 25.660 24.752 24.166 24.418 24.608 24.880 25.463
240 P33176 22.072 21.916 21.982 21.962 22.170 21.449 21.471 21.433 21.426 20.941 21.127 21.017 23.052 21.913 22.124 22.275 21.913 22.228
241 P33991 21.102 22.176 22.022 22.237 21.146 21.259 19.113 21.613 21.498 21.353 21.638 21.115 21.377 22.332 22.680 22.670 22.128 21.158
242 P33992 20.886 23.366 24.149 23.288 23.156 23.170 20.991 23.924 24.165 22.809 22.335 22.534 21.438 23.891 25.232 23.606 23.407 23.326
243 P33993 21.919 24.476 24.365 24.398 23.757 23.498 22.222 24.070 24.215 23.830 23.618 23.345 22.554 23.980 24.093 23.804 23.618 23.220
244 P34897 23.877 25.655 25.422 25.804 25.429 24.629 23.891 25.385 25.034 25.215 24.948 24.136 24.427 26.022 25.681 26.404 25.984 25.381
245 P34932 21.271 24.487 23.946 24.589 23.288 21.737 19.989 23.076 19.599 22.268 22.028 21.254 20.558 24.937 23.917 24.853 23.775 23.155
246 P35052 21.121 22.589 22.773 22.679 22.779 22.286 20.928 21.870 22.059 22.359 22.629 21.258 21.275 23.341 24.075 23.964 23.831 22.940
247 P35232 26.702 25.075 25.508 25.718 25.417 25.653 25.903 25.050 25.231 25.461 25.822 25.478 25.749 24.446 24.377 24.752 24.961 24.983
248 P35268 24.011 24.630 24.680 24.374 24.262 24.661 24.580 24.464 24.809 24.804 24.443 24.732 24.800 24.372 24.645 23.534 23.728 24.008
249 P35579 28.693 28.427 28.517 27.745 29.122 27.919 32.264 31.611 32.016 32.068 31.888 32.351 26.083 24.696 25.497 25.737 25.878 25.683
250 P35606 26.218 20.708 23.420 21.246 20.989 20.791 25.276 22.573 22.605 22.070 21.495 22.642 25.484 19.952 21.640 21.536 21.911 22.040
251 P35613 23.270 23.454 23.433 23.722 23.646 23.697 22.273 22.978 22.953 23.074 22.985 22.342 22.838 23.611 23.684 23.290 23.533 22.791
252 P35637 24.198 25.726 24.526 25.617 25.159 24.883 23.820 24.771 23.921 24.528 24.778 24.417 23.342 25.181 24.301 25.235 25.281 24.819
253 P35754 26.489 23.531 24.369 24.151 24.388 24.877 24.700 23.636 23.301 23.521 24.570 23.688 25.769 23.229 23.118 22.917 23.308 23.970
254 P35998 20.713 20.822 20.893 20.837 20.968 20.014 20.655 20.608 20.638 20.417 20.517 20.537 21.096 21.677 20.990 20.804 21.721 20.515
255 P36542 25.502 24.199 24.418 24.493 24.631 24.257 24.984 24.728 24.758 24.732 24.314 24.871 25.295 24.567 24.682 24.535 24.685 24.634
256 P36578 26.386 25.477 25.869 25.677 26.224 26.223 26.790 26.308 26.629 26.603 26.485 26.791 26.850 25.207 25.554 25.312 25.569 26.121
257 P36776 20.582 21.664 20.241 20.647 21.135 19.080 19.659 21.178 21.150 21.558 18.985 19.774 21.991 21.576 19.985 21.478 21.397 21.370
258 P37108 23.506 23.296 23.652 23.198 23.229 23.506 22.906 22.747 23.191 23.215 23.229 23.178 22.967 22.219 22.857 22.377 22.879 23.197
259 P38159 23.585 26.125 24.520 25.760 25.660 25.450 24.086 25.708 24.664 25.242 25.297 25.048 24.255 26.492 24.719 26.432 26.134 25.803
260 P38646 26.258 26.289 26.224 26.131 25.776 25.822 26.133 26.379 26.305 26.232 25.949 25.692 26.735 26.491 26.584 26.521 25.823 26.289
261 P38919 25.231 25.346 25.502 25.499 25.157 25.380 24.497 25.040 25.003 24.812 24.852 24.543 25.823 25.454 25.872 25.172 25.344 25.580
262 P39019 24.774 25.942 26.732 25.920 26.622 26.993 25.700 25.394 25.732 25.811 25.651 25.650 25.998 26.543 27.406 26.269 26.397 27.266
263 P39023 24.626 24.316 24.660 24.385 24.902 24.630 25.257 25.236 25.537 25.392 25.314 25.393 25.642 24.319 24.736 23.929 24.388 24.732
264 P39656 20.832 21.643 21.496 21.286 21.342 21.502 22.134 21.734 22.118 21.942 21.635 21.978 21.912 21.321 21.651 20.890 21.760 21.699
265 P39687 20.056 25.911 25.698 25.907 25.568 24.074 23.479 25.296 25.553 25.300 25.037 24.807 20.328 26.038 26.078 26.497 26.260 25.200
266 P39748 22.644 22.257 22.629 22.150 22.342 21.942 21.095 22.129 21.725 21.604 21.668 21.378 22.350 22.511 23.134 22.503 22.815 22.951
267 P40227 24.770 25.591 26.001 25.881 26.172 25.996 24.793 25.477 25.253 25.127 25.305 25.172 24.781 25.906 26.399 26.344 26.461 26.144
268 P40429 24.857 23.500 23.788 23.445 24.563 24.459 25.189 24.952 24.890 24.925 24.817 25.012 24.472 23.081 23.704 23.804 24.138 24.350
269 P40926 20.584 25.841 25.635 26.012 25.581 25.791 24.594 25.793 25.526 25.667 25.665 25.313 24.237 26.288 25.892 26.378 26.209 26.157
270 P40939 21.755 25.742 26.370 26.127 26.248 26.100 23.121 25.757 26.272 25.730 26.372 25.739 23.852 26.128 26.558 26.324 26.480 25.717
271 P41091 24.679 24.689 24.897 24.570 24.464 24.467 23.940 24.220 24.781 24.125 24.480 24.230 24.953 24.705 25.155 24.139 24.065 24.152
272 P41252 22.307 22.095 22.490 22.282 22.866 22.239 22.941 22.921 23.300 22.900 23.101 22.891 19.804 22.158 21.423 22.269 22.187 22.494
273 P41567 23.089 23.225 23.684 23.281 23.676 19.897 19.782 23.032 23.337 23.349 22.765 22.938 21.913 23.186 23.953 23.531 23.586 23.400
274 P42167 24.777 24.346 24.458 24.637 24.331 24.419 24.301 24.709 24.558 24.517 24.693 24.400 25.684 24.334 24.273 24.496 24.460 24.464
275 P42285 20.344 19.816 20.519 19.964 20.081 19.358 18.614 20.568 19.952 20.887 19.884 20.739 22.096 20.443 21.102 20.802 20.920 21.221
276 P42677 23.414 24.380 25.115 24.341 24.583 25.105 23.727 23.656 24.035 23.534 23.524 23.583 24.988 24.795 25.863 24.667 25.041 25.738
277 P42704 24.145 25.418 25.607 25.459 25.780 25.670 25.874 25.987 25.981 25.973 25.938 26.024 26.442 25.400 25.501 25.167 25.180 25.345
278 P42766 23.699 23.877 24.154 23.704 23.546 23.900 24.038 24.179 24.478 24.302 24.033 24.035 24.562 23.694 24.329 22.822 23.151 23.637
279 P43243 22.622 22.103 23.155 23.113 23.591 23.049 24.811 23.617 24.231 24.294 24.110 24.445 23.182 21.877 22.494 22.241 22.175 22.696
280 P43304 21.357 21.141 21.499 21.011 21.336 21.459 20.940 21.150 20.769 20.846 21.167 20.732 22.650 22.309 21.649 21.649 22.045 21.674
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# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
281 P43307 21.450 20.893 21.291 21.165 21.266 21.606 19.792 19.773 20.912 21.512 21.540 19.746 21.600 21.837 21.485 21.785 21.688 21.350
282 P45880 24.469 23.077 23.675 23.585 23.283 23.221 23.580 23.595 23.791 23.528 23.768 23.665 23.870 22.225 22.399 22.201 22.866 22.623
283 P45974 21.238 22.091 20.703 21.004 20.621 19.687 19.729 20.202 19.546 20.147 20.407 19.653 20.489 21.428 19.948 19.970 19.082 19.934
284 P46013 20.207 20.707 20.803 20.957 20.710 20.980 20.877 20.859 21.680 21.121 20.898 20.595 21.960 21.016 21.423 21.177 20.804 21.291
285 P46060 20.888 22.554 23.482 23.102 23.239 22.545 22.257 22.885 22.935 22.706 23.123 22.235 22.506 23.018 23.242 22.711 22.387 21.833
286 P46063 21.818 23.514 23.584 19.542 23.397 19.168 19.894 23.624 20.904 24.063 24.056 20.098 24.002 23.738 23.779 19.513 25.815 24.478
287 P46087 20.092 19.986 19.941 20.265 21.303 21.146 22.999 22.465 23.594 23.073 22.507 22.959 19.990 19.294 19.864 19.333 20.341 20.767
288 P46776 26.254 24.815 25.087 25.057 25.916 25.796 25.937 25.832 26.185 26.315 26.721 26.100 26.188 24.772 24.923 24.279 24.755 25.448
289 P46777 24.735 24.635 24.703 24.553 24.435 24.741 24.766 25.038 25.134 25.142 24.982 25.039 25.144 24.378 24.516 24.538 24.437 24.373
290 P46778 23.915 23.369 24.288 23.362 23.322 23.828 23.311 24.447 24.622 23.792 24.214 24.028 23.365 23.000 23.610 22.145 22.823 23.884
291 P46779 22.196 21.916 22.102 21.730 22.578 22.684 23.029 22.480 22.382 22.926 22.764 23.512 23.301 21.741 21.930 22.030 22.377 23.086
292 P46781 25.175 25.885 26.643 25.824 26.337 27.040 25.750 25.146 25.461 25.506 25.279 25.644 25.749 26.551 27.452 26.643 26.705 27.607
293 P46782 25.674 27.196 27.959 27.377 27.714 28.348 26.259 26.258 26.207 26.739 26.521 26.785 27.046 27.743 28.241 27.699 28.137 28.777
294 P46783 24.912 25.353 26.132 25.587 25.649 26.569 24.716 24.955 25.080 24.908 24.811 24.953 25.771 25.931 26.827 25.514 25.906 26.732
295 P46940 24.976 25.857 25.935 25.797 26.200 25.838 27.621 27.180 27.683 28.041 27.584 27.886 24.742 24.243 25.172 24.946 24.980 25.201
296 P47756 22.833 21.135 22.542 18.959 24.006 20.589 28.960 27.657 27.373 27.998 27.820 27.945 20.035 20.208 18.433 23.131 20.865 20.194
297 P47914 22.959 23.119 23.150 23.046 23.657 23.494 25.080 23.597 23.847 24.059 23.355 24.146 24.035 22.165 22.826 22.707 23.070 23.946
298 P48047 24.330 23.630 23.939 24.051 23.316 23.336 23.949 23.640 24.446 24.020 23.883 24.253 23.974 22.552 23.129 23.394 23.393 23.509
299 P48444 20.403 25.483 24.648 25.364 25.551 24.802 21.620 25.784 24.511 25.442 24.567 24.260 20.799 25.952 24.967 26.090 25.076 25.064
300 P48634 19.993 25.589 19.259 24.822 23.644 23.353 20.198 25.119 21.531 23.862 23.726 22.775 21.014 25.335 20.188 24.096 23.033 22.387
301 P48643 24.013 25.472 25.763 25.639 26.113 25.898 24.659 24.847 25.015 24.991 24.773 24.852 24.735 25.731 25.841 26.274 26.462 26.214
302 P49207 20.711 19.038 19.588 22.277 21.916 22.218 22.993 23.019 23.030 23.811 22.927 22.984 20.760 20.905 21.246 21.157 21.472 21.620
303 P49327 27.365 27.690 27.747 27.683 27.651 27.551 25.661 26.635 26.672 26.280 26.515 26.262 26.110 27.322 27.423 27.454 27.448 27.205
304 P49368 24.892 25.139 25.754 25.486 25.691 25.508 24.368 24.972 24.930 24.910 25.164 24.482 24.560 25.498 25.916 25.708 25.900 25.668
305 P49411 22.557 24.524 24.071 24.575 23.869 23.207 24.035 24.988 24.724 24.380 24.443 24.537 24.417 24.876 24.559 24.352 24.169 24.313
306 P49458 20.226 21.402 20.124 21.876 20.061 19.755 19.543 21.672 21.884 21.857 21.677 22.218 22.393 21.702 22.181 22.216 21.998 21.892
307 P49588 20.002 23.143 19.931 22.219 21.215 19.487 18.744 21.034 20.786 20.031 20.607 19.800 19.679 23.172 19.743 22.577 21.038 19.767
308 P49748 24.777 23.700 23.926 24.258 24.139 24.448 23.967 23.895 23.683 24.025 24.256 23.466 25.098 24.601 24.604 24.446 24.561 24.231
309 P49750 19.976 22.412 20.023 21.410 21.731 21.116 19.578 21.676 20.147 21.298 21.085 21.180 20.093 21.585 20.269 21.052 21.048 20.822
310 P49755 21.619 20.955 20.984 20.675 21.534 21.050 20.297 20.468 20.317 20.248 20.395 20.622 22.663 19.198 20.359 19.709 19.969 20.435
311 P50238 21.084 19.777 19.272 20.067 19.544 20.672 20.541 20.971 18.449 20.027 20.500 19.298 23.720 21.497 22.254 20.611 20.964 21.933
312 P50402 20.213 20.261 19.988 19.825 21.031 21.323 21.724 21.005 20.947 21.746 21.112 22.015 19.804 19.647 20.964 20.972 20.876 19.640
313 P50454 27.311 26.419 26.561 26.805 26.534 26.517 25.685 25.600 25.672 25.640 25.660 25.593 26.749 25.732 26.131 26.196 26.216 26.186
314 Q8IZP2 19.871 21.544 20.993 21.604 20.384 20.788 20.124 20.895 19.924 20.281 20.309 20.493 20.212 22.041 18.640 19.448 20.642 20.427
315 P50570 20.180 29.775 21.323 30.619 30.326 30.229 19.230 30.190 20.381 29.397 30.962 30.765 20.931 30.342 21.312 30.757 31.689 31.573
316 P50579 20.080 20.317 19.755 19.875 21.010 21.035 19.566 20.740 21.360 19.243 21.219 20.357 20.958 19.804 21.202 20.524 21.308 21.096
317 P50750 20.623 23.203 18.926 22.527 23.306 22.458 21.053 22.735 21.538 21.666 22.808 21.995 21.501 23.126 21.174 23.216 24.256 23.910
318 P50914 24.325 23.428 23.779 23.392 24.094 24.323 24.966 24.411 24.628 24.973 24.536 25.163 24.831 23.520 23.214 23.126 23.453 23.913
319 P50990 24.149 25.451 25.810 25.697 25.537 25.327 23.615 24.884 24.657 24.575 24.639 23.829 24.599 25.304 25.603 25.525 25.425 25.321
320 P50991 24.306 24.938 25.490 25.197 25.289 25.371 24.183 24.872 24.726 24.673 24.691 24.509 24.501 24.947 25.433 25.795 25.542 25.266
321 P51114 20.518 21.338 19.348 19.249 21.925 21.906 23.062 22.195 22.771 23.556 22.987 22.881 20.027 19.090 19.713 18.460 21.069 21.210
322 P51149 25.265 24.404 24.632 24.751 24.256 24.343 24.662 24.180 23.608 23.997 24.193 23.736 24.432 24.301 24.341 24.707 24.526 24.798
323 P51571 22.373 22.193 21.807 22.022 22.444 22.094 21.799 22.175 21.855 22.052 21.873 22.732 22.520 22.707 23.482 23.302 23.070 23.004
324 P51648 19.758 19.177 20.035 19.439 20.957 21.101 21.396 20.995 21.346 21.548 21.079 21.208 19.827 21.427 21.283 21.318 21.130 21.290
325 P51659 25.934 25.086 26.223 25.354 24.969 25.329 25.306 25.118 26.315 24.801 25.021 24.735 26.474 25.221 26.029 25.012 24.702 24.821
326 P51665 19.731 21.213 20.934 21.047 20.499 20.864 20.761 20.162 19.214 20.711 19.769 20.094 21.431 18.647 21.134 20.535 21.172 21.065
327 P51991 23.933 25.325 25.397 25.401 25.035 24.783 24.838 24.860 25.083 24.794 24.889 24.813 25.639 25.091 25.210 25.376 25.138 25.009
328 P52209 19.182 24.509 23.883 23.564 23.386 22.396 20.126 23.860 22.037 22.980 22.429 18.469 20.338 24.587 24.263 24.529 24.120 22.762
329 P52272 23.065 23.441 23.702 23.146 23.932 23.185 24.729 24.818 24.878 24.506 24.800 24.777 21.575 22.699 22.692 22.421 22.894 23.149
330 P52292 25.661 25.191 25.279 25.170 25.353 25.077 25.231 25.731 25.843 25.721 25.875 25.694 25.511 24.784 24.902 24.881 24.988 24.657
331 P52294 19.611 22.443 22.289 22.455 21.700 19.272 22.583 22.171 22.116 22.180 22.355 19.755 19.925 22.389 21.958 19.359 20.097 18.577
332 P52597 22.816 22.700 22.739 22.671 23.269 22.372 23.566 23.150 23.123 23.694 23.666 23.703 22.460 22.346 22.304 22.609 22.495 22.587
333 P52907 22.155 21.817 21.163 21.537 22.541 21.637 26.330 25.812 26.192 26.223 25.708 26.336 20.849 19.795 20.258 20.766 21.050 20.702
334 P52943 22.177 22.164 22.022 22.257 22.062 22.423 22.068 22.594 22.341 22.428 22.428 22.739 22.512 22.526 21.995 22.215 21.525 21.867
335 P52948 20.007 19.569 19.864 20.702 20.301 19.608 20.938 20.592 20.098 21.063 20.570 19.175 20.884 20.140 19.963 18.803 20.292 20.285
336 P53041 20.582 19.750 19.082 21.652 21.091 18.474 19.371 21.143 20.469 20.351 20.813 18.973 20.155 21.596 21.351 21.065 20.962 20.805
337 P53396 23.646 24.888 24.668 24.955 24.664 24.778 23.073 23.859 23.677 23.615 23.722 23.575 24.376 24.622 24.783 24.291 24.453 24.311
338 P53597 20.392 20.833 21.180 20.295 20.807 20.896 20.484 20.872 20.902 21.138 20.597 20.833 19.431 19.506 20.001 21.584 21.470 21.476
339 P53618 20.907 20.012 20.487 20.618 20.486 20.275 20.709 18.867 20.538 20.621 20.664 20.728 21.064 20.855 20.472 20.695 20.726 20.828
340 P53621 25.753 23.479 25.520 23.356 23.298 24.182 24.383 24.301 25.519 23.860 23.921 24.376 25.343 21.884 24.700 21.093 22.248 23.208
341 P53680 20.532 24.608 25.017 24.855 24.641 24.694 20.479 23.450 23.513 22.858 23.509 23.145 19.907 24.458 24.962 24.603 24.701 25.031
342 P54136 20.829 21.185 21.273 21.101 21.559 21.613 21.048 21.488 21.375 21.093 21.650 21.281 21.509 21.168 21.339 20.431 21.106 20.851
343 P54819 19.134 19.567 21.052 20.647 20.525 20.434 19.567 21.209 20.629 19.760 18.880 20.476 20.098 22.215 22.383 21.669 21.318 21.670
344 P54886 20.936 22.228 22.099 21.702 21.994 19.375 19.828 21.540 21.340 19.501 19.572 19.792 21.745 22.323 22.456 22.168 22.191 22.076
345 P55060 24.939 24.607 24.522 24.647 24.872 24.717 24.851 24.351 24.110 24.553 24.804 24.323 25.419 23.553 24.140 24.624 24.578 24.575
346 P55072 21.117 25.035 25.116 25.068 24.934 24.247 19.578 24.699 23.940 23.917 23.249 18.581 23.139 25.069 25.353 25.223 25.385 24.805
347 P55084 22.094 24.396 24.334 24.621 24.891 24.731 22.684 24.612 24.880 24.915 25.275 24.466 22.950 25.275 25.354 25.374 25.503 24.442
348 P55209 23.272 23.932 23.849 23.911 23.440 22.710 23.069 23.454 23.088 23.149 23.227 22.966 23.309 24.401 24.046 24.126 23.452 23.171
349 P55769 23.228 23.338 23.425 23.412 23.425 23.412 22.800 23.302 23.173 23.361 23.847 23.072 24.099 23.266 23.343 22.856 23.149 23.131
350 P55884 23.296 23.437 23.728 23.686 23.426 23.398 23.424 23.221 23.326 23.382 23.487 23.363 23.863 23.689 24.056 23.369 23.578 23.620
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# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
351 P56537 21.308 20.491 20.055 20.246 20.638 21.179 20.982 20.277 20.576 20.602 20.767 21.008 21.660 19.450 19.546 20.290 20.012 20.323
352 P58107 24.239 23.419 23.619 23.734 24.497 23.996 25.151 24.580 25.060 25.182 24.805 25.542 23.252 21.710 19.583 21.724 22.314 23.066
353 P59998 20.969 22.921 23.816 23.150 23.252 23.683 21.615 22.396 23.124 22.499 22.589 22.765 21.192 23.568 23.962 23.108 23.071 22.953
354 P60660 25.937 25.848 26.192 25.583 26.670 25.735 29.213 28.598 28.789 29.254 28.884 29.515 25.176 24.128 24.331 24.427 24.585 24.375
355 P60842 22.348 22.279 22.113 22.328 22.068 21.494 21.578 21.899 21.717 21.700 22.115 21.409 22.158 21.541 21.531 21.339 21.179 21.130
356 P60866 24.303 25.253 26.166 25.323 25.619 26.206 23.984 24.336 24.814 24.380 24.428 24.497 25.472 25.689 26.677 25.433 25.104 26.600
357 P60900 20.845 22.164 22.175 22.072 21.885 21.951 20.012 21.875 21.205 20.898 19.355 19.031 19.685 22.426 22.478 22.489 22.336 22.065
358 P60953 22.147 22.015 21.921 22.107 22.186 21.889 22.752 22.019 22.098 22.018 21.955 22.563 23.196 19.323 21.580 21.962 21.926 21.814
359 P60981 22.484 21.054 20.482 20.162 19.281 19.269 22.756 22.294 22.340 22.289 21.359 20.748 21.640 19.984 20.063 19.746 20.031 20.219
360 P61019 22.892 22.222 22.285 22.624 22.077 21.910 21.660 22.037 22.028 21.674 21.971 21.495 22.918 21.644 22.022 22.498 22.278 22.299
361 P61026 20.021 21.086 20.520 21.236 21.565 21.401 20.251 20.651 20.866 20.592 21.138 20.110 21.659 20.448 21.027 19.110 21.649 21.024
362 P61106 23.363 22.701 22.020 22.561 22.418 21.906 22.092 22.414 22.328 21.760 22.745 22.324 23.723 21.381 21.367 22.161 22.079 22.181
363 P61158 23.977 26.157 26.391 26.158 26.068 26.331 25.081 26.071 26.007 25.474 25.962 25.777 22.398 25.746 26.149 25.966 26.256 26.358
364 P61160 20.263 24.041 24.088 23.912 23.886 23.722 23.419 23.683 23.774 23.450 23.989 23.727 18.970 24.202 24.293 23.695 23.796 23.834
365 P61163 21.078 20.082 20.660 19.050 20.895 20.512 19.515 21.249 21.407 22.985 21.542 22.334 19.879 19.585 19.485 20.582 20.433 20.378
366 P61221 20.929 19.876 22.218 22.089 22.281 22.365 22.038 22.019 22.234 22.108 22.065 22.228 22.590 22.851 22.985 23.403 23.130 23.227
367 P61247 26.040 26.281 27.037 26.420 26.912 27.565 26.505 26.082 26.299 26.443 26.329 26.367 26.303 26.984 27.781 27.027 27.175 27.708
368 P61254 22.997 22.117 21.780 22.097 23.087 23.052 22.868 22.689 22.412 22.970 23.300 23.238 23.777 22.780 22.831 22.369 23.172 23.027
369 P61289 22.915 22.120 21.725 21.574 21.566 21.507 21.634 21.862 21.305 21.426 21.493 20.393 22.006 21.907 21.425 21.808 21.371 18.390
370 P61313 24.982 24.376 24.446 24.284 25.110 24.930 25.890 25.118 25.390 25.297 25.239 25.659 25.351 24.135 24.526 24.000 24.584 25.241
371 P61353 24.471 24.091 24.620 24.187 24.633 24.410 24.880 24.608 25.140 25.351 24.883 25.158 24.712 23.384 23.964 23.482 23.372 24.404
372 P61586 22.980 22.229 22.719 23.035 22.697 22.016 21.733 22.131 22.509 22.023 22.284 22.474 23.775 22.753 23.154 23.016 23.229 22.950
373 P61604 22.145 22.598 22.786 22.758 22.610 22.923 22.628 21.506 21.615 22.573 22.386 22.971 21.808 23.223 23.142 23.972 23.613 23.863
374 P61962 19.866 22.848 20.600 23.045 23.323 23.142 20.260 24.458 21.808 23.683 24.230 23.986 20.038 23.089 21.421 22.771 23.125 22.970
375 P61978 27.191 31.712 27.309 30.270 31.171 31.010 26.899 31.469 27.292 29.519 30.898 30.516 27.362 31.866 27.666 30.404 31.375 31.178
376 P61981 22.660 24.965 24.373 24.700 23.471 22.884 22.321 24.715 23.790 23.858 23.164 23.015 22.573 24.041 22.705 23.513 22.600 22.053
377 P62081 26.128 26.205 27.192 26.256 26.886 27.557 26.101 25.929 26.002 26.026 26.024 26.113 25.785 26.806 27.522 26.633 26.778 27.767
378 P62136 24.281 24.543 23.724 24.318 24.406 24.025 25.198 25.287 24.815 25.190 25.285 25.422 23.901 24.400 23.162 24.328 24.109 24.117
379 P62140 20.686 22.387 21.896 22.245 22.654 22.176 23.922 24.005 23.889 24.025 23.857 23.808 20.331 22.421 21.619 21.607 21.888 21.418
380 P62158 25.338 27.460 25.371 26.485 27.175 26.318 28.781 28.629 28.428 28.079 28.568 29.368 20.512 26.198 22.368 25.911 26.104 25.723
381 P62241 26.662 26.986 27.923 27.067 27.751 28.418 27.318 26.982 27.169 27.178 27.287 27.168 26.562 27.572 28.416 27.402 27.813 28.289
382 P62244 24.149 25.246 25.978 25.269 25.320 26.049 24.687 25.286 25.197 25.060 24.728 25.102 25.698 26.065 27.066 25.948 25.956 26.716
383 P62249 24.875 25.428 26.447 25.604 25.963 26.804 25.052 24.632 25.023 24.868 24.744 25.056 25.282 26.721 27.445 25.987 26.344 27.079
384 P62258 22.733 24.716 23.673 24.222 23.015 22.695 22.082 24.121 23.436 23.458 22.670 22.311 20.756 24.303 21.737 23.432 23.183 22.426
385 P62263 24.465 25.474 25.999 25.391 25.860 26.173 24.906 25.068 25.385 25.019 24.950 24.967 25.417 25.815 26.703 25.651 25.903 26.722
386 P62266 24.633 25.581 26.369 25.596 26.343 27.331 25.293 24.951 24.992 25.606 25.323 25.959 25.060 25.696 26.459 26.514 26.392 27.533
387 P62269 25.240 26.307 26.990 26.281 26.989 27.390 25.714 25.473 25.633 25.688 25.500 25.812 26.250 27.116 27.942 27.035 26.809 27.678
388 P62273 23.634 24.242 24.986 24.479 25.243 25.454 23.399 23.898 23.893 24.004 23.609 23.742 24.400 24.285 25.051 24.696 24.772 25.441
389 P62277 25.331 25.768 26.516 25.926 26.315 27.136 25.577 25.025 25.334 25.465 25.260 25.543 25.783 26.522 26.939 25.928 26.312 26.956
390 P62280 24.580 26.331 26.695 26.213 26.008 26.974 25.550 25.536 26.061 25.921 25.485 25.557 24.683 26.746 27.576 25.974 26.163 26.950
391 P62314 22.938 23.907 23.921 24.106 24.244 23.264 21.603 22.445 22.691 23.093 22.838 22.908 22.514 23.144 22.780 22.893 22.990 23.044
392 P62318 20.705 22.377 22.035 22.351 22.025 21.905 20.724 21.640 21.602 21.430 21.548 21.655 21.192 22.448 22.053 21.339 21.954 21.535
393 P62333 21.351 21.229 21.642 21.724 21.116 19.497 20.994 21.175 21.097 20.935 20.952 20.360 22.123 20.973 20.962 21.385 21.244 21.652
394 P62424 26.561 25.448 25.750 25.634 26.057 26.060 26.504 26.405 26.776 26.568 26.468 26.763 26.736 25.192 25.657 24.761 25.194 25.796
395 P62495 23.071 23.013 22.888 23.059 22.584 20.273 22.191 22.453 22.302 22.519 22.650 22.472 22.277 22.470 22.426 22.859 22.467 22.768
396 P62633 20.640 24.272 22.878 23.753 23.692 23.658 22.504 22.643 22.648 22.867 22.483 22.730 23.270 23.817 23.871 23.358 23.706 23.815
397 P62701 25.616 26.315 27.255 26.341 26.928 27.358 26.033 25.651 25.918 25.887 25.587 26.037 26.907 27.050 28.121 26.827 27.173 27.966
398 P62745 21.037 19.739 20.114 20.230 20.907 20.101 20.560 20.670 20.891 20.580 20.866 20.626 21.990 20.369 20.504 20.550 20.739 20.684
399 P62750 24.422 24.281 24.446 24.564 24.670 24.639 25.692 24.576 24.243 24.788 24.553 25.213 24.790 24.111 24.486 24.380 24.629 24.610
400 P62753 25.244 25.423 26.498 25.852 26.396 26.897 25.314 25.214 25.302 25.350 25.439 25.540 25.885 26.281 27.232 25.779 26.401 26.958
401 P62805 23.662 22.789 22.999 23.013 22.473 22.334 22.965 23.035 22.886 22.999 22.985 23.158 23.485 23.104 23.112 22.340 22.335 22.444
402 P62820 23.310 22.412 22.350 22.683 22.346 22.747 22.241 22.156 22.273 22.173 22.430 21.998 23.799 22.263 22.399 22.657 22.301 22.536
403 P62826 20.277 22.117 22.644 22.477 22.324 22.159 20.443 21.385 21.589 21.917 22.261 21.778 23.483 22.333 22.675 22.412 22.423 23.209
404 P62829 25.301 24.532 24.700 24.310 24.724 25.143 24.966 24.242 24.595 24.929 24.640 24.950 25.586 24.910 25.002 24.353 24.750 24.553
405 P62834 19.862 22.675 23.078 23.383 22.614 23.046 20.100 22.394 22.721 22.980 23.194 23.224 23.448 22.992 23.147 23.310 23.047 23.233
406 P62841 19.136 20.464 21.904 20.925 24.651 22.362 20.403 20.029 16.168 19.175 19.996 21.854 23.142 24.534 25.885 25.113 25.500 26.437
407 P62847 20.844 20.192 23.505 21.232 19.604 18.959 21.330 22.968 23.218 23.364 19.589 23.103 25.642 25.051 26.485 20.921 23.952 25.528
408 P62851 24.339 24.624 25.585 24.871 25.308 25.889 23.827 23.645 23.894 23.901 24.168 23.980 24.599 25.255 26.105 25.258 25.353 26.220
409 P62854 20.771 24.328 25.621 24.730 24.966 25.667 24.026 23.589 24.056 24.010 23.838 24.303 24.678 25.322 26.302 24.236 25.464 26.391
410 P62857 24.384 24.622 25.305 24.726 24.864 24.949 24.401 23.552 23.880 23.059 23.846 23.687 24.692 25.169 25.814 24.714 24.770 25.182
411 P62861 23.494 24.084 24.870 24.038 23.728 24.591 24.173 23.274 24.125 23.103 23.236 23.016 23.458 23.582 24.722 23.616 23.749 24.565
412 P62873 21.037 20.521 21.506 20.626 20.926 21.105 21.111 20.721 21.011 20.501 20.668 19.711 22.610 20.872 21.183 18.868 21.261 19.488
413 P62879 23.658 23.109 22.861 23.219 22.998 22.939 22.386 22.324 22.285 22.466 22.576 22.213 24.489 23.280 23.500 23.450 23.568 22.917
414 P62888 24.712 24.507 24.891 24.676 24.872 24.974 24.813 25.209 25.240 24.505 24.793 24.666 25.797 24.625 24.783 23.659 24.248 24.695
415 P62899 22.338 23.283 23.339 23.422 23.255 23.538 24.118 23.507 24.019 23.721 23.151 23.912 22.981 22.531 23.333 22.999 23.725 23.854
416 P62906 24.113 22.882 23.401 23.543 23.940 24.344 25.074 24.216 24.640 25.220 24.882 25.237 24.211 23.521 23.780 23.994 24.267 24.862
417 P62910 23.459 22.871 23.567 23.048 23.533 23.681 24.146 23.315 23.756 23.810 23.413 23.850 22.896 22.463 23.055 22.385 22.932 23.708
418 P62913 24.540 24.240 24.463 24.382 25.083 24.960 25.828 25.066 25.388 25.664 25.301 25.683 24.795 24.026 24.271 24.238 24.580 24.934
419 P62917 24.442 23.911 24.047 23.697 24.071 24.388 24.940 24.627 25.155 24.828 24.770 24.981 25.488 23.980 24.377 23.514 23.870 24.621
420 P62937 26.377 24.188 24.370 24.611 24.614 24.094 25.400 24.400 24.431 24.279 24.570 24.227 24.178 24.228 24.759 24.228 23.992 25.175
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 7 of 20. 
# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
421 P62979 23.913 22.704 23.413 22.541 23.553 23.419 22.872 22.913 23.133 23.408 23.109 23.378 24.177 24.287 25.460 23.405 23.695 24.796
422 P63010 20.280 28.800 29.109 28.787 28.760 28.869 18.362 27.541 27.779 27.227 27.248 26.911 20.437 28.319 28.735 28.463 28.309 28.379
423 P63104 23.017 25.000 23.889 24.854 23.539 22.670 21.761 24.740 23.637 22.997 23.559 22.459 21.831 24.420 22.645 24.293 23.023 23.179
424 P63167 26.901 25.505 26.341 26.233 25.871 25.792 25.358 24.759 25.521 25.219 26.030 25.322 27.554 26.003 26.414 26.026 25.936 26.042
425 P63173 24.384 24.579 24.631 24.945 24.607 24.802 24.092 24.474 24.982 24.538 24.585 24.487 24.001 24.469 25.154 25.224 24.784 24.574
426 P63220 20.888 22.919 23.371 22.960 23.249 23.235 21.731 21.237 21.969 19.577 19.780 21.502 23.995 24.172 25.213 23.318 24.094 24.838
427 P63244 25.669 26.708 27.526 26.773 26.848 27.474 24.837 25.494 25.721 25.746 25.624 25.577 25.940 27.071 28.052 26.856 27.127 27.808
428 P63261 29.017 29.145 29.108 28.099 29.304 28.404 32.968 31.583 31.806 31.970 31.747 32.798 25.668 26.626 24.856 26.102 26.533 26.413
429 P67809 23.761 24.532 24.711 24.536 24.668 24.118 24.085 23.734 23.837 23.725 23.842 24.236 24.900 24.103 24.689 23.990 24.602 24.450
430 P67870 20.638 23.581 24.267 23.946 20.351 23.099 22.087 25.122 24.789 25.119 24.670 24.265 21.791 23.715 23.909 24.804 24.080 24.002
431 P67936 24.104 24.955 24.375 24.454 24.300 22.635 26.911 26.773 27.191 27.010 26.833 26.971 23.287 24.858 23.818 24.461 23.681 22.959
432 P68104 30.145 28.613 29.050 29.015 29.148 29.215 29.158 28.712 28.773 28.582 28.848 28.718 29.989 28.833 29.013 28.968 29.048 29.042
433 P68363 29.141 28.802 28.898 28.763 28.891 28.792 28.405 28.552 28.518 28.698 28.789 28.466 28.518 28.146 28.157 28.551 28.487 28.341
434 P68366 20.135 24.476 24.719 19.824 24.286 24.613 26.252 23.536 23.518 23.796 24.288 23.889 23.844 22.624 22.115 23.441 23.229 23.797
435 P68371 25.105 25.672 25.566 25.326 25.028 24.697 25.356 25.747 26.110 25.060 25.240 25.136 24.887 25.144 25.007 24.549 24.847 24.872
436 P68400 22.037 25.248 25.813 25.337 24.626 24.726 22.369 26.047 26.139 25.932 26.062 25.309 20.547 24.918 25.795 25.541 24.880 24.954
437 Q71DI3 22.534 22.074 21.637 22.259 21.534 21.536 23.885 22.980 23.114 23.214 22.685 23.171 22.907 22.259 22.237 23.097 22.496 22.769
438 P78344 22.481 22.602 22.554 22.308 22.457 22.333 22.147 23.149 22.433 22.453 22.803 22.191 22.533 21.427 21.270 21.453 21.234 21.522
439 P78371 24.616 25.446 25.815 25.600 25.793 25.495 23.774 24.850 24.689 24.147 24.665 23.286 25.339 25.436 25.880 25.311 25.682 25.344
440 P78527 23.466 22.357 23.274 22.313 23.586 22.677 23.941 24.590 24.685 24.671 24.970 24.884 23.877 21.599 19.590 19.709 22.240 22.627
441 P80723 25.043 24.661 24.896 25.107 24.752 24.529 22.630 23.831 23.325 23.310 23.807 23.721 25.426 24.465 24.858 24.339 25.080 24.777
442 P82979 22.364 22.104 22.465 22.107 21.673 22.145 21.863 21.522 21.838 22.055 21.764 21.744 22.683 21.977 22.409 22.030 22.157 22.450
443 P83731 22.961 22.975 23.044 22.828 22.962 23.100 24.171 23.670 23.899 23.775 23.678 24.016 23.461 23.833 24.020 23.404 23.052 23.613
444 P83881 21.115 21.506 22.369 21.884 22.390 22.359 23.289 22.672 23.263 23.387 23.641 22.848 22.235 20.752 21.649 21.119 21.330 22.035
445 P84098 23.693 23.500 23.503 23.428 23.922 23.957 24.177 24.070 24.305 24.117 24.010 24.064 23.722 23.218 23.658 22.935 23.218 23.591
446 P84103 22.391 22.947 23.492 22.394 23.203 23.061 23.770 23.849 23.855 23.839 23.220 23.874 22.648 21.537 22.587 23.281 22.456 22.882
447 P85037 21.334 22.342 18.926 22.299 22.927 21.419 21.356 23.994 20.667 23.352 23.909 19.421 20.528 22.677 20.954 22.523 22.601 21.071
448 P98179 19.837 22.321 22.272 22.118 21.598 21.652 22.443 21.817 22.520 21.947 22.165 21.652 22.896 23.257 22.439 22.659 22.192 22.198
449 P99999 25.645 22.649 24.028 23.970 23.331 23.393 22.261 23.009 22.635 22.495 22.960 21.968 26.041 23.393 24.030 24.694 25.705 25.086
450 Q00325 20.627 19.327 19.001 20.655 23.361 23.013 24.690 23.274 23.370 24.551 24.141 24.450 24.568 23.492 23.555 23.438 23.347 23.906
451 Q00341 21.723 19.641 22.045 21.154 22.167 22.307 19.598 21.249 21.067 20.570 20.922 20.548 21.315 20.957 21.254 20.237 18.298 21.002
452 Q00610 26.686 26.764 28.088 26.847 27.030 27.131 27.110 27.327 28.760 27.462 27.254 27.884 25.929 26.382 28.176 26.562 26.358 27.118
453 Q00688 23.736 21.851 22.357 21.982 22.606 21.884 21.628 21.770 22.302 21.248 21.482 21.534 24.564 22.063 23.260 21.668 22.449 22.242
454 Q00839 26.124 26.405 26.494 26.360 26.507 26.180 27.171 26.914 27.134 27.000 26.781 27.090 26.202 25.001 25.387 25.627 25.388 25.569
455 Q01082 23.459 23.140 23.602 22.575 24.060 21.970 27.280 26.644 27.417 27.436 26.902 27.411 20.865 19.555 21.556 21.277 21.605 21.198
456 Q01105 21.026 26.829 26.561 26.834 26.693 25.210 24.617 26.722 26.161 26.709 26.396 25.309 19.660 27.248 27.519 27.692 27.384 26.447
457 Q01167 20.358 21.316 20.335 20.080 21.319 20.398 20.149 21.775 20.022 21.431 21.884 20.737 20.021 21.210 20.868 19.489 20.400 19.514
458 Q01650 24.277 23.739 24.083 23.891 24.132 23.780 24.231 24.050 23.975 23.845 23.902 23.789 24.878 23.296 23.457 23.762 23.909 23.952
459 Q01813 25.302 25.980 26.295 26.093 25.648 25.794 24.494 25.366 25.738 25.227 25.265 25.238 25.386 25.880 26.159 26.078 25.871 25.856
460 Q01844 23.396 24.630 23.565 24.592 24.416 23.894 22.244 23.960 22.443 23.643 23.448 22.932 23.956 24.298 22.675 24.585 24.622 23.690
461 Q01968 20.695 25.531 21.093 24.310 24.844 24.818 19.853 25.093 19.543 23.962 24.565 24.608 19.438 25.733 19.706 25.028 25.923 25.314
462 Q02543 24.833 23.899 24.385 24.060 24.353 24.823 25.198 24.829 25.356 25.199 25.133 25.450 25.523 23.699 24.009 23.067 23.779 24.265
463 Q02790 20.950 23.159 23.042 23.593 21.981 20.087 20.354 21.330 18.593 18.816 19.990 19.888 20.432 23.305 22.685 22.766 22.097 21.685
464 Q02809 20.311 20.941 23.834 21.198 20.993 20.554 20.328 20.768 21.290 19.923 20.563 20.562 20.505 21.470 23.269 21.275 21.207 20.639
465 Q02878 25.595 25.128 25.125 25.162 25.832 25.471 26.586 26.127 26.359 26.505 26.242 26.378 26.068 24.553 25.149 24.534 25.330 25.789
466 Q02978 22.086 19.263 21.272 20.483 21.087 21.193 21.544 22.400 19.319 21.422 22.133 21.671 19.874 19.466 19.602 18.514 20.835 20.556
467 Q03013 27.318 25.051 25.854 25.791 25.660 25.610 26.656 24.786 24.978 25.289 25.405 25.134 28.100 26.131 26.441 26.600 27.017 26.835
468 Q04637 24.625 24.260 24.452 24.331 24.350 24.285 24.239 24.639 24.467 24.045 24.341 24.184 24.633 23.948 24.132 23.964 23.821 23.796
469 Q05193 21.269 19.983 19.870 21.964 21.590 21.678 19.439 21.609 19.164 19.971 21.768 20.374 20.265 21.289 19.140 18.617 21.622 21.667
470 Q05682 22.893 21.925 22.138 22.022 22.630 22.025 23.750 23.330 24.155 23.669 23.793 23.916 23.541 21.668 22.404 21.431 21.936 21.777
471 Q06323 20.601 20.922 20.755 21.071 20.499 20.295 19.474 20.264 18.653 19.577 19.109 18.806 19.943 21.194 21.070 20.836 19.947 19.815
472 Q06830 29.296 27.442 27.786 27.850 27.839 27.547 27.641 27.150 26.805 27.096 27.155 26.819 29.464 27.439 27.865 27.646 27.944 27.920
473 Q07020 25.322 24.590 25.011 24.653 25.351 25.440 26.357 25.413 25.627 25.855 25.785 26.459 25.629 24.823 24.901 24.329 24.751 25.193
474 Q07021 20.844 24.613 19.988 24.877 19.926 20.237 19.823 19.760 19.935 25.129 24.397 18.852 23.715 25.139 24.257 26.222 25.984 25.474
475 Q07065 23.402 22.460 22.723 22.616 22.887 22.796 22.904 23.032 23.093 22.749 22.980 22.833 23.735 22.606 22.597 21.952 22.508 22.186
476 Q07666 22.324 29.285 23.517 29.197 28.918 28.469 23.499 29.285 23.949 28.859 28.703 28.067 23.269 29.205 23.918 29.345 29.199 28.601
477 Q07955 20.183 21.745 22.331 21.666 22.412 21.850 23.779 23.259 23.583 23.898 23.166 23.563 19.158 19.486 21.201 19.345 20.408 21.331
478 Q08211 24.802 24.789 25.194 24.862 25.233 25.013 25.184 25.140 25.286 25.304 25.243 25.598 25.493 24.454 24.828 24.475 24.550 24.816
479 Q08945 21.062 18.438 22.217 20.449 21.382 19.795 19.511 20.231 22.054 22.318 22.050 22.455 20.726 19.749 20.811 21.081 19.373 20.288
480 Q08J23 22.485 22.060 19.980 21.022 21.727 20.433 18.928 21.941 21.173 22.451 22.037 19.861 22.140 22.886 21.574 21.806 21.765 21.182
481 Q10471 23.171 23.485 23.606 23.701 23.562 23.120 23.538 23.773 23.718 23.644 23.527 23.033 24.618 23.349 23.145 23.644 23.414 22.987
482 Q10589 21.379 20.649 20.443 20.787 20.012 19.666 21.566 21.877 22.848 21.572 21.823 21.763 21.652 20.430 19.677 20.110 19.669 19.081
483 Q12788 20.467 18.846 24.671 21.783 22.502 20.679 19.475 21.999 24.479 22.305 22.238 21.676 21.093 20.625 24.313 21.558 21.271 21.689
484 Q12797 20.455 19.100 22.385 21.644 21.658 20.607 21.752 21.603 21.848 22.524 22.028 22.038 21.684 20.952 21.088 21.479 22.216 22.073
485 Q12874 19.927 21.078 21.065 21.057 21.224 20.953 21.087 20.327 19.469 20.632 20.923 20.973 20.973 20.810 20.542 19.579 20.712 20.759
486 Q12905 23.302 22.868 23.581 23.140 23.783 23.626 23.659 23.110 23.554 23.594 23.567 23.438 24.363 22.371 23.022 23.041 23.362 23.366
487 Q12906 22.155 22.240 22.698 22.332 22.358 21.892 22.601 22.598 23.115 23.064 22.726 22.667 22.881 21.600 22.352 22.135 22.242 22.491
488 Q12907 21.930 21.337 21.680 21.522 21.128 20.988 20.984 21.086 19.316 20.657 21.132 19.333 20.858 21.791 21.760 21.184 21.527 21.204
489 Q12965 20.530 27.904 21.827 26.966 27.561 27.153 25.849 27.168 25.967 26.605 27.109 26.847 21.156 27.561 19.846 26.764 27.484 26.819
490 Q13011 22.974 21.631 19.973 21.806 21.575 21.644 20.498 21.478 18.888 21.608 21.568 21.266 23.989 22.776 22.921 22.286 21.713 22.098
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 8 of 20. 
# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
491 Q13148 20.383 22.845 22.660 22.837 22.782 22.915 23.050 22.601 22.988 22.661 23.061 23.218 21.903 22.298 22.543 22.825 23.172 22.978
492 Q13151 19.671 23.068 23.015 22.927 22.810 23.297 23.636 23.352 23.597 23.277 23.222 23.438 22.533 20.451 19.694 22.656 22.850 22.885
493 Q13155 21.132 21.721 22.017 21.850 22.391 22.324 23.082 22.424 22.391 22.812 22.863 22.686 21.897 20.399 19.740 19.455 22.824 19.181
494 Q13162 19.990 21.549 20.894 21.394 20.295 20.827 19.101 21.007 20.565 20.146 19.979 20.348 20.639 22.818 21.758 21.692 20.599 20.031
495 Q13185 21.385 20.731 20.012 21.140 20.241 19.463 20.525 20.616 21.155 20.750 20.559 20.415 20.657 19.969 20.194 19.563 19.981 19.966
496 Q13247 20.664 19.577 20.853 20.944 21.025 20.781 22.521 22.731 22.680 23.171 22.747 23.402 19.943 20.510 20.913 20.622 19.994 19.785
497 Q13263 24.839 24.234 24.293 24.162 24.516 24.528 24.053 24.512 24.760 24.557 24.596 24.112 24.802 24.284 24.218 24.196 24.613 24.354
498 Q13283 21.526 23.983 23.866 23.629 23.967 24.087 23.860 24.193 23.908 23.862 23.507 23.938 23.374 24.290 24.189 24.055 24.060 24.541
499 Q13310 22.587 20.343 19.539 21.008 22.385 22.701 21.693 21.797 21.648 22.188 22.091 21.922 22.185 22.334 22.416 22.413 22.279 22.649
500 Q13347 21.860 22.036 22.522 22.337 22.776 23.110 22.950 22.480 23.025 23.147 22.313 22.979 20.232 22.781 23.211 23.569 23.253 23.206
501 Q13428 20.617 20.311 20.081 20.404 20.080 19.453 19.491 25.465 26.105 23.820 22.858 20.986 20.188 19.806 20.072 19.965 20.151 19.952
502 Q13435 21.222 24.032 21.987 23.191 23.505 23.192 22.080 23.184 22.093 22.584 22.750 22.298 21.707 24.277 21.604 22.896 23.054 22.694
503 Q13442 20.559 23.305 23.919 22.785 23.580 23.881 19.002 21.648 22.108 21.756 22.136 21.713 21.790 23.358 24.346 23.206 23.288 24.200
504 Q13443 20.058 25.284 19.569 25.031 25.940 25.242 20.241 25.961 20.541 25.314 26.113 25.090 20.687 25.807 20.275 25.267 25.951 25.541
505 Q13501 24.351 25.602 25.410 25.820 25.623 25.358 24.973 26.016 26.129 26.031 25.983 25.543 25.071 26.247 26.214 26.440 25.967 25.063
506 Q13573 20.565 21.788 21.434 24.508 21.766 21.474 20.576 22.890 21.622 24.341 21.228 22.265 21.173 23.072 22.299 24.363 21.509 21.623
507 Q13619 21.763 19.853 21.159 20.819 20.638 20.167 20.554 20.636 20.517 20.581 20.552 18.869 20.721 20.489 20.581 20.564 20.675 20.455
508 Q13724 20.614 22.863 20.621 19.696 19.879 19.970 20.359 23.634 18.826 20.537 19.254 19.506 23.785 23.246 23.830 23.930 24.010 23.469
509 Q13813 21.502 21.101 22.890 19.098 24.104 20.691 27.607 27.310 27.956 27.608 27.679 27.676 22.396 21.423 22.010 22.472 22.763 22.326
510 Q14103 23.362 24.175 23.987 23.738 23.917 23.828 23.737 23.878 23.709 23.626 23.716 23.930 23.562 23.278 23.768 24.342 24.085 24.333
511 Q14152 20.564 22.097 22.383 22.274 22.371 22.409 22.057 22.077 22.543 21.960 22.720 22.212 22.385 21.832 22.144 21.937 22.117 22.443
512 Q14157 22.415 22.561 22.415 22.714 22.415 22.299 22.089 22.172 21.971 22.132 22.498 21.985 22.268 22.269 22.231 21.826 22.048 22.076
513 Q14204 20.491 20.177 23.098 22.595 22.699 22.902 24.737 23.630 23.614 24.095 23.866 23.945 22.761 19.811 21.830 19.814 23.031 22.594
514 Q14444 23.730 24.957 24.709 24.737 25.493 25.819 24.195 24.323 23.995 24.292 24.412 24.182 25.108 25.918 25.660 25.486 25.694 26.037
515 Q14566 19.716 22.048 21.504 22.196 20.930 20.742 20.252 21.120 20.436 20.783 20.148 19.953 19.881 22.532 21.544 22.425 21.593 21.097
516 Q14678 24.125 22.850 23.304 23.420 23.607 22.862 23.711 23.114 23.291 22.888 23.406 22.870 25.159 22.968 22.935 22.469 22.957 23.015
517 Q14683 22.810 22.457 22.859 22.164 22.543 22.123 22.657 22.163 22.786 22.715 22.641 22.218 21.298 21.401 21.562 20.840 21.100 21.108
518 Q14697 21.449 24.141 23.780 24.241 22.968 20.474 20.118 23.167 21.693 19.282 20.043 19.385 21.839 24.459 23.789 23.662 23.731 21.977
519 Q14847 21.073 22.718 22.149 18.416 22.116 21.945 20.324 20.588 20.544 20.906 20.632 20.396 21.233 21.665 21.392 21.995 21.900 22.142
520 Q14974 25.879 25.613 25.758 25.715 25.577 25.747 24.755 24.524 24.984 24.997 24.849 24.599 26.379 25.875 25.534 25.906 26.044 25.858
521 Q14978 21.928 26.657 26.185 26.486 26.112 26.166 23.790 27.196 26.331 26.758 25.997 25.298 23.060 24.108 23.126 24.350 24.209 24.345
522 Q15019 23.618 22.399 22.677 22.552 22.106 21.913 22.459 21.980 22.504 21.747 22.044 22.092 23.809 21.636 22.475 22.602 21.585 21.979
523 Q15029 21.013 23.546 23.481 22.971 22.574 20.581 22.438 22.988 23.169 23.202 23.076 22.781 22.697 22.891 22.221 22.484 22.055 22.137
524 Q15041 22.012 21.511 21.468 21.627 21.164 21.025 22.069 22.029 22.174 21.603 21.632 21.484 23.977 22.101 23.089 22.381 22.173 21.977
525 Q15046 22.573 23.022 23.216 23.172 23.084 23.125 22.569 22.414 22.563 22.566 22.814 22.537 22.958 22.476 22.352 22.935 22.556 22.789
526 Q15056 20.466 25.368 25.530 25.594 25.442 25.387 25.212 25.238 25.189 25.799 25.144 25.281 24.043 25.200 25.562 25.558 25.170 25.280
527 Q15084 20.948 22.638 21.240 21.444 21.268 20.722 21.157 20.954 21.461 21.250 21.130 21.055 20.614 23.009 21.108 22.922 21.934 21.522
528 Q15125 23.023 22.644 23.028 22.930 22.503 19.793 19.603 22.474 22.553 22.140 22.252 19.219 23.155 21.753 21.989 22.026 22.164 21.839
529 Q15149 26.040 25.405 25.887 25.637 25.987 25.415 28.035 27.133 27.796 27.669 27.737 27.768 26.721 24.767 24.838 24.632 25.006 24.761
530 Q15233 24.171 28.440 26.003 27.904 27.965 27.538 25.960 28.370 25.630 27.436 27.121 26.534 25.434 29.330 26.642 28.463 28.480 27.997
531 Q15286 19.660 19.805 19.572 20.581 19.686 19.511 20.385 20.155 20.425 20.024 20.277 19.721 19.634 20.152 20.401 20.251 20.868 20.026
532 Q15293 23.275 23.287 23.319 23.315 23.054 22.457 23.451 23.755 24.045 23.604 23.704 23.384 22.865 22.634 22.626 22.651 22.835 22.733
533 Q15365 26.360 25.135 24.616 24.698 24.778 24.790 24.939 24.212 24.292 24.815 24.921 24.399 24.553 24.949 24.192 24.810 24.649 24.797
534 Q15366 25.470 24.528 24.561 24.558 24.255 24.845 24.352 23.809 23.870 24.026 23.939 24.120 24.408 24.164 24.359 24.338 24.413 24.845
535 Q15393 22.695 24.261 23.958 24.311 23.969 23.384 22.656 23.764 23.665 23.561 23.810 23.102 22.749 24.831 23.909 24.565 23.956 23.305
536 Q15427 20.658 23.948 18.763 19.734 23.616 23.439 19.555 23.410 21.023 22.123 22.568 22.797 21.849 24.783 21.282 23.936 23.932 23.882
537 Q15436 20.149 20.502 20.149 20.894 21.161 20.312 21.065 21.214 19.462 21.186 21.093 20.712 21.243 19.631 20.642 19.601 21.076 21.104
538 Q15459 22.458 22.270 21.679 22.292 21.607 22.477 20.265 22.034 22.410 21.770 21.569 21.973 22.778 21.954 21.512 21.124 20.887 21.110
539 Q15637 22.297 23.567 22.490 23.464 23.407 23.363 22.010 22.985 21.781 22.578 22.874 22.332 22.109 23.659 22.537 23.275 23.316 22.757
540 Q15645 20.848 22.022 22.268 22.159 22.276 22.162 21.699 21.598 21.977 22.286 22.182 22.566 21.981 21.318 19.065 22.073 21.626 21.735
541 Q15717 20.295 21.170 21.302 21.723 21.228 21.510 20.800 21.397 21.575 21.648 21.724 21.245 21.200 19.493 19.375 19.282 21.098 21.062
542 Q15758 21.997 20.575 21.182 21.344 21.886 21.575 19.689 20.607 20.852 21.023 21.457 20.804 22.685 20.654 21.289 21.537 21.013 21.195
543 Q15907 23.503 23.093 23.211 23.516 23.044 23.285 22.941 22.982 22.554 22.656 23.258 22.453 24.138 23.395 23.369 22.930 23.030 22.906
544 Q16181 22.073 21.253 21.549 21.725 22.052 22.259 23.053 21.179 22.181 21.280 22.004 21.583 24.310 22.117 22.491 22.338 22.042 22.602
545 Q16527 19.844 21.018 20.757 20.960 20.957 20.085 21.944 22.129 22.056 22.699 21.895 22.623 19.906 20.516 20.281 20.194 20.379 20.217
546 Q16576 23.205 23.569 23.262 23.172 23.197 22.597 22.910 23.285 23.333 22.472 22.904 22.552 22.659 23.523 22.817 22.533 22.542 21.837
547 Q16630 19.693 24.243 23.229 23.376 24.277 23.867 19.489 23.889 23.555 24.375 23.709 19.820 22.960 24.794 23.752 23.446 23.948 24.429
548 Q16881 24.686 23.696 22.818 23.192 23.104 22.403 22.713 22.493 22.284 22.264 22.449 22.169 23.849 24.071 23.020 24.067 23.631 23.590
549 Q16891 22.651 20.268 19.125 19.022 21.427 19.781 21.554 21.946 22.793 21.659 21.993 21.906 22.823 21.297 21.054 20.924 20.822 21.415
550 Q2TAY7 22.649 20.836 22.704 22.376 22.116 22.262 21.315 21.749 22.273 21.653 21.575 21.503 22.919 22.037 22.207 21.739 22.158 22.022
551 Q52LJ0 22.739 19.409 22.329 22.518 22.808 18.715 20.891 23.352 23.093 18.802 19.476 23.447 23.002 23.428 23.323 19.625 23.211 23.115
552 Q53H96 20.049 20.088 20.244 19.686 20.244 19.905 21.038 27.773 27.834 25.502 26.021 27.142 20.364 23.316 23.715 23.383 23.678 23.520
553 Q58FF8 25.134 24.913 24.386 25.487 24.893 23.091 23.905 24.486 24.173 23.846 23.976 23.612 26.022 25.812 25.437 25.770 25.321 25.251
554 Q5JTV8 21.898 20.110 20.652 20.247 20.401 19.516 19.508 20.684 20.837 20.760 18.827 19.898 20.999 20.524 20.403 19.706 19.974 19.410
555 Q66PJ3 21.024 20.342 20.456 20.019 20.008 19.799 21.040 19.981 18.816 20.777 20.073 19.846 18.981 19.397 19.112 18.649 19.592 18.494
556 Q6P1N0 21.190 22.308 21.140 21.694 21.206 21.596 20.124 22.101 20.837 20.881 20.990 20.792 19.762 21.462 20.922 19.882 18.941 20.883
557 Q6P2Q9 21.467 22.165 22.974 22.701 19.434 19.635 22.568 22.944 23.472 22.551 22.623 22.685 20.839 22.709 22.629 22.329 21.746 22.290
558 Q6PI48 19.355 19.497 20.097 24.687 24.203 24.571 18.953 24.449 20.219 24.179 24.160 19.020 20.655 19.522 24.037 20.315 23.977 24.052
559 Q6PKG0 21.042 20.530 20.880 19.951 21.172 21.910 20.413 20.637 20.701 20.517 20.847 20.648 19.082 20.558 21.228 20.682 20.471 21.925
560 Q6SPF0 20.216 19.808 20.577 20.111 20.178 19.719 19.615 24.277 20.713 24.425 23.294 22.172 20.618 19.303 19.567 19.121 19.192 18.414
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 9 of 20. 
# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
561 Q6UB35 20.213 20.294 21.272 21.455 21.464 19.560 19.643 22.328 21.927 21.332 22.182 18.827 20.105 20.005 21.355 20.656 19.063 19.599
562 Q6XZF7 21.152 23.286 19.970 22.154 23.433 23.442 20.343 24.386 20.245 23.330 24.010 23.724 20.608 22.611 18.820 22.616 22.959 22.913
563 Q6YN16 22.879 22.195 22.264 22.395 21.943 22.709 21.713 21.724 22.043 22.075 22.301 22.093 22.412 22.260 22.444 22.820 22.535 22.776
564 Q70E73 20.694 22.787 19.668 21.356 21.801 21.548 19.359 23.311 19.462 19.383 22.073 21.222 20.521 23.046 20.035 21.434 21.675 21.260
565 Q7KZF4 26.365 30.149 29.869 29.964 29.902 29.726 26.729 30.315 29.868 29.848 29.903 29.544 27.056 29.996 29.888 29.920 29.629 29.474
566 Q7L014 22.252 21.416 21.620 21.310 21.512 20.149 22.158 21.782 21.996 21.985 21.839 21.320 19.447 20.781 20.885 20.040 19.340 19.868
567 Q7Z2W4 21.053 21.102 21.464 21.420 22.086 21.043 22.299 22.476 22.736 22.747 22.638 22.347 19.954 20.907 20.544 21.133 20.913 20.723
568 Q7Z417 20.683 20.691 19.916 19.312 20.680 20.550 21.621 20.968 21.762 18.954 20.583 21.614 19.936 20.797 20.405 20.699 20.860 20.913
569 Q86UE4 19.985 20.114 21.238 20.971 21.413 21.288 20.874 20.739 19.555 20.528 19.250 19.121 21.766 19.869 21.070 20.954 19.922 21.119
570 Q86V81 23.849 24.892 24.884 24.410 24.842 24.704 25.903 25.616 25.765 26.264 25.969 26.347 24.567 24.286 24.814 24.468 24.417 24.635
571 Q86VP6 23.541 22.806 23.313 23.164 22.877 22.575 21.510 22.095 22.483 22.165 22.032 22.038 23.368 22.975 23.038 22.658 23.002 22.395
572 Q8IUD2 21.246 19.518 22.568 19.685 19.913 20.303 19.942 20.171 22.150 19.674 19.846 20.264 19.953 18.856 22.431 19.961 19.623 19.856
573 Q8IVH8 20.713 24.124 19.676 23.444 23.563 23.432 18.968 23.588 19.157 22.683 23.267 22.862 19.353 24.333 19.989 23.300 23.510 23.237
574 Q8N163 20.095 25.510 23.820 26.858 25.564 25.451 21.598 23.995 23.130 25.323 24.221 23.572 23.120 24.879 23.264 26.320 24.813 24.846
575 Q8N684 20.701 27.010 23.259 25.456 26.282 25.781 23.656 27.102 24.351 25.638 26.213 25.577 23.035 27.263 23.753 26.022 26.437 26.129
576 Q8NBI5 18.795 20.227 19.300 20.097 19.148 18.456 21.137 19.695 20.520 19.306 19.704 19.433 20.400 20.235 19.750 19.873 19.049 19.085
577 Q8NBJ5 18.898 23.913 24.207 23.505 23.050 22.490 19.493 22.997 23.812 22.619 22.597 22.005 20.961 24.063 24.545 23.663 22.898 23.034
578 Q8NC51 26.339 27.023 27.808 27.140 27.865 28.061 27.024 26.382 26.607 26.880 26.639 26.694 27.266 27.563 28.333 27.602 27.832 28.516
579 Q8NCA5 19.902 24.728 24.371 24.767 24.232 24.548 23.108 24.825 24.168 24.947 24.430 23.639 20.280 25.146 24.463 25.046 24.621 24.509
580 Q8NE71 21.769 19.952 20.549 21.052 20.388 20.528 20.180 21.425 20.752 20.662 20.416 20.814 19.793 19.060 20.188 20.021 20.003 19.922
581 Q8TF74 20.532 27.088 19.837 26.747 28.255 27.022 19.625 26.845 19.833 25.857 26.986 26.546 20.307 27.300 19.845 26.227 26.957 26.706
582 Q8WUM4 21.261 21.818 20.043 21.301 22.093 22.639 18.146 21.627 20.058 21.051 21.519 21.383 20.035 22.501 20.501 22.291 22.831 22.980
583 Q8WVK2 19.705 20.687 20.637 20.614 18.309 18.098 19.305 20.290 18.906 19.011 19.034 19.472 21.121 19.686 20.558 19.336 19.030 20.166
584 Q8WXF1 20.590 25.905 22.042 25.171 24.634 24.007 21.449 24.018 20.787 23.221 23.247 22.556 21.190 26.679 23.224 25.863 25.406 25.025
585 Q8WXH0 26.656 19.987 23.740 23.596 19.133 25.915 27.961 26.097 26.270 25.804 25.693 28.337 26.736 26.501 26.237 27.012 28.812 28.608
586 Q92499 23.412 25.410 25.100 25.317 25.038 25.163 24.799 25.098 24.612 25.127 25.192 24.829 24.059 24.871 24.782 24.576 24.621 23.981
587 Q92598 22.802 24.293 22.842 23.478 22.427 22.337 20.912 22.357 21.852 20.921 20.676 19.255 21.653 24.196 23.010 23.667 22.219 21.615
588 Q92616 22.977 19.969 20.740 20.963 22.725 20.435 24.195 23.206 23.150 23.630 23.511 22.942 22.018 19.212 20.101 21.458 18.836 22.385
589 Q92688 20.963 24.414 24.580 24.399 24.462 23.627 22.621 23.289 22.955 23.568 23.402 23.194 21.852 24.479 24.814 24.883 24.825 24.007
590 Q92841 23.926 25.559 24.511 24.754 25.256 25.295 24.489 25.458 24.733 24.924 25.109 24.870 23.768 25.665 24.102 24.407 24.945 24.990
591 Q92889 21.251 23.705 25.156 23.950 23.735 23.296 19.320 23.751 25.081 22.887 23.530 22.868 20.189 23.308 24.798 23.258 23.359 23.021
592 Q92896 23.559 22.397 22.992 22.960 22.493 22.254 22.926 22.475 22.804 22.162 22.695 21.822 21.893 21.477 22.486 22.091 22.257 21.583
593 Q92900 19.829 20.431 21.335 20.592 20.976 19.851 20.144 18.760 21.144 20.977 21.054 19.911 20.235 19.621 20.670 20.710 19.923 18.877
594 Q92917 20.657 21.589 19.281 20.871 21.723 21.653 20.147 21.590 19.356 21.003 21.693 20.997 19.730 21.016 19.719 21.109 21.956 21.630
595 Q92945 24.494 24.417 24.447 24.513 24.239 24.366 23.514 23.861 23.742 23.557 23.567 23.389 25.010 24.508 24.456 24.535 24.247 24.333
596 Q92973 23.916 22.519 22.984 22.781 23.072 23.176 23.329 22.763 22.718 22.594 22.743 22.546 23.492 22.481 22.806 23.095 23.281 22.911
597 Q92979 21.284 23.288 23.300 23.119 22.962 22.962 22.128 22.971 22.566 22.360 22.287 22.342 22.250 23.045 22.790 23.186 23.159 23.260
598 Q93009 20.490 23.129 23.263 23.428 23.512 23.155 22.453 23.177 23.123 22.974 23.808 22.912 21.907 23.525 22.809 23.638 23.325 23.028
599 Q96AE4 24.170 23.986 24.223 24.167 24.089 24.297 23.352 23.365 23.237 23.281 23.102 22.760 24.931 24.122 24.300 24.150 24.326 24.233
600 Q96AG4 25.227 24.982 24.795 24.692 24.751 24.903 24.909 24.689 24.804 24.818 24.808 25.033 26.785 24.495 24.882 24.960 25.033 24.859
601 Q96C36 22.642 19.668 23.151 22.999 22.788 22.744 19.874 22.907 22.908 22.352 22.661 22.331 23.878 23.895 23.545 23.113 23.006 23.365
602 Q96CW1 19.948 27.030 27.323 27.165 26.835 27.021 21.379 25.999 26.088 25.756 25.731 25.628 21.051 26.904 27.654 27.075 26.591 26.707
603 Q96D46 20.333 20.693 19.410 20.155 19.986 19.961 20.344 20.002 19.873 19.891 19.832 19.681 20.646 19.926 18.878 20.296 20.242 20.281
604 Q96EP5 19.015 23.343 22.781 23.169 22.909 22.469 21.198 22.143 21.818 22.130 22.031 21.391 20.594 22.541 22.104 22.600 22.587 22.404
605 Q96EV2 21.091 23.852 19.579 22.932 22.425 21.815 20.008 23.838 19.191 22.678 22.553 21.887 19.729 22.920 19.416 22.441 22.618 21.490
606 Q96EY1 22.661 23.486 23.172 23.218 23.200 23.635 23.826 23.514 23.463 24.508 23.852 24.126 23.070 23.186 22.594 19.810 18.809 19.741
607 Q96EY5 20.256 20.022 20.080 19.441 21.958 22.103 20.527 22.438 19.204 20.205 22.490 21.948 19.981 22.835 20.073 21.860 22.316 18.788
608 Q96GD4 20.271 21.085 20.058 22.033 19.580 20.651 19.029 20.353 19.887 20.704 21.244 19.424 19.612 21.528 19.215 22.871 20.739 20.581
609 Q96HC4 23.229 23.421 23.397 23.384 23.318 23.163 23.258 24.014 24.022 23.851 23.807 23.715 24.482 23.596 23.676 23.155 23.533 23.102
610 Q96HR8 20.624 22.170 19.769 20.951 22.145 22.857 20.572 21.455 22.089 21.589 22.115 22.143 19.490 23.092 21.439 23.266 23.486 23.498
611 Q96IX5 19.755 21.406 20.477 20.457 20.292 18.872 20.222 20.231 20.102 20.301 20.550 20.329 20.675 20.010 20.062 19.905 20.339 20.301
612 Q96IZ0 21.239 19.828 19.280 20.465 21.023 20.080 21.500 21.865 22.121 22.103 21.700 21.961 20.119 19.123 19.557 19.677 20.243 21.225
613 Q96J02 19.887 23.001 20.402 22.264 21.949 21.861 19.302 22.414 19.393 21.057 21.571 21.389 20.114 22.760 19.673 22.001 22.247 22.224
614 Q96PK6 20.052 22.520 22.511 22.658 22.807 22.359 21.484 22.622 22.041 22.463 22.602 22.059 20.411 22.513 21.342 22.285 22.235 21.804
615 Q96S19 25.868 24.572 24.650 24.827 24.556 24.489 24.873 24.068 24.305 23.735 23.968 23.627 26.521 24.414 25.020 25.144 25.151 24.888
616 Q96T88 20.324 20.643 20.680 23.350 20.709 19.858 20.814 21.168 21.522 24.070 21.354 21.268 20.871 19.654 19.902 23.592 20.412 19.100
617 Q99613 22.098 22.272 22.554 21.701 22.157 21.523 21.089 22.686 22.637 22.210 22.383 21.780 22.227 22.201 22.148 21.451 21.514 21.707
618 Q99615 20.648 21.657 22.139 21.941 21.530 21.650 20.499 21.870 22.113 22.163 21.605 21.513 20.690 21.767 21.640 21.837 21.468 21.581
619 Q99623 26.222 24.719 25.164 25.317 25.169 25.258 25.517 24.821 25.061 25.105 25.314 25.134 25.653 24.389 24.505 24.562 24.941 24.802
620 Q99700 21.277 20.886 19.845 20.962 20.651 19.125 19.211 21.182 19.846 20.748 19.501 20.553 19.757 21.533 19.548 21.138 19.853 19.165
621 Q99714 25.851 24.799 24.447 24.983 24.439 24.645 25.117 24.995 24.245 24.533 24.777 24.825 24.378 24.853 24.938 25.113 25.264 25.283
622 Q99729 22.566 22.959 23.340 23.033 23.418 23.049 23.268 22.427 22.613 23.056 22.895 22.933 23.395 22.389 22.857 23.572 23.474 23.598
623 Q99816 20.554 21.574 19.873 21.311 21.862 21.836 20.002 22.966 20.670 20.508 21.647 21.672 20.844 22.022 19.609 21.241 21.395 21.640
624 Q99832 24.753 25.914 25.951 25.839 26.015 25.771 24.573 25.529 25.804 25.487 25.310 24.868 25.062 25.853 26.311 25.997 26.219 26.132
625 Q99873 19.409 20.913 20.068 20.663 21.229 19.606 19.106 20.265 19.614 20.155 19.680 20.220 20.483 21.592 20.564 21.505 20.995 20.460
626 Q9BQE3 20.642 24.010 24.059 24.026 23.747 20.988 23.287 19.828 23.360 19.474 19.455 23.630 23.820 23.000 23.570 23.125 23.303 22.920
627 Q9BR76 20.401 22.974 22.392 22.078 21.729 19.337 24.431 24.860 24.118 24.346 24.356 24.848 21.542 19.996 20.358 19.077 22.542 22.748
628 Q9BRP8 20.288 19.533 21.237 19.603 22.221 21.349 20.173 20.745 20.446 19.878 20.593 20.502 21.159 20.975 22.011 20.916 20.875 21.331
629 Q9BSJ8 21.016 19.969 20.422 19.456 21.268 20.394 20.872 20.417 20.423 21.234 20.807 20.732 21.765 20.247 21.260 20.332 20.711 20.712
630 Q9BTT0 20.779 20.403 20.658 19.449 20.048 20.217 20.511 19.975 20.826 20.290 20.513 19.968 20.438 22.402 21.542 21.471 20.351 19.515
Supplementary Table A 
180
Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 10 of 20. 
# Uniprot GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E GST WT Y56E Y56F T275A T275E
631 Q9BVK6 20.272 20.655 20.628 20.696 20.589 20.630 20.320 20.538 20.798 19.379 20.613 19.280 22.216 19.312 20.375 20.692 20.626 20.681
632 Q9BXS5 20.538 22.038 22.421 22.778 21.506 22.096 19.837 21.366 21.303 21.652 21.478 18.983 20.614 21.709 21.504 21.495 21.194 20.789
633 Q9BY44 23.245 24.085 24.869 24.294 24.107 24.925 23.622 23.274 23.563 23.325 23.644 23.603 24.189 24.121 24.863 23.835 24.181 24.680
634 Q9BY77 19.874 22.536 23.049 22.695 22.359 22.338 25.615 23.109 23.764 24.239 23.545 23.514 24.714 24.279 23.766 23.444 23.388 23.213
635 Q9BZE4 20.108 20.790 21.148 19.611 20.794 18.511 21.270 20.890 21.488 21.060 21.342 21.767 20.887 20.519 20.685 20.306 20.495 19.440
636 Q9BZZ5 23.017 24.054 23.354 23.431 23.662 23.740 22.479 22.425 22.310 22.667 22.311 22.542 23.173 24.805 24.566 24.628 25.570 24.993
637 Q9GZT3 23.934 24.069 24.001 24.278 24.053 23.648 23.513 24.504 24.461 24.154 24.115 23.451 24.348 24.491 24.513 24.460 23.831 23.778
638 Q9H0D6 20.760 21.753 21.847 22.170 22.227 21.773 19.986 22.578 21.998 21.947 22.242 22.139 21.312 22.003 21.025 21.830 22.053 21.401
639 Q9H307 20.912 21.635 23.094 21.774 21.165 21.565 20.309 23.109 23.991 22.821 22.551 21.791 18.841 21.530 23.342 21.488 21.045 21.518
640 Q9H6R4 20.727 20.091 21.009 20.490 20.938 21.025 19.355 20.928 20.805 20.553 20.811 20.800 20.379 20.932 21.475 18.044 20.765 21.366
641 Q9H8H3 21.932 21.064 21.408 21.339 21.410 21.217 20.610 20.040 20.528 20.626 20.341 20.418 21.601 19.345 20.438 20.912 19.429 19.264
642 Q9H910 22.181 21.384 20.811 21.617 21.338 21.199 21.075 20.750 20.342 20.764 21.224 19.194 21.910 21.133 21.146 19.204 19.285 19.010
643 Q9H9B4 20.216 21.165 21.476 19.443 21.489 18.221 22.667 22.335 22.844 22.852 23.126 23.057 21.711 21.057 20.505 19.468 21.301 21.518
644 Q9HAH7 20.351 22.596 18.911 22.330 22.729 22.359 19.909 23.915 20.269 23.408 24.108 23.131 19.363 22.567 21.028 22.370 22.413 22.516
645 Q9HAV7 24.940 25.092 24.611 24.991 24.783 24.842 24.579 26.467 25.493 25.784 25.859 25.891 24.531 25.217 25.305 25.344 25.205 25.165
646 Q9HB71 25.896 26.039 26.236 26.158 26.055 25.691 24.987 25.588 25.368 25.104 25.113 25.089 24.991 25.838 25.927 25.586 25.592 25.507
647 Q9HBH1 20.493 18.919 22.021 19.731 19.536 19.307 19.215 21.599 22.333 20.513 21.552 19.669 20.771 20.297 22.153 19.240 18.796 19.093
648 Q9HC36 19.804 22.503 22.100 22.336 21.777 20.065 20.465 21.666 21.522 21.433 21.430 21.885 21.329 22.427 23.093 22.201 22.362 21.404
649 Q9NPJ3 23.728 21.584 22.107 22.128 22.373 22.524 23.787 21.789 22.220 22.034 22.133 21.770 23.326 22.487 22.733 22.931 23.019 22.793
650 Q9NQC3 20.082 19.495 22.583 20.253 21.671 19.355 20.460 21.664 21.827 21.122 21.462 21.057 23.858 22.496 22.737 22.649 23.030 22.640
651 Q9NQW6 21.746 22.162 21.838 21.793 22.204 21.693 23.138 23.148 23.295 23.306 23.077 22.985 20.628 20.243 21.169 21.416 21.226 20.908
652 Q9NR30 24.673 24.258 24.430 24.199 24.873 24.852 25.341 24.921 25.225 25.312 25.306 25.452 23.857 23.522 24.155 23.470 23.852 24.090
653 Q9NRX1 20.379 19.984 20.853 20.765 20.021 19.550 20.925 20.647 20.785 20.786 20.598 20.749 20.904 21.014 22.282 19.446 20.876 21.694
654 Q9NSC5 20.842 21.720 21.612 22.960 21.183 21.235 20.160 21.229 18.829 21.248 18.538 18.580 21.835 21.814 21.840 22.689 20.886 21.268
655 Q9NSD9 23.405 22.057 21.850 22.025 21.774 22.050 21.772 22.233 22.227 21.903 22.296 21.584 22.886 22.085 22.554 22.459 22.001 22.493
656 Q9NUI1 20.279 25.437 19.781 27.011 25.681 25.686 19.131 25.233 21.442 26.229 24.408 24.015 20.893 25.700 19.262 27.285 25.320 25.699
657 Q9NW64 20.415 20.567 20.000 20.529 20.498 18.883 19.744 20.884 19.893 21.049 20.833 19.380 21.472 19.380 19.745 20.642 20.159 19.926
658 Q9NZB2 20.314 21.926 21.701 21.756 21.893 21.558 19.427 21.389 21.592 21.070 21.159 21.300 19.664 21.924 21.177 21.344 21.512 19.298
659 Q9NZM1 20.140 19.715 22.461 22.157 22.348 21.992 21.233 21.881 21.774 21.556 21.985 21.817 23.130 22.222 21.833 22.244 22.285 21.662
660 Q9P0L0 22.442 21.259 22.183 21.424 22.097 21.846 21.839 21.831 22.262 21.654 21.832 21.068 22.609 21.097 21.452 22.253 21.883 21.977
661 Q9P258 25.674 24.800 25.105 25.040 24.565 24.957 24.902 24.724 24.891 24.663 24.635 24.526 25.974 24.884 25.159 24.659 24.793 24.735
662 Q9P289 21.048 21.106 20.467 21.174 20.762 20.706 20.087 20.548 20.897 19.592 20.390 20.828 19.220 20.262 20.143 19.918 20.339 19.903
663 Q9UHD8 19.868 21.017 21.693 21.735 21.149 21.359 21.692 21.153 21.246 21.338 21.373 20.932 22.655 20.871 20.964 21.023 20.664 20.805
664 Q9UHX1 20.598 22.129 22.323 22.356 22.514 22.243 22.244 21.728 22.007 22.065 21.539 21.715 23.082 21.631 21.789 21.905 21.837 22.051
665 Q9UK41 20.621 21.795 20.028 20.836 20.521 19.347 19.523 21.168 19.602 20.516 20.550 20.340 19.990 21.307 20.727 20.254 20.794 20.836
666 Q9UKV8 20.045 21.406 20.342 21.217 21.831 21.197 19.194 20.677 20.279 20.954 20.776 18.895 20.900 21.852 21.018 20.889 21.524 21.112
667 Q9UKY7 20.177 20.397 21.402 20.817 21.194 21.265 19.140 20.495 20.971 20.884 19.139 20.127 20.712 20.982 21.315 21.337 21.657 21.772
668 Q9UL46 21.445 21.579 21.339 21.484 20.960 20.727 18.738 20.299 19.288 20.956 19.569 19.564 21.418 21.669 21.626 21.630 21.081 20.663
669 Q9ULV4 23.127 24.269 24.473 21.278 25.324 20.218 27.878 27.730 28.382 28.431 28.083 28.784 20.253 19.572 19.792 20.135 21.093 20.920
670 Q9UMS4 23.330 23.832 23.890 23.721 23.501 23.267 23.255 23.654 24.228 23.414 23.950 23.995 23.131 23.006 23.395 23.264 23.354 23.357
671 Q9UQ35 22.781 26.999 27.121 26.948 27.001 27.421 23.173 27.487 27.489 26.915 27.112 27.120 24.300 27.727 28.342 27.837 27.638 28.186
672 Q9UQ80 25.935 25.166 25.610 25.611 25.682 25.906 25.277 25.076 25.318 25.187 25.248 25.268 26.150 25.144 25.860 25.685 26.183 26.197
673 Q9UQE7 20.666 22.682 22.703 22.332 22.293 22.105 22.052 22.201 22.609 22.429 22.244 22.017 22.675 21.684 21.897 19.476 21.954 21.592
674 Q9Y224 21.779 24.795 24.505 24.856 24.832 24.479 23.364 25.623 24.809 25.510 25.534 25.158 23.087 25.484 24.970 25.387 24.737 24.374
675 Q9Y230 22.509 22.588 23.249 22.977 23.016 22.991 22.080 22.428 22.868 22.237 21.997 21.951 22.851 22.874 23.275 22.647 22.521 22.695
676 Q9Y237 21.459 20.235 20.898 20.766 20.715 20.311 20.822 20.514 21.362 20.225 20.100 19.700 23.448 21.002 21.620 19.443 19.831 19.338
677 Q9Y262 22.436 22.132 22.255 22.127 22.211 22.060 19.570 21.914 18.449 21.823 21.978 21.367 22.158 22.517 22.331 22.443 22.473 22.317
678 Q9Y265 19.945 22.650 22.773 22.556 22.350 22.405 21.361 21.923 21.928 21.401 22.224 21.821 22.609 23.095 23.426 22.813 22.909 22.563
679 Q9Y2S6 20.506 19.617 19.768 19.646 20.086 19.524 22.188 19.330 19.462 19.407 19.194 19.357 23.231 19.394 19.887 20.085 19.922 19.280
680 Q9Y2X3 21.036 21.466 19.313 21.285 21.466 19.078 22.184 21.461 21.955 22.346 21.642 22.184 20.591 19.354 19.378 19.561 18.606 19.081
681 Q9Y2Z4 19.819 21.680 21.595 21.654 21.286 21.120 21.193 21.583 21.895 19.537 19.648 20.857 22.854 21.634 21.925 21.179 21.516 21.142
682 Q9Y383 23.742 22.827 23.318 22.927 23.523 22.987 23.119 23.253 23.355 23.067 23.103 22.968 23.228 22.949 23.544 22.564 22.715 23.441
683 Q9Y3B4 18.878 19.634 20.403 20.417 20.335 20.240 20.630 20.702 20.818 20.373 20.635 20.118 21.348 20.772 20.548 19.812 19.946 19.979
684 Q9Y3E5 20.312 20.080 19.799 20.023 20.132 20.327 20.483 20.027 20.256 19.907 20.314 20.230 21.650 19.860 20.455 19.952 20.153 19.848
685 Q9Y3F4 21.881 22.315 22.008 21.792 21.701 21.961 21.733 21.746 21.217 21.651 21.036 21.649 21.310 21.487 20.876 21.925 21.253 21.540
686 Q9Y3I0 22.417 23.309 23.217 23.558 23.234 22.939 21.969 23.294 23.144 23.204 23.411 23.090 23.056 23.685 23.043 23.335 23.195 23.219
687 Q9Y3U8 20.749 21.756 21.899 21.612 22.585 22.555 23.471 23.372 23.141 23.609 23.313 23.460 22.878 21.853 21.880 22.029 22.572 22.307
688 Q9Y4U1 24.614 23.242 23.105 23.512 23.200 23.461 23.298 23.438 23.266 22.875 23.129 22.764 24.580 22.372 22.586 22.855 22.690 22.548
689 Q9Y5X1 22.843 34.019 33.765 33.913 33.728 33.830 25.412 34.024 33.794 33.805 33.750 34.038 19.437 34.418 34.208 34.739 34.689 34.263
690 Q9Y678 22.718 19.123 20.023 22.550 22.472 19.553 20.227 22.043 21.789 21.928 22.347 22.326 20.032 21.311 21.788 22.220 22.193 21.799
691 Q9Y6E2 21.170 20.544 22.094 21.685 22.401 19.557 20.271 20.222 19.670 21.177 21.087 20.521 23.222 21.201 21.275 21.318 20.956 21.126
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 11 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
1 A1X283 10 13.1 101.580 138.310 194290000 99
2 Q13765 6 20.5 23.384 182.180 144640000 54
3 O00116 4 9.9 72.911 31.263 69689000 42
4 O00151 5 31 36.071 16.859 35858000 12
5 O00203 21 22.9 121.320 236.650 478290000 101
6 O00303 2 10.1 37.563 98.025 350360000 34
7 O00401 37 61 54.826 323.310 5091600000 632
8 O00410 24 32 123.630 323.310 1131300000 182
9 O00469 9 22.1 84.685 50.798 124070000 37
10 O00571 26 50.2 73.243 279.520 1287500000 233
11 O00750 8 7.3 184.770 67.241 82335000 22
12 O14579 4 19.5 34.482 85.225 83439000 27
13 P47813 5 37.5 16.460 237.510 48340000 14
14 O14818 7 35.9 27.887 323.310 152220000 56
15 O14874 11 43 46.360 144.180 396640000 97
16 P19105 8 50.3 19.794 323.310 1120900000 198
17 O14965 27 74.4 45.809 323.310 2053700000 533
18 O14979 7 15 46.437 89.330 275130000 93
19 O14980 5 5.8 123.380 49.225 45554000 14
20 O15056 15 14.7 165.540 86.311 137450000 91
21 O15143 13 48.1 40.949 76.193 249930000 74
22 O15144 8 42.7 34.333 79.898 173520000 62
23 O15347 3 22 22.980 9.584 47721000 8
24 O15355 3 9.5 59.271 13.320 60879000 30
25 O15371 11 29.2 63.972 81.730 198540000 55
26 O43175 16 33.4 56.650 144.010 575770000 195
27 O43242 8 20.2 60.977 22.368 116460000 43
28 O43390 13 23.2 70.942 24.044 146880000 44
29 O43426 30 29.9 173.100 265.560 314340000 146
30 O43516 17 53.7 51.258 226.690 788390000 334
31 O43684 8 31.4 37.154 71.599 116880000 72
32 O43707 43 49.8 104.850 323.310 825660000 306
33 O43747 8 9.2 91.350 17.330 74806000 27
34 O43776 11 29.9 62.942 59.812 192930000 38
35 O43809 12 49.3 26.227 142.090 1318700000 183
36 O43813 24 86.7 45.283 323.310 2259200000 246
37 O43852 2 8.3 37.106 3.876 29907000 11
38 O43865 9 23.8 58.951 24.487 241910000 45
39 O60220 2 22.7 10.998 2.759 21669000 11
40 O60506 15 29.5 69.602 214.970 490470000 144
41 O60568 6 11.5 84.784 17.432 72175000 20
42 O60664 2 7.6 47.074 113.870 45903000 18
43 Q99880 7 33.3 13.952 15.111 596490000 89
44 O60869 10 54.7 16.368 183.490 389710000 92
45 O60884 5 18.4 45.745 25.175 248070000 27
46 O60885 14 13.6 152.220 98.378 429230000 109
47 O75128 11 14.8 135.620 88.931 86475000 32
48 O75340 5 36.6 21.868 11.937 99857000 16
49 O75348 2 22.9 13.757 33.923 22254000 13
50 O75369 29 18.4 278.160 100.450 241650000 97
51 O75390 11 26.4 51.712 61.201 510870000 82
52 O75521 7 31.7 43.585 159.060 126240000 63
53 O75533 8 9.4 145.830 18.085 80524000 17
54 O75534 6 9.5 88.884 9.266 78409000 13
55 O75643 21 15.3 244.500 148.610 330780000 69
56 O75821 3 20.9 35.611 14.508 33052000 12
57 O75822 3 19 29.062 23.758 87592000 20
58 O75909 15 35.7 64.239 323.310 1208200000 196
59 O75947 4 22.4 18.491 13.821 92741000 47
60 O75964 3 32 11.428 3.911 50975000 8
61 O76003 9 51.9 37.432 123.400 482590000 51
62 O76021 8 23.7 54.972 104.380 101430000 45
63 O94826 3 6.1 67.454 20.853 95864000 35
64 O94875 20 24.5 124.110 70.356 566800000 254
65 O94973 38 47.8 103.960 323.310 1989600000 297
66 O95340 10 24.4 69.500 127.980 310060000 83
67 O95347 9 9.7 135.650 15.718 53506000 12
68 O95373 8 10.5 119.520 23.453 130550000 44
69 O95573 8 17.8 80.419 26.653 113440000 31
70 O95782 60 67.8 107.540 323.310 9747900000 1081
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 12 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
71 O95816 7 46.4 23.772 52.884 88127000 32
72 O95817 3 7.7 61.594 6.830 22091000 4
73 P00338 14 47.9 36.688 310.950 1292900000 204
74 P00367 10 26.3 61.397 104.750 243760000 55
75 P00387 5 22.6 34.234 33.925 84555000 31
76 P00390 5 13 56.256 11.488 49379000 20
77 P00558 2 6.2 44.614 4.917 13939000 4
78 P00966 7 17.7 46.530 20.450 197910000 40
79 P01891 10 42.2 40.908 111.660 217860000 88
80 P02545 29 50.2 74.139 323.310 1007500000 291
81 P02786 13 24.2 84.870 188.690 324660000 72
82 P04075 36 92 39.420 323.310 4701000000 726
83 P04183 4 32.5 25.468 133.160 94893000 30
84 P04406 28 82.4 36.053 323.310 21008000000 1222
85 P04792 12 90.7 22.782 167.530 2248700000 249
86 P04843 18 40.7 68.569 93.833 430090000 154
87 P04844 4 15.1 69.283 30.714 144720000 17
88 Q93077 9 60.8 14.105 8.523 112060000 18
89 P05023 14 19.7 112.890 323.310 334140000 113
90 P05141 17 48.3 32.852 71.460 487420000 75
91 P05198 5 21.9 36.112 21.751 95043000 37
92 P05386 5 99.1 11.514 58.967 3671400000 66
93 P05387 9 95.7 11.665 323.310 480810000 152
94 P05388 12 55.2 34.273 237.580 814090000 185
95 P05455 4 14.7 46.836 7.803 39157000 8
96 P05556 5 9 88.414 71.057 74126000 23
97 P05783 23 46.5 48.057 219.240 587320000 165
98 P06493 11 45.8 34.095 110.070 326820000 100
99 P06576 20 57.7 56.559 323.310 2162600000 352
100 P06730 2 11.5 25.097 7.198 16490000 14
101 P06748 11 38.8 32.575 320.700 1271000000 244
102 P06753 14 41.4 32.950 163.950 88242000 21
103 Q16778 6 33.3 13.920 4.479 68796000 14
104 P07195 7 24.9 36.638 14.701 96476000 41
105 P07237 10 19.5 57.116 130.070 109270000 35
106 P07355 25 67.3 38.604 323.310 2391800000 416
107 P07437 25 70.3 49.670 323.310 6527500000 976
108 P07814 25 25.1 170.590 164.360 291130000 95
109 P07900 43 52.5 84.659 323.310 2355400000 519
110 P07910 10 32.7 33.670 71.557 526150000 106
111 P07919 3 29.7 10.739 36.762 370080000 61
112 P07992 6 39.4 32.562 15.663 82127000 11
113 P08195 24 45.2 67.993 323.310 5112400000 673
114 P08237 13 19.6 85.182 264.590 131870000 39
115 P08238 51 65.5 83.263 323.310 18065000000 1577
116 P08574 7 21.5 35.422 48.428 423330000 101
117 P08621 5 15.6 51.556 84.309 219950000 37
118 P08670 35 67.2 53.651 323.310 1646900000 342
119 P08708 11 60 15.550 197.920 737350000 133
120 P08754 7 26.3 40.532 37.082 93132000 35
121 P08865 17 67.1 32.854 323.310 2174300000 244
122 P09234 3 19.5 17.394 26.213 28088000 13
123 P09496 4 13.7 27.076 3.909 72944000 17
124 P09651 19 51.3 38.746 323.310 3163400000 456
125 P09972 6 18.7 39.455 84.817 233710000 97
126 Q71UI9 7 56.2 13.509 84.948 1376800000 76
127 Q99878 9 61.7 13.936 175.820 3799700000 317
128 P0DMV9 36 67.6 70.051 323.310 4280000000 811
129 P10599 3 48.6 11.737 17.962 160170000 14
130 P10620 3 12.3 17.598 5.119 38837000 16
131 P10809 32 51.3 61.054 323.310 2337400000 596
132 P11021 28 48.3 72.332 323.310 1461400000 402
133 P11142 35 57.1 70.897 323.310 4713800000 804
134 P11413 15 38.1 59.256 279.010 400620000 95
135 P11586 23 32.3 101.560 141.370 685800000 206
136 P11940 21 31.9 70.670 323.310 880900000 319
137 P12081 7 20.6 57.410 12.291 64217000 17
138 P12236 18 49.3 32.866 201.080 1746200000 256
139 P12270 22 14.3 267.290 190.680 147900000 34
140 P12532 5 17.7 47.036 270.840 194770000 30
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 13 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
141 P12956 15 33.2 69.842 123.180 354680000 122
142 P13010 16 38.4 82.704 322.830 437700000 131
143 P13639 42 55.2 95.337 323.310 6188600000 801
144 P13987 3 19.5 14.177 18.695 51128000 9
145 P13995 5 15.7 37.895 9.213 80962000 29
146 P14314 3 6.4 59.425 34.316 43383000 29
147 P14618 26 63.7 57.936 323.310 2061900000 413
148 P14625 31 45.2 92.468 323.310 1711800000 400
149 P14866 13 47.7 64.132 212.680 452170000 138
150 P14923 6 12.6 81.744 13.381 84525000 21
151 P15311 24 43.5 69.412 259.870 604680000 204
152 P15880 17 53.2 31.324 323.310 2419400000 331
153 P15924 62 26.5 331.770 323.310 955280000 190
154 P16152 39 94.9 30.375 323.310 97567000000 2622
155 P16403 5 27.2 21.364 17.237 45910000 15
156 P16435 22 41.2 76.689 274.450 504660000 190
157 P16615 7 7.2 114.760 93.574 106070000 36
158 P17096 2 41.1 11.676 104.390 110810000 57
159 P17812 11 20.8 66.690 20.791 80451000 39
160 P17844 22 32.1 69.147 175.310 1079700000 319
161 P17858 14 25.8 85.018 219.230 326450000 94
162 P17987 25 57 60.343 314.550 1136500000 273
163 P18077 3 22.7 12.538 5.255 120410000 42
164 P18124 12 40.7 29.225 105.890 993780000 190
165 P18621 11 44 21.397 64.467 283860000 74
166 P18754 6 21.4 44.969 132.140 57746000 22
167 P18859 2 34.3 12.587 5.016 47446000 16
168 P19338 30 33.8 76.613 323.310 1988600000 450
169 P19784 18 52.6 41.213 211.560 542260000 144
170 P20290 2 23.3 22.168 7.872 84602000 14
171 P20674 5 43.3 16.762 6.176 142160000 17
172 P20700 16 38.6 66.408 42.129 316520000 93
173 P21266 42 95.6 26.559 323.310 1.17E+11 2211
174 P21291 8 57.5 20.567 319.380 561770000 110
175 P21333 46 27.2 280.740 323.310 1252000000 503
176 P21796 12 59 30.772 136.810 279310000 75
177 P22087 5 17.1 33.784 15.947 67444000 40
178 P22234 15 48.7 47.079 297.320 725620000 138
179 P22314 5 7.3 117.850 18.025 33831000 8
180 P22392 6 50 17.298 13.545 223440000 44
181 P22626 26 74.5 37.429 323.310 3186500000 529
182 P22695 5 18.3 48.442 23.180 74618000 18
183 P23193 3 16.6 33.969 18.277 24951000 14
184 P23246 34 42.4 76.149 310.920 6531000000 580
185 P23258 6 24.2 51.169 65.883 69100000 14
186 P23284 16 67.1 23.742 174.210 1596200000 304
187 P23396 28 81.5 26.688 323.310 4656400000 534
188 P23528 8 69.9 18.502 155.350 516230000 77
189 P23588 11 23.9 69.150 51.114 1064600000 114
190 P23921 16 30.9 90.069 185.550 467360000 121
191 P24534 4 25.8 24.763 59.805 126890000 39
192 P24539 5 24.6 28.908 53.793 91621000 27
193 P24752 8 24.6 45.199 157.760 115100000 38
194 P25205 18 32.1 90.980 170.400 375290000 84
195 P25398 14 81.8 14.515 323.310 2043200000 288
196 P25440 17 24 88.060 106.760 624140000 133
197 P25685 4 16.5 38.044 31.506 64438000 25
198 P25705 30 52.4 59.750 323.310 2717800000 432
199 P25786 7 30 29.555 27.660 205530000 51
200 P25787 6 36.8 25.898 42.858 128770000 34
201 P25788 5 25.9 28.433 12.522 56998000 22
202 P25789 3 12.3 29.483 5.521 80365000 16
203 P26038 10 14.9 67.819 5.057 39456000 10
204 P26196 11 35.2 54.416 97.586 276880000 76
205 P26368 5 19.8 53.500 17.957 346050000 56
206 P26373 11 29.4 24.261 104.690 438710000 109
207 P26583 4 19.1 24.033 8.905 48258000 17
208 P26599 12 39.4 57.221 323.310 1382800000 281
209 P26639 22 37.8 83.434 323.310 687860000 140
210 P26640 12 19.1 140.470 83.475 301340000 72
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, 
post-filtering. Prepared by Daniel Yagoub. Part 14 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
211 P26641 18 45.8 50.118 162.370 1430100000 291
212 P27348 5 30.6 27.764 68.848 259260000 25
213 P27635 13 60.7 24.604 16.912 172470000 49
214 P27695 9 48.4 35.554 67.246 119630000 29
215 P27797 12 43.6 48.141 266.050 670630000 156
216 P27816 9 11.2 121.000 77.724 136630000 60
217 P27824 14 23.6 67.567 77.007 878200000 220
218 P28066 4 19.9 26.411 129.630 90871000 28
219 P28072 4 17.6 25.357 7.752 86990000 24
220 P28074 10 33.8 28.480 79.915 94445000 39
221 P28482 4 14.2 41.389 6.988 39497000 18
222 P29692 7 32.4 31.121 219.690 675930000 134
223 P30048 4 26.6 27.692 36.023 85545000 31
224 P30050 9 64.2 17.818 245.890 824760000 235
225 P30153 6 14.4 65.308 27.492 275820000 29
226 P30405 11 56.5 22.040 68.184 485120000 214
227 P30419 4 12.1 56.806 89.862 89196000 32
228 P30508 8 33.9 40.885 29.484 39195000 16
229 P30566 4 12.4 54.889 18.929 189100000 26
230 P31153 4 12.7 43.660 19.803 100150000 45
231 P31327 37 34.7 164.940 323.310 1032400000 277
232 P31689 8 28.7 44.868 43.631 163830000 67
233 P31930 6 22.3 52.645 25.754 62311000 26
234 P31942 3 11.3 36.926 75.321 73536000 28
235 P31943 16 49.7 49.229 323.310 1191900000 235
236 P31948 8 21.4 62.639 323.310 193850000 81
237 P32119 14 64.1 21.892 62.879 416150000 122
238 P32322 11 53.6 33.360 237.370 380770000 100
239 P32969 13 52.1 21.863 145.140 645960000 158
240 P33176 12 18.2 109.680 160.800 94947000 37
241 P33991 7 11.1 96.557 37.342 93977000 23
242 P33992 13 21.5 82.285 86.025 330940000 75
243 P33993 17 29.8 81.307 57.146 337580000 103
244 P34897 23 61.9 55.992 323.310 1015400000 230
245 P34932 16 29 94.330 169.960 276410000 86
246 P35052 12 29.9 61.680 91.272 174350000 49
247 P35232 17 83.5 29.804 236.680 886230000 155
248 P35268 9 68.8 14.787 166.760 527980000 105
249 P35579 172 66.4 226.530 323.310 26434000000 2370
250 P35606 19 32.1 102.490 160.520 197090000 75
251 P35613 6 21 42.200 104.400 245520000 71
252 P35637 7 14.4 53.425 110.600 616360000 140
253 P35754 8 90.6 11.776 55.806 503850000 61
254 P35998 4 12.9 48.633 13.832 43114000 8
255 P36542 7 33.6 32.996 26.829 548190000 65
256 P36578 26 53.9 47.697 170.850 1530800000 404
257 P36776 4 7.1 106.490 20.329 46813000 9
258 P37108 5 51.5 14.570 94.503 172170000 87
259 P38159 20 39.1 42.331 190.220 978290000 247
260 P38646 25 44.3 73.680 323.310 1747400000 299
261 P38919 18 45 46.871 214.870 949400000 208
262 P39019 15 51.7 16.060 104.500 2005700000 323
263 P39023 15 35.5 46.108 42.020 697120000 174
264 P39656 6 14.7 50.800 28.576 70687000 23
265 P39687 11 44.2 28.585 212.940 985690000 143
266 P39748 8 23.7 42.592 111.080 125730000 40
267 P40227 22 45.6 58.024 323.310 1220800000 201
268 P40429 7 31.5 23.577 22.671 412510000 104
269 P40926 17 58.3 35.503 323.310 1231400000 324
270 P40939 33 55 82.999 323.310 1410400000 387
271 P41091 15 47.5 51.109 135.400 583450000 152
272 P41252 8 9.6 144.500 83.972 120280000 37
273 P41567 4 80.5 12.732 38.047 197460000 64
274 P42167 16 45.6 50.670 122.260 592640000 192
275 P42285 4 5.3 117.800 5.003 33624000 15
276 P42677 5 40.5 9.461 14.359 633980000 83
277 P42704 31 28.6 157.900 323.310 1106100000 209
278 P42766 7 38.2 14.551 150.940 352410000 100
279 P43243 10 19.7 94.622 72.893 216710000 82
280 P43304 5 10 80.852 13.788 68674000 15
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 15 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
281 P43307 3 11.9 32.235 37.514 55715000 15
282 P45880 8 41.5 31.566 23.095 207060000 77
283 P45974 3 7 95.785 40.604 28068000 7
284 P46013 11 5.6 358.690 63.479 54489000 15
285 P46060 9 21.6 63.541 80.407 153000000 49
286 P46063 4 12.3 73.457 53.524 294110000 18
287 P46087 7 11.1 89.301 21.421 63600000 21
288 P46776 8 39.9 16.561 79.892 1042400000 158
289 P46777 10 34 34.362 78.646 619490000 156
290 P46778 5 33.8 18.565 28.503 299760000 55
291 P46779 10 48.2 15.747 42.701 110690000 38
292 P46781 19 54.1 22.591 32.938 2041100000 247
293 P46782 15 65.2 22.876 323.310 4153900000 253
294 P46783 11 55.8 18.898 113.890 1284100000 192
295 P46940 50 36.6 189.250 323.310 1770700000 458
296 P47756 10 37.2 31.350 107.990 1136100000 88
297 P47914 4 23.3 17.752 25.111 241160000 56
298 P48047 8 46 23.277 65.696 317510000 69
299 P48444 21 46.4 57.210 179.150 768790000 192
300 P48634 22 16.8 228.860 47.483 331120000 130
301 P48643 17 46.6 59.670 187.750 1066600000 180
302 P49207 4 17.9 13.293 5.429 95636000 30
303 P49327 77 45.9 273.420 323.310 3204200000 808
304 P49368 18 36.9 60.533 175.060 993560000 259
305 P49411 14 42.3 49.541 191.370 515780000 153
306 P49458 3 34.9 10.112 7.263 80500000 37
307 P49588 5 7.2 106.810 104.860 50287000 19
308 P49748 19 38.8 70.389 323.310 468630000 118
309 P49750 5 4.9 219.980 15.257 38571000 31
310 P49755 3 17.4 24.976 37.420 39568000 17
311 P50238 4 67.5 8.533 11.999 70289000 16
312 P50402 3 17.3 28.994 216.790 34475000 14
313 P50454 17 59.1 46.440 233.680 1573900000 307
314 Q8IZP2 3 15.4 27.406 6.490 32683000 14
315 P50570 70 75.3 98.063 323.310 20343000000 1669
316 P50579 3 15.3 52.891 34.101 32700000 17
317 P50750 12 34.7 42.777 56.486 143330000 61
318 P50914 6 28.4 23.432 65.684 376760000 92
319 P50990 22 51.5 59.620 235.600 825320000 205
320 P50991 19 46.8 57.924 323.310 776410000 234
321 P51114 4 9.3 69.720 55.216 63667000 24
322 P51149 11 67.6 23.489 147.950 479600000 119
323 P51571 6 48.6 18.998 50.834 138390000 62
324 P51648 4 10.1 54.847 7.621 40539000 19
325 P51659 28 55.8 79.685 275.350 1144700000 254
326 P51665 4 17.9 37.025 22.988 32455000 14
327 P51991 14 37.3 39.594 209.910 802750000 178
328 P52209 10 35.6 53.139 169.180 287100000 47
329 P52272 11 20.4 77.515 55.271 301690000 80
330 P52292 17 52.7 57.861 323.310 842040000 253
331 P52294 4 15.4 60.221 21.750 72615000 18
332 P52597 6 26 45.671 242.970 156900000 54
333 P52907 10 50.7 32.922 145.400 426940000 99
334 P52943 3 32.2 22.492 84.266 104550000 67
335 P52948 2 1.4 197.580 1.912 23363000 4
336 P53041 4 11.4 56.878 43.338 38704000 15
337 P53396 19 26.2 120.840 69.050 472830000 116
338 P53597 2 7.2 36.249 8.875 40607000 32
339 P53618 5 9 107.140 71.757 30561000 7
340 P53621 23 26.4 138.340 305.090 476710000 114
341 P53680 3 19 17.018 37.179 440370000 51
342 P54136 6 12.3 75.378 35.495 53072000 21
343 P54819 5 34.7 26.477 73.805 49632000 10
344 P54886 11 19.4 87.301 20.961 88151000 18
345 P55060 13 18.7 110.420 123.440 524020000 112
346 P55072 21 39.3 89.321 323.310 618740000 188
347 P55084 11 30.8 51.294 64.811 626580000 148
348 P55209 7 26.9 45.374 97.461 289500000 65
349 P55769 5 36.7 14.173 42.385 252340000 61
350 P55884 14 26 92.480 67.391 283130000 75
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 16 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
351 P56537 3 17.1 26.599 7.654 18635000 5
352 P58107 25 27.2 555.610 323.310 335060000 91
353 P59998 7 43.5 19.667 64.466 185550000 42
354 P60660 12 61.6 16.930 323.310 3514800000 202
355 P60842 7 19.7 46.153 25.862 75113000 47
356 P60866 6 31.9 13.373 51.404 1097700000 177
357 P60900 5 25.2 27.399 24.435 80140000 29
358 P60953 3 22 21.258 27.150 91284000 44
359 P60981 3 24.8 18.506 6.598 44977000 18
360 P61019 6 34.4 23.545 142.370 106210000 47
361 P61026 4 22 22.541 15.992 45962000 15
362 P61106 4 27.9 23.897 31.796 121670000 44
363 P61158 16 52.6 47.371 240.120 1228600000 244
364 P61160 9 33.8 44.760 119.010 266120000 56
365 P61163 4 15.7 42.613 19.816 35064000 13
366 P61221 12 28 67.314 134.180 139340000 47
367 P61247 26 67 29.945 323.310 2710900000 439
368 P61254 6 35.2 17.258 10.416 150730000 39
369 P61289 6 31.1 29.506 55.129 66755000 23
370 P61313 13 49.5 24.146 95.413 591170000 153
371 P61353 7 45.6 15.798 14.253 500700000 74
372 P61586 6 39.4 21.768 158.590 177910000 60
373 P61604 5 53.9 10.932 19.145 166810000 48
374 P61962 8 31.3 38.926 66.677 163330000 60
375 P61978 41 68 50.976 323.310 31388000000 1310
376 P61981 9 37.2 28.302 172.330 303250000 52
377 P62081 18 70.6 22.127 323.310 2352900000 314
378 P62136 13 49.7 37.512 168.490 484970000 129
379 P62140 13 52.6 37.186 20.494 150710000 30
380 P62158 5 39.6 16.837 323.310 3378600000 126
381 P62241 21 62.5 24.205 323.310 4259300000 536
382 P62244 12 69.2 14.839 175.970 1479400000 250
383 P62249 13 59.6 16.445 59.133 1685100000 323
384 P62258 6 32.9 29.174 125.750 267960000 54
385 P62263 10 43 16.273 80.918 1269500000 275
386 P62266 11 59.4 15.807 67.929 1357200000 139
387 P62269 19 67.8 17.718 105.500 2545400000 312
388 P62273 4 48.2 6.677 17.044 538490000 74
389 P62277 13 55 17.222 147.140 1676600000 260
390 P62280 16 70.3 18.431 171.270 1824400000 231
391 P62314 3 37 13.281 8.770 176190000 26
392 P62318 3 30.2 13.916 44.522 79917000 44
393 P62333 4 12.9 44.172 6.857 56132000 18
394 P62424 14 51.1 29.995 237.570 1385800000 243
395 P62495 6 18.1 49.030 45.331 151440000 59
396 P62633 8 53.1 19.463 276.890 220780000 76
397 P62701 24 72.2 29.597 323.310 2748300000 483
398 P62745 4 27 22.123 9.444 32491000 6
399 P62750 10 47.4 17.695 88.837 532600000 123
400 P62753 13 42.6 28.680 288.060 1719700000 284
401 P62805 5 38.8 11.367 18.383 164120000 71
402 P62820 7 50.7 22.677 86.546 138530000 47
403 P62826 8 38.4 24.423 27.295 124780000 50
404 P62829 9 62.1 14.865 58.205 650200000 81
405 P62834 5 36.4 20.987 18.456 160400000 36
406 P62841 6 56.6 17.040 42.598 469180000 60
407 P62847 4 29.3 15.423 22.215 567820000 67
408 P62851 9 39.2 13.742 158.340 830120000 99
409 P62854 6 39.1 13.015 49.743 784030000 127
410 P62857 7 60.9 7.841 85.956 693060000 99
411 P62861 3 20.3 6.648 4.171 342680000 51
412 P62873 6 25 37.377 11.709 48680000 17
413 P62879 6 23.8 37.331 25.713 200580000 43
414 P62888 6 58.3 12.784 232.620 647410000 80
415 P62899 4 33.6 14.463 58.387 240620000 45
416 P62906 9 49.8 24.831 246.460 383060000 129
417 P62910 4 29.6 15.860 102.650 208750000 51
418 P62913 11 63.5 20.252 130.950 568360000 156
419 P62917 12 44 28.024 94.964 505150000 132
420 P62937 7 58.2 18.012 83.876 520400000 106
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 17 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
421 P62979 6 42.9 17.965 139.260 373190000 73
422 P63010 54 57.4 104.550 323.310 6266200000 658
423 P63104 10 46.5 27.745 148.440 325780000 56
424 P63167 9 85.4 10.366 150.390 1698700000 181
425 P63173 6 57.1 8.218 173.300 583220000 116
426 P63220 6 65.1 9.111 138.900 331490000 52
427 P63244 19 75.7 35.076 323.310 2714900000 448
428 P63261 45 94.1 41.792 323.310 28604000000 1195
429 P67809 12 53.1 35.924 201.520 424690000 211
430 P67870 3 23.3 24.942 58.763 379980000 67
431 P67936 17 61.7 28.521 311.790 1081900000 161
432 P68104 23 55.2 50.140 323.310 12913000000 1034
433 P68363 26 69.2 50.151 323.310 7980800000 775
434 P68366 22 58.7 49.924 34.124 248760000 34
435 P68371 24 70.1 49.830 87.550 925750000 134
436 P68400 15 47.6 45.143 323.310 976550000 197
437 Q71DI3 4 22.1 15.388 4.177 137700000 27
438 P78344 7 10.7 102.360 57.646 102570000 60
439 P78371 23 53.1 57.488 315.460 876860000 199
440 P78527 27 9.9 469.080 137.720 259600000 78
441 P80723 10 70.5 22.693 136.130 534800000 198
442 P82979 6 31.4 23.671 147.150 100990000 53
443 P83731 8 39.5 17.779 23.803 273420000 106
444 P83881 3 21.7 12.441 3.261 110280000 31
445 P84098 8 28.1 23.466 111.630 274310000 89
446 P84103 6 44.5 19.329 33.673 183120000 69
447 P85037 11 23.2 75.456 50.733 116940000 45
448 P98179 3 37.6 17.170 35.388 115630000 38
449 P99999 11 61 11.749 42.623 460840000 108
450 Q00325 4 20.7 40.094 18.919 229700000 43
451 Q00341 5 5 141.450 101.580 44878000 27
452 Q00610 76 53.4 191.610 323.310 4071800000 889
453 Q00688 6 40.2 25.177 108.310 157140000 37
454 Q00839 27 37.5 90.583 323.310 1691300000 391
455 Q01082 60 32.6 274.610 323.310 1007100000 299
456 Q01105 10 36.9 33.488 219.530 2450600000 211
457 Q01167 7 15.5 69.061 31.239 26009000 12
458 Q01650 5 15 55.010 172.390 361800000 114
459 Q01813 33 44.9 85.595 323.310 1327300000 283
460 Q01844 4 11 68.477 144.240 332290000 108
461 Q01968 24 33.2 104.200 134.550 492950000 148
462 Q02543 11 47.7 20.762 184.270 541390000 191
463 Q02790 8 24 51.804 21.931 107420000 37
464 Q02809 9 18.6 83.549 213.290 88955000 19
465 Q02878 16 51.7 32.728 300.720 1069600000 194
466 Q02978 2 10.2 34.061 87.491 43989000 14
467 Q03013 23 81.2 25.561 323.310 1959500000 297
468 Q04637 16 15.6 175.490 271.740 424440000 153
469 Q05193 21 21.8 97.407 46.637 34511000 10
470 Q05682 10 17.2 93.230 119.840 167220000 70
471 Q06323 4 16.9 28.723 17.314 27307000 18
472 Q06830 26 95.5 22.110 323.310 5406500000 507
473 Q07020 11 45.7 21.634 267.400 852750000 199
474 Q07021 4 34 31.362 45.487 488100000 56
475 Q07065 11 25.6 66.022 299.920 164370000 73
476 Q07666 17 36.6 48.227 323.310 7193700000 554
477 Q07955 11 47.6 27.744 12.777 103450000 35
478 Q08211 27 29.8 140.960 204.330 683490000 233
479 Q08945 5 9.4 81.074 29.226 45470000 12
480 Q08J23 9 20.1 86.470 27.529 91181000 20
481 Q10471 10 23.8 64.732 281.580 286030000 88
482 Q10589 1 8.3 19.769 61.655 42801000 13
483 Q12788 14 23.9 89.034 232.430 190470000 54
484 Q12797 7 12.8 85.862 136.630 73401000 26
485 Q12874 2 5 58.848 4.521 35236000 5
486 Q12905 7 26.7 43.062 30.825 229770000 46
487 Q12906 9 15.4 95.337 61.042 119500000 50
488 Q12907 6 22.2 40.228 13.617 56635000 27
489 Q12965 49 46.5 127.060 323.310 2155700000 569
490 Q13011 3 12.8 35.816 44.915 109620000 20
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 18 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
491 Q13148 5 18.1 44.739 101.070 140570000 34
492 Q13151 7 33.8 30.840 53.817 154700000 37
493 Q13155 3 23.1 35.348 11.884 85371000 37
494 Q13162 4 14.8 30.540 4.811 53481000 25
495 Q13185 4 21.9 20.811 11.468 22805000 13
496 Q13247 5 16.3 39.586 10.933 67664000 32
497 Q13263 16 34.9 88.549 190.340 494920000 221
498 Q13283 10 37.1 52.164 69.528 361590000 116
499 Q13310 16 29.7 70.782 65.730 88904000 39
500 Q13347 8 35.7 36.501 17.485 167290000 42
501 Q13428 10 8.7 152.100 19.015 216300000 24
502 Q13435 12 17.1 100.230 116.770 180990000 81
503 Q13442 10 37.6 20.630 323.310 217940000 66
504 Q13443 23 30.9 90.555 305.470 638070000 224
505 Q13501 16 45.2 47.687 323.310 1287900000 336
506 Q13573 9 21.6 61.494 26.240 132510000 51
507 Q13619 4 6.2 87.679 65.679 32977000 14
508 Q13724 5 12.2 91.916 16.750 148450000 17
509 Q13813 70 35.8 284.540 323.310 1350300000 394
510 Q14103 6 18 38.434 73.952 299750000 80
511 Q14152 12 10.5 166.570 63.839 99292000 28
512 Q14157 5 8.6 114.530 175.200 118120000 47
513 Q14204 14 4.9 532.400 31.428 164310000 37
514 Q14444 13 23.1 78.365 139.850 840010000 174
515 Q14566 7 10.2 92.888 12.180 63346000 29
516 Q14678 15 19.2 147.290 323.310 258460000 92
517 Q14683 8 9.3 143.230 34.952 101010000 34
518 Q14697 13 21.3 106.870 39.964 230930000 43
519 Q14847 4 15.7 29.717 87.071 69398000 35
520 Q14974 21 35.2 97.169 190.310 993950000 127
521 Q14978 14 27.8 73.602 186.710 1128900000 141
522 Q15019 8 33.8 41.487 89.892 132770000 51
523 Q15029 16 22.7 109.430 24.911 166160000 44
524 Q15041 2 11.8 23.362 19.369 128290000 37
525 Q15046 9 22.8 68.047 29.706 149300000 40
526 Q15056 10 52 27.385 59.036 765050000 99
527 Q15084 6 20.9 48.121 48.188 81389000 30
528 Q15125 1 7 26.352 28.585 109770000 12
529 Q15149 136 36.3 531.780 323.310 1965600000 692
530 Q15233 21 43.5 54.231 323.310 4461200000 222
531 Q15286 1 7 23.025 22.014 22378000 10
532 Q15293 5 22.1 38.890 90.859 210780000 78
533 Q15365 9 48.3 37.497 216.470 578160000 122
534 Q15366 8 35.3 38.580 27.933 445930000 114
535 Q15393 17 23.7 135.580 131.380 342150000 85
536 Q15427 4 19.6 44.385 134.770 208880000 40
537 Q15436 4 7.2 86.160 50.974 40846000 16
538 Q15459 5 9.5 88.885 13.189 91054000 22
539 Q15637 6 9.9 68.329 15.623 179000000 53
540 Q15645 5 19.2 48.550 23.338 83231000 16
541 Q15717 4 18.7 36.091 29.908 50016000 20
542 Q15758 2 5.5 56.598 28.651 52899000 17
543 Q15907 8 48.6 24.488 25.795 193330000 66
544 Q16181 10 29.3 50.679 199.410 117500000 36
545 Q16527 4 34.2 20.954 18.147 51445000 19
546 Q16576 7 33.4 47.820 25.260 197500000 57
547 Q16630 7 15.4 59.209 69.970 312480000 35
548 Q16881 10 25.9 70.905 48.899 210350000 43
549 Q16891 9 21 83.677 31.069 75403000 21
550 Q2TAY7 8 25.9 57.543 24.074 96476000 37
551 Q52LJ0 5 20.6 37.190 25.182 158330000 25
552 Q53H96 14 63.1 28.663 160.240 1102500000 161
553 Q58FF8 11 22 44.348 78.148 868820000 102
554 Q5JTV8 3 8.9 66.248 3.763 29495000 9
555 Q66PJ3 2 8.3 44.915 80.987 10761000 8
556 Q6P1N0 4 6 104.060 17.493 49763000 24
557 Q6P2Q9 10 6.7 273.600 91.488 126730000 28
558 Q6PI48 4 7.9 73.562 4.080 277460000 13
559 Q6PKG0 5 7.4 123.510 12.355 32384000 15
560 Q6SPF0 8 22.1 56.051 46.741 67417000 36
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 19 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
561 Q6UB35 7 10.3 105.790 4.520 58568000 9
562 Q6XZF7 19 19.3 177.350 65.620 133790000 49
563 Q6YN16 7 22.5 45.394 145.570 121150000 45
564 Q70E73 4 5 135.250 21.743 66208000 29
565 Q7KZF4 72 82.4 102.000 323.310 18824000000 1860
566 Q7L014 7 8.2 117.360 14.278 47383000 21
567 Q7Z2W4 8 16.3 101.430 71.216 70174000 38
568 Q7Z417 3 6.6 76.120 43.661 36980000 20
569 Q86UE4 5 13.6 63.836 36.324 40727000 11
570 Q86V81 8 42 26.888 175.770 595180000 95
571 Q86VP6 12 14.9 136.370 106.850 166750000 49
572 Q8IUD2 5 6.1 128.080 34.404 47809000 8
573 Q8IVH8 13 22.9 101.310 84.020 160490000 70
574 Q8N163 30 45 102.900 283.430 609920000 188
575 Q8N684 11 29.9 52.049 257.100 1322800000 144
576 Q8NBI5 1 3.1 54.528 36.325 10497000 8
577 Q8NBJ5 10 22.8 71.635 81.025 284630000 76
578 Q8NC51 21 52.9 44.965 323.310 3803000000 397
579 Q8NCA5 9 20.4 55.400 147.450 485610000 82
580 Q8NE71 3 5.3 95.925 4.142 23317000 6
581 Q8TF74 25 68.9 46.288 274.710 1616500000 490
582 Q8WUM4 7 12.2 96.022 210.230 65845000 35
583 Q8WVK2 1 10.3 18.860 6.501 7749900 2
584 Q8WXF1 12 23.1 58.743 94.330 563770000 114
585 Q8WXH0 2 0.3 796.430 1.823 6704900000 442
586 Q92499 16 29.9 82.431 170.350 571810000 120
587 Q92598 13 21.7 96.864 230.240 162830000 44
588 Q92616 11 6.7 292.750 87.591 91875000 29
589 Q92688 10 31.9 28.787 103.590 389030000 86
590 Q92841 21 33.2 80.272 323.310 673930000 219
591 Q92889 13 20 104.480 145.050 366980000 58
592 Q92896 9 10.6 134.550 123.290 117540000 41
593 Q92900 4 5 124.340 3.650 33164000 7
594 Q92917 4 18.9 52.228 75.251 32973000 17
595 Q92945 18 32.6 73.114 129.370 459480000 201
596 Q92973 13 19.8 102.350 190.250 177420000 74
597 Q92979 6 29.5 26.720 49.056 159350000 66
598 Q93009 12 17.6 128.300 36.021 199700000 70
599 Q96AE4 13 21.4 67.560 260.720 389960000 133
600 Q96AG4 12 49.2 34.930 205.830 846960000 251
601 Q96C36 5 27.8 33.637 69.619 165550000 29
602 Q96CW1 33 71.5 49.654 323.310 2354700000 412
603 Q96D46 2 6.2 57.603 9.074 17731000 16
604 Q96EP5 4 16.7 43.383 84.802 120650000 41
605 Q96EV2 7 10.6 129.980 35.863 104060000 44
606 Q96EY1 4 12.7 52.488 37.933 189820000 22
607 Q96EY5 3 18.3 28.783 22.853 64044000 22
608 Q96GD4 10 33.1 39.310 18.171 33076000 16
609 Q96HC4 13 33.1 63.944 125.150 296470000 149
610 Q96HR8 4 14 53.716 56.979 98823000 34
611 Q96IX5 3 44.8 6.458 79.268 23894000 12
612 Q96IZ0 5 25.9 36.567 40.284 36303000 16
613 Q96J02 6 6.9 102.800 11.165 71996000 32
614 Q96PK6 6 12.4 69.491 21.527 87407000 31
615 Q96S19 14 90.7 22.578 287.050 743260000 156
616 Q96T88 10 15.6 89.813 117.660 61574000 27
617 Q99613 11 16.3 105.340 117.020 105230000 53
618 Q99615 8 18.2 56.440 12.575 69466000 28
619 Q99623 13 48.2 33.296 184.700 729650000 147
620 Q99700 5 6.6 140.280 4.053 26861000 6
621 Q99714 10 62.1 26.923 197.380 610360000 95
622 Q99729 4 13.3 36.224 23.761 196350000 53
623 Q99816 5 20.5 43.944 9.695 51821000 15
624 Q99832 21 48.8 59.366 238.390 1212500000 171
625 Q99873 5 18 41.515 18.141 30781000 13
626 Q9BQE3 25 69.5 49.895 53.412 292770000 43
627 Q9BR76 11 27.4 54.234 20.673 183870000 40
628 Q9BRP8 5 35.3 22.655 42.299 43977000 14
629 Q9BSJ8 5 6.8 122.850 9.889 43136000 13
630 Q9BTT0 2 10.1 30.692 6.863 38126000 11
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Supplementary Table A: All identified proteins from SNX9 pull-down experiments, post-
filtering. Prepared by Daniel Yagoub. Part 20 of 20. 
# Uniprot Peptides
Sequence 
coverage 
[%]
Mol. 
weight 
[kDa]
Score Intensity
MS/MS 
Count
631 Q9BVK6 2 11.1 27.277 3.252 35685000 15
632 Q9BXS5 5 19.6 48.586 11.756 66811000 17
633 Q9BY44 18 46.5 64.989 140.200 410580000 147
634 Q9BY77 5 20 46.089 18.032 168160000 30
635 Q9BZE4 4 7.4 73.964 6.908 39952000 9
636 Q9BZZ5 6 20.4 59.004 54.697 333830000 27
637 Q9GZT3 7 78 12.349 60.677 439620000 92
638 Q9H0D6 7 11.8 108.580 14.256 83368000 30
639 Q9H307 6 10 81.613 27.306 131610000 22
640 Q9H6R4 5 8.1 127.590 39.732 38389000 10
641 Q9H8H3 3 17.2 28.319 14.761 35042000 25
642 Q9H910 4 32.1 20.063 34.907 47982000 28
643 Q9H9B4 5 25.8 35.619 60.373 76008000 34
644 Q9HAH7 4 13.3 48.388 183.100 113220000 49
645 Q9HAV7 10 46.1 24.279 118.330 922940000 150
646 Q9HB71 11 59.2 26.210 233.850 1088300000 153
647 Q9HBH1 5 33.7 27.013 19.837 45527000 8
648 Q9HC36 6 17.4 47.019 12.680 92480000 15
649 Q9NPJ3 3 25 14.960 16.921 137200000 50
650 Q9NQC3 6 10.4 129.930 101.560 106440000 40
651 Q9NQW6 10 14.7 124.200 91.986 99396000 43
652 Q9NR30 25 37 87.343 252.540 496110000 138
653 Q9NRX1 3 19.8 27.924 15.552 42550000 9
654 Q9NSC5 7 23 39.836 21.712 65144000 15
655 Q9NSD9 11 22.9 66.115 25.691 124530000 32
656 Q9NUI1 20 71.2 30.777 153.210 813900000 173
657 Q9NW64 2 5.2 46.895 2.859 23784000 11
658 Q9NZB2 8 11 121.890 143.720 57244000 15
659 Q9NZM1 7 4.8 234.710 25.691 118600000 23
660 Q9P0L0 5 16.9 27.893 48.665 79225000 41
661 Q9P258 18 46 56.084 323.310 723790000 223
662 Q9P289 3 10.8 46.528 10.659 30447000 14
663 Q9UHD8 7 17.1 65.401 20.503 61070000 37
664 Q9UHX1 6 17.7 59.875 14.507 93008000 43
665 Q9UK41 2 14.9 25.425 10.779 25797000 17
666 Q9UKV8 6 8.6 97.207 20.887 37263000 11
667 Q9UKY7 3 33.3 27.335 20.657 36761000 13
668 Q9UL46 2 11.3 27.401 10.927 45277000 21
669 Q9ULV4 22 42 53.248 323.310 1970300000 250
670 Q9UMS4 9 31.2 55.180 41.954 279190000 117
671 Q9UQ35 26 10.8 299.610 323.310 3997900000 512
672 Q9UQ80 21 61.9 43.786 323.310 1024500000 267
673 Q9UQE7 11 13.2 141.540 172.760 100360000 36
674 Q9Y224 10 54.5 28.068 104.360 652420000 99
675 Q9Y230 11 32.4 51.156 27.254 167930000 69
676 Q9Y237 2 10.7 13.810 9.554 57700000 20
677 Q9Y262 7 15.2 66.726 323.310 93413000 39
678 Q9Y265 10 29.8 50.227 22.692 147940000 32
679 Q9Y2S6 2 37.5 7.066 17.672 32973000 6
680 Q9Y2X3 5 11.9 59.578 9.651 44104000 17
681 Q9Y2Z4 6 21.2 53.198 35.820 74157000 38
682 Q9Y383 7 24.2 46.513 153.020 210100000 78
683 Q9Y3B4 2 22.4 14.585 14.416 29412000 17
684 Q9Y3E5 2 18.4 19.193 85.302 28320000 8
685 Q9Y3F4 7 27.1 38.438 230.300 69153000 54
686 Q9Y3I0 8 26.9 55.210 196.510 202450000 60
687 Q9Y3U8 2 10.5 12.254 5.469 145360000 37
688 Q9Y4U1 5 27.7 31.728 20.680 222040000 64
689 Q9Y5X1 77 88.1 66.591 323.310 356020000000 9182
690 Q9Y678 6 9.6 97.717 29.765 82180000 22
691 Q9Y6E2 6 16.9 48.162 86.300 78166000 21
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Supplementary Table B: Proteins identified as showing specific binding to wild-type SNX9 
(relative to GST-only control). Prepared by Daniel Yagoub. 
Uniprot GST GST GST WT WT WT
Average 
GST 
intensity
Average 
WT 
intensity
Std Dev 
GST
Std Dev 
WT
T-test test 
statistic 
GST_WT
T-test
p-value
Difference 
GST_WT
P50570 21.056 20.418 20.538 29.775 30.190 30.342 20.671 30.102 0.339 0.293 -4.175 0.000 -9.432
O43516 20.022 19.697 20.264 26.157 26.241 26.486 19.994 26.295 0.285 0.171 -2.875 0.000 -6.301
P25786 20.169 20.313 20.246 23.825 23.637 24.020 20.243 23.827 0.072 0.192 -1.692 0.000 -3.585
P61978 27.191 26.899 27.362 31.712 31.469 31.866 27.151 31.683 0.234 0.200 -2.081 0.000 -4.532
Q01968 20.101 20.211 20.673 25.531 25.093 25.733 20.329 25.452 0.304 0.327 -2.269 0.000 -5.124
Q8TF74 20.481 19.453 20.380 27.088 26.845 27.300 20.105 27.078 0.567 0.228 -2.964 0.000 -6.973
O14965 21.318 21.104 20.861 27.493 26.651 26.722 21.094 26.955 0.229 0.467 -2.548 0.000 -5.861
O75909 20.680 19.730 19.934 26.230 26.418 26.909 20.115 26.519 0.500 0.351 -2.722 0.000 -6.404
Q07666 22.324 23.499 23.269 29.285 29.285 29.205 23.031 29.259 0.623 0.046 -2.638 0.000 -6.228
O95782 21.166 22.251 21.838 29.252 28.235 29.061 21.752 28.849 0.548 0.541 -2.904 0.000 -7.098
Q7KZF4 26.365 26.729 27.056 30.149 30.315 29.996 26.717 30.153 0.346 0.160 -1.548 0.000 -3.436
P63010 21.150 20.026 20.754 28.800 27.541 28.319 20.643 28.220 0.570 0.635 -3.040 0.000 -7.577
O43426 20.141 21.150 20.672 24.696 24.822 24.641 20.655 24.719 0.505 0.093 -1.770 0.000 -4.065
Q96CW1 20.490 21.379 20.634 27.030 25.999 26.904 20.834 26.644 0.477 0.562 -2.395 0.000 -5.810
O60885 20.918 21.356 20.139 25.937 25.915 25.538 20.805 25.796 0.616 0.224 -2.099 0.000 -4.992
P04075 21.591 21.994 20.552 28.021 27.323 28.192 21.379 27.845 0.744 0.461 -2.581 0.000 -6.466
O00401 20.077 19.687 21.818 28.998 28.745 29.014 20.528 28.919 1.135 0.151 -3.154 0.000 -8.392
Q13443 20.137 18.986 20.350 25.284 25.961 25.807 19.824 25.684 0.734 0.355 -2.372 0.000 -5.860
Q9NUI1 20.547 19.622 21.289 25.437 25.233 25.700 20.486 25.456 0.835 0.234 -1.987 0.001 -4.970
P23246 23.585 25.015 24.616 29.148 28.778 29.656 24.405 29.194 0.738 0.441 -1.918 0.001 -4.789
Q92889 19.765 19.375 20.630 23.705 23.751 23.308 19.923 23.588 0.642 0.244 -1.529 0.001 -3.665
P48634 21.443 19.892 21.151 25.589 25.119 25.335 20.829 25.348 0.824 0.235 -1.811 0.001 -4.519
P53680 19.551 20.479 20.129 24.608 23.450 24.458 20.053 24.172 0.469 0.630 -1.679 0.001 -4.119
O15056 19.931 19.598 19.941 23.576 23.858 22.622 19.823 23.352 0.195 0.648 -1.476 0.001 -3.529
Q9HC36 19.474 19.338 19.772 22.503 21.666 22.427 19.528 22.198 0.222 0.463 -1.163 0.001 -2.671
O14874 19.237 18.659 20.502 24.349 24.198 24.376 19.466 24.307 0.943 0.096 -1.901 0.001 -4.841
Q9Y5X1 22.843 25.412 20.943 34.019 34.024 34.418 23.066 34.154 2.243 0.229 -3.358 0.001 -11.088
P52209 20.793 20.696 19.489 24.509 23.860 24.587 20.326 24.319 0.726 0.399 -1.611 0.001 -3.993
Q70E73 20.736 19.898 19.690 22.787 23.311 23.046 20.108 23.048 0.554 0.262 -1.249 0.001 -2.940
P48444 21.489 19.254 20.511 25.483 25.784 25.952 20.418 25.740 1.121 0.237 -2.000 0.001 -5.322
Q9UQ35 22.781 23.173 24.300 26.999 27.487 27.727 23.418 27.404 0.789 0.371 -1.592 0.001 -3.986
P26639 20.288 21.561 20.631 24.935 24.141 25.352 20.827 24.809 0.658 0.616 -1.580 0.002 -3.983
O43865 20.217 21.155 21.367 23.836 24.502 23.713 20.913 24.017 0.612 0.424 -1.277 0.002 -3.104
P19784 20.674 18.822 19.584 24.444 25.891 24.362 19.694 24.899 0.931 0.860 -1.906 0.002 -5.206
O15143 21.069 19.406 20.127 23.939 23.715 23.514 20.201 23.723 0.834 0.212 -1.411 0.002 -3.522
P33992 20.201 20.991 21.438 23.366 23.924 23.891 20.877 23.727 0.627 0.313 -1.186 0.002 -2.850
O94973 21.946 19.182 19.843 26.877 25.948 26.597 20.324 26.474 1.443 0.477 -2.137 0.002 -6.150
Q8IVH8 20.881 19.625 21.082 24.124 23.588 24.333 20.529 24.015 0.790 0.384 -1.390 0.002 -3.486
O43809 23.584 24.290 24.871 27.025 26.521 26.959 24.248 26.835 0.645 0.274 -1.076 0.003 -2.587
Q96EV2 20.854 19.317 20.229 23.852 23.838 22.920 20.133 23.536 0.773 0.534 -1.339 0.003 -3.403
Q8NBJ5 20.571 19.399 20.961 23.913 22.997 24.063 20.311 23.658 0.813 0.577 -1.300 0.004 -3.347
Q9HAH7 20.509 19.740 20.170 22.596 23.915 22.567 20.140 23.026 0.385 0.770 -1.156 0.004 -2.887
Q15233 24.171 25.960 25.434 28.440 28.370 29.330 25.188 28.713 0.919 0.535 -1.348 0.005 -3.525
P63104 23.017 21.761 21.831 25.000 24.740 24.420 22.203 24.720 0.706 0.290 -1.031 0.005 -2.516
P61962 20.783 20.366 20.418 22.848 24.458 23.089 20.523 23.465 0.227 0.868 -1.168 0.005 -2.942
Q6XZF7 20.111 20.293 20.667 23.286 24.386 22.611 20.357 23.428 0.283 0.896 -1.208 0.005 -3.070
P25440 19.697 19.516 21.041 25.801 25.965 23.629 20.085 25.131 0.833 1.304 -1.744 0.005 -5.047
P85037 19.635 19.408 20.356 22.342 23.994 22.677 19.800 23.004 0.495 0.873 -1.242 0.005 -3.205
Q8WXF1 19.900 21.449 19.890 25.905 24.018 26.679 20.413 25.534 0.897 1.369 -1.739 0.006 -5.121
P68400 21.128 22.369 19.686 25.248 26.047 24.918 21.061 25.404 1.343 0.580 -1.527 0.007 -4.343
P34932 21.271 20.603 19.403 24.487 23.076 24.937 20.426 24.166 0.947 0.971 -1.344 0.009 -3.741
P40939 21.755 23.121 23.852 25.742 25.757 26.128 22.910 25.876 1.064 0.219 -1.129 0.009 -2.966
Q8N684 20.130 23.656 23.035 27.010 27.102 27.263 22.273 27.125 1.882 0.128 -1.570 0.011 -4.852
Q15427 20.484 19.324 21.849 23.948 23.410 24.783 20.553 24.047 1.264 0.692 -1.234 0.014 -3.494
A1X283 21.702 19.844 22.033 24.040 23.887 24.276 21.193 24.068 1.180 0.196 -1.069 0.014 -2.875
P39687 20.455 23.479 20.071 25.911 25.296 26.038 21.335 25.748 1.866 0.397 -1.423 0.016 -4.413
Q8NCA5 20.678 23.108 20.010 24.728 24.825 25.146 21.265 24.900 1.631 0.219 -1.232 0.019 -3.634
Q14697 21.242 19.434 21.839 24.141 23.167 24.459 20.839 23.922 1.252 0.674 -1.093 0.020 -3.084
Q01105 20.586 24.617 20.263 26.829 26.722 27.248 21.822 26.933 2.426 0.278 -1.499 0.022 -5.111
Q8N163 20.385 21.598 23.120 25.510 23.995 24.879 21.701 24.794 1.371 0.761 -1.065 0.027 -3.093
P55072 20.694 18.606 23.139 25.035 24.699 25.069 20.813 24.934 2.269 0.204 -1.243 0.035 -4.121
Q12965 20.145 25.849 19.411 27.904 27.168 27.561 21.801 27.544 3.524 0.369 -1.419 0.048 -5.743
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Supplementary Table C: DAVID functional clustering of specific SNX9-interacting 
proteins (biological processes: BP; cellular compartment: CC; molecular function: MF). 
Prepared by Daniel Yagoub. Part 1 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
CC
GO:0030666 endocytic 
vesicle membrane
7 11.290 0.000
O94973, P50570, O95782, 
P63010, P53680, Q96CW1, 
O00401
61 8 687 9.855 0.001 0.001 0.010
CC
GO:0030122 AP-2 adaptor 
complex
5 8.065 0.000
O94973, O95782, P63010, 
P53680, Q96CW1
61 5 687 11.262 0.040 0.020 0.300
MF
GO:0035615 clathrin 
adaptor activity
5 8.065 0.000
O94973, O95782, P63010, 
P53680, Q96CW1
62 5 681 10.984 0.044 0.044 0.332
BP
GO:0048013 ephrin 
receptor signaling pathway
7 11.290 0.001
O94973, O15143, O95782, 
P63010, P53680, Q96CW1, 
O00401
59 16 677 5.020 0.421 0.239 1.749
CC
GO:0036020 endolysosome 
membrane
5 8.065 0.002
O94973, O95782, P63010, 
P53680, Q96CW1
61 7 687 8.044 0.219 0.079 1.819
BP
GO:0050690 regulation of 
defense response to virus 
by virus
5 8.065 0.003
O94973, O95782, P63010, 
P53680, Q96CW1
59 8 677 7.172 0.684 0.319 3.650
BO
GO:0072583 clathrin-
mediated endocytosis
5 8.065 0.003
O94973, O95782, P63010, 
P53680, Q96CW1
59 8 677 7.172 0.684 0.319 3.650
BO
GO:0007018 microtubule-
based movement
5 8.065 0.003
O94973, O95782, P63010, 
P53680, Q96CW1
59 8 677 7.172 0.684 0.319 3.650
CC
GO:0030669 clathrin-
coated endocytic vesicle 
membrane
5 8.065 0.003
O94973, O95782, P63010, 
P53680, Q96CW1
61 8 687 7.039 0.370 0.109 3.375
BP
GO:0042059 negative 
regulation of epidermal 
growth factor receptor 
signaling pathway
5 8.065 0.004
O94973, O95782, P63010, 
P53680, Q96CW1
59 9 677 6.375 0.857 0.277 6.078
BP
GO:0019886 antigen 
processing and 
presentation of exogenous 
peptide antigen via MHC 
class II
6 9.677 0.008
O94973, P50570, O95782, 
P63010, P53680, Q96CW1
59 16 677 4.303 0.972 0.400 10.910
BP
GO:0006886 intracellular 
protein transport
7 11.290 0.022
O94973, Q9Y5X1, P48444, 
O95782, P63010, P53680, 
Q96CW1
59 27 677 2.975 1.000 0.618 26.715
CC
GO:0030117 membrane 
coat
4 6.452 0.026
O94973, O43426, P63010, 
P53680
61 8 687 5.631 0.986 0.457 27.186
BP
GO:0060071 Wnt signaling 
pathway, planar cell 
polarity pathway
6 9.677 0.054
P25786, O94973, O95782, 
P63010, P53680, Q96CW1
59 25 677 2.754 1.000 0.783 54.534
MF
GO:0008565 protein 
transporter activity
4 6.452 0.084
O94973, O95782, P63010, 
P53680
62 12 681 3.661 1.000 0.836 65.497
CC
GO:0030131 clathrin 
adaptor complex
3 4.839 0.090 O94973, P63010, Q96CW1 61 6 687 5.631 1.000 0.817 67.888
BP
GO:0016192 vesicle-
mediated transport
4 6.452 0.194
O94973, P63010, P53680, 
Q96CW1
59 18 677 2.550 1.000 0.986 95.279
CC
GO:0005886 plasma 
membrane
12 19.355 0.497
O15056, O94973, P50570, 
Q9Y5X1, O95782, Q70E73, 
Q01968, P63010, P68400, 
P53680, Q96CW1, O00401
61 121 687 1.117 1.000 0.999 99.976
Annotation Cluster 1
Enrichment Score: 2.242
Supplementary Table C: DAVID functional clustering of specific SNX9-interacting 
proteins (biological processes: BP; cellular compartment: CC; molecular function: MF). 
Prepared by Daniel Yagoub. Part 2 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
BP GO:0006897 endocytosis 6 9.677 0.001
Q12965, P50570, O43516, 
Q9Y5X1, O95782, Q8TF74
59 11 677 6.259 0.411 0.411 1.692
BP
GO:0030048 actin filament-
based movement
3 4.839 0.039 Q12965, O43516, Q8TF74 59 4 677 8.606 1.000 0.684 42.748
MF
GO:0051015 actin filament 
binding
4 6.452 0.288
Q12965, O15143, O43516, 
Q8TF74
62 21 681 2.092 1.000 0.963 98.394
Annotation Cluster 2
Enrichment Score: 1.624
Supplementary Table C 
193
Supplementary Table C: DAVID functional clustering of specific SNX9-interacting 
proteins (biological processes: BP; cellular compartment: CC; molecular function: MF). 
Prepared by Daniel Yagoub. Part 3 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
BP
GO:0046856 
phosphatidylinositol 
dephosphorylation
3 4.839 0.020 O15056, O43426, Q01968 59 3 677 11.475 1.000 0.635 25.348
MF
GO:0004439 
phosphatidylinositol-4,5-
bisphosphate 5-
phosphatase activity
3 4.839 0.022 O15056, O43426, Q01968 62 3 681 10.984 0.976 0.606 23.983
BP
GO:0006661 
phosphatidylinositol 
biosynthetic process
3 4.839 0.039 O15056, O43426, Q01968 59 4 677 8.606 1.000 0.684 42.748
Annotation Cluster 3
Enrichment Score: 1.584
Supplementary Table C: DAVID functional clustering of specific SNX9-interacting 
proteins (biological processes: BP; cellular compartment: CC; molecular function: MF). 
Prepared by Daniel Yagoub.  Part 4 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
BP
GO:0006468 protein 
phosphorylation
6 9.677 0.004
P19784, Q8IVH8, O75909, 
P68400, O14965, O14874
59 14 677 4.918 0.847 0.313 5.868
MF
GO:0004674 protein 
serine/threonine kinase 
activity
6 9.677 0.005
P19784, Q8IVH8, O75909, 
P68400, O14965, O14874
62 14 681 4.707 0.578 0.350 6.150
MF
GO:0004672 protein kinase 
activity
4 6.452 0.052
P19784, Q8IVH8, P68400, 
O14965
62 10 681 4.394 1.000 0.770 47.752
MF GO:0016301 kinase activity 4 6.452 0.122
Q8IVH8, P68400, O14874, 
P63104
62 14 681 3.138 1.000 0.884 79.453
BP
GO:1901796 regulation of 
signal transduction by p53 
class mediator
3 4.839 0.145 P19784, P68400, O14965 59 8 677 4.303 1.000 0.961 88.996
MF GO:0005524 ATP binding 10 16.129 0.808
P19784, P33992, P34932, 
Q12965, P26639, Q8IVH8, 
P68400, O14965, O14874, 
P55072
62 123 681 0.893 1.000 1.000 100.000
Annotation Cluster 4
Enrichment Score: 1.297
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Supplementary Table C: DAVID functional clustering of specific SNX9-interacting proteins 
(biological processes: BP; cellular compartment: CC; molecular function: MF). Prepared by 
Daniel Yagoub. Part 5 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
BP
GO:0045892 negative 
regulation of transcription, 
DNA-templated
7 11.290 0.010
Q15233, Q01105, Q07666, 
P85037, Q8N163, P23246, 
Q8WXF1
59 23 677 3.492 0.986 0.415 12.921
CC GO:0042382 paraspeckles 4 6.452 0.010
Q15233, P23246, O43809, 
Q8WXF1
61 6 687 7.508 0.821 0.291 11.989
MF
GO:0000976 transcription 
regulatory region 
sequence-specific DNA 
binding
3 4.839 0.022 Q15233, P23246, Q8WXF1 62 3 681 10.984 0.976 0.606 23.983
BP
GO:0042752 regulation of 
circadian rhythm
4 6.452 0.025
Q15233, Q8N163, P23246, 
Q8WXF1
59 8 677 5.737 1.000 0.628 29.596
BP
GO:0048511 rhythmic 
process
4 6.452 0.035
Q8N163, P23246, P68400, 
Q8WXF1
59 9 677 5.100 1.000 0.694 39.181
BP
GO:0006397 mRNA 
processing
6 9.677 0.093
Q15233, Q15427, Q07666, 
Q8N163, P23246, O43809
59 29 677 2.374 1.000 0.895 74.850
MF
GO:0001047 core promoter 
binding
3 4.839 0.094 Q15233, P23246, Q8WXF1 62 6 681 5.492 1.000 0.835 69.670
CC GO:0016363 nuclear matrix 4 6.452 0.157
Q15233, P61962, P23246, 
Q8WXF1
61 16 687 2.816 1.000 0.920 87.337
MF
GO:0000166 nucleotide 
binding
8 12.903 0.269
Q15233, O15056, Q15427, 
Q96EV2, Q8N684, O43426, 
P23246, Q8WXF1
62 59 681 1.489 1.000 0.961 97.776
BP GO:0008380 RNA splicing 4 6.452 0.314
Q15233, Q15427, Q8N163, 
P23246
59 23 677 1.996 1.000 0.998 99.516
Annotation Cluster 5
Enrichment Score: 1.265
Supplementary Table C: DAVID functional clustering of specific SNX9-interacting 
proteins (biological processes: BP; cellular compartment: CC; molecular function: MF). 
Prepared by Daniel Yagoub. Part 6 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
BP
GO:0038096 Fc-gamma 
receptor signaling pathway 
involved in phagocytosis
4 6.452 0.092
O15143, O43516, Q8TF74, 
O00401
59 13 677 3.531 1.000 0.905 74.459
CC
GO:0015629 actin 
cytoskeleton
6 9.677 0.124
Q12965, P26639, O15143, 
P04075, O43516, O00401
61 31 687 2.180 1.000 0.885 79.981
MF
GO:0051015 actin filament 
binding
4 6.452 0.288
Q12965, O15143, O43516, 
Q8TF74
62 21 681 2.092 1.000 0.963 98.394
Annotation Cluster 6
Enrichment Score: 0.827
Supplementary Table C: DAVID functional clustering of specific SNX9-interacting 
proteins (biological processes: BP; cellular compartment: CC; molecular function: MF). 
Prepared by Daniel Yagoub. Part 7 of 7. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
BP
GO:0098609 cell-cell 
adhesion
5 8.065 0.951
Q7KZF4, P04075, Q9Y5X1, 
P61978, P63104
59 85 677 0.67497508 1.000 1.000 100.000
CC
GO:0005913 cell-cell 
adherens junction
5 8.065 0.971
Q7KZF4, P04075, Q9Y5X1, 
P61978, P63104
61 91 687 0.61880742 1.000 1.000 100.000
MF
GO:0098641 cadherin 
binding involved in cell-
cell adhesion
5 8.065 0.976
Q7KZF4, P04075, Q9Y5X1, 
P61978, P63104
62 91 681 0.60350939 1.000 1.000 100.000
Annotation Cluster 7
Enrichment Score: 0.015
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Supplementary Table D: Proteins identified as showing reduced binding to SNX9-
Y56E relative to wild-type SNX9. Prepared by Daniel Yagoub. 
Uniprot WT WT WT Y56E Y56E Y56E
Average 
WT 
intensity
Average 
Y56E 
intensity
Std Dev 
WT
Std Dev 
Y56E
T-test test 
statistic 
WT_Y56E
T-test
p-value
Difference 
WT_Y56E
O43516 26.157 26.241 26.486 19.495 19.796 19.843 26.295 19.711 0.171 0.189 3.066 0.000 6.584
O00401 28.998 28.745 29.014 20.110 19.970 19.467 28.919 19.849 0.151 0.338 4.097 0.000 9.070
Q07666 29.285 29.285 29.205 23.517 23.949 23.918 29.259 23.795 0.046 0.241 2.551 0.000 5.464
P61978 31.712 31.469 31.866 27.309 27.292 27.666 31.683 27.423 0.200 0.211 1.965 0.000 4.260
O75909 26.230 26.418 26.909 19.384 20.261 19.748 26.519 19.798 0.351 0.441 2.891 0.000 6.721
Q8TF74 27.088 26.845 27.300 19.479 18.396 19.590 27.078 19.155 0.228 0.659 3.297 0.000 7.923
P50570 29.775 30.190 30.342 21.323 19.017 21.312 30.102 20.551 0.293 1.328 3.429 0.000 9.552
Q13443 25.284 25.961 25.807 19.475 19.043 20.657 25.684 19.725 0.355 0.836 2.361 0.000 5.959
Q8IVH8 24.124 23.588 24.333 20.573 19.859 20.633 24.015 20.355 0.384 0.430 1.569 0.000 3.660
Q8N684 27.010 27.102 27.263 23.259 24.351 23.753 27.125 23.788 0.128 0.547 1.436 0.001 3.337
O60885 25.937 25.915 25.538 20.569 21.671 19.861 25.796 20.700 0.224 0.912 2.005 0.001 5.096
O43426 24.696 24.822 24.641 20.196 21.441 20.016 24.719 20.551 0.093 0.776 1.700 0.001 4.168
O00750 22.539 22.032 23.152 19.266 19.291 19.695 22.575 19.417 0.561 0.241 1.342 0.001 3.157
Q01968 25.531 25.093 25.733 20.502 19.269 21.353 25.452 20.375 0.327 1.048 1.928 0.001 5.078
P48634 25.589 25.119 25.335 20.536 21.531 19.332 25.348 20.467 0.235 1.101 1.842 0.002 4.881
P23246 29.148 28.778 29.656 26.186 25.514 26.685 29.194 26.128 0.441 0.588 1.265 0.002 3.066
Q96EV2 23.852 23.838 22.920 20.711 20.091 19.328 23.536 20.043 0.534 0.693 1.395 0.002 3.493
Q70E73 22.787 23.311 23.046 20.452 19.190 18.811 23.048 19.484 0.262 0.859 1.415 0.002 3.564
Q9NUI1 25.437 25.233 25.700 18.992 21.442 18.750 25.456 19.728 0.234 1.489 1.996 0.003 5.728
O15056 23.576 23.858 22.622 18.923 20.889 18.875 23.352 19.563 0.648 1.149 1.372 0.008 3.789
Q6XZF7 23.286 24.386 22.611 20.790 18.377 19.149 23.428 19.439 0.896 1.232 1.385 0.011 3.989
Q12965 27.904 27.168 27.561 21.827 25.967 19.951 27.544 22.581 0.369 3.078 1.309 0.050 4.963
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Supplementary Table E: Proteins identified as showing reduced binding to SNX9-Y56E 
relative to SNX9-Y56F. Prepared by Daniel Yagoub. 
Uniprot Y56F Y56F Y56F Y56E Y56E Y56E
Average 
Y56F
Average 
Y56E
Std Dev 
Y56F
Std Dev 
Y56E
T-test test 
statistic 
Y56F_Y56E
T-test
p-value
Difference 
Y56F_Y56E
O00401 27.496 27.235 27.132 20.110 19.970 19.467 27.288 19.849 0.187 0.338 3.346 0.000 7.438
Q07666 29.197 28.859 29.345 23.517 23.949 23.918 29.134 23.795 0.249 0.241 2.427 0.000 5.339
O43516 24.581 24.264 25.038 19.495 19.796 19.843 24.628 19.711 0.389 0.189 2.186 0.000 4.917
Q8TF74 26.747 25.857 26.227 19.479 18.396 19.590 26.277 19.155 0.447 0.659 2.895 0.000 7.122
Q13443 25.031 25.314 25.267 19.475 19.043 20.657 25.204 19.725 0.152 0.836 2.200 0.000 5.479
P50570 30.619 29.397 30.757 21.323 19.017 21.312 30.258 20.551 0.749 1.328 3.370 0.000 9.707
O75909 25.858 24.515 26.543 19.384 20.261 19.748 25.638 19.798 1.032 0.441 2.206 0.001 5.841
O43426 24.822 24.294 24.429 20.196 21.441 20.016 24.515 20.551 0.275 0.776 1.601 0.001 3.964
P04844 19.554 18.511 19.845 22.761 23.580 22.849 19.303 23.063 0.701 0.449 -1.516 0.001 -3.760
Q9NUI1 27.011 26.229 27.285 18.992 21.442 18.750 26.842 19.728 0.548 1.489 2.439 0.001 7.114
Q01968 24.310 23.962 25.028 20.502 19.269 21.353 24.433 20.375 0.543 1.048 1.514 0.004 4.059
O15056 23.892 23.427 23.043 18.923 20.889 18.875 23.454 19.563 0.425 1.149 1.437 0.005 3.891
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Supplementary Table F: Enriched Uniprot sequence annotation features in wild-
type SNX9-interacting proteins. Prepared by Daniel Yagoub. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Pro
13 20.968 0.000
P25440, O43516, Q8TF74, P23246, 
O60885, Q15233, Q13443, Q15427, 
P48634, Q8N684, O43426, 
Q8NCA5, P61978
62 24 687 6.002 0.000 0.000 0.000
UP SEQ 
FEATURE
compositionally 
biased region:Pro-rich
13 20.968 0.000
Q07666, O43516, P50570, P85037, 
Q9UQ35, A1X283, O15056, 
Q96EV2, Q6XZF7, Q8N684, 
O43426, Q9HAH7, O00401
62 31 687 4.647 0.001 0.000 0.004
UP SEQ 
FEATURE
splice variant 34 54.839 0.001
P25440, P25786, Q07666, O43516, 
P85037, Q8N163, Q9UQ35, 
P23246, P63010, Q13443, O43865, 
O15056, O94973, Q8N684, 
Q9NUI1, P61978, P53680, 
Q9HAH7, Q01105, O75909, 
P50570, Q8TF74, Q70E73, Q01968, 
O60885, Q8WXF1, Q96EV2, 
Q6XZF7, Q14697, P48634, Q8IVH8, 
O43426, O95782, Q96CW1
62 232 687 1.624 0.110 0.038 0.641
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Gln
5 8.065 0.008
Q15233, P48634, O75909, P23246, 
O60885
62 10 687 5.540 0.842 0.369 9.669
UP SEQ 
FEATURE
domain:Protein kinase 4 6.452 0.038 P19784, Q8IVH8, P68400, O14965 62 9 687 4.925 1.000 0.836 39.220
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Arg
4 6.452 0.051 Q15233, P48634, P23246, O60885 62 10 687 4.432 1.000 0.869 48.908
UP SEQ 
FEATURE
compositionally 
biased region:Ser-rich
4 6.452 0.066 P25440, Q6XZF7, Q9UQ35, O60885 62 11 687 4.029 1.000 0.896 58.226
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Ser
4 6.452 0.066 P25440, O43516, O43426, O60885 62 11 687 4.029 1.000 0.896 58.226
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Supplementary Table G: Enriched Uniprot sequence annotation features in 
proteins identified as showing reduced binding to SNX9-Y56E relative to wild-type 
SNX9. Prepared by Daniel Yagoub. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
UP SEQ 
FEATURE
compositionally 
biased region:Pro-rich
10 45.455 0.000
O15056, Q96EV2, Q6XZF7, Q07666, 
O00750, Q8N684, P50570, O43516, 
O43426, O00401
22 31 687 10.073 0.000 0.000 0.000
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Pro
9 40.909 0.000
Q13443, P48634, Q8N684, O43516, 
O43426, Q8TF74, P61978, P23246, 
O60885
22 24 687 11.710 0.000 0.000 0.000
UP SEQ 
FEATURE
splice variant 19 86.364 0.000
Q07666, P50570, O43516, O75909, 
Q8TF74, Q70E73, Q01968, P23246, 
O60885, Q13443, O15056, Q96EV2, 
Q6XZF7, P48634, Q8IVH8, Q8N684, 
O43426, Q9NUI1, P61978
22 232 687 2.557 0.000 0.000 0.001
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Gln
4 18.182 0.003 P48634, O75909, P23246, O60885 22 10 687 12.491 0.287 0.081 2.968
UP SEQ 
FEATURE
domain:RRM 4 18.182 0.029 O15056, Q96EV2, Q8N684, O43426 22 23 687 5.431 0.980 0.543 29.399
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Arg
3 13.636 0.035 P48634, P23246, O60885 22 10 687 9.368 0.990 0.536 33.648
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Ser
3 13.636 0.041 O43516, O43426, O60885 22 11 687 8.517 0.996 0.547 38.979
UP SEQ 
FEATURE
domain:WH2 2 9.091 0.060 O43516, Q8TF74 22 2 687 31.227 1.000 0.638 51.547
UP SEQ 
FEATURE
repeat:3-2 2 9.091 0.060 P48634, P61978 22 2 687 31.227 1.000 0.638 51.547
UP SEQ 
FEATURE
region of 
interest:Binds actin
2 9.091 0.060 O43516, Q8TF74 22 2 687 31.227 1.000 0.638 51.547
UP SEQ 
FEATURE
repeat:3-1 2 9.091 0.060 P48634, P61978 22 2 687 31.227 1.000 0.638 51.547
UP SEQ 
FEATURE
domain:SAC 2 9.091 0.060 O15056, O43426 22 2 687 31.227 1.000 0.638 51.547
UP SEQ 
FEATURE
repeat:3-3 2 9.091 0.060 P48634, P61978 22 2 687 31.227 1.000 0.638 51.547
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Supplementary Table H: Enriched Uniprot sequence annotation features in 
proteins identified as showing reduced binding to SNX9-Y56E relative to SNX9-
Y56F. Prepared by Daniel Yagoub. 
Category Term Count % PValue Proteins
List 
Total
Pop 
Hits
Pop 
Total
Fold 
Enrichment
Bonferroni Benjamini FDR
UP SEQ 
FEATURE
compositionally 
biased region:Pro-rich
6 50.000 0.000
O15056, Q07666, P50570, O43516, 
O43426, O00401
12 31 687 11.081 0.003 0.003 0.051
UP SEQ 
FEATURE
splice variant 10 83.333 0.001
Q13443, O15056, Q07666, O75909, 
P50570, O43516, O43426, Q8TF74, 
Q9NUI1, Q01968
12 232 687 2.468 0.080 0.041 1.393
UP SEQ 
FEATURE
compositionally 
biased region:Poly-Pro
4 33.333 0.005 Q13443, O43516, O43426, Q8TF74 12 24 687 9.542 0.263 0.097 5.028
UP SEQ 
FEATURE
region of 
interest:Binds actin
2 16.667 0.032 O43516, Q8TF74 12 2 687 57.250 0.851 0.379 27.574
UP SEQ 
FEATURE
domain:SAC 2 16.667 0.032 O15056, O43426 12 2 687 57.250 0.851 0.379 27.574
UP SEQ 
FEATURE
domain:WH2 2 16.667 0.032 O43516, Q8TF74 12 2 687 57.250 0.851 0.379 27.574
UP SEQ 
FEATURE
region of 
interest:Catalytic
2 16.667 0.078 O15056, O43426 12 5 687 22.900 0.992 0.615 55.438
